
<html lang="en"     class="pb-page"  data-request-id="4aaa7b14-7bca-43e1-9f3c-434c98065923"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2016.59.issue-1;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.5b00789;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery" /></meta><meta name="dc.Creator" content="Shibing  Tang" /></meta><meta name="dc.Creator" content="Min  Xie" /></meta><meta name="dc.Creator" content="Nan  Cao" /></meta><meta name="dc.Creator" content="Sheng  Ding" /></meta><meta name="dc.Description" content="In vitro cell models are invaluable tools for studying diseases and discovering drugs. Human induced pluripotent stem cells, particularly derived from patients, are an advantageous resource for gen..." /></meta><meta name="Description" content="In vitro cell models are invaluable tools for studying diseases and discovering drugs. Human induced pluripotent stem cells, particularly derived from patients, are an advantageous resource for gen..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 4, 2015" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00789" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00789" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00789" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00789" /></link>
        
    
    

<title>Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00789" /></meta><meta property="og:title" content="Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b00789/20160804/images/large/jm-2015-00789q_0002.jpeg" /></meta><meta property="og:description" content="In vitro cell models are invaluable tools for studying diseases and discovering drugs. Human induced pluripotent stem cells, particularly derived from patients, are an advantageous resource for generating ample supplies of cells to create unique platforms that model disease. This manuscript will review recent developments in modeling a variety of diseases (including their cellular phenotypes) with induced pluripotent stem cells derived from patients. It will also describe how researchers have exploited these models to validate drugs as potential therapeutics for these devastating diseases." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00789"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00789">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00789&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00789&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00789&amp;href=/doi/10.1021/acs.jmedchem.5b00789" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 2-15</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01945" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.5b00825" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shibing++Tang">Shibing Tang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Min++Xie">Min Xie</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nan++Cao">Nan Cao</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sheng++Ding">Sheng Ding</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Gladstone Institutes, 1650 Owens Street, San Francisco, California 94158, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#493a212c272e672d20272e092e25282d3a3d26272c673c2a3a2f672c2d3c"><span class="__cf_email__" data-cfemail="e6958e838881c8828f8881a6818a87829592898883c893859580c8838293">[email protected]</span></a>. Phone: (415) 734-2717. Fax: (415) 355-0141.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00789&amp;href=/doi/10.1021%2Facs.jmedchem.5b00789" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 2–15</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 31, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 May 2015</li><li><span class="item_label"><b>Published</b> online</span>4 September 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 January 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00789" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00789</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DShibing%2BTang%252C%2BMin%2BXie%252C%2BNan%2BCao%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D1%26contentID%3Dacs.jmedchem.5b00789%26title%3DPatient-Specific%2BInduced%2BPluripotent%2BStem%2BCells%2Bfor%2BDisease%2BModeling%2Band%2BPhenotypic%2BDrug%2BDiscovery%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D15%26publicationDate%3DJanuary%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00789"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3435</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">19</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00789" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Shibing&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Min&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Nan&quot;,&quot;last_name&quot;:&quot;Cao&quot;},{&quot;first_name&quot;:&quot;Sheng&quot;,&quot;last_name&quot;:&quot;Ding&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;2-15&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00789&quot;},&quot;abstract&quot;:&quot;In vitro cell models are invaluable tools for studying diseases and discovering drugs. Human induced pluripotent stem cells, particularly derived from patients, are an advantageous resource for generating ample supplies of cells to create unique platforms that model disease. This manuscript will review recent developments in modeling a variety of diseases (including their cellular phenotypes) with induced pluripotent stem cells derived from patients. It will also describe how researchers have exploited these models to validate drugs as potential therapeutics for these devastating diseases.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00789&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00789" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00789&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00789" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00789&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00789" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00789&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00789&amp;href=/doi/10.1021/acs.jmedchem.5b00789" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00789" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00789" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (764 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00789%26sid%3Dliteratum%253Aachs%26pmid%3D26322868%26genre%3Darticle%26aulast%3DTang%26date%3D2016%26atitle%3DPatient-Specific%2BInduced%2BPluripotent%2BStem%2BCells%2Bfor%2BDisease%2BModeling%2Band%2BPhenotypic%2BDrug%2BDiscovery%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D1%26spage%3D2%26epage%3D15%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290982" title="Diseases and disorders">Diseases and disorders</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292316" title="Transition metals">Transition metals</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=291881" title="Differentiation">Differentiation</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/jmcmar.2016.59.issue-1/20160114/jmcmar.2016.59.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b00789/20160804/images/medium/jm-2015-00789q_0002.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b00789/20160804/images/large/jm-2015-00789q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00789&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In vitro cell models are invaluable tools for studying diseases and discovering drugs. Human induced pluripotent stem cells, particularly derived from patients, are an advantageous resource for generating ample supplies of cells to create unique platforms that model disease. This manuscript will review recent developments in modeling a variety of diseases (including their cellular phenotypes) with induced pluripotent stem cells derived from patients. It will also describe how researchers have exploited these models to validate drugs as potential therapeutics for these devastating diseases.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82013" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82013" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i2" class="anchor-spacer"></div><h3 class="article-section__title" id="_i2"> Phenotypic Drug Discovery</h3><div class="NLM_p last">Modern efforts for drug discovery search for therapeutics that cure or alleviate disease. In preclinical settings, drug discovery involves routinely testing chemical entities in disease models and evaluating their pharmacological effects. To find these entities, drug candidates are screened through two fundamentally different approaches: target-based drug discovery (TDD) and phenotypic drug discovery (PDD). TDD measures the interactions between drug candidates and a single, well-defined drug target, usually with biochemical assays. TDD has tremendous merit; however, it can be limited by incomplete knowledge of the molecular mechanisms underlying a disease. Because TDD is intended for only one drug target, it could miss a significant off-target and/or polypharmacological effect of the drug.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> PDD, however, is not limited to a specific drug target. Instead, it relies on phenotypes of organisms, tissues, or living cells (such as their morphology, functions, and/or biomarkers) to model the specific phenotypic parameters of a disorder. Thus, PDD can measure phenotypic readouts to reveal drug candidates that induce changes in pathological hallmarks, such as a switch from a pathological to healthy state, and their pharmacological and biological effects. PDD is an advantageous pathological and physiological approach that has arguably achieved a higher success rate in the launch of novel classes of drugs for treating diseases.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Human Induced Pluripotent Stem Cells</h3><div class="NLM_p">Living cells can reflect an organism’s essential physiological activities and invaluably support modeling diseases and screening for potential drugs in vitro. Human cells are undoubtedly the most relevant platform for these models because they avoid concerns about interspecies differences in physiology, pharmacology, and cellular processes. However, how disease-relevant human cells are applied depends on their accessibility. For example, human lines of cancer cells are readily available and have been widely used in oncology studies and anticancer therapies.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Nonetheless, researchers must consider how difficulties in harvesting and propagating large varieties of disease-relevant human cells can restrict their applications in modeling diseases and discovering drugs.</div><div class="NLM_p">Fortunately, cell-reprogramming technology has substantially expanded the availability of human cells.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> This technology can be used to convert human somatic cells into induced pluripotent stem cells (iPSCs) by forcing expression of a group of transcription factors.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Human iPSCs closely resemble human embryonic stem cells (ESCs) because they can proliferate indefinitely and differentiate into all cell types found in a human body,<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> including neurons,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> cardiomyocytes (CMs),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> hepatocytes (HCs),<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and chondrocytes.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Thus, iPSCs can serve as an unlimited source of human cells for modeling disease.</div><div class="NLM_p">Reprogramming iPSCs from cells taken from patients opens many possibilities in disease modeling and PDD (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). For example, iPSCs retain the genetic characteristics of their donors, which enables genotype-dependent pathophysiology to manifest at the cellular level to recapitulate pathological biomarkers and, thereby, support studies of genetic disorders. In recent years, patient-derived iPSCs have been used to study a number of devastating diseases,<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> which have shed new light on their phenotypic traits and cellular mechanisms. Therefore, human iPSCs have tremendous potential in discovering drugs through phenotypic approaches. In this manuscript, we will review recent developments in applying patient-derived iPSCs to disease modeling and PDD, with a particular focus on neurological disorders and heart disease that greatly burden healthcare and urgently call for effective therapies.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b00789/20160804/images/medium/jm-2015-00789q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b00789/20160804/images/large/jm-2015-00789q_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Process for generating induced pluripotent stem cells derived from patients and using them for disease modeling and phenotypic drug discovery. Induced pluripotent stem cells (iPSCs) can be generated from patient-specific somatic cells and then transformed into desired cell types by directed differentiation. Control cells can be either derived from healthy donors or generated by genetically correcting patient-specific iPSCs through targeted genome editing. These model cells can be used to study and compare phenotypes between control and diseased cells in a dish and to perform screening assays for phenotypic drug discovery. These approaches can enrich our knowledge of diseases and reveal drugs that effectively benefit patients.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b00789/20160804/images/large/jm-2015-00789q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00789&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Neurological Disease</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34158" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34158" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Primary neural cells from humans are accessible only through surgical resection or post-mortem biopsies and, thus, are too scarce to be widely used to study neurological disease. Alternatively, iPSCs are an abundant source of human neural cells. While generating specific types of neural cells from iPSCs can be challenging, methods to generate these cells are improving;<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> iPSCs can now be differentiated into neural cells and used to model neurological disorders.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> Here, we will review recent studies of neurological diseases, focusing on those that use patient-derived iPSCs to model disease and pharmacologically rescue cellular-disease phenotypes. We will also discuss how researchers validated the relevance of the cellular phenotypes seen in the iPSCs to the actual diseases, and we will highlight strategies for robustly inducing these phenotypes to provide readouts for PDD.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Familial Dysautonomia</h3><div class="NLM_p">Familial dysautonomia (FD) is a rare, but fatal, degenerative disease caused by mutations in the <i>IKBKAP</i> gene,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> which primarily affects the neural crest (NC) lineage. Specifically, these mutations cause defects in the splicing of <i>IKBKAP</i> in peripheral neurons, which causes them to die or lose motility. To model FD with human cells, researchers from the Studer Lab generated iPSCs from fibroblasts isolated from FD patients (FD-iPSCs) and differentiated them into NC (FD-NC) precursor cells.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In these cells, the ratio of wild-type to mutant <i>IKBKAP</i> (WT- versus MU-<i>IKBKAP</i>) transcripts was much lower than control cells derived from healthy individuals (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The FD-NC precursors also exhibited reduced neurogenesis and migration, further demonstrating that FD-NC precursors recapitulated the pathogenesis of FD. Interestingly, treating FD-NC precursors with kinentin, a plant cytokinin known to rescue defects in <i>IKBKAP</i> splicing, significantly increased normal splicing and decreased mutant splicing of <i>IKBKAP</i> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Continuously treating these cells with kinentin also improved the neurogenesis of these precursors but not their migratory propensity. Nonetheless, these findings support that FD-associated pathological phenotypes could be partially rescued with a pharmacological treatment.</div><div class="NLM_p last">More recently, this same group successfully applied iPSC-based PDD to a high-throughput system that they developed to screen for compounds that rescue defects in the expression of <i>IKBKAP</i> in the FD-NC model.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Specifically, with quantitative reverse transcription polymerase chain reaction (qRT-PCR), they measured the <i>IKBKAP</i> level in reference to the <i>18S</i> internal control. To achieve high reproducibility, they optimized the experimental parameters against the density of cells in each well. With this system, the authors screened a library of 6912 compounds and identified 43 hits that increased wild-type <i>IKBKAP</i>. Among these hits, seven compounds rescued <i>IKBKAP</i> expression in the FD-NC model and similar cell lines. Most notably, 6-chloro-2,3,4,5-tetrahydro-3-methyl-1<i>H</i>-3-benzazepine (SKF-86466, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and yohimbine, two known antagonists of the α<sub>2</sub>-adrenergic receptor, rescued defects in <i>IKBKAP</i> splicing, supporting that the α<sub>2</sub>-adrenergic receptor affects the expression of <i>IKBKAP</i> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Unfortunately, none of these compounds rescued the migratory defects of FD-NC precursors. Nonetheless, the authors demonstrated the feasibility of screening phenotypes and the value of confirming chemical compounds with an iPSC-derived model of disease with a defined genetic cause but unknown molecular mechanism. With this approach, researchers also evaluated active compounds with known molecular mechanisms to discover potential therapeutic targets for treating FD.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Spinal Muscular Atrophy</h3><div class="NLM_p last">Spinal muscular atropy (SMA) is characterized by progressive muscle weakness caused by mutations in the <i>SMN1</i> gene. This mutation reduces the production of survival of motor neuron (SMN) protein to cause the selective loss of motor neurons (MNs) in the anterior horn of the spinal cord.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Ebert et al. successfully modeled SMA with patient-derived iPSCs (SMA-iPSCs) deficient in SMN protein.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> They confirmed that while both control and SMA-iPSCs could generate MNs, the number of MNs in the SMA-iPSC culture significantly decreased over time, mimicking the death of MNs and the neurodegeneration process in vitro (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). By immunostaining, they found that the nuclear gems that contain SMN proteins were present in control iPSCs but not in SMA-iPSCs. Furthermore, they found that valproic acid (VPA), a histone deacetylase inhibitor, and tobramycin, an aminoglycoside antibiotic, enhanced the production of SMN in SMA-iPSCs (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). These findings support that patient-derived iPSCs can recapitulate the pathology and phenotypes of SMA.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Rett Syndrome</h3><div class="NLM_p last">Rett syndrome (RTT), a progressive neurodevelopmental disorder, is caused by mutations in the <i>MECP2</i> gene that lead to a loss of function methyl-CpG-binding protein 2 (MeCP2).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In a mouse model of RTT, Chao et al. found that altering MeCP2 affects the formation of glutamatergic synapses.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Marchetto et al. then confirmed the role of MeCP2 in the pathology of RTT with neurons generated from iPSCs derived from RTT patients (RTT-neurons).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Marchetto et al. observed decreased densities of synaptic puncta in RTT-neurons, which reflected a decrease in the number of glutamatergic synapses compared to control neurons (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). They also found that knocking down MeCP2 in neurons from wild-type human iPSCs reduced the number of glutamatergic synapses, mimicking the consequences of the loss of function of MeCP2. Gentamicin, an aminoglycoside antibiotic, was found to increase the number of glutamatergic synapses in RTT-neurons (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). These results support that RTT-neurons represent a valuable model for studying RTT.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Machado–Joseph Disease</h3><div class="NLM_p last">Machado–Joseph disease (MJD) is a rare, hereditary cerebral ataxia caused by the expansion of polyglutamine (polyQ)-encoding CAG repeats in the <i>MJD1</i>gene, which produces polyQ-expanded ataxin-3 protein. Aberrant proteolysis of this protein generates aggregates that initiate MJD. In iPSC-derived neurons from MJD patients (MJD-neurons), Koch et al. stimulated the excitatory transmitter <span class="smallcaps smallerCapital">l</span>-glutamate and observed an increased cleavage of polyQ-expanded ataxin-3 and a dose-dependent aggregation of its fragments (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> These aggregates were reduced by inhibiting caspases (with Ac-YVAD-CHO, Z-DEVD-FMK, or Z-VAD-FMK) and calpain (with ALLN or calpeptin). Depleting calcium (Ca<sup>2+</sup>) (with EDTA) and blocking Ca<sup>2+</sup> influx (with D-APV, NBQX, or tetrodotoxin) also reduced the ataxin-3 aggregates (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). In this study, the authors confirmed the known pathogenesis of the MJD. Further investigations into the molecular pathways that influence the pathological cleavage and aggregation of the mutant ataxin-3 may bring about new therapeutic strategies to treat MJD. The authors also established an iPSC-based model of MJD dependent on the mutant ataxin-3, which will be useful to explore new entities to treat this disease.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Schizophrenia</h3><div class="NLM_p last">Schizophrenia (SCZD) is a psychocognitive disorder that affects 1% of the population.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> SCZD patients are currently treated with antipsychotic drugs that target dopamine receptor D2, but they still suffer from inadequate efficacies and side effects.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Thus, we need more effective treatments for this disease. The pathology of SCZD is largely affected by disrupted neural connectivity.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> By developing an in vitro cellular model that recapitulates this disrupted connectivity, researchers can further study the molecular mechanisms that underlie this disease and explore new medications to treat it with PDD. Brennand et al. have already reported a successful in vitro model of SCZD that uses iPSCs.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Here, they traced the monosynaptic connections among neurons generated from SCZD iPSCs (SCZD-neurons) with a rabies virus and found that these neurons displayed decreased neuronal connectivity, which they rescued with loxapine, an antipsychotic drug (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). This study illustrated that neurons derived from patient-specific iPSCs can recapitulate, at the cellular level, a typical disease phenotype of SCZD, which has strong and convoluted genetic risk factors.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> This study also demonstrated the alteration of the disease phenotype by an established antipsychotic drug. Although neural cells alone are unlikely to perfectly model a complicated psychocognitive disease or fully reveal the side effects of antipsychotics, a cellular model will nonetheless be useful for the early stage of discovery of novel, antipsychotic drugs.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Amyotrophic Lateral Sclerosis</h3><div class="NLM_p">Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the loss of MNs.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> A number of genetic factors have been linked to ALS. For example, a subset of ALS patients carries mutations in the <i>TARDBP</i> gene, which generally leads to aggregation of TAR DNA-binding protein-43 (TDP-43).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> To recapitulate TDP-43-associated proteinopathies in vitro, Egawa et al. generated iPSC lines from ALS patients (ALS-iPSC) with mutations in <i>TARDBP</i>.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> From these lines, they derived neural populations containing MNs (ALS-MNs), which contained higher levels of detergent-insoluble TDP-43 aggregates (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). They also found that these cells expressed lower levels of medium polypeptide neurofilament (NEFM), similar to that observed in the spinal motor neurons from ALS patients.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The authors further challenged these cells with arsenite, which is widely used to model oxidative stress associated with ALS, and then screened the cells for compounds that protect them from the oxidative stress. They found that anacardic acid improved survival, reduced insoluble TDP-43, and increased NEFM expression in ALS-MNs (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). These findings suggest that an MN survival assay could be used to evaluate therapeutics for ALS. Similarly, Yang et al. established another survival assay in which MNs were subjected to stress induced by removing tropic factors from the culture medium (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> They found that kenpaullone, a glycogen synthase kinase (GSK)-3β inhibitor, promoted the survival of both ALS-MNs and their control counterparts (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_p">Interestingly, in the absence of additional stressors, Burkhart et al. established a screening assay based on readouts of TDP-43 aggregation in patient-derived MNs.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> They reprogrammed fibroblasts from three sporadic-ALS patients with unknown genetic etiology, one of whom was confirmed with TDP-43 pathology by autopsy. In contrast to control MNs, ALS-MNs stained positive for TDP-43 aggregates (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Burkhart et al. then set up an automated, imaged-based system to screen compounds for their effects on TDP-43 aggregates in ALS-MNs. Out of 1757 compounds, 38 reduced the percentage of cells positive for TDP-43 aggregates. This study demonstrated that even when the genetic cause and molecular basis of a disease are unknown, researchers can still rely on a phenotypic approach to search for therapeutics. Furthermore, it supports that a high-throughput system that screens for phenotypic drugs can be built upon a platform provided by patient-derived iPSCs.</div><div class="NLM_p last">Glutamate-induced excitotoxicity has been implicated to damage the MNs in ALS patients.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Improperly stimulated, hyperexcited MNs fire excessively and die.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Wainger et al. successfully recapitulated the hyperexcitability of ALS-MNs in vitro (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> They derived MNs from ALS patients with three separate genetic etiologies and employed multielectrode arrays (MEAs) to monitor the firing of MNs and the currents generated by MNs. MEAs recorded higher spontaneous firing rates of all three classes of ALS-MNs than MNs derived from control donors. The hyperexcitability of ALS-MNs was rigorously confirmed in whole-cell patch-clamp assays, which recorded greater number of action potentials generated by ALS-MNs (with <i>SOD1</i> mutations) than control MNs during ramp depolarization. With the whole-cell patch-clamp technique, Wainger et al. recorded decreased amplitude of the outward delayed-rectifier potassium current generated by the ALS-MNs with <i>SOD1</i> (A4V/+) mutation compared to the genetically corrected controls. Retigabine (an anticonvulsant) and flupirtine (an analgesic), both known to open the voltage-gated potassium channel Kv7, were found to prevent ALS-MNs from exhibiting hyperexcitability (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Retigabine also partially rescued the death of ALS-MNs with <i>SOD1</i> mutations. This study not only uncovered that potassium channel openers can protect MNs from excitotoxicity in familial ALS, it also demonstrated that electrophysiological behaviors of neurons can be useful phenotypes for PDD.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Parkinson’s Disease</h3><div class="NLM_p">Parkinson’s disease (PD) is characterized by motor symptoms and dementia and is the second-most common neurodegenerative disorder.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Although drugs that effectively control Parkinsonian symptoms already exist, their side effects still warrant new and more effective therapeutics.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> PD involves a major loss of dopaminergic (DA) neurons and damage to non-DA neurons.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Mitochondrial dysfunction<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and oxidative stress<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> have also been implicated as major contributors to PD pathogenesis. While most cases of PD are sporadic, a number of genetic factors have been linked to familial PD (fPD).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><div class="NLM_p">To study PD, Copper et al. generated iPSC-derived neural cells from patient donors harboring mutations in <i>PINK</i> or <i>LRRK2</i>, which have been associated with fPD. These cells displayed changes in mitochondrial function and were more vulnerable to mitochondrial toxins, such as valinomycin and concanamycin A (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Coenzyme Q10 (CoQ10), rapamycin, and 3-(3,5-dibromo-4-hydroxybenzylidene)-5-iodo-1,3-dihydroindol-2-one (GW5074, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>)<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> protected against the effects of mitochondrial toxins on these neural cells; however, the exact cellular responses varied depending on the mutations, toxins, and rescue agents (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Nonetheless, this study supports that therapeutics that rescue dysfunctional mitochondrial phenotypes may benefit patients suffering from PD.</div><div class="NLM_p">Another group applied targeted gene editing and cell reprogramming to establish a number of cellular phenotypes of PD caused by the <i>LRRK2</i> (G2019S) mutation.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Here, Reinhardt et al. generated iPSC lines carrying the <i>LRRK2</i> (G2019S) mutation and differentiated them into midbrain DA neurons. They then corrected the mutation in these lines to create the corresponding isogenic controls. They also generated a wild-type iPSC line and an isogenic, gene-edited line with targeted insertion of mutant <i>LRRK2</i>. In the midbrain DA (mDA) neurons differentiated from these iPSC lines, the authors clearly identified a number of PD-associated biomarkers induced by the <i>LRRK2</i> (G2019S) mutation (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). They also confirmed that mutant <i>LRRK2</i> produced PD-associated cellular phenotypes that were previously reported, such as shortened neurites, defective autophagy, increased sensitivities to neurotoxins, and elevated oxidative stress. They also observed increased levels of pathological markers of PD, such as tau protein, phosphorylated tau (p-tau), and α-synuclein (α-Syn), in mDA neurons expressing mutant <i>LRRK2</i>. They then profiled the gene expression in these neurons and found that mutant <i>LRRK2</i> upregulated novel genes. To confirm the contributions of these genes, the authors knocked them down while inducing oxidative stress to the mDA neurons by withdrawing the B27 supplement and/or exposing the cells to the Parkinsonian neurotoxin rotenone. They found that knocking down these genes improved the survival of mutant mDA neurons under stresses, implicating that these genes could be new therapeutic targets for <i>LRRK2</i>-associated neurodegeneration. The authors further showed that pharmacologically inhibiting the phosphorylation of extracellular signal-regulated kinase (ERK) and/or the LRRK kinase ameliorated the DA neurons’ increased vulnerabilities to oxidative stress and neurotoxins (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). This study highlights that by combining targeted gene editing and cell reprogramming, researchers can more easily establish reliable disease phenotypes, elucidate the genetic and/or molecular contributors to a disease, and ultimately, search for novel therapeutic strategies and agents.</div><div class="NLM_p">α-Syn is a strong contributor to PD, which is largely influenced by nitrosative stress.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a> Chung et al. confirmed that nitrosative stress correlates with α-Syn toxicity in both yeast and rat models involving cortical neurons.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> On the basis of these findings, they developed an iPSC-based assay to screen for compounds that rescue α-Syn toxicity. They obtained neurons differentiated from iPSCs derived from PD patients (PD-neurons) harboring <i>SNCA</i><sup>A53T</sup> and from isogenic, mutant-corrected iPSCs. Using a copper complex as a fluorescent-based sensor, they confirmed that the intraneuronal nitric oxide (NO) level was higher in PD-neurons compared to isogenic controls, indicating that mutant <i>SNCA</i> induces α-Syn toxicity (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). They also showed that <i>N</i>-(2-chlorobenzyl)-1-(2,5-dimethylphenyl)-1<i>H</i>-benzo[<i>d</i>]imidazole-5-carboxamide (NAB2),<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> a small molecule found to rescue yeast from α-Syn toxicity, reduced the NO level in PD-neurons (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). This study is an inspiring example of creating robust and disease-relevant cellular phenotypes suitable for screening drugs.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Compound Screening in Neurological Diseases with Patient iPSC-Based Cell Models</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">disease</th><th class="colsep0 rowsep0" align="center">genetic etiology</th><th class="colsep0 rowsep0" align="center">disease-relevant cells</th><th class="colsep0 rowsep0" align="center">disease-relevant phenotype(s)</th><th class="colsep0 rowsep0" align="center">rescue agent(s)</th><th class="colsep0 rowsep0" align="center">refs</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FD</td><td class="colsep0 rowsep0" align="left"><i>IKBKAP</i> mutations</td><td class="colsep0 rowsep0" align="left">NC precursors</td><td class="colsep0 rowsep0" align="left">Decreased expression of WT <i>IKBKAP</i> compared to MU <i>IKBKAP</i>; reduced neurogenesis</td><td class="colsep0 rowsep0" align="left">Kinentin; SKF-86466; yohimbine</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">17, 18</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SMA</td><td class="colsep0 rowsep0" align="left"><i>SMN1</i> mutations</td><td class="colsep0 rowsep0" align="left">iPSCs</td><td class="colsep0 rowsep0" align="left">Reduced SMN protein</td><td class="colsep0 rowsep0" align="left">VPA; tobramycin</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">20</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RTT</td><td class="colsep0 rowsep0" align="left"><i>MECP2</i> mutations</td><td class="colsep0 rowsep0" align="left">Neurons</td><td class="colsep0 rowsep0" align="left">Reduced number of glutamatergic synapses</td><td class="colsep0 rowsep0" align="left">Gentamicin</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">23</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MJD</td><td class="colsep0 rowsep0" align="left">Expanded CAG repeats in <i>MJD1</i></td><td class="colsep0 rowsep0" align="left">Neurons</td><td class="colsep0 rowsep0" align="left">Fragmentation and aggregation of ataxin-3</td><td class="colsep0 rowsep0" align="left">Caspase inhibitors; calpine inhibitors; EDTA; D-APV; NBQX; tetrodotoxin</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">24</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SCZD</td><td class="colsep0 rowsep0" align="left">Undetermined</td><td class="colsep0 rowsep0" align="left">Neurons</td><td class="colsep0 rowsep0" align="left">Reduced neuronal connectivity</td><td class="colsep0 rowsep0" align="left">Loxapine</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">28</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ALS</td><td class="colsep0 rowsep0" align="left"><i>TARDBP</i> mutations</td><td class="colsep0 rowsep0" align="left">MNs</td><td class="colsep0 rowsep0" align="left">Increased cell death</td><td class="colsep0 rowsep0" align="left">Anacardic acid</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">32</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>SOD1</i> (L144F); <i>TARDBP</i> (M337V)</td><td class="colsep0 rowsep0" align="left">MNs</td><td class="colsep0 rowsep0" align="left">Increased cell death</td><td class="colsep0 rowsep0" align="left">Kenpaullone</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">34</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Undetermined</td><td class="colsep0 rowsep0" align="left">MNs</td><td class="colsep0 rowsep0" align="left">Intracellular TDP-43 aggregation</td><td class="colsep0 rowsep0" align="left">Digoxin; lanatoside C; proscillaridin A, etc.</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">35</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>SOD1</i> mutations; <i>C9orf72</i> mutations; <i>FUS</i> mutations</td><td class="colsep0 rowsep0" align="left">MNs</td><td class="colsep0 rowsep0" align="left">Hyperexcitability; increased cell death</td><td class="colsep0 rowsep0" align="left">Retigabine; flupirtine</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">38</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PD</td><td class="colsep0 rowsep0" align="left"><i>PINK</i> (Q456X); <i>LRRK2</i> (G2019S); <i>LRRK2</i> (R1441C)</td><td class="colsep0 rowsep0" align="left">Neural cells</td><td class="colsep0 rowsep0" align="left">Increased cell death</td><td class="colsep0 rowsep0" align="left">CoQ10; GW5074; rapamycin</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">45</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>LRRK2</i> (G2019S)</td><td class="colsep0 rowsep0" align="left">mDA neurons</td><td class="colsep0 rowsep0" align="left">Increased apoptosis; increased phosporylated ERK1/2</td><td class="colsep0 rowsep0" align="left">LRRK2-IN-1; PD0325901</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">46</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>SNCA</i> (A53T)</td><td class="colsep0 rowsep0" align="left">Neurons</td><td class="colsep0 rowsep0" align="left">Increased NO production</td><td class="colsep0 rowsep0" align="left">NAB2</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">49</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">fAD</td><td class="colsep0 rowsep0" align="left"><i>PSEN1</i> (A246E); <i>PSEN2</i> (N141I)</td><td class="colsep0 rowsep0" align="left">Neurons</td><td class="colsep0 rowsep0" align="left">Increased Aβ42/Aβ40 ratio</td><td class="colsep0 rowsep0" align="left">Compound E</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">56</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>APP</i> (Dp)</td><td class="colsep0 rowsep0" align="left">Neurons</td><td class="colsep0 rowsep0" align="left">Increased p-tau/t-tau; activated GSK-3β</td><td class="colsep0 rowsep0" align="left">β-Secretase inhibitor II; OM99-2</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">58</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>APP</i> (E693)</td><td class="colsep0 rowsep0" align="left">Neurons</td><td class="colsep0 rowsep0" align="left">Elevated Aβ oligomers, BIP, PRDX4, ROS; cleaved caspase-4</td><td class="colsep0 rowsep0" align="left">β-Secretase inhibitor IV; DHA</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">59</a></td></tr></tbody></table></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Alzheimer’s Disease</h3><div class="NLM_p">Alzheimer’s disease (AD) is characterized by progressive dementia and cognitive deficits and is the most prevalent neurodegenerative disorder. Yet, there is still no effective treatment for this devastating disease,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> and its multifactorial pathogenesis has yet to be fully elucidated.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Familial AD (fAD) is caused by mutations in <i>PSEN1</i>, <i>PSEN2</i>, and <i>APP</i>,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> while sporadic AD (sAD) (the more common form) has been linked to a prominent genetic risk factor, <i>APOE</i>, although patients with sAD are genetically heterogeneous. Unfortunately, modeling sAD in vitro is also confounded by the complex genetic and environmental factors that contribute to the disease. Despite these challenges, researchers have identified and validated a number of molecular hallmarks of AD pathology, paving the way for modeling phenotypes of AD and discovering drugs that combat the disease.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Below, we will describe several studies that have illustrated the possibility of using neurons generated from patient-derived iPSCs to recapitulate and pharmacologically alter the pathological features of AD.</div><div class="NLM_p">In fAD, mutations in <i>PSEN1</i> and <i>PSEN2</i> lead to increased production of β-amyloid (Aβ) peptides.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> These peptides are secreted from neurons and aggregate to form pathological fibrils and plaques in the brain, a known pathogenetic mechanism of AD. The 42-amino-acid Aβ peptide (Aβ42) is more prone to aggregate and, therefore, more toxic than the most abundant 40-amino-acid form (Aβ40). The ratio of Aβ42 to Aβ40 has been used as a biomarker for AD. For example, Tagi et al. observed that Aβ42/Aβ40 ratios increased in the medium of iPSC-derived neurons from the fAD patients (fAD-neurons) (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>)<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> and were dose-dependently reduced by the γ-secretase inhibitors Compound E and Compound W (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_p">Another prominent pathological feature of AD involves neurofibrillary tangles composed of p-tau.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Indeed, an important biomarker for AD is an increased ratio of p-tau to total tau (t-tau). In a cellular model of AD, Israel et al. recapitulated elevated p-tau in neurons differentiated from iPSCs derived from patients carrying a duplication of the <i>APP</i> gene, aka <i>APP</i> (Dp).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Compared to control neurons derived from healthy donors, the fAD-neurons secreted more Aβ, maintained a higher p-tau/t-tau ratio (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) and expressed more activated GSK-3β, a kinase that phosphorylates tau. The authors also found that while both β-secretase inhibitors (β-secretase inhibitor II, OM99-2) and γ-secretase inhibitors (Compound E, DAPT) suppressed Aβ secretion in fAD-neurons, only β-secretase inhibitors reduced the p-tau/t-tau ratio and the level of activated GSK-3β (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). In this same study, Israel et al. also generated iPSC-derived neurons from two sAD patients (sAD-neurons). Interestingly, sAD-neurons from only one patient exhibited increased Aβ, p-tau/t-tau and activated GSK-3β, implicating disease heterogeneity between these patients.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b00789/20160804/images/medium/jm-2015-00789q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b00789/20160804/images/large/jm-2015-00789q_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b00789/20160804/images/large/jm-2015-00789q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00789&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Kondo et al. reported a study in which they modeled a rare case of fAD with an <i>APP</i> (E693) mutation.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> AD patients with this particular mutation exhibit early-onset symptoms without Aβ deposits; however, the <i>APP</i> (E693) mutation gave rise to a special form of Aβ that is prone to oligomerize. In their study, Kondo et al. established relevant disease biomarkers and demonstrated the possibility of alleviating these phenotypes in neurons. Here, the authors generated fAD-neurons from patients with <i>APP</i> (E693) and confirmed their elevated levels of intracellular Aβ oligomers with specific antibodies (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). In these fAD-neurons, they found elevated levels of four biomarkers associated with endoplasmic reticulum (ER) stress, including binding immunoglobulin protein (BIP), peroxiredoxin-4 (PRDX4), reactive oxygen species (ROS), and cleaved caspase-4. These findings implicate that Aβ oligomers contribute to fAD pathology. When the fAD-neurons were treated with β-secretase inhibitor IV, these biomarkers decreased as Aβ oligomers gradually disappeared (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Interestingly, docosahexaenoic acid (DHA) reduced the biomarkers of ER stress without changing the amount of Aβ oligomers (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_p last">The studies on fAD discussed above clearly demonstrate that patient-derived iPSCs are excellent platforms for the modeling of this disease with well-defined genetic causes. Established pathological hallmarks of AD can serve as valuable phenotypic readouts in cellular models.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Cardiac Disease</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73363" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73363" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Primary human CMs are difficult to obtain in adequate quantities and maintain in vitro for a long period. Fortunately, with advanced iPSC technology and differentiation methods, human CMs can now be obtained in large quantities from iPSC (iPSC-CMs).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Human CMs display unique electrophysiological characteristics, such as beating and ion-channel activities, which can be conveniently evaluated by well-developed techniques, including multielectrode arrays and patch-clamp recordings. On the basis of their availability and the technical convenience to monitor their behaviors, iPSC-CMs have served as useful surrogates to model heart disease in vitro and discover potential drugs to treat it.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div><div class="NLM_p">Since an early study of LEOPARD syndrome in 2010,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> many researchers have focused on modeling heart disease in vitro with patient-derived iPSC-CMs.<a onclick="showRef(event, 'ref61 ref63'); return false;" href="javascript:void(0);" class="ref ref61 ref63">(61, 63)</a> Additionally, researchers have used iPSC-CMs to screen cardiotoxicities related to pharmaceuticals in drug development.<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64, 65)</a> For the purpose of this article, we will focus on the significant progress made in modeling cardiac disorders with patient-specific iPSC-CMs. We will also highlight examples that replicate and pharmacologically alleviate the phenotypes of these disorders at a cellular level.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Long QT Syndrome</h3><div class="NLM_p">Heart function largely depends on its electrical activity, which can be measured by electrocardiogram. When the heart’s electrical cycle is evaluated with this approach, the QT interval is the time between the start of the Q wave and the end of the T wave, which represents the time needed for electrical depolarization and repolarization of the ventricles. An abnormally prolonged QT interval indicates an increased risk of arrhythmia that may cause sudden cardiac death. Inherited long QT syndrome (LQTS) is a genetically heterogeneous disorder mainly caused by mutations in genes that encode critical subunits of the cardiac ion channels that orchestrate cardiac action potentials.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> In patients with inherited LQTS, dysfunction of these ion channels prolongs action potential duration (APD) in CMs, which underlies the abnormal electrical activities in LQTS hearts.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><div class="NLM_p">LQTS type 1 and type 2 (LQT1 and LQT2) are characterized by a prolonged ventricular repolarization and a propensity to arrhythmias. They are caused by mutations in <i>KCNQ1</i> and <i>KCNH2</i>, respectively, both of which encode for cardiac potassium (K<sup>+</sup>) channels.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> The iPSC-CMs derived from LQT1 and LQT2 patients showed longer APD, reduced the delayed rectifier K<sup>+</sup> current (<i>I</i><sub>Kr</sub> (rapid) or <i>I</i><sub>Ks</sub> (slow)), and developed arrhythmias after β-adrenergic stimulation (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).<a onclick="showRef(event, 'ref68 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref68 ref69 ref70">(68-70)</a> These abnormal effects were reversed after treating cells with either a β-blocker (propranolol), an ATP-sensitive K<sup>+</sup>-channel (K<sub>ATP</sub>) opener (pinacidil), or an experimental K<sup>+</sup>-channel opener (2-[[4-[2-(3,4-dichlorophenyl)ethyl]phenyl]amino]benzoic acid (PD118057), <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>)<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><div class="NLM_p">LQTS type 3 (LQT3) is caused by gain-of-function mutations in <i>SCN5A</i>, which encodes the cardiac sodium (Na<sup>+</sup>) channel.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> iPSC-CMs from patients carrying a hereditary missense mutation in <i>SCN5A</i> replicated the disease phenotypes, including prolonged APD and aberrant behaviors of Na<sup>+</sup>-channel gating (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71, 72)</a> These abnormal functions can be ameliorated by mexiletine, a Na<sup>+</sup>-channel blocker and antiarrhythmic drug (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><div class="NLM_p">LQTS type 8 (LQT8), or Timothy syndrome, is induced by a missense mutation in the gene <i>CACNA1C</i>, which encodes the L-type Ca<sup>2+</sup> channel Ca<sub>V</sub>1.2 in humans.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> LQT8 is a rare congenital disorder that often causes death in early childhood. Yazawa et al. modeled this disease with iPSC-CMs generated from patients with Timothy syndrome and then recapitulated the disease phenotypes in vitro.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Indeed, they observed prolonged APD, excess Ca<sup>2+</sup> influx, irregular contraction, and impaired Ca<sup>2+</sup>-channel gating in these iPSC-CMs (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). They also rescued these phenotypes with roscovitine, a cyclin-dependent kinase (CDK) inhibitor that enhances Ca<sub>V</sub>1.2 signaling (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><div class="NLM_p">Overall, LQTS is the most studied cardiac disease using patient-derived iPSC-CMs. Although iPSC-CMs in the dish are more similar to fetal CMs rather than adult CMs, these studies have demonstrated that iPSC-CMs can model LQTS and predict a drug’s response in vitro. iPSC-CMs therefore represent a distinctive platform to understand the mechanisms and discover drugs to treat LQTS.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Modeling Cardiac Diseases and Screening Compounds with iPSC-Derived Cardiomyocytes from Diseased Patients</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">disease</th><th class="colsep0 rowsep0" align="center">genetic etiology</th><th class="colsep0 rowsep0" align="center">disease-relevant phenotypes</th><th class="colsep0 rowsep0" align="center">rescue agent(s)</th><th class="colsep0 rowsep0" align="center">refs</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LQT1</td><td class="colsep0 rowsep0" align="left"><i>KCNQ1</i> (R190Q)</td><td class="colsep0 rowsep0" align="left">Prolonged APD; reduced I<sub>Ks</sub> current; increased susceptibility with β-adrenergic stimulation</td><td class="colsep0 rowsep0" align="left">Propranolol</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">68</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LQT2</td><td class="colsep0 rowsep0" align="left"><i>KCNH2</i> (G1681A)</td><td class="colsep0 rowsep0" align="left">Prolonged APD; increased susceptibility to arrhythmogenic chemicals</td><td class="colsep0 rowsep0" align="left">Propranolol; nadolol; nicorandil; PD118057</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">69</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>KCNH2</i> (A614V)</td><td class="colsep0 rowsep0" align="left">Prolonged APD; reduced I<sub>Kr</sub> current; arrhythmias</td><td class="colsep0 rowsep0" align="left">Nifedipine; pinacidil; ranolazine</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">70</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LQT3</td><td class="colsep0 rowsep0" align="left"><i>SCN5A</i> (F1473C)</td><td class="colsep0 rowsep0" align="left">Prolonged APD; aberrant Na<sup>+</sup> channel gating</td><td class="colsep0 rowsep0" align="left">Mexiletine</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">71</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>SCN5A</i> (V1763M)</td><td class="colsep0 rowsep0" align="left">Prolonged APD; irregular behaviors of Na<sup>+</sup> channel gating</td><td class="colsep0 rowsep0" align="left">Mexiletine</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">72</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LQT8 (Timothy syndrome)</td><td class="colsep0 rowsep0" align="left"><i>CACNA1C</i> (G406R)</td><td class="colsep0 rowsep0" align="left">Prolonged APD; irregular behaviors of Ca<sup>2+</sup>-channel gating</td><td class="colsep0 rowsep0" align="left">Roscovitine</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">74</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CPVT1</td><td class="colsep0 rowsep0" align="left"><i>RYR2</i> (S406L); <i>RYR2</i> (M4109R)</td><td class="colsep0 rowsep0" align="left">Irregular Ca<sup>2+</sup> signaling; increased susceptibility to DADs and arrhythmia</td><td class="colsep0 rowsep0" align="left">Dantrolene; flecainide; thapsigargin; propranolol</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref75 ref76">75, 76</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DCM</td><td class="colsep0 rowsep0" align="left"><i>TNNT2</i> (R173W)</td><td class="colsep0 rowsep0" align="left">Decreased contractility; aberrant Ca<sup>2+</sup> signaling; abnormal distribution of sarcomeric α-actinin</td><td class="colsep0 rowsep0" align="left">Metoprolol</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">78</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HCM</td><td class="colsep0 rowsep0" align="left"><i>MYH7</i> (R663H)</td><td class="colsep0 rowsep0" align="left">Enlarged cell; contractile arrhythmia; aberrant Ca<sup>2+</sup> homeostasis</td><td class="colsep0 rowsep0" align="left">Propranolol; verapamil; nifedipin; diltiazem; lidocaine; mexiletine; ranolazine</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">81</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Barth syndrome</td><td class="colsep0 rowsep0" align="left"><i>TAZ</i> (517delG); <i>TAZ</i> (T328C)</td><td class="colsep0 rowsep0" align="left">Mitochondrial dysfunction; abnormal organization of sarcomeres; impaired contractile function</td><td class="colsep0 rowsep0" align="left">Linoleic acid; mitoTEMPO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">84</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Diabetic cardiomyopathy</td><td class="colsep0 rowsep0" align="left">Undetermined</td><td class="colsep0 rowsep0" align="left">Cellular hypertrophy; sarcomeric disarray; altered Ca<sup>2+</sup> transient; increased arrhythmia and oxidative stress</td><td class="colsep0 rowsep0" align="left">28 compounds, including fluspirilene and thapsigargin</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">85</a></td></tr></tbody></table></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Catecholaminergic Polymorphic Ventricular Tachycardia</h3><div class="NLM_p last">Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) can cause ventricular arrhythmias and sudden cardiac death in young people.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> CPVT1 is a familial disorder caused by mutations in the gene <i>RYR2</i> that encodes the cardiac ryanodine–receptor channel that handles the storage of Ca<sup>2+</sup> in the sarcoplasmic reticulum (SR). The mutation in the <i>RYR2</i> gene causes an irregular concentration of diastolic Ca<sup>2+</sup> in CMs. Two research groups generated iPSC-CMs from CPVT1 patients and then challenged them with the adrenergic agonist isoproterenol to successfully recapitulate CPTV1 phenotypes in vitro,<a onclick="showRef(event, 'ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref75 ref76">(75, 76)</a> such as elevated concentrations of diastolic Ca<sup>2+</sup>, an increased propensity to delayed afterdepolarizations (DADs), and arrhythmia (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). These phenotypes were abolished by compounds such as dantrolene and flecainide and completely rescued by thapsigargin, a potent intracellular Ca<sup>2+</sup> releaser (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Thus, cardiomyocytes derived from iPSCs isolated from CPVT1 patients could provide an approach for researchers to discover effective therapeutics for this disease.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Dilated Cardiomyopathy</h3><div class="NLM_p last">Cardiomyopathies are disorders linked to impaired structure and function of heart muscle that result in heart failure or sudden cardiac death.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> The most common form of cardiomyopathy is dilated cardiomyopathy (DCM), which is characterized by left ventricular dilatation and global systolic dysfunction. In a family with inherited DCM, researchers discovered a point mutation in the gene <i>TNNT2</i> that encodes the sarcomeric protein cardiac troponin T.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> They then derived iPSC-CMs from patients of this family, which exhibited reduced contractility, abnormal sarcomeric organization, aberrant Ca<sup>2+</sup> flux, and increased susceptibility to stress compared to control iPSC-CMs derived from healthy individuals (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Interestingly, these phenotypes were ameliorated by the clinical drug metoprolol, a β-adrenergic blocker (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). This study indicates that iPSC-CMs could be used as a valuable platform for investigating DCM and for screening phenotypes while developing new drugs.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Hypertrophic Cardiomyopathy</h3><div class="NLM_p last">Hypertrophic cardiomyopathy (HCM) is another type of hereditary cardiomyopathy that is estimated to be the most prevalent congenital heart dysfunction worldwide.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> HCM is caused by mutations in genes that encode proteins in the cardiac sarcomere.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> These mutations lead to hypertrophic CMs with disorganized sarcomere structure and abnormal electrophysiological properties, ultimately leading to thickening of the myocardium of the left ventricle. Recently, Lan et al. generated iPSC-CMs from HCM patients and studied the molecular mechanisms underlying the disease.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Here, they generated iPSC-CMs from a 10-member family carrying a missense mutation (R663H) in the gene <i>MYH7</i>. These iPSC-CMs replicated many phenotypes of the disease, including enlarged cell bodies, contractile arrhythmias, and aberrant Ca<sup>2+</sup>-handling activities (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). CMs derived from human ESCs overexpressing the mutant <i>MYH7</i> exhibited similar abnormal Ca<sup>2+</sup> transients and arrhythmias, confirming the significance of this particular mutation to HCM. Importantly, with a pharmaceutical screen for clinical drugs, researchers found that either β-adrenergic blockers (e.g., propranolol) or Ca<sup>2+</sup>-channel blockers (e.g., verapamil) can abolish cellular abnormalities in patient-derived iPSC-CMs, validating that Ca<sup>2+</sup> homeostasis affects the development of HCM at the cellular level (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). These findings support that iPSC-CMs can be effectively used to elucidate the pathophysiology of cardiomyopathy and screen for drug candidates that target this disease.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Barth Syndrome</h3><div class="NLM_p last">Barth syndrome (BTHS) is a multisystem mitochondrial myopathy mainly characterized by cardiac and skeletal dysfunctions.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> BTHS is caused by mutations in the gene <i>TAZ,</i> which encodes tafazzin, an acyltransferase responsible for the normal structure of cardiolipin, a key phospholipid protein in the inner membrane of mitochondria.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> When <i>TAZ</i> is mutated, an immature form of cardiolipin, called monolysocardiolipin, accumulates and causes structural and functional abnormalities of mitochondria. Recently, Wang et al. modeled BTHS disease with patient-derived iPSC-CMs.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Consistent with the clinical manifestation of the disease, patient iPSC-CMs showed metabolic abnormalities caused by impaired mitochondrial function, contractile deficits, and elevated ROS in mitochondria despite normal ATP levels in the whole cell (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Importantly, the authors validated that the single mutation causes these disease phenotypes in CMs by combining state-of-the-art techniques in three independent approaches. They found that knocking down <i>TAZ</i> in primary neonatal rat CMs with shRNAs replicated abnormalities; transfecting BTHS iPSC-CMs with modified RNA that encodes wild-type <i>TAZ</i> rescued abnormalities; and performing targeted mutation of <i>TAZ</i> with Cas9 in control iPSC-CMs reproduced abnormalities. Furthermore, they found that they could correct cellular defects in sacomeric organization and function with either linoleic acid, a precursor of mature cardiolipin and ROS scavenger, or mitoTEMPO, a mitochondria-targeted ROS scavenger (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Therefore, these results strongly implicate that mitochondrial ROS is a critical intermediate that links <i>TAZ</i> mutations to cardiomyopathy, thereby providing new insights into the pathophysiology of BTHS with CMs derived from iPSCs.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Diabetic Cardiomyopathy</h3><div class="NLM_p last">The cases using patient-specific iPSC-CMs for disease modeling and chemical screening discussed so far share several common characteristics: the diseases are usually monogenic disorders with known genetic causes; the etiologies of disease are congenital and symptoms are early onset; and protocols to obtain CMs are available. Most cardiac disorders in newborns or adults, however, are polygenic, from complex origins, and late in onset. Therefore, researchers would benefit from iPSC-CM models that recapitulate these more complicated disorders. Drawnel et al., from the pharmaceutical company Roche, showed that these complex disorders could be modeled with iPSC-CMs in vitro.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> In their report, they studied diabetic cardiomyopathy, which develops from metabolic dysfunction in diabetes and progresses to DCM and heart failure. It is the leading cause of death in people with type 2 diabetes mellitus (T2DM). Despite the tremendous need, there is no cure or specific treatment available for diabetic cardiomyopathy because of its complex pathology and the lack of practical assays for drug discovery. To model this disease, researchers need CMs with higher maturity. Drawnel et al. developed a maturation medium (MM) by adding insulin and fatty acids to standard medium. When CMs were cultured in this MM, they showed more matured phenotypes, such as upregulated expression of α-actinin, a contractile marker that represents mature sarcomeric integrity. After incubating MM-treated CMs in a diabetic milieu (DM) containing glucose and two diabetic stressors, endothelin 1 and cortisol, matured CMs produced from normal iPSCs displayed structural and functional abnormalities similar to that seen in diabetic cardiomyopathy, such as sarcomeric disarray, increased oxidative stress, and arrhythmia (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). These phenotypes were confirmed in iPSC-CMs generated from T2DM patients. When the patient-derived iPSC-CMs were incubated in only the MM condition without glucose and diabetic stressors, they exhibited similar disease phenotypes as healthy CMs cultured in DM medium. On the basis of these findings, the authors successfully reproduced diabetic cardiomyopathy in vitro with iPSC-CMs by either environmentally or genetically driven models. With these cells, the authors completed a high-content phenotypic screen of 480 compounds using several screenable readouts, i.e., the levels of actinin-α, the size of the cell nucleus, and the production of B-type natriuretic peptide. Of these, 28 dose-dependently improved the outcome of the disease phenotypes (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). These results implicate that iPSC-CMs can model disorders with unknown genetic bases and complex origins, which can be used as a powerful platform for PDD.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Other Diseases</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65042" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65042" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Since iPSC technology emerged, it has enabled researchers to model a number of diseases in vitro. Below, we will summarize recent progress in hepatic, hematological, and skeletal diseases, with a particular focus on designing phenotypic cell assays and chemical screens.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Hepatic Disease</h3><div class="NLM_p last">A few research groups have developed patient-derived HCs from iPSCs (iPSC-HCs) to recapitulate phenotypes and reflect pharmalogical responses in vitro for a variety of liver diseases.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> For example, Wilson’s disease (WD) is caused by mutations in the liver transport gene <i>ATP7B</i>, which results in progressive liver damage caused by an accumulation of copper ions (Cu<sup>2+</sup>) in HCs.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Zhang et al. generated iPSC-HCs from a WD patient (WD-HCs),<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> which showed abnormal cytoplasmic localization of mutated ATP7B protein and defective Cu<sup>2+</sup> transport when compared with primary human HCs (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). These phenotypes were partially reversed by a natural product, curcumin. Another group evaluated α-1 antitrypsin deficiency (AATD), a condition characterized by accumulation of misfolded α-1 antitrypsin (AAT) in HCs.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Here, the authors optimized a procedure to differentiate HCs from patient iPSCs and screened phenotypes based on the intracellular levels of the AAT protein. In a library of 2800 clinical chemicals (FDA-approved or passed a phase 1 clinical trial), the authors identified five compounds as promising hits, which each showed positive effects in many iPSC-HCs lines (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Because these compounds have already been used in clinical trials, they can bypass the early stages of drug discovery and potentially be repositioned as drugs to treat hepatic diseases. This study provides a good example of how to align iPSC technique in PDD.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Hematological Disease</h3><div class="NLM_p">Shwachman–Diamond syndrome (SDS) is an inherited pediatric disorder characterized by hematologic abnormalities and exocrine pancreatic insufficiency. SDS is caused by mutations in the <i>SBDS</i> gene,<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> which reduces expression of SBDS protein in patients; however, the link between mutations in <i>SBDS</i> and pathology within the hematopoietic and pancreatic lineages remains unknown. Tulpile et al. modeled SDS by obtaining iPSCs from patients with SDS (SDS-iPSCs).<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> They overexpressed normal SBDS protein in these lines to create gene-corrected controls. When differentiated into target cells, SDS-iPSCs, but not gene-corrected controls, showed the defects of hematopoietic and pancreatic differentiation observed in patients (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). The authors also compared the cellular phenotypes and biochemical features of culture medium and found that elevated protease levels that kill myeloid and pancreatic-acinar cells was a molecular mechanism of SDS. Aprotinin, a protease inhibitor, effectively rescued the abnormalities in culture (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). This work demonstrates the potential impact of iPSCs for modeling disease and discovering pharmacological methods to target the disease mechanism.</div><div class="NLM_p last">In another study, Liu et al. modeled Fanconi anemia (FA) with iPSCs.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> FA is caused by mutations in any of the 16 <i>FANC</i> genes and is characterized by genomic instability, progressive failure of bone marrow, and endocrine defects.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> FA cells have defective mechanisms to repair DNA and are genomically unstable, which creates challenges in generating iPSCs from FA patients, even under fine-tuned conditions such as hypoxia.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Nevertheless, Liu et al. reprogrammed iPSCs from FA-patient fibroblasts with a <i>FANCA</i> mutation (FA-iPSCs) with an integration-free method. These cells recapitulated FA defects at the cellular level, such as defective abilities of DNA repair and hematopoietic differentiation (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Importantly, the authors validated that the <i>FANCA</i> mutation caused the cellular abnormalities in two independent lines of isogenic cells: targeted correction of <i>FANCA</i> gene in FA-iPSCs reversed defects, and precise mutation of <i>FANCA</i> gene in human ESCs resulted in similar defects. Interestingly, to further explore the pathology of FA, they differentiated two types of adult stem/progenitor cells from FA iPSCs, i.e., mesenchymal stem cells (MSCs) and neural stem cells (NSCs), which manifested various abnormalities. For example, MSCs showed characteristics of premature senescence, which might represent part of the molecular mechanism of the disease. In addition, several compounds were identified as hits that can promote hematopoietic differentiation of FA-iPSCs (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), which validates the model as a valuable platform for small-molecule screening.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Skeletal Disease</h3><div class="NLM_p">Marfan syndrome (MFS) is a heritable connective-tissue disorder caused by a mutation in the <i>FBN1</i> gene, which encodes fibrillin-1, an extracellular matrix protein.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Quarto et al.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> modeled MFS by generating iPSCs from MFS-patient dermal cells (MFS-iPSCs) and found that these cells manifested impaired osteogenic differentiation in vitro because of an enhanced transforming growth factor (TGF)-β signaling (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). This finding was supported by results showing that a TGF-β signaling inhibitor (4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1<i>H</i>-imidazol-2-yl]benzamide (SB-431542), <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>)<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> rescued the deficits of skeletogenesis in MFS-iPSCs, while a BMP-signaling inhibitor (noggin) did not.</div><div class="NLM_p">Fibrodysplasia ossificans progressiva (FOP) is a rare, but debilitating, genetic disease caused by hyperactive mutations in <i>ACVR1</i> gene.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> It has also been modeled by reprogramming patient fibroblasts into iPSCs (FOP-iPSCs).<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Activating the <i>ACVR1</i> gene leads to increased mineralization that causes abnormal endochondral bone formation in patient’s soft tissues. Remarkably, FOP-iPSCs similarly exhibited enhanced mineralization and increased chondrogenesis in vitro compared to healthy controls (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Interestingly these disease phenotypes were blocked by DMH1, a small-molecule inhibitor of BMP signaling, which could be interesting for further drug development for this disease.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Modeling Miscellaneous Diseases and Screening Compounds with Patient iPSCs or iPSC-Derived Cells</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">disease</th><th class="colsep0 rowsep0" align="center">genetic etiology</th><th class="colsep0 rowsep0" align="center">disease-relevant cells</th><th class="colsep0 rowsep0" align="center">disease-relevant phenotypes</th><th class="colsep0 rowsep0" align="center">rescue molecule(s)</th><th class="colsep0 rowsep0" align="center">refs</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">WD</td><td class="colsep0 rowsep0" align="left"><i>ATP7B</i> (R778L)</td><td class="colsep0 rowsep0" align="left">HCs</td><td class="colsep0 rowsep0" align="left">Irregular cellular localization of mutated ATP7B; aberrant Cu<sup>2+</sup> transport</td><td class="colsep0 rowsep0" align="left">Curcumin</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">88</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AATD</td><td class="colsep0 rowsep0" align="left"><i>AAT</i> (E342K)</td><td class="colsep0 rowsep0" align="left">HCs</td><td class="colsep0 rowsep0" align="left">Intracellular accumulation of misfolded mutant α1-antitrypsin</td><td class="colsep0 rowsep0" align="left">Carbamazepine; lithium salt; valproic acid; glipizide; thiamine</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">89</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SDS</td><td class="colsep0 rowsep0" align="left"><i>SBDS</i> mutations</td><td class="colsep0 rowsep0" align="left">iPSCs</td><td class="colsep0 rowsep0" align="left">Impaired abilities of hematopoietic and pancreatic differentiation</td><td class="colsep0 rowsep0" align="left">Aprotinin</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">91</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FA</td><td class="colsep0 rowsep0" align="left"><i>FANCA</i> mutations</td><td class="colsep0 rowsep0" align="left">iPSCs</td><td class="colsep0 rowsep0" align="left">Defective abilities of DNA repair and hematopoietic differentiation</td><td class="colsep0 rowsep0" align="left">Doramapimod; tremulacin</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">92</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MFS</td><td class="colsep0 rowsep0" align="left"><i>FBN1</i> (G 3839-1T);<i>FBN1</i> (1642del3ins20bp)</td><td class="colsep0 rowsep0" align="left">iPSCs</td><td class="colsep0 rowsep0" align="left">Impaired ability of osteogenic differentiation</td><td class="colsep0 rowsep0" align="left">SB-431542</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">96</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FOP</td><td class="colsep0 rowsep0" align="left"><i>ACVR1</i> (R206H)</td><td class="colsep0 rowsep0" align="left">iPSCs</td><td class="colsep0 rowsep0" align="left">Enhanced chondrogenesis; increased mineralization</td><td class="colsep0 rowsep0" align="left">DMH1</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">98</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TD1; ACH</td><td class="colsep0 rowsep0" align="left"><i>FGFR3</i> (R248C); <i>FGFR3</i> (G380R)</td><td class="colsep0 rowsep0" align="left">iPSCs</td><td class="colsep0 rowsep0" align="left">Impaired ability of chondrogenic differentiation</td><td class="colsep0 rowsep0" align="left">Statins</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">99</a></td></tr></tbody></table></div></div><div class="NLM_p last">Recently, Yamashita et al. studied the skeletal disorders of achondroplasia (ACH) and thanatophoric dysplasia type 1 (TD1) and provided another good example of how to use iPSCs to model bone disease and reposition drugs.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> Both ACH and TD1 are caused by gain-of-function mutations in the gene <i>FGFR3</i>,<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> which encodes a transmembrane tyrosine receptor. When FGFR3 protein accumulates, it affects downstream pathways to suppress the differentiation and proliferation of cartilage cells, chondrocytes. Similarly, the authors found that iPSCs derived from patients showed higher expression of FGFR3 protein compared with control iPSCs. Importantly, the patient-derived iPSCs manifested abnormal cartilage formation when differentiated toward chondrocytes and displayed decreased proliferation and increased apoptosis after chondrogenic differentiation, which well recapitulated the abnormalities of the diseases in vitro (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Treating patient iPSCs with statins, such as lovastatin, led to degradation of mutated FGFR3 protein and restored normal chondrogenic differentiation (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Notably, statins also promoted bone growth in a mouse model that harbored the ACH mutation but not wild-type mice. Despite these encouraging findings, extensive evaluation is still needed before using statins to treat the skeletal dysplasias in patients, particularly children, because statins inhibit cholesterol, which is critical for development. The results of this study demonstrate that iPSCs can effectively model skeletal disorders and support chemical screening in the search for clinical drugs.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Summary and Outlook</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67511" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67511" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Since its discovery, the technique for cell reprogramming has continued to improve and support growing applications of human iPSCs in disease modeling and PDD. For example, nonintegrative approaches have enabled researchers to generate transgene-free iPSCs that are genetically identical to their donors, a significant advantage for building cell models.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Nonetheless, a number of technical challenges need to be overcome to unleash the great potential of human iPSCs in disease modeling and drug discovery (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a></div><div class="NLM_p">Many disease-relevant cell types are currently inaccessible through the directed differentiation of iPSCs. Fortunately, the toolbox of cell reprogramming and cell differentiation will continue to expand, thereby increasing the varieties of cells types accessible. As illustrated by a number of studies previously discussed, even in cases where researchers cannot easily obtain a specific cell type affected by a disease, they can rely on the readily available patient-derived iPSCs to model the disease, provided that the iPSCs exhibit the disease-relevant phenotypes responsive to pharmacological treatments.</div><div class="NLM_p">Many existing methods for the differentiation of human iPSCs are still complex, laborious, and cost-inefficient. Suboptimal differentiation methods often generate heterogeneous cellular compositions that can impede the investigation of a specific cell type of interest. Some current differentiation methods can only produce immature cells that inadequately resemble the functional, mature cells in the human body.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Improved methods for cell differentiation and/or cell culturing may overcome these obstacles that restrict the application of human iPSCs. For example, a recent study reported that highly pure CMs in good yields can be produced from human iPSCs in simple, chemically defined conditions.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Current Limitations of Human iPSC-Based Cell Models and Emerging Solutions</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">current limitations</th><th class="colsep0 rowsep0" align="center">emerging solutions</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Limited, inefficient differentiation methods to produce disease-relevant cells; heterogeneous compositions of differentiated cells; immaturity of target cells</td><td class="colsep0 rowsep0" align="left">Invention and/or improvement of differentiation protocols and/or cell culture conditions</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Confounding variations in genetic background among cell sources</td><td class="colsep0 rowsep0" align="left">Targeted genome editing technology</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Difficulties in modeling disorders without a strong genetic background</td><td class="colsep0 rowsep0" align="left">Proper pathogenic stimuli to induce phenotypes</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Difficulties in modeling disorders at the tissue level</td><td class="colsep0 rowsep0" align="left">3D organoid models</td></tr></tbody></table></div></div><div class="NLM_p">Patient-derived iPSCs retain the genetic predispositions of the diseases of interest and are particularly useful for studying disorders with strong genetic components. By comparing patient-derived cells with control cells derived from healthy donors, researchers can identify disease-related phenotypes; however, they must consider that the difference in phenotypes may be an artifact that merely reflects the genetic heterogeneity among donors. Fortunately, isogenic control cells can be created by genetically correcting patient-derived iPSCs with targeted genome editing techniques. This approach can help researchers easily identify phenotypes caused by the disease-related mutations. Alternatively, researchers can introduce precise mutations into iPSC lines through targeted genome editing so that the exact contributions of a genetic risk factor can be stringently evaluated. Thus, targeted genome editing can uniquely tailor human iPSCs and will continue to be widely used to create cell models of diseases.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a></div><div class="NLM_p">By understanding the pathophysiology underlying diseases, researchers can apply effective strategies that evoke and/or enhance disease-relevant phenotypes in cell models and, hopefully, discover drugs by phenotypic screening.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> In many studies discussed above, disease-relevant phenotypes were induced by pathogenic stresses, which could be used to recapitulate the phenotypes of diseases that are linked with age, environmental factors, and/or epigenetic components.</div><div class="NLM_p">Future efforts may build on three-dimensional (3D), organoid models with in vitro cell cultures, an important field where human iPSCs have already set firm roots.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Researchers have already generated 3D cardiac tissues from human iPSCs that successfully model the human heart.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Recently, they also developed organoids with iPSCs that mimic the cerebrum.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Compared with conventional two-dimensional cell cultures, 3D models incorporate the spatial and structural features of tissues and/or organs affected by diseases and thereby could reveal more relevant information. For example, one study recapitulated the pathological phenotypes of AD with a 3D model.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Here, the authors used a 3D culture of neurons that presumably better resembled the structural and pathophysiological microenvironment in a brain affected by AD. With this model, they showed, for the first time in a disease model of AD, the causative link between Aβ pathology and tauopathy. These findings support that researchers will continue to develop effective 3D models to reveal more relevant disease mechanism.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></div><div class="NLM_p">Cell models are widely used to model diseases and elucidate their mechanisms, which benefits PDD. After validating the pathophysiology of a disease with these cell models, researchers can then select relevant and robust phenotypic readouts for specific drug screening assays. Strategies and methods to design cell-based, high-throughput screening assays have been comprehensively reviewed elsewhere.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> PPD is useful not only for finding therapeutically useful entities but also for exploring disease mechanisms. For example, researchers can use compounds with established biological functions to test phenotypic, cellular models to learn the mechanisms and/or drug targets in diseases. When novel compounds without known functions are discovered in phenotypic assays, researchers can use them to identify their molecular target(s) and potentially uncover new insights into the disease of interest.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a></div><div class="NLM_p last">In summary, human iPSCs supply ample cells as fundamental tools for researchers to study diseases. By coupling patient-derived iPSCs with techniques such as targeted genome editing, researchers have drastically enhanced their ability to build in vitro models of diseases and investigate their mechanisms. These models can also be used for cell-based, phenotypic assays to discover drug candidates and hopefully lead to the discovery and development of drugs that effectively treat or cure devastating diseases.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00789" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44431" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44431" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sheng Ding</span> - <span class="hlFld-Affiliation affiliation">Gladstone
Institutes, 1650 Owens
Street, San Francisco, California 94158, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c3b0aba6ada4eda7aaada483a4afa2a7b0b7acada6edb6a0b0a5eda6a7b6"><span class="__cf_email__" data-cfemail="a7d4cfc2c9c089c3cec9c0e7c0cbc6c3d4d3c8c9c289d2c4d4c189c2c3d2">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shibing Tang</span> - <span class="hlFld-Affiliation affiliation">Gladstone
Institutes, 1650 Owens
Street, San Francisco, California 94158, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Min Xie</span> - <span class="hlFld-Affiliation affiliation">Gladstone
Institutes, 1650 Owens
Street, San Francisco, California 94158, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nan Cao</span> - <span class="hlFld-Affiliation affiliation">Gladstone
Institutes, 1650 Owens
Street, San Francisco, California 94158, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>S.T. and M.X. contributed equally to this manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80366" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80366" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Shibing Tang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00789&amp;id=BIO-d3158e1830-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Shibing Tang</b> received his B.Sc. in Chemistry from Jilin University in 2006 and his Ph.D. in Organic Chemistry from Lanzhou University in 2011. Since 2011, he has been a postdoctoral fellow at the Gladstone Institutes under the supervision of Prof. Sheng Ding. His current research focuses on discovering novel small molecules that control cell fates and functions, elucidating their molecular targets, and examining their therapeutic potential in disease models.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Min Xie</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00789&amp;id=BIO-d3158e1835-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Min Xie</b> received his B.Sc. in Chemistry from Peking University in 2003. After obtaining his Ph.D. in Organic Chemistry from the University of Illinois at Urbana—Champaign in 2010, he joined Dr. Sheng Ding’s lab as a postdoctoral fellow. Currently at the Gladstone Institutes, he is participating in the discovery and preclinical development of small-molecule drugs for the treatment of cancers, neurodegenerative diseases, and metabolic diseases.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Nan Cao</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00789&amp;id=BIO-d3158e1840-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Nan Cao</b> is currently a postdoctoral fellow at the Gladstone Institutes. He received his Ph.D. degree in Cell Biology from the Key Laboratory of Stem Cell Biology, Chinese Academy of Science. His research mainly focuses on conversion of noncardiac cells into cardiac progenitors and/or cardiomyocytes by chemical strategies and exploring the underlying mechanisms.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Sheng Ding</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00789&amp;id=BIO-d3158e1845-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Sheng Ding</b> is currently William K. Bowes, Jr. Distinguished Investigator and Professor at Gladstone Institutes and Department of Pharmaceutical Chemistry, University of California, San Francisco. He obtained his B.S. in Chemistry from California Institute of Technology in 1999 and a Ph.D. in Chemistry from The Scripps Research Institute in 2003. Before moving to Gladstone in 2011, Dr. Ding was an Assistant Professor and then Associate Professor of Chemistry at Scripps from 2003 to 2011. Dr. Ding has pioneered in developing and applying innovative chemical approaches to stem cell biology and regeneration, with a focus on discovering and characterizing small molecules that control cell fate/function, including stem cell maintenance, differentiation, and reprogramming. Ding has published over 100 research articles and reviews and made several seminal contributions to the stem cell field.</p></figure></div><div class="ack" id="ACK-d3158e1858-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68788" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68788" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">S.D. is supported by funding from National Institute of Child Health and Human Development, National Heart, Lung, and Blood Institute, and National Eye Institute/National Institutes of Health, California Institute for Regenerative Medicine, and the Gladstone Institutes. We thank Crystal Herron from the Gladstone Institutes for critical reading and editing of this manuscript. The authors apologize to all scientists whose research could not be properly discussed and cited in this review owing to space limitations.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i35" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i35"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i36" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i36"> Abbreviations Used</h2><tr><td class="NLM_term">3D</td><td class="NLM_def"><p class="first last">three-dimensional</p></td></tr><tr><td class="NLM_term">α-Syn</td><td class="NLM_def"><p class="first last">α-synuclein</p></td></tr><tr><td class="NLM_term">AAT</td><td class="NLM_def"><p class="first last">α-1 antitrypsin</p></td></tr><tr><td class="NLM_term">AATD</td><td class="NLM_def"><p class="first last">α-1 antitrypsin deficiency</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">β-amyloid</p></td></tr><tr><td class="NLM_term">ACH</td><td class="NLM_def"><p class="first last">achondroplasia</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ALS</td><td class="NLM_def"><p class="first last">amyotrophic lateral sclerosis</p></td></tr><tr><td class="NLM_term">APD</td><td class="NLM_def"><p class="first last">action potential duration</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">β-amyloid</p></td></tr><tr><td class="NLM_term">BIP</td><td class="NLM_def"><p class="first last">binding immunoglobulin protein</p></td></tr><tr><td class="NLM_term">BMP</td><td class="NLM_def"><p class="first last">bone morphogenetic protein</p></td></tr><tr><td class="NLM_term">BTHS</td><td class="NLM_def"><p class="first last">Barth syndrome</p></td></tr><tr><td class="NLM_term">CDK</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase</p></td></tr><tr><td class="NLM_term">CM</td><td class="NLM_def"><p class="first last">cardiomyocyte</p></td></tr><tr><td class="NLM_term">CoQ10</td><td class="NLM_def"><p class="first last">coenzyme Q10</p></td></tr><tr><td class="NLM_term">CPVT1</td><td class="NLM_def"><p class="first last">catecholaminergic polymorphic ventricular tachycardia type 1</p></td></tr><tr><td class="NLM_term">DA</td><td class="NLM_def"><p class="first last">dopaminergic</p></td></tr><tr><td class="NLM_term">DAD</td><td class="NLM_def"><p class="first last">delayed afterdepolarization</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dilated cardiomyopathy</p></td></tr><tr><td class="NLM_term">DHA</td><td class="NLM_def"><p class="first last">docosahexaenoic acid</p></td></tr><tr><td class="NLM_term">DM</td><td class="NLM_def"><p class="first last">diabetic milieu</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">endoplasmic reticulum</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular signal-regulated kinase</p></td></tr><tr><td class="NLM_term">FA</td><td class="NLM_def"><p class="first last">Fanconi anemia</p></td></tr><tr><td class="NLM_term">fA</td><td class="NLM_def"><p class="first last">familial Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">FD</td><td class="NLM_def"><p class="first last">familial dysautonomia</p></td></tr><tr><td class="NLM_term">FOP</td><td class="NLM_def"><p class="first last">fibrodysplasia ossificans progressive</p></td></tr><tr><td class="NLM_term">fPD</td><td class="NLM_def"><p class="first last">familial Parkinson’s disease</p></td></tr><tr><td class="NLM_term">GSK</td><td class="NLM_def"><p class="first last">glycogen synthase kinase</p></td></tr><tr><td class="NLM_term">HC</td><td class="NLM_def"><p class="first last">hepatocyte</p></td></tr><tr><td class="NLM_term">HCM</td><td class="NLM_def"><p class="first last">hypertrophic cardiomyopathy</p></td></tr><tr><td class="NLM_term">iPSC</td><td class="NLM_def"><p class="first last">induced pluripotent stem cell</p></td></tr><tr><td class="NLM_term">LQTS</td><td class="NLM_def"><p class="first last">long QT syndrome</p></td></tr><tr><td class="NLM_term">LQT1</td><td class="NLM_def"><p class="first last">long QT syndrome type 1</p></td></tr><tr><td class="NLM_term">mDA</td><td class="NLM_def"><p class="first last">midbrain dopaminergic</p></td></tr><tr><td class="NLM_term">MEA</td><td class="NLM_def"><p class="first last">multielectrode array</p></td></tr><tr><td class="NLM_term">MeCP2</td><td class="NLM_def"><p class="first last">methyl-CpG-binding protein 2</p></td></tr><tr><td class="NLM_term">MFS</td><td class="NLM_def"><p class="first last">Marfan syndrome</p></td></tr><tr><td class="NLM_term">MJD</td><td class="NLM_def"><p class="first last">Machado–Joseph disease</p></td></tr><tr><td class="NLM_term">MM</td><td class="NLM_def"><p class="first last">maturation medium</p></td></tr><tr><td class="NLM_term">MN</td><td class="NLM_def"><p class="first last">motor neuron</p></td></tr><tr><td class="NLM_term">MSC</td><td class="NLM_def"><p class="first last">mesenchymal stem cell</p></td></tr><tr><td class="NLM_term">MU</td><td class="NLM_def"><p class="first last">mutant</p></td></tr><tr><td class="NLM_term">NC</td><td class="NLM_def"><p class="first last">neural crest</p></td></tr><tr><td class="NLM_term">NEFM</td><td class="NLM_def"><p class="first last">medium polypeptide neurofilament</p></td></tr><tr><td class="NLM_term">NO</td><td class="NLM_def"><p class="first last">nitric oxide</p></td></tr><tr><td class="NLM_term">NSC</td><td class="NLM_def"><p class="first last">neural stem cell</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">PDD</td><td class="NLM_def"><p class="first last">phenotypic drug discovery</p></td></tr><tr><td class="NLM_term">polyQ</td><td class="NLM_def"><p class="first last">polyglutamine</p></td></tr><tr><td class="NLM_term">PRDX4</td><td class="NLM_def"><p class="first last">eroxiredoxin-4</p></td></tr><tr><td class="NLM_term">p-tau</td><td class="NLM_def"><p class="first last">phosphorylated tau</p></td></tr><tr><td class="NLM_term">qRT-PCR</td><td class="NLM_def"><p class="first last">quantitative reverse transcription polymerase chain reaction</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">RTT</td><td class="NLM_def"><p class="first last">Rett syndrome</p></td></tr><tr><td class="NLM_term">sAD</td><td class="NLM_def"><p class="first last">sporadic Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">SCZD</td><td class="NLM_def"><p class="first last">schizophrenia</p></td></tr><tr><td class="NLM_term">SDS</td><td class="NLM_def"><p class="first last">Shwachman–Diamond syndrome</p></td></tr><tr><td class="NLM_term">SMA</td><td class="NLM_def"><p class="first last">spinal muscular atropy</p></td></tr><tr><td class="NLM_term">SMN</td><td class="NLM_def"><p class="first last">survival of motor neuron</p></td></tr><tr><td class="NLM_term">SR</td><td class="NLM_def"><p class="first last">sarcoplasmic reticulum</p></td></tr><tr><td class="NLM_term">t-tau</td><td class="NLM_def"><p class="first last">total tau</p></td></tr><tr><td class="NLM_term">T2DM</td><td class="NLM_def"><p class="first last">type 2 diabetes mellitus</p></td></tr><tr><td class="NLM_term">TD1</td><td class="NLM_def"><p class="first last">thanatophoric dysplasia type 1</p></td></tr><tr><td class="NLM_term">TDD</td><td class="NLM_def"><p class="first last">target-based drug discovery</p></td></tr><tr><td class="NLM_term">TDP-43</td><td class="NLM_def"><p class="first last">TAR DNA-binding protein 43</p></td></tr><tr><td class="NLM_term">TGF</td><td class="NLM_def"><p class="first last">transforming growth factor</p></td></tr><tr><td class="NLM_term">VPA</td><td class="NLM_def"><p class="first last">valproic acid</p></td></tr><tr><td class="NLM_term">WD</td><td class="NLM_def"><p class="first last">Wilson’s disease</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild-type</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23440" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23440" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 113 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Anighoro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rastelli, G.</span><span> </span><span class="NLM_article-title">Polypharmacology: challenges and opportunities in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7874</span><span class="NLM_x">–</span> <span class="NLM_lpage">7887</span><span class="refDoi"> DOI: 10.1021/jm5006463</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5006463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7874-7887&author=A.+Anighoroauthor=J.+Bajorathauthor=G.+Rastelli&title=Polypharmacology%3A+challenges+and+opportunities+in+drug+discovery&doi=10.1021%2Fjm5006463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology: Challenges and Opportunities in Drug Discovery</span></div><div class="casAuthors">Anighoro, Andrew; Bajorath, Jurgen; Rastelli, Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7874-7887</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  At present, the legendary magic bullet, i.e., a drug with high potency and selectivity toward a specific biol. target, shares the spotlight with an emerging and alternative polypharmacol. approach.  Polypharmacol. suggests that more effective drugs can be developed by specifically modulating multiple targets.  It is generally thought that complex diseases such as cancer and central nervous system diseases may require complex therapeutic approaches.  In this respect, a drug that "hits" multiple sensitive nodes belonging to a network of interacting targets offers the potential for higher efficacy and may limit drawbacks generally arising from the use of a single-target drug or a combination of multiple drugs.  In this review, we will compare advantages and disadvantages of multitarget vs. combination therapies, discuss potential drug promiscuity arising from off-target effects, comment on drug repurposing, and introduce approaches to the computational design of multitarget drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFOTyEu80AZrVg90H21EOLACvtfcHk0lj6Y56HDeAA8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I&md5=5ab36c961a84462d90bc25130d90a281</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm5006463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5006463%26sid%3Dliteratum%253Aachs%26aulast%3DAnighoro%26aufirst%3DA.%26aulast%3DBajorath%26aufirst%3DJ.%26aulast%3DRastelli%26aufirst%3DG.%26atitle%3DPolypharmacology%253A%2520challenges%2520and%2520opportunities%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7874%26epage%3D7887%26doi%3D10.1021%2Fjm5006463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Swinney, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, J.</span><span> </span><span class="NLM_article-title">How were new medicines discovered?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span><span class="refDoi"> DOI: 10.1038/nrd3480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnrd3480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21701501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlCmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=507-519&author=D.+C.+Swinneyauthor=J.+Anthony&title=How+were+new+medicines+discovered%3F&doi=10.1038%2Fnrd3480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">How were new medicines discovered?</span></div><div class="casAuthors">Swinney, David C.; Anthony, Jason</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">507-519</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Preclin. strategies that are used to identify potential drug candidates include target-based screening, phenotypic screening, modification of natural substances and biol.-based approaches.  To investigate whether some strategies have been more successful than others in the discovery of new drugs, we analyzed the discovery strategies and the mol. mechanism of action (MMOA) for new mol. entities and new biologics that were approved by the US Food and Drug Administration between 1999 and 2008.  Out of the 259 agents that were approved, 75 were first-in-class drugs with new MMOAs, and out of these, 50 (67%) were small mols. and 25 (33%) were biologics.  The results also show that the contribution of phenotypic screening to the discovery of first-in-class small-mol. drugs exceeded that of target-based approaches - with 28 and 17 of these drugs coming from the two approaches, resp. - in an era in which the major focus was on target-based approaches.  We postulate that a target-centric approach for first-in-class drugs, without consideration of an optimal MMOA, may contribute to the current high attrition rates and low productivity in pharmaceutical research and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE8Ah1iNz76bVg90H21EOLACvtfcHk0lj6Y56HDeAA8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlCmsbs%253D&md5=7503620f8fbadb0a829f6ea2029936a2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd3480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3480%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26aulast%3DAnthony%26aufirst%3DJ.%26atitle%3DHow%2520were%2520new%2520medicines%2520discovered%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D507%26epage%3D519%26doi%3D10.1038%2Fnrd3480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Wilding, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodmer, W. F.</span><span> </span><span class="NLM_article-title">Cancer cell lines for drug discovery and development</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">2377</span><span class="NLM_x">–</span> <span class="NLM_lpage">2384</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-2971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1158%2F0008-5472.CAN-13-2971" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=2377-2384&author=J.+L.+Wildingauthor=W.+F.+Bodmer&title=Cancer+cell+lines+for+drug+discovery+and+development&doi=10.1158%2F0008-5472.CAN-13-2971"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-2971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-2971%26sid%3Dliteratum%253Aachs%26aulast%3DWilding%26aufirst%3DJ.%2BL.%26aulast%3DBodmer%26aufirst%3DW.%2BF.%26atitle%3DCancer%2520cell%2520lines%2520for%2520drug%2520discovery%2520and%2520development%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D2377%26epage%3D2384%26doi%3D10.1158%2F0008-5472.CAN-13-2971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichisaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomoda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, S.</span><span> </span><span class="NLM_article-title">Induction of pluripotent stem cells from adult human fibroblasts by defined factors</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">861</span><span class="NLM_x">–</span> <span class="NLM_lpage">872</span><span class="refDoi"> DOI: 10.1016/j.cell.2007.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.cell.2007.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=18035408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCntbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=861-872&author=K.+Takahashiauthor=K.+Tanabeauthor=M.+Ohnukiauthor=M.+Naritaauthor=T.+Ichisakaauthor=K.+Tomodaauthor=S.+Yamanaka&title=Induction+of+pluripotent+stem+cells+from+adult+human+fibroblasts+by+defined+factors&doi=10.1016%2Fj.cell.2007.11.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of pluripotent stem cells from adult human fibroblasts by defined factors</span></div><div class="casAuthors">Takahashi, Kazutoshi; Tanabe, Koji; Ohnuki, Mari; Narita, Megumi; Ichisaka, Tomoko; Tomoda, Kiichiro; Yamanaka, Shinya</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">861-872</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Successful reprogramming of differentiated human somatic cells into a pluripotent state would allow creation of patient- and disease-specific stem cells.  The authors previously reported generation of induced pluripotent stem (iPS) cells, capable of germline transmission, from mouse somatic cells by transduction of four defined transcription factors.  Here, the authors demonstrate the generation of iPS cells from adult human dermal fibroblasts with the same four factors: Oct3/4, Sox2, Klf4, and c-Myc.  Human iPS cells were similar to human embryonic stem (ES) cells in morphol., proliferation, surface antigens, gene expression, epigenetic status of pluripotent cell-specific genes, and telomerase activity.  Furthermore, these cells could differentiate into cell types of the three germ layers in vitro and in teratomas.  These findings demonstrate that iPS cells can be generated from adult human fibroblasts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1iQxQ2EQuJbVg90H21EOLACvtfcHk0liGCLCFLNFQLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCntbbK&md5=da3902c033f131a8cf28032cbeff1e24</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DTanabe%26aufirst%3DK.%26aulast%3DOhnuki%26aufirst%3DM.%26aulast%3DNarita%26aufirst%3DM.%26aulast%3DIchisaka%26aufirst%3DT.%26aulast%3DTomoda%26aufirst%3DK.%26aulast%3DYamanaka%26aufirst%3DS.%26atitle%3DInduction%2520of%2520pluripotent%2520stem%2520cells%2520from%2520adult%2520human%2520fibroblasts%2520by%2520defined%2520factors%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D861%26epage%3D872%26doi%3D10.1016%2Fj.cell.2007.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vodyanik, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smuga-Otto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antosiewicz-Bourget, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frane, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsdottir, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruotti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slukvin, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span> </span><span class="NLM_article-title">Induced pluripotent stem cell lines derived from human somatic cells</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1917</span><span class="NLM_x">–</span> <span class="NLM_lpage">1920</span><span class="refDoi"> DOI: 10.1126/science.1151526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1126%2Fscience.1151526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=18029452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGjsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=1917-1920&author=J.+Yuauthor=M.+A.+Vodyanikauthor=K.+Smuga-Ottoauthor=J.+Antosiewicz-Bourgetauthor=J.+L.+Franeauthor=S.+Tianauthor=J.+Nieauthor=G.+A.+Jonsdottirauthor=V.+Ruottiauthor=R.+Stewartauthor=I.+I.+Slukvinauthor=J.+A.+Thomson&title=Induced+pluripotent+stem+cell+lines+derived+from+human+somatic+cells&doi=10.1126%2Fscience.1151526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells</span></div><div class="casAuthors">Yu, Junying; Vodyanik, Maxim A.; Smuga-Otto, Kim; Antosiewicz-Bourget, Jessica; Frane, Jennifer L.; Tian, Shulan; Nie, Jeff; Jonsdottir, Gudrun A.; Ruotti, Victor; Stewart, Ron; Slukvin, Igor I.; Thomson, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">5858</span>),
    <span class="NLM_cas:pages">1917-1920</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Somatic cell nuclear transfer allows trans-acting factors present in the mammalian oocyte to reprogram somatic cell nuclei to an undifferentiated state.  We show that four factors (OCT4, SOX2, NANOG, and LIN28) are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells.  These induced pluripotent human stem cells have normal karyotypes, express telomerase activity, express cell surface markers and genes that characterize human ES cells, and maintain the developmental potential to differentiate into advanced derivs. of all three primary germ layers.  Such induced pluripotent human cell lines should be useful in the prodn. of new disease models and in drug development, as well as for applications in transplantation medicine, once tech. limitations (for example, mutation through viral integration) are eliminated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwgDWKSXh3QLVg90H21EOLACvtfcHk0liGCLCFLNFQLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGjsLbN&md5=5bef3593837787a32e44303837d6444d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1151526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1151526%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DVodyanik%26aufirst%3DM.%2BA.%26aulast%3DSmuga-Otto%26aufirst%3DK.%26aulast%3DAntosiewicz-Bourget%26aufirst%3DJ.%26aulast%3DFrane%26aufirst%3DJ.%2BL.%26aulast%3DTian%26aufirst%3DS.%26aulast%3DNie%26aufirst%3DJ.%26aulast%3DJonsdottir%26aufirst%3DG.%2BA.%26aulast%3DRuotti%26aufirst%3DV.%26aulast%3DStewart%26aufirst%3DR.%26aulast%3DSlukvin%26aufirst%3DI.%2BI.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26atitle%3DInduced%2520pluripotent%2520stem%2520cell%2520lines%2520derived%2520from%2520human%2520somatic%2520cells%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D1917%26epage%3D1920%26doi%3D10.1126%2Fscience.1151526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">González, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boué, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izpisúa Belmonte, J. C.</span><span> </span><span class="NLM_article-title">Methods for making induced pluripotent stem cells: reprogramming à la carte</span> <span class="citation_source-journal">Nat. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1038/nrg2937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnrg2937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21339765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVGkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=231-242&author=F.+Gonz%C3%A1lezauthor=S.+Bou%C3%A9author=J.+C.+Izpis%C3%BAa+Belmonte&title=Methods+for+making+induced+pluripotent+stem+cells%3A+reprogramming+%C3%A0+la+carte&doi=10.1038%2Fnrg2937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Methods for making induced pluripotent stem cells: reprogramming a la carte</span></div><div class="casAuthors">Gonzalez, Federico; Boue, Stephanie; Belmonte, Juan Carlos Izpisua</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">231-242</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There are now myriad variations on techniques to reprogramme somatic cells into pluripotent stem cells, but which options should researchers choose This Review sets out the choices, focusing on how the desired downstream application should guide the reprogramming strategy.  Pluripotent stem-cell lines can be obtained through the reprogramming of somatic cells from different tissues and species by ectopic expression of defined factors.  In theory, these cells - known as induced pluripotent stem cells (iPSCs) - are suitable for various purposes, including disease modeling, autologous cell therapy, drug or toxicity screening and basic research.  Recent methodol. improvements are increasing the ease and efficiency of reprogramming, and reducing the genomic modifications required to complete the process.  However, depending on the downstream applications, certain technologies have advantages over others.  Here, we provide a comprehensive overview of the existing reprogramming approaches with the aim of providing readers with a better understanding of the reprogramming process and a basis for selecting the most suitable method for basic or clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraFE8Fhchm_LVg90H21EOLACvtfcHk0liGCLCFLNFQLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVGkt7c%253D&md5=8802267a97cc92950b7190eac5650874</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrg2937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg2937%26sid%3Dliteratum%253Aachs%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DF.%26aulast%3DBou%25C3%25A9%26aufirst%3DS.%26aulast%3DIzpis%25C3%25BAa%2BBelmonte%26aufirst%3DJ.%2BC.%26atitle%3DMethods%2520for%2520making%2520induced%2520pluripotent%2520stem%2520cells%253A%2520reprogramming%2520%25C3%25A0%2520la%2520carte%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2011%26volume%3D12%26spage%3D231%26epage%3D242%26doi%3D10.1038%2Fnrg2937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Kim, D.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaslavsky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J.</span><span> </span><span class="NLM_article-title">Optimizing neuronal differentiation from induced pluripotent stem cells to model ASD</span> <span class="citation_source-journal">Front. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="refDoi"> DOI: 10.3389/fncel.2014.00109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.3389%2Ffncel.2014.00109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24782713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGnsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=109&author=D.-S.+Kimauthor=P.+J.+Rossauthor=K.+Zaslavskyauthor=J.+Ellis&title=Optimizing+neuronal+differentiation+from+induced+pluripotent+stem+cells+to+model+ASD&doi=10.3389%2Ffncel.2014.00109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing neuronal differentiation from induced pluripotent stem cells to model ASD</span></div><div class="casAuthors">Kim, Dae-Sung; Ross, P. Joel; Zaslavsky, Kirill; Ellis, James</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109/1-109/16, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Autism spectrum disorder (ASD) is an early-onset neurodevelopmental disorder characterized by deficits in social communication, and restricted and repetitive patterns of behavior.  Despite its high prevalence, discovery of pathophysiol. mechanisms underlying ASD has lagged due to a lack of appropriate model systems.  Recent advances in induced pluripotent stem cell (iPSC) technol. and neural differentiation techniques allow for detailed functional analyses of neurons generated from living individuals with ASD.  Refinement of cortical neuron differentiation methods from iPSCs will enable mechanistic studies of specific neuronal subpopulations that may be preferentially impaired in ASD.  In this review, we summarize recent accomplishments in differentiation of cortical neurons from human pluripotent stems cells and efforts to establish in vitro model systems to study ASD using personalized neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp12Pr3jSLWzrVg90H21EOLACvtfcHk0liI5MaVw_jn_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGnsbvE&md5=2bbe40bee0e974e63ba8e0a220c851b8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2014.00109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2014.00109%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.-S.%26aulast%3DRoss%26aufirst%3DP.%2BJ.%26aulast%3DZaslavsky%26aufirst%3DK.%26aulast%3DEllis%26aufirst%3DJ.%26atitle%3DOptimizing%2520neuronal%2520differentiation%2520from%2520induced%2520pluripotent%2520stem%2520cells%2520to%2520model%2520ASD%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D109%26doi%3D10.3389%2Ffncel.2014.00109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Lian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azarin, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazeltine, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamp, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palecek, S. P.</span><span> </span><span class="NLM_article-title">Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">162</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span><span class="refDoi"> DOI: 10.1038/nprot.2012.150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnprot.2012.150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23257984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1KisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=162-175&author=X.+Lianauthor=J.+Zhangauthor=S.+M.+Azarinauthor=K.+Zhuauthor=L.+B.+Hazeltineauthor=X.+Baoauthor=C.+Hsiaoauthor=T.+J.+Kampauthor=S.+P.+Palecek&title=Directed+cardiomyocyte+differentiation+from+human+pluripotent+stem+cells+by+modulating+Wnt%2F%CE%B2-catenin+signaling+under+fully+defined+conditions&doi=10.1038%2Fnprot.2012.150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions</span></div><div class="casAuthors">Lian, Xiaojun; Zhang, Jianhua; Azarin, Samira M.; Zhu, Kexian; Hazeltine, Laurie B.; Bao, Xiaoping; Hsiao, Cheston; Kamp, Timothy J.; Palecek, Sean P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">162-175</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The protocol described here efficiently directs human pluripotent stem cells (hPSCs) to functional cardiomyocytes in a completely defined, growth factor- and serum-free system by temporal modulation of regulators of canonical Wnt signaling.  Appropriate temporal application of a glycogen synthase kinase 3 (GSK3) inhibitor combined with the expression of β-catenin shRNA or a chem. Wnt inhibitor is sufficient to produce a high yield (0.8-1.3 million cardiomyocytes per cm2) of virtually pure (80-98%) functional cardiomyocytes in 14 d from multiple hPSC lines without cell sorting or selection.  Qual. (immunostaining) and quant. (flow cytometry) characterization of differentiated cells is described to assess the expression of cardiac transcription factors and myofilament proteins.  Flow cytometry of BrdU incorporation or Ki67 expression in conjunction with cardiac sarcomere myosin protein expression can be used to det. the proliferative capacity of hPSC-derived cardiomyocytes.  Functional human cardiomyocytes differentiated via these protocols may constitute a potential cell source for heart disease modeling, drug screening and cell-based therapeutic applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKfgKIeSpJybVg90H21EOLACvtfcHk0liI5MaVw_jn_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1KisLk%253D&md5=e8a8e7f0ab41ce99452cb8c4562129e7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2012.150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2012.150%26sid%3Dliteratum%253Aachs%26aulast%3DLian%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAzarin%26aufirst%3DS.%2BM.%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DHazeltine%26aufirst%3DL.%2BB.%26aulast%3DBao%26aufirst%3DX.%26aulast%3DHsiao%26aufirst%3DC.%26aulast%3DKamp%26aufirst%3DT.%2BJ.%26aulast%3DPalecek%26aufirst%3DS.%2BP.%26atitle%3DDirected%2520cardiomyocyte%2520differentiation%2520from%2520human%2520pluripotent%2520stem%2520cells%2520by%2520modulating%2520Wnt%252F%25CE%25B2-catenin%2520signaling%2520under%2520fully%2520defined%2520conditions%26jtitle%3DNat.%2520Protoc.%26date%3D2013%26volume%3D8%26spage%3D162%26epage%3D175%26doi%3D10.1038%2Fnprot.2012.150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschudy-Seney, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roll, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behbahan, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahuja, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolstikov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khoobyari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolta, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willenbring, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zern, M. A.</span><span> </span><span class="NLM_article-title">Highly efficient differentiation of functional hepatocytes from human induced pluripotent stem cells</span> <span class="citation_source-journal">Stem Cells Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.5966/sctm.2012-0160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.5966%2Fsctm.2012-0160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23681950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVOktbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=409-419&author=X.+Maauthor=Y.+Duanauthor=B.+Tschudy-Seneyauthor=G.+Rollauthor=I.+S.+Behbahanauthor=T.+P.+Ahujaauthor=V.+Tolstikovauthor=C.+Wangauthor=J.+McGeeauthor=S.+Khoobyariauthor=J.+A.+Noltaauthor=H.+Willenbringauthor=M.+A.+Zern&title=Highly+efficient+differentiation+of+functional+hepatocytes+from+human+induced+pluripotent+stem+cells&doi=10.5966%2Fsctm.2012-0160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Highly efficient differentiation of functional hepatocytes from human induced pluripotent stem cells</span></div><div class="casAuthors">Ma, Xiaocui; Duan, Yuyou; Tschudy-Seney, Benjamin; Roll, Garrett; Behbahan, Iman Saramipoor; Ahuja, Tuess P.; Tolstikov, Vladimir; Wang, Charles; McGee, Jeannine; Khoobyari, Shiva; Nolta, Jan A.; Willenbring, Holger; Zern, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cells Translational Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">409-419</span>CODEN:
                <span class="NLM_cas:coden">SCTMC7</span>;
        ISSN:<span class="NLM_cas:issn">2157-6564</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">Human induced pluripotent stem cells (hiPSCs) hold great potential for use in regenerative medicine, novel drug development, and disease progression/developmental studies.  Here, we report highly efficient differentiation of hiPSCs toward a relatively homogeneous population of functional hepatocytes.  HiPSC-derived hepatocytes (hiHs) not only showed a high expression of hepatocyte-specific proteins and liver-specific functions, but they also developed a functional biotransformation system including phase I and II metabolizing enzymes and phase III transporters.  Nuclear receptors, which are crit. for regulating the expression of metabolizing enzymes, were also expressed in hiHs.  HiHs also responded to different compds./inducers of cytochrome P 450 as mature hepatocytes do.  To follow up on this observation, we analyzed the drug metabolizing capacity of hiHs in real time using a novel ultraperformance liq. chromatog.-tandem mass spectrometry.  We found that, like freshly isolated primary human hepatocytes, the seven major metabolic pathways of the drug bufuralol were found in hiHs.  In addn., transplanted hiHs engrafted, integrated, and proliferated in livers of an immune-deficient mouse model, and secreted human albumin, indicating that hiHs also function in vivo.  In conclusion, we have generated a method for the efficient generation of hepatocytes from induced pluripotent stem cells in vitro and in vivo, and it appears that the cells function similarly to primary human hepatocytes, including developing a complete metabolic function.  These results represent a significant step toward using patient/disease-specific hepatocytes for cell-based therapeutics as well as for pharmacol. and toxicol. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5XXj8lY8uArVg90H21EOLACvtfcHk0liI5MaVw_jn_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVOktbvN&md5=6b9582854d52592d09b4f21654e15704</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.5966%2Fsctm.2012-0160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5966%252Fsctm.2012-0160%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DDuan%26aufirst%3DY.%26aulast%3DTschudy-Seney%26aufirst%3DB.%26aulast%3DRoll%26aufirst%3DG.%26aulast%3DBehbahan%26aufirst%3DI.%2BS.%26aulast%3DAhuja%26aufirst%3DT.%2BP.%26aulast%3DTolstikov%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DMcGee%26aufirst%3DJ.%26aulast%3DKhoobyari%26aufirst%3DS.%26aulast%3DNolta%26aufirst%3DJ.%2BA.%26aulast%3DWillenbring%26aufirst%3DH.%26aulast%3DZern%26aufirst%3DM.%2BA.%26atitle%3DHighly%2520efficient%2520differentiation%2520of%2520functional%2520hepatocytes%2520from%2520human%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DStem%2520Cells%2520Transl.%2520Med.%26date%3D2013%26volume%3D2%26spage%3D409%26epage%3D419%26doi%3D10.5966%2Fsctm.2012-0160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Diekman, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoforou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willard, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leong, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilak, F.</span><span> </span><span class="NLM_article-title">Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">19172</span><span class="NLM_x">–</span> <span class="NLM_lpage">19177</span><span class="refDoi"> DOI: 10.1073/pnas.1210422109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1073%2Fpnas.1210422109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23115336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVagtrjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=19172-19177&author=B.+O.+Diekmanauthor=N.+Christoforouauthor=V.+P.+Willardauthor=H.+Sunauthor=J.+Sanchez-Adamsauthor=K.+W.+Leongauthor=F.+Guilak&title=Cartilage+tissue+engineering+using+differentiated+and+purified+induced+pluripotent+stem+cells&doi=10.1073%2Fpnas.1210422109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells</span></div><div class="casAuthors">Diekman, Brian O.; Christoforou, Nicolas; Willard, Vincent P.; Sun, Haosi; Sanchez-Adams, Johannah; Leong, Kam W.; Guilak, Farshid</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">19172-19177, S19172/1-S19172/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The development of regenerative therapies for cartilage injury has been greatly aided by recent advances in stem cell biol.  Induced pluripotent stem cells (iPSCs) have the potential to provide an abundant cell source for tissue engineering, as well as generating patient-matched in vitro models to study genetic and environmental factors in cartilage repair and osteoarthritis.  However, both cell therapy and modeling approaches require a purified and uniformly differentiated cell population to predictably recapitulate the physiol. characteristics of cartilage.  Here, iPSCs derived from adult mouse fibroblasts were chondrogenically differentiated and purified by type II collagen (Col2)-driven green fluorescent protein (GFP) expression.  Col2 and aggrecan gene expression levels were significantly up-regulated in GFP+ cells compared with GFP- cells and decreased with monolayer expansion.  An in vitro cartilage defect model was used to demonstrate integrative repair by GFP+ cells seeded in agarose, supporting their potential use in cartilage therapies.  In chondrogenic pellet culture, cells synthesized cartilage-specific matrix as indicated by high levels of glycosaminoglycans and type II collagen and low levels of type I and type X collagen.  The feasibility of cell expansion after initial differentiation was illustrated by homogenous matrix deposition in pellets from twice-passaged GFP+ cells.  Finally, at. force microscopy anal. showed increased microscale elastic moduli assocd. with collagen alignment at the periphery of pellets, mimicking zonal variation in native cartilage.  This study demonstrates the potential use of iPSCs for cartilage defect repair and for creating tissue models of cartilage that can be matched to specific genetic backgrounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI2gcVQL1I9bVg90H21EOLACvtfcHk0lhEh-5IP4VdjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVagtrjO&md5=f888cdf3556d11efd0ce1938871e8e7f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1210422109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1210422109%26sid%3Dliteratum%253Aachs%26aulast%3DDiekman%26aufirst%3DB.%2BO.%26aulast%3DChristoforou%26aufirst%3DN.%26aulast%3DWillard%26aufirst%3DV.%2BP.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DSanchez-Adams%26aufirst%3DJ.%26aulast%3DLeong%26aufirst%3DK.%2BW.%26aulast%3DGuilak%26aufirst%3DF.%26atitle%3DCartilage%2520tissue%2520engineering%2520using%2520differentiated%2520and%2520purified%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D19172%26epage%3D19177%26doi%3D10.1073%2Fpnas.1210422109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Merkle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggan, K.</span><span> </span><span class="NLM_article-title">Modeling human disease with pluripotent stem cells: from genome association to function</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">656</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span><span class="refDoi"> DOI: 10.1016/j.stem.2013.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.stem.2013.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23746975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFOjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=656-668&author=F.+T.+Merkleauthor=K.+Eggan&title=Modeling+human+disease+with+pluripotent+stem+cells%3A+from+genome+association+to+function&doi=10.1016%2Fj.stem.2013.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling Human Disease with Pluripotent Stem Cells: from Genome Association to Function</span></div><div class="casAuthors">Merkle, Florian T.; Eggan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stem Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">656-668</span>CODEN:
                <span class="NLM_cas:coden">CSCEC4</span>;
        ISSN:<span class="NLM_cas:issn">1875-9777</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Mechanistic insights into human disease may enable the development of treatments that are effective in broad patient populations.  The confluence of gene-editing technologies, induced pluripotent stem cells, and genome-wide assocn. as well as DNA sequencing studies is enabling new approaches for illuminating the mol. basis of human disease.  We discuss the opportunities and challenges of combining these technologies and provide a workflow for interrogating the contribution of disease-assocd. candidate genetic variants to disease-relevant phenotypes.  Finally, we discuss the potential utility of human pluripotent stem cells for placing disease-assocd. genetic variants into mol. pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnjRzBTuEcZbVg90H21EOLACvtfcHk0lhEh-5IP4VdjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFOjtrs%253D&md5=d35abcd12c26d92b17aa52585e5fc50c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2013.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2013.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DMerkle%26aufirst%3DF.%2BT.%26aulast%3DEggan%26aufirst%3DK.%26atitle%3DModeling%2520human%2520disease%2520with%2520pluripotent%2520stem%2520cells%253A%2520from%2520genome%2520association%2520to%2520function%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2013%26volume%3D12%26spage%3D656%26epage%3D668%26doi%3D10.1016%2Fj.stem.2013.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Sterneckert, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schöler, H. R.</span><span> </span><span class="NLM_article-title">Investigating human disease using stem cell models</span> <span class="citation_source-journal">Nat. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span><span class="refDoi"> DOI: 10.1038/nrg3764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnrg3764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=25069490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ams7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=625-639&author=J.+L.+Sterneckertauthor=P.+Reinhardtauthor=H.+R.+Sch%C3%B6ler&title=Investigating+human+disease+using+stem+cell+models&doi=10.1038%2Fnrg3764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Investigating human disease using stem cell models</span></div><div class="casAuthors">Sterneckert, Jared L.; Reinhardt, Peter; Schoeler, Hans R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">625-639</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tractable and accurate disease models are essential for understanding disease pathogenesis and for developing new therapeutics.  As stem cells are capable of self-renewal and differentiation, they are ideally suited both for generating these models and for obtaining the large quantities of cells required for drug development and transplantation therapies.  Although proof of principle for the use of adult stem cells and embryonic stem cells in disease modeling has been established, induced pluripotent stem cells (iPSCs) have demonstrated the greatest utility for modeling human diseases.  Furthermore, combining gene editing with iPSCs enables the generation of models of genetically complex disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof-24iJeeEtbVg90H21EOLACvtfcHk0lhEh-5IP4VdjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ams7zN&md5=488855da74e86cae153c693c82e23e8a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrg3764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg3764%26sid%3Dliteratum%253Aachs%26aulast%3DSterneckert%26aufirst%3DJ.%2BL.%26aulast%3DReinhardt%26aufirst%3DP.%26aulast%3DSch%25C3%25B6ler%26aufirst%3DH.%2BR.%26atitle%3DInvestigating%2520human%2520disease%2520using%2520stem%2520cell%2520models%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2014%26volume%3D15%26spage%3D625%26epage%3D639%26doi%3D10.1038%2Fnrg3764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Zeng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunsberger, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeonov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, M.</span><span> </span><span class="NLM_article-title">Concise review: modeling central nervous system diseases using induced pluripotent stem cells</span> <span class="citation_source-journal">Stem Cells Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1418</span><span class="NLM_x">–</span> <span class="NLM_lpage">1428</span><span class="refDoi"> DOI: 10.5966/sctm.2014-0102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.5966%2Fsctm.2014-0102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=25368377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGis74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=1418-1428&author=X.+Zengauthor=J.+G.+Hunsbergerauthor=A.+Simeonovauthor=N.+Malikauthor=Y.+Peiauthor=M.+Rao&title=Concise+review%3A+modeling+central+nervous+system+diseases+using+induced+pluripotent+stem+cells&doi=10.5966%2Fsctm.2014-0102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Concise review: modeling central nervous system diseases using induced pluripotent stem cells</span></div><div class="casAuthors">Zeng, Xianmin; Hunsberger, Joshua G.; Simeonov, Anton; Malik, Nasir; Pei, Ying; Rao, Mahendra</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cells Translational Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1418-1428</span>CODEN:
                <span class="NLM_cas:coden">SCTMC7</span>;
        ISSN:<span class="NLM_cas:issn">2157-6564</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">A review.  Induced pluripotent stem cells (iPSCs) offer an opportunity to delve into the mechanisms underlying development while also affording the potential to take advantage of a no. of naturally occurring mutations that contribute to either disease susceptibility or resistance.  Just as with any new field, several models of screening are being explored, and innovators are working on the most efficient methods to overcome the inherent limitations of primary cell screens using iPSCs.  In the present review, we provide a background regarding why iPSCs represent a paradigm shift for central nervous system (CNS) disease modeling.  We describe the efforts in the field to develop more biol. relevant CNS disease models, which should provide screening assays useful for the pharmaceutical industry.  We also provide some examples of successful uses for iPSC-based screens and suggest that addnl. development could revolutionize the field of drug discovery.  The development and implementation of these advanced iPSC-based screens will create a more efficient disease-specific process underpinned by the biol. mechanism in a patient- and disease-specific manner rather than by trial-and-error.  Moreover, with careful and strategic planning, shared resources can be developed that will enable exponential advances in the field.  This will undoubtedly lead to more sensitive and accurate screens for early diagnosis and allow the identification of patient-specific therapies, thus, paving the way to personalized medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDVaYKRANkJrVg90H21EOLACvtfcHk0liR8S-wiSKOgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGis74%253D&md5=9fde9588bb07918b193a699e1e29e31f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.5966%2Fsctm.2014-0102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5966%252Fsctm.2014-0102%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DX.%26aulast%3DHunsberger%26aufirst%3DJ.%2BG.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DMalik%26aufirst%3DN.%26aulast%3DPei%26aufirst%3DY.%26aulast%3DRao%26aufirst%3DM.%26atitle%3DConcise%2520review%253A%2520modeling%2520central%2520nervous%2520system%2520diseases%2520using%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DStem%2520Cells%2520Transl.%2520Med.%26date%3D2014%26volume%3D3%26spage%3D1418%26epage%3D1428%26doi%3D10.5966%2Fsctm.2014-0102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Qiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeliovich, A.</span><span> </span><span class="NLM_article-title">Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">957</span><span class="NLM_x">–</span> <span class="NLM_lpage">969</span><span class="refDoi"> DOI: 10.1016/j.neuron.2013.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.neuron.2013.06.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=957-969&author=L.+Qiangauthor=R.+Fujitaauthor=A.+Abeliovich&title=Remodeling+neurodegeneration%3A+somatic+cell+reprogramming-based+models+of+adult+neurological+disorders&doi=10.1016%2Fj.neuron.2013.06.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2013.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2013.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DQiang%26aufirst%3DL.%26aulast%3DFujita%26aufirst%3DR.%26aulast%3DAbeliovich%26aufirst%3DA.%26atitle%3DRemodeling%2520neurodegeneration%253A%2520somatic%2520cell%2520reprogramming-based%2520models%2520of%2520adult%2520neurological%2520disorders%26jtitle%3DNeuron%26date%3D2013%26volume%3D78%26spage%3D957%26epage%3D969%26doi%3D10.1016%2Fj.neuron.2013.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ross, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akimov, S. S.</span><span> </span><span class="NLM_article-title">Human-induced pluripotent stem cells: potential for neurodegenerative diseases</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">R17</span><span class="NLM_x">–</span> <span class="NLM_lpage">R26</span><span class="refDoi"> DOI: 10.1093/hmg/ddu204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1093%2Fhmg%2Fddu204" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=R17-R26&author=C.+A.+Rossauthor=S.+S.+Akimov&title=Human-induced+pluripotent+stem+cells%3A+potential+for+neurodegenerative+diseases&doi=10.1093%2Fhmg%2Fddu204"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddu204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddu204%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DC.%2BA.%26aulast%3DAkimov%26aufirst%3DS.%2BS.%26atitle%3DHuman-induced%2520pluripotent%2520stem%2520cells%253A%2520potential%2520for%2520neurodegenerative%2520diseases%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2014%26volume%3D23%26spage%3DR17%26epage%3DR26%26doi%3D10.1093%2Fhmg%2Fddu204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Anderson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kichula, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rork, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, B. Y.</span><span> </span><span class="NLM_article-title">Familial Dysautonomia is caused by mutations of the IKAP gene</span> <span class="citation_source-journal">Am. J. Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">758</span><span class="refDoi"> DOI: 10.1086/318808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1086%2F318808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=11179021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD3MXit1aks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2001&pages=753-758&author=S.+L.+Andersonauthor=R.+Coliauthor=I.+W.+Dalyauthor=E.+A.+Kichulaauthor=M.+J.+Rorkauthor=S.+A.+Volpiauthor=J.+Eksteinauthor=B.+Y.+Rubin&title=Familial+Dysautonomia+is+caused+by+mutations+of+the+IKAP+gene&doi=10.1086%2F318808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Familial dysautonomia is caused by mutations of the IKAP gene</span></div><div class="casAuthors">Anderson, Sylvia L.; Coli, Rocco; Daly, Ira W.; Kichula, Elizabeth A.; Rork, Matthew J.; Volpi, Sabrina A.; Ekstein, Josef; Rubin, Berish Y.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">753-758</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">The defective gene DYS, which is responsible for familial dysautonomia (FD) and has been mapped to a 0.5-cM region on chromosome 9q31, has eluded identification.  The authors identified and characterized the RNAs encoded by this region of chromosome 9 in cell lines derived from individuals homozygous for the major FD haplotype, and the authors obsd. that the RNA encoding the IκB kinase complex-assocd. protein (IKAP) lacks exon 20 and, as a result of a frameshift, encodes a truncated protein.  Sequence anal. reveals a T→C transition in the donor splice site of intron 20.  In individuals bearing a minor FD haplotype, a missense mutation in exon 19 disrupts a consensus serine/threonine kinase phosphorylation site.  This mutation results in defective phosphorylation of IKAP.  These mutations were obsd. to be present in a random sample of Ashkenazi Jewish individuals, at approx. the predicted carrier frequency of FD.  These findings demonstrate that mutations in the gene encoding IKAP are responsible for FD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjF98Tj8RQbrVg90H21EOLACvtfcHk0liR8S-wiSKOgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXit1aks74%253D&md5=d0727b5f21efa7541c8289d09266b7d5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1086%2F318808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F318808%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DS.%2BL.%26aulast%3DColi%26aufirst%3DR.%26aulast%3DDaly%26aufirst%3DI.%2BW.%26aulast%3DKichula%26aufirst%3DE.%2BA.%26aulast%3DRork%26aufirst%3DM.%2BJ.%26aulast%3DVolpi%26aufirst%3DS.%2BA.%26aulast%3DEkstein%26aufirst%3DJ.%26aulast%3DRubin%26aufirst%3DB.%2BY.%26atitle%3DFamilial%2520Dysautonomia%2520is%2520caused%2520by%2520mutations%2520of%2520the%2520IKAP%2520gene%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2001%26volume%3D68%26spage%3D753%26epage%3D758%26doi%3D10.1086%2F318808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Lee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papapetrou, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomishima, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fasano, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganat, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadelain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studer, L.</span><span> </span><span class="NLM_article-title">Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">461</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span><span class="refDoi"> DOI: 10.1038/nature08320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature08320" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=402-406&author=G.+Leeauthor=E.+P.+Papapetrouauthor=H.+Kimauthor=S.+M.+Chambersauthor=M.+J.+Tomishimaauthor=C.+A.+Fasanoauthor=Y.+M.+Ganatauthor=J.+Menonauthor=F.+Shimizuauthor=A.+Vialeauthor=V.+Tabarauthor=M.+Sadelainauthor=L.+Studer&title=Modelling+pathogenesis+and+treatment+of+familial+dysautonomia+using+patient-specific+iPSCs&doi=10.1038%2Fnature08320"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature08320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08320%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DG.%26aulast%3DPapapetrou%26aufirst%3DE.%2BP.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DChambers%26aufirst%3DS.%2BM.%26aulast%3DTomishima%26aufirst%3DM.%2BJ.%26aulast%3DFasano%26aufirst%3DC.%2BA.%26aulast%3DGanat%26aufirst%3DY.%2BM.%26aulast%3DMenon%26aufirst%3DJ.%26aulast%3DShimizu%26aufirst%3DF.%26aulast%3DViale%26aufirst%3DA.%26aulast%3DTabar%26aufirst%3DV.%26aulast%3DSadelain%26aufirst%3DM.%26aulast%3DStuder%26aufirst%3DL.%26atitle%3DModelling%2520pathogenesis%2520and%2520treatment%2520of%2520familial%2520dysautonomia%2520using%2520patient-specific%2520iPSCs%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D402%26epage%3D406%26doi%3D10.1038%2Fnature08320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Lee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeltner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhinder, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee-Clavin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djaballah, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studer, L.</span><span> </span><span class="NLM_article-title">Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1244</span><span class="NLM_x">–</span> <span class="NLM_lpage">1248</span><span class="refDoi"> DOI: 10.1038/nbt.2435</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnbt.2435" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=1244-1248&author=G.+Leeauthor=C.+N.+Ramirezauthor=H.+Kimauthor=N.+Zeltnerauthor=B.+Liuauthor=C.+Raduauthor=B.+Bhinderauthor=Y.+J.+Kimauthor=I.+Y.+Choiauthor=B.+Mukherjee-Clavinauthor=H.+Djaballahauthor=L.+Studer&title=Large-scale+screening+using+familial+dysautonomia+induced+pluripotent+stem+cells+identifies+compounds+that+rescue+IKBKAP+expression&doi=10.1038%2Fnbt.2435"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2435%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DG.%26aulast%3DRamirez%26aufirst%3DC.%2BN.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DZeltner%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DRadu%26aufirst%3DC.%26aulast%3DBhinder%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DY.%2BJ.%26aulast%3DChoi%26aufirst%3DI.%2BY.%26aulast%3DMukherjee-Clavin%26aufirst%3DB.%26aulast%3DDjaballah%26aufirst%3DH.%26aulast%3DStuder%26aufirst%3DL.%26atitle%3DLarge-scale%2520screening%2520using%2520familial%2520dysautonomia%2520induced%2520pluripotent%2520stem%2520cells%2520identifies%2520compounds%2520that%2520rescue%2520IKBKAP%2520expression%26jtitle%3DNat.%2520Biotechnol.%26date%3D2012%26volume%3D30%26spage%3D1244%26epage%3D1248%26doi%3D10.1038%2Fnbt.2435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kolb, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissel, J. T.</span><span> </span><span class="NLM_article-title">Spinal muscular atrophy: a timely review</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">984</span><span class="refDoi"> DOI: 10.1001/archneurol.2011.74</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1001%2Farchneurol.2011.74" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21482919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A280%3ADC%252BC3MjksVKjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2011&pages=979-984&author=S.+J.+Kolbauthor=J.+T.+Kissel&title=Spinal+muscular+atrophy%3A+a+timely+review&doi=10.1001%2Farchneurol.2011.74"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Spinal muscular atrophy: a timely review</span></div><div class="casAuthors">Kolb Stephen J; Kissel John T</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">979-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Spinal muscular atrophy (SMA) is a neurodegenerative disease characterized by loss of motor neurons in the anterior horn of the spinal cord and resultant weakness.  The most common form of SMA, accounting for 95% of cases, is autosomal recessive proximal SMA associated with mutations in the survival of motor neurons (SMN1) gene.  Relentless progress during the past 15 years in the understanding of the molecular genetics and pathophysiology of SMA has resulted in a unique opportunity for rational, effective therapeutic trials.  The goal of SMA therapy is to increase the expression levels of the SMN protein in the correct cells at the right time.  With this target in sight, investigators can now effectively screen potential therapies in vitro, test them in accurate, reliable animal models, move promising agents forward to clinical trials, and accurately diagnose patients at an early or presymptomatic stage of disease.  A major challenge for the SMA community will be to prioritize and develop the most promising therapies in an efficient, timely, and safe manner with the guidance of the appropriate regulatory agencies.  This review will take a historical perspective to highlight important milestones on the road to developing effective therapies for SMA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQy90kBbekgJf69nzq6467DfW6udTcc2eaM1kOra7M0Zbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjksVKjsA%253D%253D&md5=0dca2120de923052563b6d2f3905a87d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1001%2Farchneurol.2011.74&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneurol.2011.74%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DS.%2BJ.%26aulast%3DKissel%26aufirst%3DJ.%2BT.%26atitle%3DSpinal%2520muscular%2520atrophy%253A%2520a%2520timely%2520review%26jtitle%3DArch.%2520Neurol.%26date%3D2011%26volume%3D68%26spage%3D979%26epage%3D984%26doi%3D10.1001%2Farchneurol.2011.74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Ebert, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, F. F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattis, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorson, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svendsen, C. N.</span><span> </span><span class="NLM_article-title">Induced pluripotent stem cells from a spinal muscular atrophy patient</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">457</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span><span class="refDoi"> DOI: 10.1038/nature07677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature07677" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=19098894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFWnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2009&pages=277-280&author=A.+D.+Ebertauthor=J.+Yuauthor=F.+F.+Roseauthor=V.+B.+Mattisauthor=C.+L.+Lorsonauthor=J.+A.+Thomsonauthor=C.+N.+Svendsen&title=Induced+pluripotent+stem+cells+from+a+spinal+muscular+atrophy+patient&doi=10.1038%2Fnature07677"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Induced pluripotent stem cells from a spinal muscular atrophy patient</span></div><div class="casAuthors">Ebert, Allison D.; Yu, Junying; Rose, Ferrill F., Jr.; Mattis, Virginia B.; Lorson, Christian L.; Thomson, James A.; Svendsen, Clive N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">457</span>
        (<span class="NLM_cas:issue">7227</span>),
    <span class="NLM_cas:pages">277-280</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Spinal muscular atrophy is one of the most common inherited forms of neurol. disease leading to infant mortality.  Patients have selective loss of lower motor neurons resulting in muscle weakness, paralysis and often death.  Although patient fibroblasts have been used extensively to study spinal muscular atrophy, motor neurons have a unique anatomy and physiol. which may underlie their vulnerability to the disease process.  Here the authors report the generation of induced pluripotent stem cells from skin fibroblast samples taken from a child with spinal muscular atrophy.  These cells expanded robustly in culture, maintained the disease genotype and generated motor neurons that showed selective deficits compared to those derived from the child's unaffected mother.  This is the first study to show that human induced pluripotent stem cells can be used to model the specific pathol. seen in a genetically inherited disease.  As such, it represents a promising resource to study disease mechanisms, screen new drug compds. and develop new therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpITfd6GqT6_bVg90H21EOLACvtfcHk0liv9VVBdDAlSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFWnsw%253D%253D&md5=0763383c1a78f8279ec939cc13da4b18</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature07677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07677%26sid%3Dliteratum%253Aachs%26aulast%3DEbert%26aufirst%3DA.%2BD.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DRose%26aufirst%3DF.%2BF.%26aulast%3DMattis%26aufirst%3DV.%2BB.%26aulast%3DLorson%26aufirst%3DC.%2BL.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DSvendsen%26aufirst%3DC.%2BN.%26atitle%3DInduced%2520pluripotent%2520stem%2520cells%2520from%2520a%2520spinal%2520muscular%2520atrophy%2520patient%26jtitle%3DNature%26date%3D2009%26volume%3D457%26spage%3D277%26epage%3D280%26doi%3D10.1038%2Fnature07677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Amir, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Veyver, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francke, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, H. Y.</span><span> </span><span class="NLM_article-title">Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span><span class="refDoi"> DOI: 10.1038/13810</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2F13810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10508514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlOhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1999&pages=185-188&author=R.+E.+Amirauthor=I.+B.+Van+den+Veyverauthor=M.+Wanauthor=C.+Q.+Tranauthor=U.+Franckeauthor=H.+Y.+Zoghbi&title=Rett+syndrome+is+caused+by+mutations+in+X-linked+MECP2%2C+encoding+methyl-CpG-binding+protein+2&doi=10.1038%2F13810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</span></div><div class="casAuthors">Amir, Ruthie E.; Van den Veyver, Ignatia B.; Wan, Mimi; Tran, Charles Q.; Francke, Uta; Zoghbi, Huda Y.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-188</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Rett syndrome (RTT, MIM 312750) is a progressive neurodevelopmental disorder and one of the most common causes of mental retardation in females, with an incidence of 1 in 10,000-15,000.  Patients with classic RTT appear to develop normally until 6-18 mo of age, then gradually lose speech and purposeful hand use, and develop microcephaly, seizures, autism, ataxia, intermittent hyperventilation and stereotypic hand movements.  After initial regression, the condition stabilizes and patients usually survive into adulthood.  As RTT occurs almost exclusively in females, it has been proposed that RTT is caused by an X-linked dominant mutation with lethality in hemizygous males.  Previous exclusion mapping studies using RTT families mapped the locus to Xq28.  Using a systematic gene screening approach, the authors have identified mutations in the gene (MECP2) encoding X-linked methyl-CpG-binding protein 2 (MeCP2) as the cause of some cases of RTT.  MeCP2 selectively binds CpG dinucleotides in the mammalian genome and mediates transcriptional repression through interaction with histone deacetylase and the corepressor SIN3A.  In 5 of 21 sporadic patients, the authors found 3 de novo missense mutations in the region encoding the highly conserved methyl-binding domain (MBD) as well as a de novo frameshift and a de novo nonsense mutation, both of which disrupt the transcription repression domain (TRD).  In two affected half-sisters of a RTT family, the authors found segregation of an addnl. missense mutation not detected in their obligate carrier mother.  This suggests that the mother is a germline mosaic for this mutation.  The authors' study reports the first disease-causing mutations in RTT and points to abnormal epigenetic regulation as the mechanism underlying the pathogenesis of RTT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7yw7uglP4ErVg90H21EOLACvtfcHk0liv9VVBdDAlSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlOhtbo%253D&md5=ca0a168eb91cd1514c38058a1955c289</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2F13810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F13810%26sid%3Dliteratum%253Aachs%26aulast%3DAmir%26aufirst%3DR.%2BE.%26aulast%3DVan%2Bden%2BVeyver%26aufirst%3DI.%2BB.%26aulast%3DWan%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DC.%2BQ.%26aulast%3DFrancke%26aufirst%3DU.%26aulast%3DZoghbi%26aufirst%3DH.%2BY.%26atitle%3DRett%2520syndrome%2520is%2520caused%2520by%2520mutations%2520in%2520X-linked%2520MECP2%252C%2520encoding%2520methyl-CpG-binding%2520protein%25202%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D23%26spage%3D185%26epage%3D188%26doi%3D10.1038%2F13810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Chao, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenmund, C.</span><span> </span><span class="NLM_article-title">MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span><span class="refDoi"> DOI: 10.1016/j.neuron.2007.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.neuron.2007.08.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=58-65&author=H.+T.+Chaoauthor=H.+Y.+Zoghbiauthor=C.+Rosenmund&title=MeCP2+controls+excitatory+synaptic+strength+by+regulating+glutamatergic+synapse+number&doi=10.1016%2Fj.neuron.2007.08.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2007.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2007.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DChao%26aufirst%3DH.%2BT.%26aulast%3DZoghbi%26aufirst%3DH.%2BY.%26aulast%3DRosenmund%26aufirst%3DC.%26atitle%3DMeCP2%2520controls%2520excitatory%2520synaptic%2520strength%2520by%2520regulating%2520glutamatergic%2520synapse%2520number%26jtitle%3DNeuron%26date%3D2007%26volume%3D56%26spage%3D58%26epage%3D65%26doi%3D10.1016%2Fj.neuron.2007.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Marchetto, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carromeu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acab, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muotri, A. R.</span><span> </span><span class="NLM_article-title">A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">539</span><span class="refDoi"> DOI: 10.1016/j.cell.2010.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.cell.2010.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21074045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahtbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2010&pages=527-539&author=M.+C.+Marchettoauthor=C.+Carromeuauthor=A.+Acabauthor=D.+Yuauthor=G.+W.+Yeoauthor=Y.+Muauthor=G.+Chenauthor=F.+H.+Gageauthor=A.+R.+Muotri&title=A+model+for+neural+development+and+treatment+of+Rett+syndrome+using+human+induced+pluripotent+stem+cells&doi=10.1016%2Fj.cell.2010.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells</span></div><div class="casAuthors">Marchetto, Maria C. N.; Carromeu, Cassiano; Acab, Allan; Yu, Diana; Yeo, Gene W.; Mu, Yangling; Chen, Gong; Gage, Fred H.; Muotri, Alysson R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-539</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Autism spectrum disorders (ASD) are complex neurodevelopmental diseases in which different combinations of genetic mutations may contribute to the phenotype.  Using Rett syndrome (RTT) as an ASD genetic model, we developed a culture system using induced pluripotent stem cells (iPSCs) from RTT patients' fibroblasts.  RTT patients' iPSCs are able to undergo X-inactivation and generate functional neurons.  Neurons derived from RTT-iPSCs had fewer synapses, reduced spine d., smaller soma size, altered calcium signaling and electrophysiol. defects when compared to controls.  Our data uncovered early alterations in developing human RTT neurons.  Finally, we used RTT neurons to test the effects of drugs in rescuing synaptic defects.  Our data provide evidence of an unexplored developmental window, before disease onset, in RTT syndrome where potential therapies could be successfully employed.  Our model recapitulates early stages of a human neurodevelopmental disease and represents a promising cellular tool for drug screening, diagnosis and personalized treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVs6bKz90wyLVg90H21EOLACvtfcHk0lgUUZJhtLCXEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahtbrE&md5=e65138528f9ad3678f5c8e0e0cf2d162</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetto%26aufirst%3DM.%2BC.%26aulast%3DCarromeu%26aufirst%3DC.%26aulast%3DAcab%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DYeo%26aufirst%3DG.%2BW.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGage%26aufirst%3DF.%2BH.%26aulast%3DMuotri%26aufirst%3DA.%2BR.%26atitle%3DA%2520model%2520for%2520neural%2520development%2520and%2520treatment%2520of%2520Rett%2520syndrome%2520using%2520human%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DCell%26date%3D2010%26volume%3D143%26spage%3D527%26epage%3D539%26doi%3D10.1016%2Fj.cell.2010.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Koch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breuer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jungverdorben, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesavan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poppe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladewig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tüting, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klockgether, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evert, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wüllner, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brüstle, O.</span><span> </span><span class="NLM_article-title">Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">480</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span><span class="refDoi"> DOI: 10.1038/nature10671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature10671" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=480&publication_year=2011&pages=543-546&author=P.+Kochauthor=P.+Breuerauthor=M.+Peitzauthor=J.+Jungverdorbenauthor=J.+Kesavanauthor=D.+Poppeauthor=J.+Doerrauthor=J.+Ladewigauthor=J.+Mertensauthor=T.+T%C3%BCtingauthor=P.+Hoffmannauthor=T.+Klockgetherauthor=B.+O.+Evertauthor=U.+W%C3%BCllnerauthor=O.+Br%C3%BCstle&title=Excitation-induced+ataxin-3+aggregation+in+neurons+from+patients+with+Machado-Joseph+disease&doi=10.1038%2Fnature10671"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnature10671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10671%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DP.%26aulast%3DBreuer%26aufirst%3DP.%26aulast%3DPeitz%26aufirst%3DM.%26aulast%3DJungverdorben%26aufirst%3DJ.%26aulast%3DKesavan%26aufirst%3DJ.%26aulast%3DPoppe%26aufirst%3DD.%26aulast%3DDoerr%26aufirst%3DJ.%26aulast%3DLadewig%26aufirst%3DJ.%26aulast%3DMertens%26aufirst%3DJ.%26aulast%3DT%25C3%25BCting%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DP.%26aulast%3DKlockgether%26aufirst%3DT.%26aulast%3DEvert%26aufirst%3DB.%2BO.%26aulast%3DW%25C3%25BCllner%26aufirst%3DU.%26aulast%3DBr%25C3%25BCstle%26aufirst%3DO.%26atitle%3DExcitation-induced%2520ataxin-3%2520aggregation%2520in%2520neurons%2520from%2520patients%2520with%2520Machado-Joseph%2520disease%26jtitle%3DNature%26date%3D2011%26volume%3D480%26spage%3D543%26epage%3D546%26doi%3D10.1038%2Fnature10671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Camp, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuhausen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiobech, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polloi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myles-Worsley, M.</span><span> </span><span class="NLM_article-title">Genomewide multipoint linkage analysis of seven extended Palauan pedigrees with schizophrenia, by a Markov-chain Monte Carlo method</span> <span class="citation_source-journal">Am. J. Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1278</span><span class="NLM_x">–</span> <span class="NLM_lpage">1289</span><span class="refDoi"> DOI: 10.1086/324590</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1086%2F324590" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=11668428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD38XhslShug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2001&pages=1278-1289&author=N.+J.+Campauthor=S.+L.+Neuhausenauthor=J.+Tiobechauthor=A.+Polloiauthor=H.+Coonauthor=M.+Myles-Worsley&title=Genomewide+multipoint+linkage+analysis+of+seven+extended+Palauan+pedigrees+with+schizophrenia%2C+by+a+Markov-chain+Monte+Carlo+method&doi=10.1086%2F324590"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Genomewide multipoint linkage analysis of seven extended Palauan pedigrees with schizophrenia, by a Markov-chain Monte Carlo method</span></div><div class="casAuthors">Camp, Nicola J.; Neuhausen, Susan L.; Tiobech, Josepha; Polloi, Anthony; Coon, Hilary; Myles-Worsley, Marina</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1278-1289</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Palauans are an isolated population in Micronesia with lifetime prevalence of schizophrenia (SCZD) of 2%, compared to the world rate of ∼1%.  The possible enrichment for SCZD genes, in conjunction with the potential for reduced etiol. heterogeneity and the opportunity to ascertain statistically powerful extended pedigrees, makes Palauans a population of choice for the mapping of SCZD genes.  We have used a Markov-chain Monte Carlo method to perform a genome wide multipoint anal. in 7 extended pedigrees from Palau.  Robust multipoint parametric and nonparametric linkage (NPL) analyses were performed under three nested diagnostic classifications-core, spectrum, and broad.  We obsd. four regions of interest across the genome.  Two of these regions-on chromosomes 2p13-14 (for which, under core diagnostic classification, NPL = 6.5 and parametric LOD = 4.8) and 13q12-22 (for which, under broad diagnostic classification, parametric LOD = 3.6, and, under spectrum diagnostic classification, parametric LOD = 3.5)-had evidence for linkage with genome wide significance, after correction for multiple testing; with the current pedigree resource and genotyping, these regions are estd. to be 4.3 cM and 19.75 cM in size, resp.  A 3rd region, with intermediate evidence for linkage, was identified on chromosome 5q22-qterd (for which, under broad diagnostic classification, parametric LOD = 2.5).  The fourth region of interest had only borderline suggestive evidence for linkage (on 3q24-28; for this region, under broad diagnostic classification, parametric LOD = 2.0).  All regions exhibited evidence for genetic heterogeneity.  Our findings provide significant evidence for susceptibility loci on chromosomes 2p13-14 and 13q12-22 and support both a model of genetic heterogeneity and the utility of a broader set of diagnostic classifications in the population from Palau.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa1bBLf6V0pbVg90H21EOLACvtfcHk0lgUUZJhtLCXEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhslShug%253D%253D&md5=651209dd80bc69dfaf047bc297964768</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1086%2F324590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F324590%26sid%3Dliteratum%253Aachs%26aulast%3DCamp%26aufirst%3DN.%2BJ.%26aulast%3DNeuhausen%26aufirst%3DS.%2BL.%26aulast%3DTiobech%26aufirst%3DJ.%26aulast%3DPolloi%26aufirst%3DA.%26aulast%3DCoon%26aufirst%3DH.%26aulast%3DMyles-Worsley%26aufirst%3DM.%26atitle%3DGenomewide%2520multipoint%2520linkage%2520analysis%2520of%2520seven%2520extended%2520Palauan%2520pedigrees%2520with%2520schizophrenia%252C%2520by%2520a%2520Markov-chain%2520Monte%2520Carlo%2520method%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2001%26volume%3D69%26spage%3D1278%26epage%3D1289%26doi%3D10.1086%2F324590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Miyamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarskog, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleischhacker, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberman, J. A.</span><span> </span><span class="NLM_article-title">Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1206</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span><span class="refDoi"> DOI: 10.1038/mp.2012.47</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fmp.2012.47" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22584864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslahtrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=1206-1227&author=S.+Miyamotoauthor=N.+Miyakeauthor=L.+F.+Jarskogauthor=W.+W.+Fleischhackerauthor=J.+A.+Lieberman&title=Pharmacological+treatment+of+schizophrenia%3A+a+critical+review+of+the+pharmacology+and+clinical+effects+of+current+and+future+therapeutic+agents&doi=10.1038%2Fmp.2012.47"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents</span></div><div class="casAuthors">Miyamoto, S.; Miyake, N.; Jarskog, L. F.; Fleischhacker, W. W.; Lieberman, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1206-1227</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the introduction of chlorpromazine and throughout the development of the new-generation antipsychotic drugs (APDs) beginning with clozapine, the D2 receptor has been the target for the development of APDs.  Pharmacol. actions to reduce neurotransmission through the D2 receptor have been the only proven therapeutic mechanism for psychoses.  A no. of novel non-D2 mechanisms of action of APDs have been explored over the past 40 years but none has definitively been proven effective.  At the same time, the effectiveness of treatments and range of outcomes for patients are far from satisfactory.  The relative success of antipsychotics in treating pos. symptoms is limited by the fact that a substantial no. of patients are refractory to current medications and by their lack of efficacy for neg. and cognitive symptoms, which often det. the level of functional impairment.  In addn., while the newer antipsychotics produce fewer motor side effects, safety and tolerability concerns about wt. gain and endocrinopathies have emerged.  Consequently, there is an urgent need for more effective and better-tolerated antipsychotic agents, and to identify new mol. targets and develop mechanistically novel compds. that can address the various symptom dimensions of schizophrenia.  In recent years, a variety of new exptl. pharmacol. approaches have emerged, including compds. acting on targets other than the dopamine D2 receptor.  However, there is still an ongoing debate as to whether drugs selective for singe mol. targets (i.e., magic bullets') or drugs selectively non-selective for several mol. targets (i.e., magic shotguns', multifunctional drugs' or intramol. polypharmacy') will lead to more effective new medications for schizophrenia.  In this context, current and future drug development strategies can be seen to fall into three categories: (1) refinement of precedented mechanisms of action to provide drugs of comparable or superior efficacy and side-effect profiles to existing APDs; (2) development of novel (and presumably non-D2) mechanism APDs; (3) development of compds. to be used as adjuncts to APDs to augment efficacy by targeting specific symptom dimensions of schizophrenia and particularly those not responsive to traditional APD treatment.  In addn., efforts are being made to det. if the products of susceptibility genes in schizophrenia, identified by genetic linkage and assocn. studies, may be viable targets for drug development.  Finally, a focus on early detection and early intervention aimed at halting or reversing progressive pathophysiol. processes in schizophrenia has gained great influence.  This has encouraged future drug development and therapeutic strategies that are neuroprotective.  This article provides an update and crit. review of the pharmacol. and clin. profiles of current APDs and drugs acting on novel targets with potential to be therapeutic agents in the future.  Mol. Psychiatry (2012) 17, 1206-1227; doi:10.1038/mp.2012.47; published online 15 May 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8qXbq8buMvLVg90H21EOLACvtfcHk0liiRJp-uB8auw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslahtrbI&md5=f0240f40a88e012daaebd216efc438b1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fmp.2012.47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2012.47%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DS.%26aulast%3DMiyake%26aufirst%3DN.%26aulast%3DJarskog%26aufirst%3DL.%2BF.%26aulast%3DFleischhacker%26aufirst%3DW.%2BW.%26aulast%3DLieberman%26aufirst%3DJ.%2BA.%26atitle%3DPharmacological%2520treatment%2520of%2520schizophrenia%253A%2520a%2520critical%2520review%2520of%2520the%2520pharmacology%2520and%2520clinical%2520effects%2520of%2520current%2520and%2520future%2520therapeutic%2520agents%26jtitle%3DMol.%2520Psychiatry%26date%3D2012%26volume%3D17%26spage%3D1206%26epage%3D1227%26doi%3D10.1038%2Fmp.2012.47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Karlsgodt, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutkenhoff, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willhite, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Erp, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, T. D.</span><span> </span><span class="NLM_article-title">Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia</span> <span class="citation_source-journal">Dev. Psychopathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1297</span><span class="NLM_x">–</span> <span class="NLM_lpage">1327</span><span class="refDoi"> DOI: 10.1017/S095457940800062X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1017%2FS095457940800062X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=18838043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A280%3ADC%252BD1cnksFyhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2008&pages=1297-1327&author=K.+H.+Karlsgodtauthor=D.+Sunauthor=A.+M.+Jimenezauthor=E.+S.+Lutkenhoffauthor=R.+Willhiteauthor=T.+G.+Van+Erpauthor=T.+D.+Cannon&title=Developmental+disruptions+in+neural+connectivity+in+the+pathophysiology+of+schizophrenia&doi=10.1017%2FS095457940800062X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia</span></div><div class="casAuthors">Karlsgodt Katherine H; Sun Daqiang; Jimenez Amy M; Lutkenhoff Evan S; Willhite Rachael; van Erp Theo G M; Cannon Tyrone D</div><div class="citationInfo"><span class="NLM_cas:title">Development and psychopathology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1297-327</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Schizophrenia has been thought of as a disorder of reduced functional and structural connectivity.  Recent advances in neuroimaging techniques such as functional magnetic resonance imaging, structural magnetic resonance imaging, diffusion tensor imaging, and small animal imaging have advanced our ability to investigate this hypothesis.  Moreover, the power of longitudinal designs possible with these noninvasive techniques enable the study of not just how connectivity is disrupted in schizophrenia, but when this disruption emerges during development.  This article reviews genetic and neurodevelopmental influences on structural and functional connectivity in human populations with or at risk for schizophrenia and in animal models of the disorder.  We conclude that the weight of evidence across these diverse lines of inquiry points to a developmental disruption of neural connectivity in schizophrenia and that this disrupted connectivity likely involves susceptibility genes that affect processes involved in establishing intra- and interregional connectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTeIDy8YQwcWZdYoSR9eyvsfW6udTcc2eZKwbP2k_Dww7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cnksFyhtw%253D%253D&md5=2fe8f6ad2b69d487ddc11f48f3eaed09</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1017%2FS095457940800062X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS095457940800062X%26sid%3Dliteratum%253Aachs%26aulast%3DKarlsgodt%26aufirst%3DK.%2BH.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DJimenez%26aufirst%3DA.%2BM.%26aulast%3DLutkenhoff%26aufirst%3DE.%2BS.%26aulast%3DWillhite%26aufirst%3DR.%26aulast%3DVan%2BErp%26aufirst%3DT.%2BG.%26aulast%3DCannon%26aufirst%3DT.%2BD.%26atitle%3DDevelopmental%2520disruptions%2520in%2520neural%2520connectivity%2520in%2520the%2520pathophysiology%2520of%2520schizophrenia%26jtitle%3DDev.%2520Psychopathol.%26date%3D2008%26volume%3D20%26spage%3D1297%26epage%3D1327%26doi%3D10.1017%2FS095457940800062X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Brennand, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelboin-Burkhart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sangar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, F. H.</span><span> </span><span class="NLM_article-title">Modelling schizophrenia using human induced pluripotent stem cells</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">473</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span><span class="refDoi"> DOI: 10.1038/nature09915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature09915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21490598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslCmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=473&publication_year=2011&pages=221-225&author=K.+J.+Brennandauthor=A.+Simoneauthor=J.+Jouauthor=C.+Gelboin-Burkhartauthor=N.+Tranauthor=S.+Sangarauthor=Y.+Liauthor=Y.+Muauthor=G.+Chenauthor=D.+Yuauthor=S.+McCarthyauthor=J.+Sebatauthor=F.+H.+Gage&title=Modelling+schizophrenia+using+human+induced+pluripotent+stem+cells&doi=10.1038%2Fnature09915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling schizophrenia using human induced pluripotent stem cells</span></div><div class="casAuthors">Brennand, Kristen J.; Simone, Anthony; Jou, Jessica; Gelboin-Burkhart, Chelsea; Tran, Ngoc; Sangar, Sarah; Li, Yan; Mu, Yang-Ling; Chen, Gong; Yu, Diana; McCarthy, Shane; Sebat, Jonathan; Gage, Fred H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">473</span>
        (<span class="NLM_cas:issue">7346</span>),
    <span class="NLM_cas:pages">221-225</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Schizophrenia (SCZD) is a debilitating neurol. disorder with a world-wide prevalence of 1%; there is a strong genetic component, with an estd. heritability of 80-85%.  Although post-mortem studies have revealed reduced brain vol., cell size, spine d. and abnormal neural distribution in the prefrontal cortex and hippocampus of SCZD brain tissue and neuropharmacol. studies have implicated dopaminergic, glutamatergic and GABAergic activity in SCZD, the cell types affected in SCZD and the mol. mechanisms underlying the disease state remain unclear.  To elucidate the cellular and mol. defects of SCZD, we directly reprogrammed fibroblasts from SCZD patients into human induced pluripotent stem cells (hiPSCs) and subsequently differentiated these disorder-specific hiPSCs into neurons (Supplementary Fig. 1).  SCZD hiPSC neurons showed diminished neuronal connectivity in conjunction with decreased neurite no., PSD95-protein levels and glutamate receptor expression.  Gene expression profiles of SCZD hiPSC neurons identified altered expression of many components of the cAMP and WNT signaling pathways.  Key cellular and mol. elements of the SCZD phenotype were ameliorated following treatment of SCZD hiPSC neurons with the antipsychotic loxapine.  To date, hiPSC neuronal pathol. has only been demonstrated in diseases characterized by both the loss of function of a single gene product and rapid disease progression in early childhood.  We now report hiPSC neuronal phenotypes and gene expression changes assocd. with SCZD, a complex genetic psychiatric disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjnAfLsN16LbVg90H21EOLACvtfcHk0liiRJp-uB8auw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslCmtbk%253D&md5=dcdd5cf2036e4ba0334693c21dd21a28</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnature09915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09915%26sid%3Dliteratum%253Aachs%26aulast%3DBrennand%26aufirst%3DK.%2BJ.%26aulast%3DSimone%26aufirst%3DA.%26aulast%3DJou%26aufirst%3DJ.%26aulast%3DGelboin-Burkhart%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DN.%26aulast%3DSangar%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DMcCarthy%26aufirst%3DS.%26aulast%3DSebat%26aufirst%3DJ.%26aulast%3DGage%26aufirst%3DF.%2BH.%26atitle%3DModelling%2520schizophrenia%2520using%2520human%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DNature%26date%3D2011%26volume%3D473%26spage%3D221%26epage%3D225%26doi%3D10.1038%2Fnature09915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Rodriguez-Murillo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogos, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karayiorgou, M.</span><span> </span><span class="NLM_article-title">The genetic architecture of schizophrenia: new mutations and emerging paradigms</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span><span class="refDoi"> DOI: 10.1146/annurev-med-072010-091100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1146%2Fannurev-med-072010-091100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2012&pages=63-80&author=L.+Rodriguez-Murilloauthor=J.+A.+Gogosauthor=M.+Karayiorgou&title=The+genetic+architecture+of+schizophrenia%3A+new+mutations+and+emerging+paradigms&doi=10.1146%2Fannurev-med-072010-091100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1146%2Fannurev-med-072010-091100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-med-072010-091100%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Murillo%26aufirst%3DL.%26aulast%3DGogos%26aufirst%3DJ.%2BA.%26aulast%3DKarayiorgou%26aufirst%3DM.%26atitle%3DThe%2520genetic%2520architecture%2520of%2520schizophrenia%253A%2520new%2520mutations%2520and%2520emerging%2520paradigms%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2012%26volume%3D63%26spage%3D63%26epage%3D80%26doi%3D10.1146%2Fannurev-med-072010-091100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Robberecht, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philips, T.</span><span> </span><span class="NLM_article-title">The changing scene of amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span><span class="refDoi"> DOI: 10.1038/nrn3430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnrn3430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23463272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsVOiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=248-264&author=W.+Robberechtauthor=T.+Philips&title=The+changing+scene+of+amyotrophic+lateral+sclerosis&doi=10.1038%2Fnrn3430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The changing scene of amyotrophic lateral sclerosis</span></div><div class="casAuthors">Robberecht, Wim; Philips, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">248-264</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Several recent breakthroughs have provided notable insights into the pathogenesis of amyotrophic lateral sclerosis (ALS), with some even shifting our thinking about this neurodegenerative disease and raising the question as to whether this disorder is a proteinopathy, a ribonucleopathy or both.  In addn., these breakthroughs have revealed mechanistic links between ALS and frontotemporal dementia, as well as between ALS and other neurodegenerative diseases, such as the cerebellar atrophies, myotonic dystrophy and inclusion body myositis.  Here, we summarize the new findings in ALS research, discuss what they have taught us about this disease and examine issues that are still outstanding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUCWEu29GwdLVg90H21EOLACvtfcHk0liYm8wa9N0Img"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsVOiur4%253D&md5=def3da74cf76bde78ecc1fa9eed87a74</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrn3430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3430%26sid%3Dliteratum%253Aachs%26aulast%3DRobberecht%26aufirst%3DW.%26aulast%3DPhilips%26aufirst%3DT.%26atitle%3DThe%2520changing%2520scene%2520of%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D248%26epage%3D264%26doi%3D10.1038%2Fnrn3430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigio, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesulam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fushimi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. Y.</span><span> </span><span class="NLM_article-title">An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">822</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span><span class="refDoi"> DOI: 10.1038/nsmb.2053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnsmb.2053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21666678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVWqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=822-830&author=W.+Guoauthor=Y.+Chenauthor=X.+Zhouauthor=A.+Karauthor=P.+Rayauthor=X.+Chenauthor=E.+J.+Raoauthor=M.+Yangauthor=H.+Yeauthor=L.+Zhuauthor=J.+Liuauthor=M.+Xuauthor=Y.+Yangauthor=C.+Wangauthor=D.+Zhangauthor=E.+H.+Bigioauthor=M.+Mesulamauthor=Y.+Shenauthor=Q.+Xuauthor=K.+Fushimiauthor=J.+Y.+Wu&title=An+ALS-associated+mutation+affecting+TDP-43+enhances+protein+aggregation%2C+fibril+formation+and+neurotoxicity&doi=10.1038%2Fnsmb.2053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity</span></div><div class="casAuthors">Guo, Weirui; Chen, Yanbo; Zhou, Xiaohong; Kar, Amar; Ray, Payal; Chen, Xiaoping; Rao, Elizabeth J.; Yang, Mengxue; Ye, Haihong; Zhu, Li; Liu, Jianghong; Xu, Meng; Yang, Yanlian; Wang, Chen; Zhang, David; Bigio, Eileen H.; Mesulam, Marsel; Shen, Yan; Xu, Qi; Fushimi, Kazuo; Wu, Jane Y.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">822-830</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in TARDBP, encoding TAR DNA-binding protein-43 (TDP-43), are assocd. with TDP-43 proteinopathies, including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD).  We compared wild-type TDP-43 and an ALS-assocd. mutant TDP-43 in vitro and in vivo.  The A315T mutant enhances neurotoxicity and the formation of aberrant TDP-43 species, including protease-resistant fragments.  The C-terminus of TDP-43 shows sequence similarity to prion proteins.  Synthetic peptides flanking residue 315 form amyloid fibrils in vitro and cause neuronal death in primary cultures.  These data provide evidence for biochem. similarities between TDP-43 and prion proteins, raising the possibility that TDP-43 derivs. may cause spreading of the disease phenotype among neighboring neurons.  Our work also suggests that decreasing the abundance of neurotoxic TDP-43 species, enhancing degrdn. or clearance of such TDP-43 derivs. and blocking the spread of the disease phenotype may have therapeutic potential for TDP-43 proteinopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs0RuzmtnWW7Vg90H21EOLACvtfcHk0liYm8wa9N0Img"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVWqtLY%253D&md5=d0e763411d1402b6da1e2f596e50bdc9</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2053%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DKar%26aufirst%3DA.%26aulast%3DRay%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DRao%26aufirst%3DE.%2BJ.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DBigio%26aufirst%3DE.%2BH.%26aulast%3DMesulam%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DFushimi%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DJ.%2BY.%26atitle%3DAn%2520ALS-associated%2520mutation%2520affecting%2520TDP-43%2520enhances%2520protein%2520aggregation%252C%2520fibril%2520formation%2520and%2520neurotoxicity%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D822%26epage%3D830%26doi%3D10.1038%2Fnsmb.2053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Egawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitaoka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naitoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asaka, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morizane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamawaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hioki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamaoka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakahata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetto, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, H.</span><span> </span><span class="NLM_article-title">Drug screening for ALS using patient-specific induced pluripotent stem cells</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">145ra104</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3004052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1126%2Fscitranslmed.3004052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22855461" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=145ra104&author=N.+Egawaauthor=S.+Kitaokaauthor=K.+Tsukitaauthor=M.+Naitohauthor=K.+Takahashiauthor=T.+Yamamotoauthor=F.+Adachiauthor=T.+Kondoauthor=K.+Okitaauthor=I.+Asakaauthor=T.+Aoiauthor=A.+Watanabeauthor=Y.+Yamadaauthor=A.+Morizaneauthor=J.+Takahashiauthor=T.+Ayakiauthor=H.+Itoauthor=K.+Yoshikawaauthor=S.+Yamawakiauthor=S.+Suzukiauthor=D.+Watanabeauthor=H.+Hiokiauthor=T.+Kanekoauthor=K.+Makiokaauthor=K.+Okamotoauthor=H.+Takumaauthor=A.+Tamaokaauthor=K.+Hasegawaauthor=T.+Nonakaauthor=M.+Hasegawaauthor=A.+Kawataauthor=M.+Yoshidaauthor=T.+Nakahataauthor=R.+Takahashiauthor=M.+C.+Marchettoauthor=F.+H.+Gageauthor=S.+Yamanakaauthor=H.+Inoue&title=Drug+screening+for+ALS+using+patient-specific+induced+pluripotent+stem+cells&doi=10.1126%2Fscitranslmed.3004052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3004052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3004052%26sid%3Dliteratum%253Aachs%26aulast%3DEgawa%26aufirst%3DN.%26aulast%3DKitaoka%26aufirst%3DS.%26aulast%3DTsukita%26aufirst%3DK.%26aulast%3DNaitoh%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DAdachi%26aufirst%3DF.%26aulast%3DKondo%26aufirst%3DT.%26aulast%3DOkita%26aufirst%3DK.%26aulast%3DAsaka%26aufirst%3DI.%26aulast%3DAoi%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DMorizane%26aufirst%3DA.%26aulast%3DTakahashi%26aufirst%3DJ.%26aulast%3DAyaki%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DYoshikawa%26aufirst%3DK.%26aulast%3DYamawaki%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DD.%26aulast%3DHioki%26aufirst%3DH.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DMakioka%26aufirst%3DK.%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DTakuma%26aufirst%3DH.%26aulast%3DTamaoka%26aufirst%3DA.%26aulast%3DHasegawa%26aufirst%3DK.%26aulast%3DNonaka%26aufirst%3DT.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DKawata%26aufirst%3DA.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DNakahata%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DMarchetto%26aufirst%3DM.%2BC.%26aulast%3DGage%26aufirst%3DF.%2BH.%26aulast%3DYamanaka%26aufirst%3DS.%26aulast%3DInoue%26aufirst%3DH.%26atitle%3DDrug%2520screening%2520for%2520ALS%2520using%2520patient-specific%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D145ra104%26doi%3D10.1126%2Fscitranslmed.3004052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Strong, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesavapany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pant, H. C.</span><span> </span><span class="NLM_article-title">The pathobiology of amyotrophic lateral sclerosis: a proteinopathy?</span> <span class="citation_source-journal">J. Neuropathol. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">649</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span><span class="refDoi"> DOI: 10.1097/01.jnen.0000173889.71434.ea</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1097%2F01.jnen.0000173889.71434.ea" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=16106213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVemsL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2005&pages=649-664&author=M.+J.+Strongauthor=S.+Kesavapanyauthor=H.+C.+Pant&title=The+pathobiology+of+amyotrophic+lateral+sclerosis%3A+a+proteinopathy%3F&doi=10.1097%2F01.jnen.0000173889.71434.ea"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The pathobiology of amyotrophic lateral sclerosis: a proteinopathy?</span></div><div class="casAuthors">Strong, Michael J.; Kesavapany, Sashi; Pant, Harish C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology & Experimental Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">649-664</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Amyotrophic lateral sclerosis (ALS) is increasingly considered to be a disorder of multiple etiologies that have in common progressive degeneration of both upper and lower motor neurons, ultimately giving rise to a relentless loss of muscle function.  This progressive degeneration is assocd. with heightened levels of oxidative injury, excitotoxicity, and mitochondrial dysfunction-all occurring concurrently.  In this article, we review the evidence that suggests, in common with other age-dependent neurodegenerative disorders, that ALS can be considered a disorder of protein aggregation.  Morphol., this is evident as Bunina bodies, ubiquitin-immunoreactive fibrils or aggregates, neurofilamentous aggregates, mutant copper/zinc superoxide dismutase (SOD1) aggregates in familial ALS variants harboring mutations in SOD1, peripherin-immunoreactive aggregates within spinal motor neurons and as neuroaxonal spheroids, and in an increasingly greater population of patients with ALS with cognitive impairment, both intra- and extraneuronal tau aggregates.  We review the evidence that somatotopically specific patterns of altered kinase and phosphatase activity are assocd. with alterations in the phosphorylation state of these proteins, altering either soly. or assembly characteristics.  The role of nonneuronal cells in mediating motor neuronal injury is discussed in the context of alterations in tyrosine kinase activity and enhanced protein phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWAmzTh9eWX7Vg90H21EOLACvtfcHk0liQyFhAfAOzjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVemsL3K&md5=af483a63c7b9cadd240094ad93eea93e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1097%2F01.jnen.0000173889.71434.ea&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.jnen.0000173889.71434.ea%26sid%3Dliteratum%253Aachs%26aulast%3DStrong%26aufirst%3DM.%2BJ.%26aulast%3DKesavapany%26aufirst%3DS.%26aulast%3DPant%26aufirst%3DH.%2BC.%26atitle%3DThe%2520pathobiology%2520of%2520amyotrophic%2520lateral%2520sclerosis%253A%2520a%2520proteinopathy%253F%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2005%26volume%3D64%26spage%3D649%26epage%3D664%26doi%3D10.1097%2F01.jnen.0000173889.71434.ea" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Yang, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerqueira, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainger, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosowski, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schein, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackeifi, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arvanites, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidow, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, L. L.</span><span> </span><span class="NLM_article-title">A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">713</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span><span class="refDoi"> DOI: 10.1016/j.stem.2013.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.stem.2013.04.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=713-726&author=Y.+M.+Yangauthor=S.+K.+Guptaauthor=K.+J.+Kimauthor=B.+E.+Powersauthor=A.+Cerqueiraauthor=B.+J.+Waingerauthor=H.+D.+Ngoauthor=K.+A.+Rosowskiauthor=P.+A.+Scheinauthor=C.+A.+Ackeifiauthor=A.+C.+Arvanitesauthor=L.+S.+Davidowauthor=C.+J.+Woolfauthor=L.+L.+Rubin&title=A+small+molecule+screen+in+stem-cell-derived+motor+neurons+identifies+a+kinase+inhibitor+as+a+candidate+therapeutic+for+ALS&doi=10.1016%2Fj.stem.2013.04.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2013.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2013.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%2BM.%26aulast%3DGupta%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DK.%2BJ.%26aulast%3DPowers%26aufirst%3DB.%2BE.%26aulast%3DCerqueira%26aufirst%3DA.%26aulast%3DWainger%26aufirst%3DB.%2BJ.%26aulast%3DNgo%26aufirst%3DH.%2BD.%26aulast%3DRosowski%26aufirst%3DK.%2BA.%26aulast%3DSchein%26aufirst%3DP.%2BA.%26aulast%3DAckeifi%26aufirst%3DC.%2BA.%26aulast%3DArvanites%26aufirst%3DA.%2BC.%26aulast%3DDavidow%26aufirst%3DL.%2BS.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26atitle%3DA%2520small%2520molecule%2520screen%2520in%2520stem-cell-derived%2520motor%2520neurons%2520identifies%2520a%2520kinase%2520inhibitor%2520as%2520a%2520candidate%2520therapeutic%2520for%2520ALS%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2013%26volume%3D12%26spage%3D713%26epage%3D726%26doi%3D10.1016%2Fj.stem.2013.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Burkhardt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volfson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lievers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoukat-Mumtaz, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grskovic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irion, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bright, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griswold-Prenner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javaherian, A.</span><span> </span><span class="NLM_article-title">A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1016/j.mcn.2013.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.mcn.2013.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23891805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCit7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=355-364&author=M.+F.+Burkhardtauthor=F.+J.+Martinezauthor=S.+Wrightauthor=C.+Ramosauthor=D.+Volfsonauthor=M.+Masonauthor=J.+Garnesauthor=V.+Dangauthor=J.+Lieversauthor=U.+Shoukat-Mumtazauthor=R.+Martinezauthor=H.+Gaiauthor=R.+Blakeauthor=E.+Vaisbergauthor=M.+Grskovicauthor=C.+Johnsonauthor=S.+Irionauthor=J.+Brightauthor=B.+Cooperauthor=L.+Nguyenauthor=I.+Griswold-Prennerauthor=A.+Javaherian&title=A+cellular+model+for+sporadic+ALS+using+patient-derived+induced+pluripotent+stem+cells&doi=10.1016%2Fj.mcn.2013.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells</span></div><div class="casAuthors">Burkhardt, Matthew F.; Martinez, Fernando J.; Wright, Sarah; Ramos, Carla; Volfson, Dmitri; Mason, Michael; Garnes, Jeff; Dang, Vu; Lievers, Jeffery; Shoukat-Mumtaz, Uzma; Martinez, Rita; Gai, Hui; Blake, Robert; Vaisberg, Eugeni; Grskovic, Marica; Johnson, Charles; Irion, Stefan; Bright, Jessica; Cooper, Bonnie; Nguyen, Leane; Griswold-Prenner, Irene; Javaherian, Ashkan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">355-364</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Development of therapeutics for genetically complex neurodegenerative diseases such as sporadic amyotrophic lateral sclerosis (ALS) has largely been hampered by lack of relevant disease models.  Reprogramming of sporadic ALS patients' fibroblasts into induced pluripotent stem cells (iPSC) and differentiation into affected neurons that show a disease phenotype could provide a cellular model for disease mechanism studies and drug discovery.  Here we report the reprogramming to pluripotency of fibroblasts from a large cohort of healthy controls and ALS patients and their differentiation into motor neurons.  We demonstrate that motor neurons derived from three sALS patients show de novo TDP-43 aggregation and that the aggregates recapitulate pathol. in postmortem tissue from one of the same patients from which the iPSC were derived.  We configured a high-content chem. screen using the TDP-43 aggregate endpoint both in lower motor neurons and upper motor neuron like cells and identified FDA-approved small mol. modulators including Digoxin demonstrating the feasibility of patient-derived iPSC-based disease modeling for drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-15aZvERjwbVg90H21EOLACvtfcHk0liQyFhAfAOzjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCit7vE&md5=fabc97dd02cb4c29d33e8fbee1b7c882</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2013.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2013.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DBurkhardt%26aufirst%3DM.%2BF.%26aulast%3DMartinez%26aufirst%3DF.%2BJ.%26aulast%3DWright%26aufirst%3DS.%26aulast%3DRamos%26aufirst%3DC.%26aulast%3DVolfson%26aufirst%3DD.%26aulast%3DMason%26aufirst%3DM.%26aulast%3DGarnes%26aufirst%3DJ.%26aulast%3DDang%26aufirst%3DV.%26aulast%3DLievers%26aufirst%3DJ.%26aulast%3DShoukat-Mumtaz%26aufirst%3DU.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DGai%26aufirst%3DH.%26aulast%3DBlake%26aufirst%3DR.%26aulast%3DVaisberg%26aufirst%3DE.%26aulast%3DGrskovic%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DC.%26aulast%3DIrion%26aufirst%3DS.%26aulast%3DBright%26aufirst%3DJ.%26aulast%3DCooper%26aufirst%3DB.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DGriswold-Prenner%26aufirst%3DI.%26aulast%3DJavaherian%26aufirst%3DA.%26atitle%3DA%2520cellular%2520model%2520for%2520sporadic%2520ALS%2520using%2520patient-derived%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2013%26volume%3D56%26spage%3D355%26epage%3D364%26doi%3D10.1016%2Fj.mcn.2013.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Pasinelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. H.</span><span> </span><span class="NLM_article-title">Molecular biology of amyotrophic lateral sclerosis: insights from genetics</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span><span class="refDoi"> DOI: 10.1038/nrn1971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnrn1971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=16924260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlCgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=710-723&author=P.+Pasinelliauthor=R.+H.+Brown&title=Molecular+biology+of+amyotrophic+lateral+sclerosis%3A+insights+from+genetics&doi=10.1038%2Fnrn1971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular biology of amyotrophic lateral sclerosis: insights from genetics</span></div><div class="casAuthors">Pasinelli, Piera; Brown, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">710-723</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Amyotrophic lateral sclerosis (ALS) is a paralytic disorder caused by motor neuron degeneration.  Mutations in more than 50 human genes cause diverse types of motor neuron pathol.  Moreover, defects in five Mendelian genes lead to motor neuron disease, with two mutations reproducing the ALS phenotype.  Analyses of these genetic effects have generated new insights into the diverse mol. pathways involved in ALS pathogenesis.  Here, we present an overview of the mechanisms for motor neuron death and of the role of non-neuronal cells in ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGeL8ButRoa7Vg90H21EOLACvtfcHk0liBoKue6iPtlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlCgtro%253D&md5=0c023f607f81378751f0b2c3cd8310f7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnrn1971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1971%26sid%3Dliteratum%253Aachs%26aulast%3DPasinelli%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DR.%2BH.%26atitle%3DMolecular%2520biology%2520of%2520amyotrophic%2520lateral%2520sclerosis%253A%2520insights%2520from%2520genetics%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D710%26epage%3D723%26doi%3D10.1038%2Fnrn1971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Cleveland, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothstein, J. D.</span><span> </span><span class="NLM_article-title">From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">806</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span><span class="refDoi"> DOI: 10.1038/35097565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2F35097565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=11715057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmt1WitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=806-819&author=D.+W.+Clevelandauthor=J.+D.+Rothstein&title=From+Charcot+to+Lou+Gehrig%3A+deciphering+selective+motor+neuron+death+in+ALS&doi=10.1038%2F35097565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS</span></div><div class="casAuthors">Cleveland, Don W.; Rothstein, Jeffrey D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">806-819</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since its description by Charcot more than 130 yr ago, the mechanism underlying the characteristic selective degeneration and death of motor neurons in amyotrophic lateral sclerosis has remained a mystery.  Modern genetics has now identified mutations in two genes, SOD1 and ALS2, as primary causes of the disease, and has implicated others as potential contributors.  Insights into these abnormalities, together with errors in the handling of synaptic glutamate and the potential excitotoxic response that this alteration provokes, have provided leads for the development of new strategies to identify an as yet elusive remedy for this progressive, fatal disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprMhUigZJiOLVg90H21EOLACvtfcHk0liBoKue6iPtlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmt1WitLs%253D&md5=503e3cc792616168c18f412977475664</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2F35097565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35097565%26sid%3Dliteratum%253Aachs%26aulast%3DCleveland%26aufirst%3DD.%2BW.%26aulast%3DRothstein%26aufirst%3DJ.%2BD.%26atitle%3DFrom%2520Charcot%2520to%2520Lou%2520Gehrig%253A%2520deciphering%2520selective%2520motor%2520neuron%2520death%2520in%2520ALS%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2001%26volume%3D2%26spage%3D806%26epage%3D819%26doi%3D10.1038%2F35097565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Wainger, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiskinis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiskow, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandoe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulting, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cudkowicz, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bean, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, C. J.</span><span> </span><span class="NLM_article-title">Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1016/j.celrep.2014.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.celrep.2014.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24703839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1egsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=1-11&author=B.+J.+Waingerauthor=E.+Kiskinisauthor=C.+Mellinauthor=O.+Wiskowauthor=S.+S.+Hanauthor=J.+Sandoeauthor=N.+P.+Perezauthor=L.+A.+Williamsauthor=S.+Leeauthor=G.+Boultingauthor=J.+D.+Berryauthor=R.+H.+Brownauthor=M.+E.+Cudkowiczauthor=B.+P.+Beanauthor=K.+Egganauthor=C.+J.+Woolf&title=Intrinsic+membrane+hyperexcitability+of+amyotrophic+lateral+sclerosis+patient-derived+motor+neurons&doi=10.1016%2Fj.celrep.2014.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons</span></div><div class="casAuthors">Wainger, Brian J.; Kiskinis, Evangelos; Mellin, Cassidy; Wiskow, Ole; Han, Steve S. W.; Sandoe, Jackson; Perez, Numa P.; Williams, Luis A.; Lee, Seungkyu; Boulting, Gabriella; Berry, James D.; Brown, Robert H.; Cudkowicz, Merit E.; Bean, Bruce P.; Eggan, Kevin; Woolf, Clifford J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease of the motor nervous system.  We show using multielectrode array and patch-clamp recordings that hyperexcitability detected by clin. neurophysiol. studies of ALS patients is recapitulated in induced pluripotent stem cell-derived motor neurons from ALS patients harboring superoxide dismutase 1 (SOD1), C9orf72, and fused-in-sarcoma mutations.  Motor neurons produced from a genetically cor. but otherwise isogenic SOD1+/+ stem cell line do not display the hyperexcitability phenotype.  SOD1A4V/+ ALS patient-derived motor neurons have reduced delayed-rectifier potassium current amplitudes relative to control-derived motor neurons, a deficit that may underlie their hyperexcitability.  The Kv7 channel activator retigabine both blocks the hyperexcitability and improves motor neuron survival in vitro when tested in SOD1 mutant ALS cases.  Therefore, electrophysiol. characterization of human stem cell-derived neurons can reveal disease-related mechanisms and identify therapeutic candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhZaC_0cXv57Vg90H21EOLACvtfcHk0liBoKue6iPtlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1egsbk%253D&md5=aaf70b5f2825003ddd049a13840e64a5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DWainger%26aufirst%3DB.%2BJ.%26aulast%3DKiskinis%26aufirst%3DE.%26aulast%3DMellin%26aufirst%3DC.%26aulast%3DWiskow%26aufirst%3DO.%26aulast%3DHan%26aufirst%3DS.%2BS.%26aulast%3DSandoe%26aufirst%3DJ.%26aulast%3DPerez%26aufirst%3DN.%2BP.%26aulast%3DWilliams%26aufirst%3DL.%2BA.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DBoulting%26aufirst%3DG.%26aulast%3DBerry%26aufirst%3DJ.%2BD.%26aulast%3DBrown%26aufirst%3DR.%2BH.%26aulast%3DCudkowicz%26aufirst%3DM.%2BE.%26aulast%3DBean%26aufirst%3DB.%2BP.%26aulast%3DEggan%26aufirst%3DK.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26atitle%3DIntrinsic%2520membrane%2520hyperexcitability%2520of%2520amyotrophic%2520lateral%2520sclerosis%2520patient-derived%2520motor%2520neurons%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D7%26spage%3D1%26epage%3D11%26doi%3D10.1016%2Fj.celrep.2014.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">de Lau, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breteler, M. M.</span><span> </span><span class="NLM_article-title">Epidemiology of Parkinson’s disease</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">535</span><span class="refDoi"> DOI: 10.1016/S1474-4422(06)70471-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2FS1474-4422%2806%2970471-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=16713924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A280%3ADC%252BD283osVehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=525-535&author=L.+M.+de+Lauauthor=M.+M.+Breteler&title=Epidemiology+of+Parkinson%E2%80%99s+disease&doi=10.1016%2FS1474-4422%2806%2970471-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology of Parkinson's disease</span></div><div class="casAuthors">de Lau Lonneke M L; Breteler Monique M B</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">525-35</span>
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    </div><div class="casAbstract">The causes of Parkinson's disease (PD), the second most common neurodegenerative disorder, are still largely unknown.  Current thinking is that major gene mutations cause only a small proportion of all cases and that in most cases, non-genetic factors play a part, probably in interaction with susceptibility genes.  Numerous epidemiological studies have been done to identify such non-genetic risk factors, but most were small and methodologically limited.  Larger, well-designed prospective cohort studies have only recently reached a stage at which they have enough incident patients and person-years of follow-up to investigate possible risk factors and their interactions.  In this article, we review what is known about the prevalence, incidence, risk factors, and prognosis of PD from epidemiological studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcREGHHqwISPvJVVjGoY74BafW6udTcc2eZ7v2W-0MXZ5Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD283osVehtg%253D%253D&md5=2c22b5eb8ff98db0a23d568123adea4b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2806%2970471-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252806%252970471-9%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLau%26aufirst%3DL.%2BM.%26aulast%3DBreteler%26aufirst%3DM.%2BM.%26atitle%3DEpidemiology%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DLancet%2520Neurol.%26date%3D2006%26volume%3D5%26spage%3D525%26epage%3D535%26doi%3D10.1016%2FS1474-4422%2806%2970471-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Connolly, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, A. E.</span><span> </span><span class="NLM_article-title">Pharmacological treatment of Parkinson disease: a review</span> <span class="citation_source-journal">J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">1670</span><span class="NLM_x">–</span> <span class="NLM_lpage">1683</span><span class="refDoi"> DOI: 10.1001/jama.2014.3654</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1001%2Fjama.2014.3654" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24756517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFems7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2014&pages=1670-1683&author=B.+S.+Connollyauthor=A.+E.+Lang&title=Pharmacological+treatment+of+Parkinson+disease%3A+a+review&doi=10.1001%2Fjama.2014.3654"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological treatment of Parkinson disease: a review</span></div><div class="casAuthors">Connolly, Barbara S.; Lang, Anthony E.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1670-1683, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">1538-3598</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">A review.  Importance: Parkinson disease is the second most common neurodegenerative disease worldwide.  Although no available therapies alter the underlying neurodegenerative process, symptomatic therapies can improve patient quality of life.  Objective: To provide an evidence-based review of the initial pharmacol. management of the classic motor symptoms of Parkinson disease; describe management of medication-related motor complications (such as motor fluctuations and dyskinesia), and other medication adverse effects (nausea, psychosis, and impulse control disorders and related behaviors); and discuss the management of selected nonmotor symptoms of Parkinson disease, including rapid eye movement sleep behavior disorder, cognitive impairment, depression, orthostatic hypotension, and sialorrhea.  Evidence Review: Refs. were identified using searches of PubMed between Jan. 1985 and Feb. 2014 for English-language human studies and the full database of the Cochrane Library.  The classification of studies by quality (classes I-IV) was assessed using the levels of evidence guidelines from the American Academy of Neurol. and the highest-quality data for each topic.  Results: Although levodopa is the most effective medication available for treating the motor symptoms of Parkinson disease, in certain instances (eg, mild symptoms, tremor as the only or most prominent symptom, aged <60 years) other medications (eg, monoamine oxidase type B inhibitors [MAOBIs], amantadine, anticholinergics, β-blockers, or dopamine agonists) may be initiated first to avoid levodopa-related motor complications.  Motor fluctuations may be managed by modifying the levodopa dosing regimen or by adding several other medications, such as MAOBIs, catechol-O-methyltransferase inhibitors, or dopamine agonists.  Impulse control disorders are typically managed by reducing or withdrawing dopaminergic medication, particularly dopamine agonists.  Evidence-based management of some nonmotor symptoms is limited by a paucity of high-quality pos. studies.  Conclusions and Relevance: Strong evidence supports using levodopa and dopamine agonists for motor symptoms at all stages of Parkinson disease.  Dopamine agonists and drugs that block dopamine metab. are effective for motor fluctuations and clozapine is effective for hallucinations.  Cholinesterase inhibitors may improve symptoms of dementia and antidepressants and pramipexole may improve depression.  Evidence supporting other therapies for motor and nonmotor features is less well established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq4bHOyyI7XrVg90H21EOLACvtfcHk0lio1CYtYjiUuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFems7rP&md5=a3faf879f5febdfc11a8992db89f2e67</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1001%2Fjama.2014.3654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2014.3654%26sid%3Dliteratum%253Aachs%26aulast%3DConnolly%26aufirst%3DB.%2BS.%26aulast%3DLang%26aufirst%3DA.%2BE.%26atitle%3DPharmacological%2520treatment%2520of%2520Parkinson%2520disease%253A%2520a%2520review%26jtitle%3DJ.%2520Am.%2520Med.%2520Assoc.%26date%3D2014%26volume%3D311%26spage%3D1670%26epage%3D1683%26doi%3D10.1001%2Fjama.2014.3654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Hall, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landeck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bye, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leanza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Double, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halliday, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirik, D.</span><span> </span><span class="NLM_article-title">Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson’s disease</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">2493</span><span class="NLM_x">–</span> <span class="NLM_lpage">2508</span><span class="refDoi"> DOI: 10.1093/brain/awu193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1093%2Fbrain%2Fawu193" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2014&pages=2493-2508&author=H.+Hallauthor=S.+Reyesauthor=N.+Landeckauthor=C.+Byeauthor=G.+Leanzaauthor=K.+Doubleauthor=L.+Thompsonauthor=G.+Hallidayauthor=D.+Kirik&title=Hippocampal+Lewy+pathology+and+cholinergic+dysfunction+are+associated+with+dementia+in+Parkinson%E2%80%99s+disease&doi=10.1093%2Fbrain%2Fawu193"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawu193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawu193%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DH.%26aulast%3DReyes%26aufirst%3DS.%26aulast%3DLandeck%26aufirst%3DN.%26aulast%3DBye%26aufirst%3DC.%26aulast%3DLeanza%26aufirst%3DG.%26aulast%3DDouble%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DL.%26aulast%3DHalliday%26aufirst%3DG.%26aulast%3DKirik%26aufirst%3DD.%26atitle%3DHippocampal%2520Lewy%2520pathology%2520and%2520cholinergic%2520dysfunction%2520are%2520associated%2520with%2520dementia%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBrain%26date%3D2014%26volume%3D137%26spage%3D2493%26epage%3D2508%26doi%3D10.1093%2Fbrain%2Fawu193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Exner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutz, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winklhofer, K. F.</span><span> </span><span class="NLM_article-title">Mitochondrial dysfunction in Parkinson’s disease: molecular mechanisms and pathophysiological consequences</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">3038</span><span class="NLM_x">–</span> <span class="NLM_lpage">3062</span><span class="refDoi"> DOI: 10.1038/emboj.2012.170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Femboj.2012.170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22735187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpt1SgsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=3038-3062&author=N.+Exnerauthor=A.+K.+Lutzauthor=C.+Haassauthor=K.+F.+Winklhofer&title=Mitochondrial+dysfunction+in+Parkinson%E2%80%99s+disease%3A+molecular+mechanisms+and+pathophysiological+consequences&doi=10.1038%2Femboj.2012.170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences</span></div><div class="casAuthors">Exner, Nicole; Lutz, Anne Kathrin; Haass, Christian; Winklhofer, Konstanze F.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3038-3062</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Neurons are critically dependent on mitochondrial integrity based on specific morphol., biochem., and physiol. features.  They are characterized by high rates of metabolic activity and need to respond promptly to activity-dependent fluctuations in bioenergetic demand.  The dimensions and polarity of neurons require efficient transport of mitochondria to hot spots of energy consumption, such as presynaptic and postsynaptic sites.  Moreover, the postmitotic state of neurons in combination with their exposure to intrinsic and extrinsic neuronal stress factors call for a high fidelity of mitochondrial quality control systems.  Consequently, it is not surprising that mitochondrial alterations can promote neuronal dysfunction and degeneration.  In particular, mitochondrial dysfunction has long been implicated in the etiopathogenesis of Parkinson's disease (PD), based on the observation that mitochondrial toxins can cause parkinsonism in humans and animal models.  Substantial progress towards understanding the role of mitochondria in the disease process has been made by the identification and characterization of genes causing familial variants of PD.  Studies on the function and dysfunction of these genes revealed that various aspects of mitochondrial biol. appear to be affected in PD, comprising mitochondrial biogenesis, bioenergetics, dynamics, transport, and quality control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH4-kE75wmUbVg90H21EOLACvtfcHk0lio1CYtYjiUuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpt1SgsL8%253D&md5=82274488828864faa56ec1d6b875c476</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Femboj.2012.170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2012.170%26sid%3Dliteratum%253Aachs%26aulast%3DExner%26aufirst%3DN.%26aulast%3DLutz%26aufirst%3DA.%2BK.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DWinklhofer%26aufirst%3DK.%2BF.%26atitle%3DMitochondrial%2520dysfunction%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520molecular%2520mechanisms%2520and%2520pathophysiological%2520consequences%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26spage%3D3038%26epage%3D3062%26doi%3D10.1038%2Femboj.2012.170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Henchcliffe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis</span> <span class="citation_source-journal">Nat. Clin. Pract. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">600</span><span class="NLM_x">–</span> <span class="NLM_lpage">609</span><span class="refDoi"> DOI: 10.1038/ncpneuro0924</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fncpneuro0924" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=18978800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWktbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=600-609&author=C.+Henchcliffeauthor=M.+F.+Beal&title=Mitochondrial+biology+and+oxidative+stress+in+Parkinson+disease+pathogenesis&doi=10.1038%2Fncpneuro0924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis</span></div><div class="casAuthors">Henchcliffe, Claire; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">600-609</span>CODEN:
                <span class="NLM_cas:coden">NCPND4</span>;
        ISSN:<span class="NLM_cas:issn">1745-834X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mitochondrial dysfunction and oxidative stress have been strongly implicated in the pathogenesis of Parkinson disease (PD), and the products of several PD-assocd. genes become localized to the mitochondria under certain conditions.  In this article, Henchcliffe and Beal review recent developments in mitochondrial biol. that have contributed to our understanding of the disease process in PD, and they discuss how this knowledge might aid in the development of 'mitochondrial therapies' for PD.  Parkinson disease (PD) is assocd. with progressive loss of dopaminergic neurons in the substantia nigra, as well as with more-widespread neuronal changes that cause complex and variable motor and nonmotor symptoms.  Recent rapid advances in PD genetics have revealed a prominent role for mitochondrial dysfunction in the pathogenesis of the disease, and the products of several PD-assocd. genes, including SNCA, Parkin, PINK1, DJ-1, LRRK2 and HTR2A, show a degree of localization to the mitochondria under certain conditions.  Impaired mitochondrial function is likely to increase oxidative stress and might render cells more vulnerable to this and other related processes, including excitotoxicity.  The mitochondria, therefore, represent a highly promising target for the development of disease biomarkers by use of genetic, biochem. and bioimaging approaches.  Novel therapeutic interventions that modify mitochondrial function are currently under development, and a large phase III clin. trial is underway to examine whether high-dose oral coenzyme Q10 will slow disease progression.  In this Review, we examine evidence for the roles of mitochondrial dysfunction and increased oxidative stress in the neuronal loss that leads to PD and discuss how this knowledge might further improve patient management and aid in the development of 'mitochondrial therapy' for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqneg1PjpRmGrVg90H21EOLACvtfcHk0lhujRQeSvsiAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWktbnM&md5=699436613ceae22565abf37aa4dfd9f9</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fncpneuro0924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncpneuro0924%26sid%3Dliteratum%253Aachs%26aulast%3DHenchcliffe%26aufirst%3DC.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DMitochondrial%2520biology%2520and%2520oxidative%2520stress%2520in%2520Parkinson%2520disease%2520pathogenesis%26jtitle%3DNat.%2520Clin.%2520Pract.%2520Neurol.%26date%3D2008%26volume%3D4%26spage%3D600%26epage%3D609%26doi%3D10.1038%2Fncpneuro0924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Shulman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Jager, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feany, M. B.</span><span> </span><span class="NLM_article-title">Parkinson’s disease: genetics and pathogenesis</span> <span class="citation_source-journal">Annu. Rev. Pathol.: Mech. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span><span class="refDoi"> DOI: 10.1146/annurev-pathol-011110-130242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1146%2Fannurev-pathol-011110-130242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21034221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtVWrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=193-222&author=J.+M.+Shulmanauthor=P.+L.+De+Jagerauthor=M.+B.+Feany&title=Parkinson%E2%80%99s+disease%3A+genetics+and+pathogenesis&doi=10.1146%2Fannurev-pathol-011110-130242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Parkinson's disease: genetics and pathogenesis</span></div><div class="casAuthors">Shulman, Joshua M.; De Jager, Philip L.; Feany, Mel B.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pathology: Mechanisms of Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">193-222</span>CODEN:
                <span class="NLM_cas:coden">ARPMCU</span>;
        ISSN:<span class="NLM_cas:issn">1553-4006</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Recent investigation into the mechanisms of Parkinson's disease (PD) has generated remarkable insight while simultaneously challenging traditional conceptual frameworks.  Although the disease remains defined clin. by its cardinal motor manifestations and pathol. by midbrain dopaminergic cell loss in assocn. with Lewy bodies, it is now recognized that PD has substantially more widespread impact, causing a host of nonmotor symptoms and assocd. pathol. in multiple regions throughout the nervous system.  Further, the discovery and validation of PD-susceptibility genes contradict the historical view that environmental factors predominate, and blur distinctions between familial and sproadic disease.  Genetic advances have also promoted the development of improved animal models, highlighted responsible mol. pathways, and revealed mechanistic overlap with other neurodegenerative disorders.  In this review, we synthesize emerging lessons on PD pathogenesis from clin., pathol., and genetic studies toward a unified concept of the disorder that may accelerate the design and testing of the next generation of PD therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiywhYI9S77LVg90H21EOLACvtfcHk0lhujRQeSvsiAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtVWrsrg%253D&md5=bcef535a4b0e9b7cda6932dc9eb3b685</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pathol-011110-130242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pathol-011110-130242%26sid%3Dliteratum%253Aachs%26aulast%3DShulman%26aufirst%3DJ.%2BM.%26aulast%3DDe%2BJager%26aufirst%3DP.%2BL.%26aulast%3DFeany%26aufirst%3DM.%2BB.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%253A%2520genetics%2520and%2520pathogenesis%26jtitle%3DAnnu.%2520Rev.%2520Pathol.%253A%2520Mech.%2520Dis.%26date%3D2011%26volume%3D6%26spage%3D193%26epage%3D222%26doi%3D10.1146%2Fannurev-pathol-011110-130242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Cooper, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrabi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guardia-Laguarta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziotto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo-Reid, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargus, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deleidi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogetofte, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Torres, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskowitz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzulli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpicelli-Daley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uitti, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opala, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarffe, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marder, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surmeier, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wszolek, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przedborski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krainc, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacson, O.</span><span> </span><span class="NLM_article-title">Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson’s disease</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">141ra90</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3003985</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1126%2Fscitranslmed.3003985" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22764206" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=141ra90&author=O.+Cooperauthor=H.+Seoauthor=S.+Andrabiauthor=C.+Guardia-Laguartaauthor=J.+Graziottoauthor=M.+Sundbergauthor=J.+R.+McLeanauthor=L.+Carrillo-Reidauthor=Z.+Xieauthor=T.+Osbornauthor=G.+Hargusauthor=M.+Deleidiauthor=T.+Lawsonauthor=H.+Bogetofteauthor=E.+Perez-Torresauthor=L.+Clarkauthor=C.+Moskowitzauthor=J.+Mazzulliauthor=L.+Chenauthor=L.+Volpicelli-Daleyauthor=N.+Romeroauthor=H.+Jiangauthor=R.+J.+Uittiauthor=Z.+Huangauthor=G.+Opalaauthor=L.+A.+Scarffeauthor=V.+L.+Dawsonauthor=C.+Kleinauthor=J.+Fengauthor=O.+A.+Rossauthor=J.+Q.+Trojanowskiauthor=V.+M.+Leeauthor=K.+Marderauthor=D.+J.+Surmeierauthor=Z.+K.+Wszolekauthor=S.+Przedborskiauthor=D.+Kraincauthor=T.+M.+Dawsonauthor=O.+Isacson&title=Pharmacological+rescue+of+mitochondrial+deficits+in+iPSC-derived+neural+cells+from+patients+with+familial+Parkinson%E2%80%99s+disease&doi=10.1126%2Fscitranslmed.3003985"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003985%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DO.%26aulast%3DSeo%26aufirst%3DH.%26aulast%3DAndrabi%26aufirst%3DS.%26aulast%3DGuardia-Laguarta%26aufirst%3DC.%26aulast%3DGraziotto%26aufirst%3DJ.%26aulast%3DSundberg%26aufirst%3DM.%26aulast%3DMcLean%26aufirst%3DJ.%2BR.%26aulast%3DCarrillo-Reid%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DOsborn%26aufirst%3DT.%26aulast%3DHargus%26aufirst%3DG.%26aulast%3DDeleidi%26aufirst%3DM.%26aulast%3DLawson%26aufirst%3DT.%26aulast%3DBogetofte%26aufirst%3DH.%26aulast%3DPerez-Torres%26aufirst%3DE.%26aulast%3DClark%26aufirst%3DL.%26aulast%3DMoskowitz%26aufirst%3DC.%26aulast%3DMazzulli%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DVolpicelli-Daley%26aufirst%3DL.%26aulast%3DRomero%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DUitti%26aufirst%3DR.%2BJ.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DOpala%26aufirst%3DG.%26aulast%3DScarffe%26aufirst%3DL.%2BA.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DRoss%26aufirst%3DO.%2BA.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DMarder%26aufirst%3DK.%26aulast%3DSurmeier%26aufirst%3DD.%2BJ.%26aulast%3DWszolek%26aufirst%3DZ.%2BK.%26aulast%3DPrzedborski%26aufirst%3DS.%26aulast%3DKrainc%26aufirst%3DD.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DIsacson%26aufirst%3DO.%26atitle%3DPharmacological%2520rescue%2520of%2520mitochondrial%2520deficits%2520in%2520iPSC-derived%2520neural%2520cells%2520from%2520patients%2520with%2520familial%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D141ra90%26doi%3D10.1126%2Fscitranslmed.3003985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Reinhardt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burbulla, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schöndorf, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glatza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höing, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargus, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhingra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brockmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maisel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krüger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsytsyura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiel, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Psathaki, O. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klingauf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhlmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klewin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schöler, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterneckert, J.</span><span> </span><span class="NLM_article-title">Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">354</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1016/j.stem.2013.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.stem.2013.01.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=354-367&author=P.+Reinhardtauthor=B.+Schmidauthor=L.+F.+Burbullaauthor=D.+C.+Sch%C3%B6ndorfauthor=L.+Wagnerauthor=M.+Glatzaauthor=S.+H%C3%B6ingauthor=G.+Hargusauthor=S.+A.+Heckauthor=A.+Dhingraauthor=G.+Wuauthor=S.+M%C3%BCllerauthor=K.+Brockmannauthor=T.+Klubaauthor=M.+Maiselauthor=R.+Kr%C3%BCgerauthor=D.+Bergauthor=Y.+Tsytsyuraauthor=C.+S.+Thielauthor=O.+E.+Psathakiauthor=J.+Klingaufauthor=T.+Kuhlmannauthor=M.+Klewinauthor=H.+M%C3%BCllerauthor=T.+Gasserauthor=H.+R.+Sch%C3%B6lerauthor=J.+Sterneckert&title=Genetic+correction+of+a+LRRK2+mutation+in+human+iPSCs+links+parkinsonian+neurodegeneration+to+ERK-dependent+changes+in+gene+expression&doi=10.1016%2Fj.stem.2013.01.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2013.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2013.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DReinhardt%26aufirst%3DP.%26aulast%3DSchmid%26aufirst%3DB.%26aulast%3DBurbulla%26aufirst%3DL.%2BF.%26aulast%3DSch%25C3%25B6ndorf%26aufirst%3DD.%2BC.%26aulast%3DWagner%26aufirst%3DL.%26aulast%3DGlatza%26aufirst%3DM.%26aulast%3DH%25C3%25B6ing%26aufirst%3DS.%26aulast%3DHargus%26aufirst%3DG.%26aulast%3DHeck%26aufirst%3DS.%2BA.%26aulast%3DDhingra%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DBrockmann%26aufirst%3DK.%26aulast%3DKluba%26aufirst%3DT.%26aulast%3DMaisel%26aufirst%3DM.%26aulast%3DKr%25C3%25BCger%26aufirst%3DR.%26aulast%3DBerg%26aufirst%3DD.%26aulast%3DTsytsyura%26aufirst%3DY.%26aulast%3DThiel%26aufirst%3DC.%2BS.%26aulast%3DPsathaki%26aufirst%3DO.%2BE.%26aulast%3DKlingauf%26aufirst%3DJ.%26aulast%3DKuhlmann%26aufirst%3DT.%26aulast%3DKlewin%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DGasser%26aufirst%3DT.%26aulast%3DSch%25C3%25B6ler%26aufirst%3DH.%2BR.%26aulast%3DSterneckert%26aufirst%3DJ.%26atitle%3DGenetic%2520correction%2520of%2520a%2520LRRK2%2520mutation%2520in%2520human%2520iPSCs%2520links%2520parkinsonian%2520neurodegeneration%2520to%2520ERK-dependent%2520changes%2520in%2520gene%2520expression%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2013%26volume%3D12%26spage%3D354%26epage%3D367%26doi%3D10.1016%2Fj.stem.2013.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Irwin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Parkinson’s disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">626</span><span class="NLM_x">–</span> <span class="NLM_lpage">636</span><span class="refDoi"> DOI: 10.1038/nrn3549</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnrn3549" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23900411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=626-636&author=D.+J.+Irwinauthor=V.+M.+Y.+Leeauthor=J.+Q.+Trojanowski&title=Parkinson%E2%80%99s+disease+dementia%3A+convergence+of+%CE%B1-synuclein%2C+tau+and+amyloid-%CE%B2+pathologies&doi=10.1038%2Fnrn3549"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies</span></div><div class="casAuthors">Irwin, David J.; Lee, Virginia M.-Y.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">626-636</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Dementia is increasingly being recognized in cases of Parkinson's disease (PD); such cases are termed PD dementia (PDD).  The spread of fibrillar α-synuclein (α-syn) pathol. from the brainstem to limbic and neocortical structures seems to be the strongest neuropathol. correlate of emerging dementia in PD.  In addn., up to 50% of patients with PDD also develop sufficient nos. of amyloid-β plaques and tau-contg. neurofibrillary tangles for a secondary diagnosis of Alzheimer's disease, and these pathologies may act synergistically with α-syn pathol. to confer a worse prognosis.  An understanding of the relationships between these three distinct pathologies and their resultant clin. phenotypes is crucial for the development of effective disease-modifying treatments for PD and PDD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQHKxvVpPusLVg90H21EOLACvtfcHk0lj6yBP6Ke7rug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7bN&md5=e8de266b3d41136269251f1857ec72db</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnrn3549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3549%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DD.%2BJ.%26aulast%3DLee%26aufirst%3DV.%2BM.%2BY.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%2520dementia%253A%2520convergence%2520of%2520%25CE%25B1-synuclein%252C%2520tau%2520and%2520amyloid-%25CE%25B2%2520pathologies%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D626%26epage%3D636%26doi%3D10.1038%2Fnrn3549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Wilkaniec, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strosznajder, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamczyk, A.</span><span> </span><span class="NLM_article-title">Toxicity of extracellular secreted α-synuclein: Its role in nitrosative stress and neurodegeneration</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">776</span><span class="NLM_x">–</span> <span class="NLM_lpage">783</span><span class="refDoi"> DOI: 10.1016/j.neuint.2013.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.neuint.2013.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23416621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjt1aisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=776-783&author=A.+Wilkaniecauthor=J.+B.+Strosznajderauthor=A.+Adamczyk&title=Toxicity+of+extracellular+secreted+%CE%B1-synuclein%3A+Its+role+in+nitrosative+stress+and+neurodegeneration&doi=10.1016%2Fj.neuint.2013.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity of extracellular secreted alpha-synuclein: Its role in nitrosative stress and neurodegeneration</span></div><div class="casAuthors">Wilkaniec, Anna; Strosznajder, Joanna B.; Adamczyk, Agata</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">776-783</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  It has been demonstrated that both oligomerization and accumulation of α-synuclein (ASN) are the key mol. processes involved in the pathophysiol. of neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease and other synucleinopathies.  Alterations of ASN expression and impairment of its degrdn. can lead to the formation of intracellular deposits of this protein, called Lewy bodies.  Overexpressed or misfolded ASN could be secreted to the extracellular space.  Today the prion-like transmission of ASN oligomers to neighboring cells is believed to be responsible for protein modification and propagation of neurodegeneration in the brain.  It was presented that oxidative/nitrosative stress may play a key role in ASN secretion and spread of ASN pathol.  Moreover, ASN-evoked protein oxidn., nitration and nitrosylation lead to disturbances in synaptic transmission and cell death.  The interaction of secreted ASN with other amyloidogenic proteins and its involvement in irreversible mitochondrial disturbances and oxidative stress were also described.  A better understanding of the mechanisms of ASN secretion and dysfunction may help to explain the mol. mechanisms of neurodegeneration and may be the basis for the development of novel therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4XNGYKhjAzrVg90H21EOLACvtfcHk0lj6yBP6Ke7rug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjt1aisrc%253D&md5=91abc3f2f1916850d48e44de5b6cc432</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2013.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2013.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DWilkaniec%26aufirst%3DA.%26aulast%3DStrosznajder%26aufirst%3DJ.%2BB.%26aulast%3DAdamczyk%26aufirst%3DA.%26atitle%3DToxicity%2520of%2520extracellular%2520secreted%2520%25CE%25B1-synuclein%253A%2520Its%2520role%2520in%2520nitrosative%2520stress%2520and%2520neurodegeneration%26jtitle%3DNeurochem.%2520Int.%26date%3D2013%26volume%3D62%26spage%3D776%26epage%3D783%26doi%3D10.1016%2Fj.neuint.2013.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Chung, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khurana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auluck, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardiff, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzulli, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soldner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baru, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freyzon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mungenast, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muffat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitalipova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pluth, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jui, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schüle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krainc, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaenisch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, S.</span><span> </span><span class="NLM_article-title">Identification and rescue of α-synuclein toxicity in parkinson patient-derived neurons</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">983</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span><span class="refDoi"> DOI: 10.1126/science.1245296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1126%2Fscience.1245296" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2013&pages=983-987&author=C.+Y.+Chungauthor=V.+Khuranaauthor=P.+K.+Auluckauthor=D.+F.+Tardiffauthor=J.+R.+Mazzulliauthor=F.+Soldnerauthor=V.+Baruauthor=Y.+Louauthor=Y.+Freyzonauthor=S.+Choauthor=A.+E.+Mungenastauthor=J.+Muffatauthor=M.+Mitalipovaauthor=M.+D.+Pluthauthor=N.+T.+Juiauthor=B.+Sch%C3%BCleauthor=S.+J.+Lippardauthor=L.+H.+Tsaiauthor=D.+Kraincauthor=S.+L.+Buchwaldauthor=R.+Jaenischauthor=S.+Lindquist&title=Identification+and+rescue+of+%CE%B1-synuclein+toxicity+in+parkinson+patient-derived+neurons&doi=10.1126%2Fscience.1245296"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1126%2Fscience.1245296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1245296%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.%2BY.%26aulast%3DKhurana%26aufirst%3DV.%26aulast%3DAuluck%26aufirst%3DP.%2BK.%26aulast%3DTardiff%26aufirst%3DD.%2BF.%26aulast%3DMazzulli%26aufirst%3DJ.%2BR.%26aulast%3DSoldner%26aufirst%3DF.%26aulast%3DBaru%26aufirst%3DV.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DFreyzon%26aufirst%3DY.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DMungenast%26aufirst%3DA.%2BE.%26aulast%3DMuffat%26aufirst%3DJ.%26aulast%3DMitalipova%26aufirst%3DM.%26aulast%3DPluth%26aufirst%3DM.%2BD.%26aulast%3DJui%26aufirst%3DN.%2BT.%26aulast%3DSch%25C3%25BCle%26aufirst%3DB.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26aulast%3DTsai%26aufirst%3DL.%2BH.%26aulast%3DKrainc%26aufirst%3DD.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26aulast%3DJaenisch%26aufirst%3DR.%26aulast%3DLindquist%26aufirst%3DS.%26atitle%3DIdentification%2520and%2520rescue%2520of%2520%25CE%25B1-synuclein%2520toxicity%2520in%2520parkinson%2520patient-derived%2520neurons%26jtitle%3DScience%26date%3D2013%26volume%3D342%26spage%3D983%26epage%3D987%26doi%3D10.1126%2Fscience.1245296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Tardiff, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jui, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khurana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tambe, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamadurai, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancaster, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, S.</span><span> </span><span class="NLM_article-title">Yeast reveal a "druggable" Rsp5/Nedd4 network that ameliorates α-synuclein toxicity in neurons</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">983</span><span class="refDoi"> DOI: 10.1126/science.1245321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1126%2Fscience.1245321" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2013&pages=979-983&author=D.+F.+Tardiffauthor=N.+T.+Juiauthor=V.+Khuranaauthor=M.+A.+Tambeauthor=M.+L.+Thompsonauthor=C.+Y.+Chungauthor=H.+B.+Kamaduraiauthor=H.+T.+Kimauthor=A.+K.+Lancasterauthor=K.+A.+Caldwellauthor=G.+A.+Caldwellauthor=J.+C.+Rochetauthor=S.+L.+Buchwaldauthor=S.+Lindquist&title=Yeast+reveal+a+%22druggable%22+Rsp5%2FNedd4+network+that+ameliorates+%CE%B1-synuclein+toxicity+in+neurons&doi=10.1126%2Fscience.1245321"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1126%2Fscience.1245321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1245321%26sid%3Dliteratum%253Aachs%26aulast%3DTardiff%26aufirst%3DD.%2BF.%26aulast%3DJui%26aufirst%3DN.%2BT.%26aulast%3DKhurana%26aufirst%3DV.%26aulast%3DTambe%26aufirst%3DM.%2BA.%26aulast%3DThompson%26aufirst%3DM.%2BL.%26aulast%3DChung%26aufirst%3DC.%2BY.%26aulast%3DKamadurai%26aufirst%3DH.%2BB.%26aulast%3DKim%26aufirst%3DH.%2BT.%26aulast%3DLancaster%26aufirst%3DA.%2BK.%26aulast%3DCaldwell%26aufirst%3DK.%2BA.%26aulast%3DCaldwell%26aufirst%3DG.%2BA.%26aulast%3DRochet%26aufirst%3DJ.%2BC.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26aulast%3DLindquist%26aufirst%3DS.%26atitle%3DYeast%2520reveal%2520a%2520%2522druggable%2522%2520Rsp5%252FNedd4%2520network%2520that%2520ameliorates%2520%25CE%25B1-synuclein%2520toxicity%2520in%2520neurons%26jtitle%3DScience%26date%3D2013%26volume%3D342%26spage%3D979%26epage%3D983%26doi%3D10.1126%2Fscience.1245321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Chiang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span> </span><span class="NLM_article-title">Emerging therapeutics for Alzheimer’s disease</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span><span class="refDoi"> DOI: 10.1146/annurev-pharmtox-011613-135932</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1146%2Fannurev-pharmtox-011613-135932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24392696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVSqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=381-405&author=K.+Chiangauthor=E.+H.+Koo&title=Emerging+therapeutics+for+Alzheimer%E2%80%99s+disease&doi=10.1146%2Fannurev-pharmtox-011613-135932"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging therapeutics for Alzheimer's disease</span></div><div class="casAuthors">Chiang, Karen; Koo, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">381-405</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Despite decades of intense research, therapeutics for Alzheimer's disease (AD) are still limited to symptomatic treatments that possess only short-term efficacy.  Recently, several large-scale Phase III trials targeting amyloid-β prodn. or clearance have failed to show efficacy, leading to a reexamn. of the amyloid hypothesis as well as highlighting the need to explore alternatives in both clin. testing strategies and drug discovery targets.  In this review, we discuss therapeutics currently being tested in clin. trials and up-and-coming interventions that have shown promise in animal models, devoting attention to the mechanisms that may underlie their ability to influence disease progression and placing particular emphasis on tau therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtr6-78RIRjLVg90H21EOLACvtfcHk0li9fFdT3Q32mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVSqt7s%253D&md5=2282a36b965704b1cfb3796f1a685eda</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-011613-135932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-011613-135932%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DK.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26atitle%3DEmerging%2520therapeutics%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2014%26volume%3D54%26spage%3D381%26epage%3D405%26doi%3D10.1146%2Fannurev-pharmtox-011613-135932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">Alzheimer mechanisms and therapeutic strategies</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">1204</span><span class="NLM_x">–</span> <span class="NLM_lpage">1222</span><span class="refDoi"> DOI: 10.1016/j.cell.2012.02.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.cell.2012.02.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22424230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1CqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2012&pages=1204-1222&author=Y.+Huangauthor=L.+Mucke&title=Alzheimer+mechanisms+and+therapeutic+strategies&doi=10.1016%2Fj.cell.2012.02.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer Mechanisms and Therapeutic Strategies</span></div><div class="casAuthors">Huang, Yadong; Mucke, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1204-1222</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  There are still no effective treatments to prevent, halt, or reverse Alzheimer's disease, but research advances over the past three decades could change this gloomy picture.  Genetic studies demonstrate that the disease has multiple causes.  Interdisciplinary approaches combining biochem., mol. and cell biol., and transgenic modeling have revealed some of its mol. mechanisms.  Progress in chem., radiol., and systems biol. is beginning to provide useful biomarkers, and the emergence of personalized medicine is poised to transform pharmaceutical development and clin. trials.  However, investigative and drug development efforts should be diversified to fully address the multifactoriality of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx4Jw1D9na57Vg90H21EOLACvtfcHk0li9fFdT3Q32mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1CqurY%253D&md5=4f44f2d5019321a668029282777946d1</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.02.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.02.040%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DAlzheimer%2520mechanisms%2520and%2520therapeutic%2520strategies%26jtitle%3DCell%26date%3D2012%26volume%3D148%26spage%3D1204%26epage%3D1222%26doi%3D10.1016%2Fj.cell.2012.02.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Bertram, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lill, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span> </span><span class="NLM_article-title">The genetics of Alzheimer disease: back to the future</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1016/j.neuron.2010.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.neuron.2010.10.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2010&pages=270-281&author=L.+Bertramauthor=C.+M.+Lillauthor=R.+E.+Tanzi&title=The+genetics+of+Alzheimer+disease%3A+back+to+the+future&doi=10.1016%2Fj.neuron.2010.10.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2010.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2010.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DBertram%26aufirst%3DL.%26aulast%3DLill%26aufirst%3DC.%2BM.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26atitle%3DThe%2520genetics%2520of%2520Alzheimer%2520disease%253A%2520back%2520to%2520the%2520future%26jtitle%3DNeuron%26date%3D2010%26volume%3D68%26spage%3D270%26epage%3D281%26doi%3D10.1016%2Fj.neuron.2010.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Serrano-Pozo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frosch, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span> </span><span class="NLM_article-title">Neuropathological alterations in Alzheimer disease</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">a006189</span><span class="refDoi"> DOI: 10.1101/cshperspect.a006189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1101%2Fcshperspect.a006189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22229116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFWgt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=a006189&author=A.+Serrano-Pozoauthor=M.+P.+Froschauthor=E.+Masliahauthor=B.+T.+Hyman&title=Neuropathological+alterations+in+Alzheimer+disease&doi=10.1101%2Fcshperspect.a006189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathological alterations in Alzheimer disease</span></div><div class="casAuthors">Serrano-Pozo, Alberto; Frosch, Matthew P.; Masliah, Eliezer; Hyman, Bradley T.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">a006189/1-a006189/23</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  The neuropathol. hallmarks of Alzheimer disease (AD) include "pos." lesions such as amyloid plaques and cerebral amyloid angiopathy, neurofibrillary tangles, and glial responses, and "neg." lesions such as neuronal and synaptic loss.  Despite their inherently cross-sectional nature, postmortem studies have enabled the staging of the progression of both amyloid and tangle pathologies, and, consequently, the development of diagnostic criteria that are now used worldwide.  In addn., clinicopathol. correlation studies have been crucial to generate hypotheses about the pathophysiol. of the disease, by establishing that there is a continuum between "normal" aging and AD dementia, and that the amyloid plaque build-up occurs primarily before the onset of cognitive deficits, while neurofibrillary tangles, neuron loss, and particularly synaptic loss, parallel the progression of cognitive decline.  Importantly, these cross-sectional neuropathol. data have been largely validated by longitudinal in vivo studies using modern imaging biomarkers such as amyloid PET and volumetric MRI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohEFWLIBeaLrVg90H21EOLACvtfcHk0li_fBcIniVd2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFWgt7c%253D&md5=ac33eb37912f670122c03fda4a1d2162</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006189%26sid%3Dliteratum%253Aachs%26aulast%3DSerrano-Pozo%26aufirst%3DA.%26aulast%3DFrosch%26aufirst%3DM.%2BP.%26aulast%3DMasliah%26aufirst%3DE.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26atitle%3DNeuropathological%2520alterations%2520in%2520Alzheimer%2520disease%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2011%26volume%3D1%26spage%3Da006189%26doi%3D10.1101%2Fcshperspect.a006189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertram, L.</span><span> </span><span class="NLM_article-title">Twenty years of the Alzheimer’s disease amyloid hypothesis: a genetic perspective</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span><span class="refDoi"> DOI: 10.1016/j.cell.2005.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.cell.2005.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=15734686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVWnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2005&pages=545-555&author=R.+E.+Tanziauthor=L.+Bertram&title=Twenty+years+of+the+Alzheimer%E2%80%99s+disease+amyloid+hypothesis%3A+a+genetic+perspective&doi=10.1016%2Fj.cell.2005.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective</span></div><div class="casAuthors">Tanzi, Rudolph E.; Bertram, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">545-555</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  From Alois Alzheimer's description of Auguste D.'s brain in 1907 to George Glenner's biochem. dissection of β-amyloid in 1984, the "amyloid hypothesis" of Alzheimer's disease has continued to gain support over the past two decades, particularly from genetic studies.  Here we assess the amyloid hypothesis based on both known and putative Alzheimer's disease genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPVQvwUmMmXrVg90H21EOLACvtfcHk0li_fBcIniVd2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVWnu7k%253D&md5=3f88dc7dda6b726429789c61d5992493</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2005.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2005.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DBertram%26aufirst%3DL.%26atitle%3DTwenty%2520years%2520of%2520the%2520Alzheimer%25E2%2580%2599s%2520disease%2520amyloid%2520hypothesis%253A%2520a%2520genetic%2520perspective%26jtitle%3DCell%26date%3D2005%26volume%3D120%26spage%3D545%26epage%3D555%26doi%3D10.1016%2Fj.cell.2005.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Yagi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akamatsu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nihei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span> </span><span class="NLM_article-title">Modeling familial Alzheimer’s disease with induced pluripotent stem cells</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4530</span><span class="NLM_x">–</span> <span class="NLM_lpage">4539</span><span class="refDoi"> DOI: 10.1093/hmg/ddr394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1093%2Fhmg%2Fddr394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21900357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVGrsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=4530-4539&author=T.+Yagiauthor=D.+Itoauthor=Y.+Okadaauthor=W.+Akamatsuauthor=Y.+Niheiauthor=T.+Yoshizakiauthor=S.+Yamanakaauthor=H.+Okanoauthor=N.+Suzuki&title=Modeling+familial+Alzheimer%E2%80%99s+disease+with+induced+pluripotent+stem+cells&doi=10.1093%2Fhmg%2Fddr394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling familial Alzheimer's disease with induced pluripotent stem cells</span></div><div class="casAuthors">Yagi, Takuya; Ito, Daisuke; Okada, Yohei; Akamatsu, Wado; Nihei, Yoshihiro; Yoshizaki, Takahito; Yamanaka, Shinya; Okano, Hideyuki; Suzuki, Norihiro</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4530-4539</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most common form of age-related dementia, characterized by progressive memory loss and cognitive disturbance.  Mutations of presenilin 1 (PS1) and presenilin 2 (PS2) are causative factors for autosomal-dominant early-onset familial AD (FAD).  Induced pluripotent stem cell (iPSC) technol. can be used to model human disorders and provide novel opportunities to study cellular mechanisms and establish therapeutic strategies against various diseases, including neurodegenerative diseases.  Here we generate iPSCs from fibroblasts of FAD patients with mutations in PS1 (A246E) and PS2 (N141I), and characterize the differentiation of these cells into neurons.  We find that FAD-iPSC-derived differentiated neurons have increased amyloid β42 secretion, recapitulating the mol. pathogenesis of mutant presenilins.  Furthermore, secretion of amyloid β42 from these neurons sharply responds to γ-secretase inhibitors and modulators, indicating the potential for identification and validation of candidate drugs.  Our findings demonstrate that the FAD-iPSC-derived neuron is a valid model of AD and provides an innovative strategy for the study of age-related neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYj221SQsO-7Vg90H21EOLACvtfcHk0li_fBcIniVd2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVGrsbnF&md5=80193f43d2ebcf4e3a73c0c02a3739c5</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddr394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddr394%26sid%3Dliteratum%253Aachs%26aulast%3DYagi%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DD.%26aulast%3DOkada%26aufirst%3DY.%26aulast%3DAkamatsu%26aufirst%3DW.%26aulast%3DNihei%26aufirst%3DY.%26aulast%3DYoshizaki%26aufirst%3DT.%26aulast%3DYamanaka%26aufirst%3DS.%26aulast%3DOkano%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DN.%26atitle%3DModeling%2520familial%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2011%26volume%3D20%26spage%3D4530%26epage%3D4539%26doi%3D10.1093%2Fhmg%2Fddr394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Hampel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoessler, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Total and phosphorylated tau protein as biological markers of Alzheimer’s disease</span> <span class="citation_source-journal">Exp. Gerontol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1016/j.exger.2009.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.exger.2009.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=19853650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFynt7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=30-40&author=H.+Hampelauthor=K.+Blennowauthor=L.+M.+Shawauthor=Y.+C.+Hoesslerauthor=H.+Zetterbergauthor=J.+Q.+Trojanowski&title=Total+and+phosphorylated+tau+protein+as+biological+markers+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.exger.2009.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Total and phosphorylated tau protein as biological markers of Alzheimer's disease</span></div><div class="casAuthors">Hampel, Harald; Blennow, Kaj; Shaw, Leslie M.; Hoessler, Yvonne C.; Zetterberg, Henrik; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Gerontology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-40</span>CODEN:
                <span class="NLM_cas:coden">EXGEAB</span>;
        ISSN:<span class="NLM_cas:issn">0531-5565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Advances in our understanding of tau-mediated neurodegeneration in Alzheimer's disease (AD) are moving this disease pathway to center stage for the development of biomarkers and disease modifying drug discovery efforts.  Immunoassays were developed detecting total (t-tau) and tau phosphorylated at specific epitopes (p-tauX) in cerebrospinal fluid (CSF), methods to analyze tau in blood are at the exptl. beginning.  Clin. research consistently demonstrated CSF t- and p-tau increased in AD compared to controls.  Measuring these tau species proved informative for classifying AD from relevant differential diagnoses.  Tau phosphorylated at threonine 231 (p-tau231) differentiated between AD and frontotemporal dementia, tau phosphorylated at serine 181 (p-tau181) enhanced classification between AD and dementia with Lewy bodies.  T- and p-tau are considered "core" AD biomarkers that have been successfully validated by controlled large-scale multi-center studies.  Tau biomarkers are implemented in clin. trials to reflect biol. activity, mechanisms of action of compds., support enrichment of target populations, provide endpoints for proof-of-concept and confirmatory trials on disease modification.  World-wide quality control initiatives are underway to set required methodol. and protocol stds.  Discussions with regulatory authorities gain momentum defining the role of tau biomarkers for trial designs and how they may be further qualified for surrogate marker status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhPszOrNFIc7Vg90H21EOLACvtfcHk0li_fBcIniVd2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFynt7nN&md5=96851e57d604016c581d4723b21a545f</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.exger.2009.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exger.2009.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DHampel%26aufirst%3DH.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DHoessler%26aufirst%3DY.%2BC.%26aulast%3DZetterberg%26aufirst%3DH.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DTotal%2520and%2520phosphorylated%2520tau%2520protein%2520as%2520biological%2520markers%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExp.%2520Gerontol.%26date%3D2010%26volume%3D45%26spage%3D30%26epage%3D40%26doi%3D10.1016%2Fj.exger.2009.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Israel, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyna, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hefferan, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gorp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazor, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boscolo, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remes, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, L. S.</span><span> </span><span class="NLM_article-title">Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">482</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span><span class="refDoi"> DOI: 10.1038/nature10821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature10821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22278060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ejsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2012&pages=216-220&author=M.+A.+Israelauthor=S.+H.+Yuanauthor=C.+Bardyauthor=S.+M.+Reynaauthor=Y.+Muauthor=C.+Herreraauthor=M.+P.+Hefferanauthor=S.+Van+Gorpauthor=K.+L.+Nazorauthor=F.+S.+Boscoloauthor=C.+T.+Carsonauthor=L.+C.+Laurentauthor=M.+Marsalaauthor=F.+H.+Gageauthor=A.+M.+Remesauthor=E.+H.+Kooauthor=L.+S.+Goldstein&title=Probing+sporadic+and+familial+Alzheimer%E2%80%99s+disease+using+induced+pluripotent+stem+cells&doi=10.1038%2Fnature10821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells</span></div><div class="casAuthors">Israel, Mason A.; Yuan, Shauna H.; Bardy, Cedric; Reyna, Sol M.; Mu, Yangling; Herrera, Cheryl; Hefferan, Michael P.; Van Gorp, Sebastiaan; Nazor, Kristopher L.; Boscolo, Francesca S.; Carson, Christian T.; Laurent, Louise C.; Marsala, Martin; Gage, Fred H.; Remes, Anne M.; Koo, Edward H.; Goldstein, Lawrence S. B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">482</span>
        (<span class="NLM_cas:issue">7384</span>),
    <span class="NLM_cas:pages">216-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Induced pluripotent stem cells are shown to be useful for studying phenotypes relevant to familial and sporadic Alzheimer's disease, even though it can take decades for the disease to manifest in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe7GR8O1bN17Vg90H21EOLACvtfcHk0lhEurOAz33Olg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ejsrY%253D&md5=6ca7f428574f0aa547066fc0879cbe1b</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fnature10821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10821%26sid%3Dliteratum%253Aachs%26aulast%3DIsrael%26aufirst%3DM.%2BA.%26aulast%3DYuan%26aufirst%3DS.%2BH.%26aulast%3DBardy%26aufirst%3DC.%26aulast%3DReyna%26aufirst%3DS.%2BM.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DHerrera%26aufirst%3DC.%26aulast%3DHefferan%26aufirst%3DM.%2BP.%26aulast%3DVan%2BGorp%26aufirst%3DS.%26aulast%3DNazor%26aufirst%3DK.%2BL.%26aulast%3DBoscolo%26aufirst%3DF.%2BS.%26aulast%3DCarson%26aufirst%3DC.%2BT.%26aulast%3DLaurent%26aufirst%3DL.%2BC.%26aulast%3DMarsala%26aufirst%3DM.%26aulast%3DGage%26aufirst%3DF.%2BH.%26aulast%3DRemes%26aufirst%3DA.%2BM.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DGoldstein%26aufirst%3DL.%2BS.%26atitle%3DProbing%2520sporadic%2520and%2520familial%2520Alzheimer%25E2%2580%2599s%2520disease%2520using%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DNature%26date%3D2012%26volume%3D482%26spage%3D216%26epage%3D220%26doi%3D10.1038%2Fnature10821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Kondo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutoku, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohsawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yahata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asaka, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadoya, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choshi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakahata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hioki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naitoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamawaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, H.</span><span> </span><span class="NLM_article-title">Modeling Alzheimer’s disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">487</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1016/j.stem.2013.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.stem.2013.01.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=487-496&author=T.+Kondoauthor=M.+Asaiauthor=K.+Tsukitaauthor=Y.+Kutokuauthor=Y.+Ohsawaauthor=Y.+Sunadaauthor=K.+Imamuraauthor=N.+Egawaauthor=N.+Yahataauthor=K.+Okitaauthor=K.+Takahashiauthor=I.+Asakaauthor=T.+Aoiauthor=A.+Watanabeauthor=K.+Watanabeauthor=C.+Kadoyaauthor=R.+Nakanoauthor=D.+Watanabeauthor=K.+Maruyamaauthor=O.+Horiauthor=S.+Hibinoauthor=T.+Choshiauthor=T.+Nakahataauthor=H.+Hiokiauthor=T.+Kanekoauthor=M.+Naitohauthor=K.+Yoshikawaauthor=S.+Yamawakiauthor=S.+Suzukiauthor=R.+Hataauthor=S.+Uenoauthor=T.+Sekiauthor=K.+Kobayashiauthor=T.+Todaauthor=K.+Murakamiauthor=K.+Irieauthor=W.+L.+Kleinauthor=H.+Moriauthor=T.+Asadaauthor=R.+Takahashiauthor=N.+Iwataauthor=S.+Yamanakaauthor=H.+Inoue&title=Modeling+Alzheimer%E2%80%99s+disease+with+iPSCs+reveals+stress+phenotypes+associated+with+intracellular+A%CE%B2+and+differential+drug+responsiveness&doi=10.1016%2Fj.stem.2013.01.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2013.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2013.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DKondo%26aufirst%3DT.%26aulast%3DAsai%26aufirst%3DM.%26aulast%3DTsukita%26aufirst%3DK.%26aulast%3DKutoku%26aufirst%3DY.%26aulast%3DOhsawa%26aufirst%3DY.%26aulast%3DSunada%26aufirst%3DY.%26aulast%3DImamura%26aufirst%3DK.%26aulast%3DEgawa%26aufirst%3DN.%26aulast%3DYahata%26aufirst%3DN.%26aulast%3DOkita%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DAsaka%26aufirst%3DI.%26aulast%3DAoi%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DKadoya%26aufirst%3DC.%26aulast%3DNakano%26aufirst%3DR.%26aulast%3DWatanabe%26aufirst%3DD.%26aulast%3DMaruyama%26aufirst%3DK.%26aulast%3DHori%26aufirst%3DO.%26aulast%3DHibino%26aufirst%3DS.%26aulast%3DChoshi%26aufirst%3DT.%26aulast%3DNakahata%26aufirst%3DT.%26aulast%3DHioki%26aufirst%3DH.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DNaitoh%26aufirst%3DM.%26aulast%3DYoshikawa%26aufirst%3DK.%26aulast%3DYamawaki%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DHata%26aufirst%3DR.%26aulast%3DUeno%26aufirst%3DS.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DToda%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DK.%26aulast%3DIrie%26aufirst%3DK.%26aulast%3DKlein%26aufirst%3DW.%2BL.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DAsada%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DIwata%26aufirst%3DN.%26aulast%3DYamanaka%26aufirst%3DS.%26aulast%3DInoue%26aufirst%3DH.%26atitle%3DModeling%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520iPSCs%2520reveals%2520stress%2520phenotypes%2520associated%2520with%2520intracellular%2520A%25CE%25B2%2520and%2520differential%2520drug%2520responsiveness%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2013%26volume%3D12%26spage%3D487%26epage%3D496%26doi%3D10.1016%2Fj.stem.2013.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Mummery, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elefanty, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamp, T. J.</span><span> </span><span class="NLM_article-title">Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span><span class="refDoi"> DOI: 10.1161/CIRCRESAHA.110.227512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1161%2FCIRCRESAHA.110.227512" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2012&pages=344-358&author=C.+L.+Mummeryauthor=J.+Zhangauthor=E.+S.+Ngauthor=D.+A.+Elliottauthor=A.+G.+Elefantyauthor=T.+J.+Kamp&title=Differentiation+of+human+embryonic+stem+cells+and+induced+pluripotent+stem+cells+to+cardiomyocytes%3A+a+methods+overview&doi=10.1161%2FCIRCRESAHA.110.227512"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.110.227512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.110.227512%26sid%3Dliteratum%253Aachs%26aulast%3DMummery%26aufirst%3DC.%2BL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DNg%26aufirst%3DE.%2BS.%26aulast%3DElliott%26aufirst%3DD.%2BA.%26aulast%3DElefanty%26aufirst%3DA.%2BG.%26aulast%3DKamp%26aufirst%3DT.%2BJ.%26atitle%3DDifferentiation%2520of%2520human%2520embryonic%2520stem%2520cells%2520and%2520induced%2520pluripotent%2520stem%2520cells%2520to%2520cardiomyocytes%253A%2520a%2520methods%2520overview%26jtitle%3DCirc.%2520Res.%26date%3D2012%26volume%3D111%26spage%3D344%26epage%3D358%26doi%3D10.1161%2FCIRCRESAHA.110.227512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Matsa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burridge, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span> </span><span class="NLM_article-title">Human stem cells for modeling heart disease and for drug discovery</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">239ps6</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3008921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1126%2Fscitranslmed.3008921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24898747" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=239ps6&author=E.+Matsaauthor=P.+W.+Burridgeauthor=J.+C.+Wu&title=Human+stem+cells+for+modeling+heart+disease+and+for+drug+discovery&doi=10.1126%2Fscitranslmed.3008921"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3008921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3008921%26sid%3Dliteratum%253Aachs%26aulast%3DMatsa%26aufirst%3DE.%26aulast%3DBurridge%26aufirst%3DP.%2BW.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26atitle%3DHuman%2520stem%2520cells%2520for%2520modeling%2520heart%2520disease%2520and%2520for%2520drug%2520discovery%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D239ps6%26doi%3D10.1126%2Fscitranslmed.3008921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Carvajal-Vergara, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sevilla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Souza, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ang, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaniel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edelmann, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waghray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenbelt, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemischka, I. R.</span><span> </span><span class="NLM_article-title">Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">808</span><span class="NLM_x">–</span> <span class="NLM_lpage">812</span><span class="refDoi"> DOI: 10.1038/nature09005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature09005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=808-812&author=X.+Carvajal-Vergaraauthor=A.+Sevillaauthor=S.+L.+D%E2%80%99Souzaauthor=Y.+S.+Angauthor=C.+Schanielauthor=D.+F.+Leeauthor=L.+Yangauthor=A.+D.+Kaplanauthor=E.+D.+Adlerauthor=R.+Rozovauthor=Y.+Geauthor=N.+Cohenauthor=L.+J.+Edelmannauthor=B.+Changauthor=A.+Waghrayauthor=J.+Suauthor=S.+Pardoauthor=K.+D.+Lichtenbeltauthor=M.+Tartagliaauthor=B.+D.+Gelbauthor=I.+R.+Lemischka&title=Patient-specific+induced+pluripotent+stem-cell-derived+models+of+LEOPARD+syndrome&doi=10.1038%2Fnature09005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnature09005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09005%26sid%3Dliteratum%253Aachs%26aulast%3DCarvajal-Vergara%26aufirst%3DX.%26aulast%3DSevilla%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DS.%2BL.%26aulast%3DAng%26aufirst%3DY.%2BS.%26aulast%3DSchaniel%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DD.%2BF.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DKaplan%26aufirst%3DA.%2BD.%26aulast%3DAdler%26aufirst%3DE.%2BD.%26aulast%3DRozov%26aufirst%3DR.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DN.%26aulast%3DEdelmann%26aufirst%3DL.%2BJ.%26aulast%3DChang%26aufirst%3DB.%26aulast%3DWaghray%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DPardo%26aufirst%3DS.%26aulast%3DLichtenbelt%26aufirst%3DK.%2BD.%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26aulast%3DLemischka%26aufirst%3DI.%2BR.%26atitle%3DPatient-specific%2520induced%2520pluripotent%2520stem-cell-derived%2520models%2520of%2520LEOPARD%2520syndrome%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D808%26epage%3D812%26doi%3D10.1038%2Fnature09005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Mercola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willems, E.</span><span> </span><span class="NLM_article-title">Induced pluripotent stem cells in cardiovascular drug discovery</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span><span class="refDoi"> DOI: 10.1161/CIRCRESAHA.111.250266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1161%2FCIRCRESAHA.111.250266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23371902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2013&pages=534-548&author=M.+Mercolaauthor=A.+Colasauthor=E.+Willems&title=Induced+pluripotent+stem+cells+in+cardiovascular+drug+discovery&doi=10.1161%2FCIRCRESAHA.111.250266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Induced Pluripotent Stem Cells in Cardiovascular Drug Discovery</span></div><div class="casAuthors">Mercola, Mark; Colas, Alexandre; Willems, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">534-548</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The unexpected discovery that somatic cells can be reprogrammed to a pluripotent state yielding induced pluripotent stem cells has made it possible to produce cardiovascular cells exhibiting inherited traits and disorders.  Use of these cells in high throughput analyses should broaden our insight into fundamental disease mechanisms and provide many benefits for patients, including new therapeutics and individually tailored therapies.  Here we review recent progress in generating induced pluripotent stem cell-based models of cardiovascular disease and their multiple applications in drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFERiffTl3IrVg90H21EOLACvtfcHk0lh1VXXRbnQgsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWgs7w%253D&md5=1bafac2daf2625f0cd8f40112d59e978</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.111.250266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.111.250266%26sid%3Dliteratum%253Aachs%26aulast%3DMercola%26aufirst%3DM.%26aulast%3DColas%26aufirst%3DA.%26aulast%3DWillems%26aufirst%3DE.%26atitle%3DInduced%2520pluripotent%2520stem%2520cells%2520in%2520cardiovascular%2520drug%2520discovery%26jtitle%3DCirc.%2520Res.%26date%3D2013%26volume%3D112%26spage%3D534%26epage%3D548%26doi%3D10.1161%2FCIRCRESAHA.111.250266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Sinnecker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laugwitz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, A.</span><span> </span><span class="NLM_article-title">Induced pluripotent stem cell-derived cardiomyocytes for drug development and toxicity testing</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2014.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.pharmthera.2014.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24657289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1eqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2014&pages=246-252&author=D.+Sinneckerauthor=K.+L.+Laugwitzauthor=A.+Moretti&title=Induced+pluripotent+stem+cell-derived+cardiomyocytes+for+drug+development+and+toxicity+testing&doi=10.1016%2Fj.pharmthera.2014.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Induced pluripotent stem cell-derived cardiomyocytes for drug development and toxicity testing</span></div><div class="casAuthors">Sinnecker, Daniel; Laugwitz, Karl-Ludwig; Moretti, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-252</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Induced pluripotent stem cell (iPSC) technol. is creating exciting new opportunities for cardiovascular research by providing platforms to study the mechanisms of disease pathogenesis that could lead to new therapies or reveal drug sensitivities.  In this review, the potential usefulness of iPSC-derived cardiomyocytes in drug development as well as in drug toxicity testing is discussed, with a focus on the achievements that have been already made in this regard.  Moreover, the crucial steps that have to be taken before this technol. can be broadly used in drug discovery and toxicol. assessments are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokJL-d2p89U7Vg90H21EOLACvtfcHk0lh1VXXRbnQgsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1eqtro%253D&md5=11862e0ca7ef5136686c0564361e4e8e</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DSinnecker%26aufirst%3DD.%26aulast%3DLaugwitz%26aufirst%3DK.%2BL.%26aulast%3DMoretti%26aufirst%3DA.%26atitle%3DInduced%2520pluripotent%2520stem%2520cell-derived%2520cardiomyocytes%2520for%2520drug%2520development%2520and%2520toxicity%2520testing%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D143%26spage%3D246%26epage%3D252%26doi%3D10.1016%2Fj.pharmthera.2014.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Mordwinkin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burridge, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span> </span><span class="NLM_article-title">A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards</span> <span class="citation_source-journal">J. Cardiovasc. Transl. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1007/s12265-012-9423-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1007%2Fs12265-012-9423-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23229562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A280%3ADC%252BC3s3gtF2itA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=22-30&author=N.+M.+Mordwinkinauthor=P.+W.+Burridgeauthor=J.+C.+Wu&title=A+review+of+human+pluripotent+stem+cell-derived+cardiomyocytes+for+high-throughput+drug+discovery%2C+cardiotoxicity+screening%2C+and+publication+standards&doi=10.1007%2Fs12265-012-9423-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards</span></div><div class="casAuthors">Mordwinkin Nicholas M; Burridge Paul W; Wu Joseph C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cardiovascular translational research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Drug attrition rates have increased in past years, resulting in growing costs for the pharmaceutical industry and consumers.  The reasons for this include the lack of in vitro models that correlate with clinical results and poor preclinical toxicity screening assays.  The in vitro production of human cardiac progenitor cells and cardiomyocytes from human pluripotent stem cells provides an amenable source of cells for applications in drug discovery, disease modeling, regenerative medicine, and cardiotoxicity screening.  In addition, the ability to derive human-induced pluripotent stem cells from somatic tissues, combined with current high-throughput screening and pharmacogenomics, may help realize the use of these cells to fulfill the potential of personalized medicine.  In this review, we discuss the use of pluripotent stem cell-derived cardiomyocytes for drug discovery and cardiotoxicity screening, as well as current hurdles that must be overcome for wider clinical applications of this promising approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0iX2-R-iDTY2y4bB4mnvYfW6udTcc2ea7MnT78t-Z_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3gtF2itA%253D%253D&md5=c64c5af61307d04247eee7a830f69946</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1007%2Fs12265-012-9423-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12265-012-9423-2%26sid%3Dliteratum%253Aachs%26aulast%3DMordwinkin%26aufirst%3DN.%2BM.%26aulast%3DBurridge%26aufirst%3DP.%2BW.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26atitle%3DA%2520review%2520of%2520human%2520pluripotent%2520stem%2520cell-derived%2520cardiomyocytes%2520for%2520high-throughput%2520drug%2520discovery%252C%2520cardiotoxicity%2520screening%252C%2520and%2520publication%2520standards%26jtitle%3DJ.%2520Cardiovasc.%2520Transl.%2520Res.%26date%3D2013%26volume%3D6%26spage%3D22%26epage%3D30%26doi%3D10.1007%2Fs12265-012-9423-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Goldenberg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, A. J.</span><span> </span><span class="NLM_article-title">Long QT syndrome</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2291</span><span class="NLM_x">–</span> <span class="NLM_lpage">2300</span><span class="refDoi"> DOI: 10.1016/j.jacc.2008.02.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.jacc.2008.02.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=18549912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A280%3ADC%252BD1czotFKrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2291-2300&author=I.+Goldenbergauthor=A.+J.+Moss&title=Long+QT+syndrome&doi=10.1016%2Fj.jacc.2008.02.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Long QT syndrome</span></div><div class="casAuthors">Goldenberg Ilan; Moss Arthur J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2291-300</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The hereditary long QT syndrome (LQTS) is a genetic channelopathy with variable penetrance that is associated with increased propensity to syncope, polymorphous ventricular tachycardia (torsades de pointes), and sudden arrhythmic death.  This inherited cardiac disorder constitutes an important cause of malignant ventricular arrhythmias and sudden cardiac death in young individuals with normal cardiac morphology.  Risk assessment in affected LQTS patients relies upon a constellation of electrocardiographic, clinical, and genetic factors.  Administration of beta-blockers is the mainstay therapy in affected patients, and primary prevention with an implantable cardioverter defibrillator or left cervicothoracic sympathetic denervation are therapeutic options in patients who remain symptomatic despite beta-blocker therapy.  Accumulating data from the International LQTS Registry have recently facilitated a comprehensive analysis of risk factors for aborted cardiac arrest or sudden cardiac death in pre-specified age groups, including the childhood, adolescence, adulthood, and post-40 periods.  These analyses have consistently indicated that the phenotypic expression of LQTS is time dependent and age specific, warranting continuous risk assessment in affected patients.  Furthermore, the biophysical function, type, and location of the ion-channel mutation are currently emerging as important determinants of outcome in genotyped patients.  These new data may be used to improve risk stratification and for the development of gene-specific therapies that may reduce the risk of life-threatening cardiac events in patients with this inherited cardiac disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnjRnC0qWXOrxanA7vODO6fW6udTcc2eb9f7-DPQ4dF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czotFKrsg%253D%253D&md5=de93c414806e91dd3e5556b7839c20b4</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2008.02.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2008.02.068%26sid%3Dliteratum%253Aachs%26aulast%3DGoldenberg%26aufirst%3DI.%26aulast%3DMoss%26aufirst%3DA.%2BJ.%26atitle%3DLong%2520QT%2520syndrome%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2008%26volume%3D51%26spage%3D2291%26epage%3D2300%26doi%3D10.1016%2Fj.jacc.2008.02.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Moss, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kass, R. S.</span><span> </span><span class="NLM_article-title">Long QT syndrome: from channels to cardiac arrhythmias</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">2018</span><span class="NLM_x">–</span> <span class="NLM_lpage">2024</span><span class="refDoi"> DOI: 10.1172/JCI25537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1172%2FJCI25537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=16075042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntFCmt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=2018-2024&author=A.+J.+Mossauthor=R.+S.+Kass&title=Long+QT+syndrome%3A+from+channels+to+cardiac+arrhythmias&doi=10.1172%2FJCI25537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Long QT syndrome: From channels to cardiac arrhythmias</span></div><div class="casAuthors">Moss, Arthur J.; Kass, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2018-2024</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Long QT syndrome, a rare genetic disorder assocd. with life-threatening arrhythmias, has provided a wealth of information about fundamental mechanisms underlying human cardiac electrophysiol. that has come about because of truly collaborative interactions between clin. and basic scientists.  Our understanding of the mechanisms that control the crit. plateau and repolarization phases of the human ventricular action potential has been raised to new levels through these studies, which have clarified the manner in which both potassium and sodium channels regulate this crit. period of elec. activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVt_KGvZsuKrVg90H21EOLACvtfcHk0liLlNk-x-CIQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntFCmt78%253D&md5=bb3b40480997574d10aa009eec8d51e0</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1172%2FJCI25537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI25537%26sid%3Dliteratum%253Aachs%26aulast%3DMoss%26aufirst%3DA.%2BJ.%26aulast%3DKass%26aufirst%3DR.%2BS.%26atitle%3DLong%2520QT%2520syndrome%253A%2520from%2520channels%2520to%2520cardiac%2520arrhythmias%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26spage%3D2018%26epage%3D2024%26doi%3D10.1172%2FJCI25537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Moretti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bott-Flügel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höhnke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyfarth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinnecker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schömig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laugwitz, K. L.</span><span> </span><span class="NLM_article-title">Patient-specific induced pluripotent stem-cell models for long-QT syndrome</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">1397</span><span class="NLM_x">–</span> <span class="NLM_lpage">1409</span><span class="refDoi"> DOI: 10.1056/NEJMoa0908679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1056%2FNEJMoa0908679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=20660394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGks73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1397-1409&author=A.+Morettiauthor=M.+Bellinauthor=A.+Wellingauthor=C.+B.+Jungauthor=J.+T.+Lamauthor=L.+Bott-Fl%C3%BCgelauthor=T.+Dornauthor=A.+Goedelauthor=C.+H%C3%B6hnkeauthor=F.+Hofmannauthor=M.+Seyfarthauthor=D.+Sinneckerauthor=A.+Sch%C3%B6migauthor=K.+L.+Laugwitz&title=Patient-specific+induced+pluripotent+stem-cell+models+for+long-QT+syndrome&doi=10.1056%2FNEJMoa0908679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Patient-specific induced pluripotent stem-cell models for long-QT syndrome</span></div><div class="casAuthors">Moretti, Alessandra; Bellin, Milena; Welling, Andrea; Jung, Christian Billy; Lam, Jason T.; Bott-Flugel, Lorenz; Dorn, Tatjana; Goedel, Alexander; Hohnke, Christian; Hofmann, Franz; Seyfarth, Melchior; Sinnecker, Daniel; Schomig, Albert; Laugwitz, Karl-Ludwig</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1397-1409</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Long-QT syndromes are heritable diseases assocd. with prolongation of the QT interval on an ECG and a high risk of sudden cardiac death due to ventricular tachyarrhythmia.  In long-QT syndrome type 1, mutations occur in the KCNQ1 gene, which encodes the repolarizing potassium channel mediating the delayed rectifier IKs current.  Methods: We screened a family affected by long-QT syndrome type 1 and identified an autosomal dominant missense mutation (R190Q) in the KCNQ1 gene.  We obtained dermal fibroblasts from two family members and two healthy controls and infected them with retroviral vectors encoding the human transcription factors OCT3/4, SOX2, KLF4, and c-MYC to generate pluripotent stem cells.  With the use of a specific protocol, these cells were then directed to differentiate into cardiac myocytes.  Results: Induced pluripotent stem cells maintained the disease genotype of long-QT syndrome type 1 and generated functional myocytes.  Individual cells showed a "ventricular," "atrial," or "nodal" phenotype, as evidenced by the expression of cell-type-specific markers and as seen in recordings of the action potentials in single cells.  The duration of the action potential was markedly prolonged in "ventricular" and "atrial" cells derived from patients with long-QT syndrome type 1, as compared with cells from control subjects.  Further characterization of the role of the R190Q-KCNQ1 mutation in the pathogenesis of long-QT syndrome type 1 revealed a dominant neg. trafficking defect assocd. with a 70 to 80% redn. in IKs current and altered channel activation and deactivation properties.  Moreover, we showed that myocytes derived from patients with long-QT syndrome type 1 had an increased susceptibility to catecholamine-induced tachyarrhythmia and that beta-blockade attenuated this phenotype.  Conclusions: We generated patient-specific pluripotent stem cells from members of a family affected by long-QT syndrome type 1 and induced them to differentiate into functional cardiac myocytes.  The patient-derived cells recapitulated the electrophysiol. features of the disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok8xgTGHQSe7Vg90H21EOLACvtfcHk0liLlNk-x-CIQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGks73N&md5=871d9acee55cb2fc1e89a2752de0481d</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0908679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0908679%26sid%3Dliteratum%253Aachs%26aulast%3DMoretti%26aufirst%3DA.%26aulast%3DBellin%26aufirst%3DM.%26aulast%3DWelling%26aufirst%3DA.%26aulast%3DJung%26aufirst%3DC.%2BB.%26aulast%3DLam%26aufirst%3DJ.%2BT.%26aulast%3DBott-Fl%25C3%25BCgel%26aufirst%3DL.%26aulast%3DDorn%26aufirst%3DT.%26aulast%3DGoedel%26aufirst%3DA.%26aulast%3DH%25C3%25B6hnke%26aufirst%3DC.%26aulast%3DHofmann%26aufirst%3DF.%26aulast%3DSeyfarth%26aufirst%3DM.%26aulast%3DSinnecker%26aufirst%3DD.%26aulast%3DSch%25C3%25B6mig%26aufirst%3DA.%26aulast%3DLaugwitz%26aufirst%3DK.%2BL.%26atitle%3DPatient-specific%2520induced%2520pluripotent%2520stem-cell%2520models%2520for%2520long-QT%2520syndrome%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D1397%26epage%3D1409%26doi%3D10.1056%2FNEJMoa0908679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Matsa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamohan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staniforth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denning, C.</span><span> </span><span class="NLM_article-title">Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">952</span><span class="NLM_x">–</span> <span class="NLM_lpage">962</span><span class="refDoi"> DOI: 10.1093/eurheartj/ehr073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1093%2Feurheartj%2Fehr073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21367833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFaksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=952-962&author=E.+Matsaauthor=D.+Rajamohanauthor=E.+Dickauthor=L.+Youngauthor=I.+Mellorauthor=A.+Staniforthauthor=C.+Denning&title=Drug+evaluation+in+cardiomyocytes+derived+from+human+induced+pluripotent+stem+cells+carrying+a+long+QT+syndrome+type+2+mutation&doi=10.1093%2Feurheartj%2Fehr073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation</span></div><div class="casAuthors">Matsa, Elena; Rajamohan, Divya; Dick, Emily; Young, Lorraine; Mellor, Ian; Staniforth, Andrew; Denning, Chris</div><div class="citationInfo"><span class="NLM_cas:title">European Heart Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">952-962</span>CODEN:
                <span class="NLM_cas:coden">EHJODF</span>;
        ISSN:<span class="NLM_cas:issn">0195-668X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Aims: Congenital long QT syndromes (LQTSs) are assocd. with prolonged ventricular repolarization and sudden cardiac death.  Limitations to existing clin. therapeutic management strategies prompted us to develop a novel human in vitro drug-evaluation system for LQTS type 2 (LQT2) that will complement the existing in vitro and in vivo models.  Methods and results: Skin fibroblasts from a patient with a KCNH2 G1681A mutation (encodes IKr potassium ion channel) were reprogrammed to human induced pluripotent stem cells (hiPSCs), which were subsequently differentiated to functional cardiomyocytes.  Relative to controls (including the patient's mother), multi-electrode array and patch-clamp electrophysiol. of LQT2-hiPSC cardiomyocytes showed prolonged field/action potential duration.  When LQT2-hiPSC cardiomyocytes were exposed to E4031 (an IKr blocker), arrhythmias developed and these presented as early after depolarizations (EADs) in the action potentials.  In contrast to control cardiomyocytes, LQT2-hiPSC cardiomyocytes also developed EADs when challenged with the clin. used stressor, isoprenaline.  This effect was reversed by β-blockers, propranolol, and nadolol, the latter being used for the patient's therapy.  Treatment of cardiomyocytes with exptl. potassium channel enhancers, nicorandil and PD118057, caused action potential shortening and in some cases could abolish EADs.  Notably, combined treatment with isoprenaline (enhancers/isoprenaline) caused EADs, but this effect was reversed by nadolol.  Conclusions Findings: from this paper demonstrate that patient LQT2-hiPSC cardiomyocytes respond appropriately to clin. relevant pharmacol. and will be a valuable human in vitro model for testing exptl. drug combinations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoFWAzoN3q-bVg90H21EOLACvtfcHk0lhXmlhSNFBmqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFaksb0%253D&md5=37730314b1646fec879ce24aa17abf5e</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1093%2Feurheartj%2Fehr073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurheartj%252Fehr073%26sid%3Dliteratum%253Aachs%26aulast%3DMatsa%26aufirst%3DE.%26aulast%3DRajamohan%26aufirst%3DD.%26aulast%3DDick%26aufirst%3DE.%26aulast%3DYoung%26aufirst%3DL.%26aulast%3DMellor%26aufirst%3DI.%26aulast%3DStaniforth%26aufirst%3DA.%26aulast%3DDenning%26aufirst%3DC.%26atitle%3DDrug%2520evaluation%2520in%2520cardiomyocytes%2520derived%2520from%2520human%2520induced%2520pluripotent%2520stem%2520cells%2520carrying%2520a%2520long%2520QT%2520syndrome%2520type%25202%2520mutation%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2011%26volume%3D32%26spage%3D952%26epage%3D962%26doi%3D10.1093%2Feurheartj%2Fehr073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Itzhaki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maizels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwi-Dantsis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winterstern, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gepstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammerman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gepstein, L.</span><span> </span><span class="NLM_article-title">Modelling the long QT syndrome with induced pluripotent stem cells</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">471</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span><span class="refDoi"> DOI: 10.1038/nature09747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature09747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21240260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFCqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=471&publication_year=2011&pages=225-229&author=I.+Itzhakiauthor=L.+Maizelsauthor=I.+Huberauthor=L.+Zwi-Dantsisauthor=O.+Caspiauthor=A.+Wintersternauthor=O.+Feldmanauthor=A.+Gepsteinauthor=G.+Arbelauthor=H.+Hammermanauthor=M.+Boulosauthor=L.+Gepstein&title=Modelling+the+long+QT+syndrome+with+induced+pluripotent+stem+cells&doi=10.1038%2Fnature09747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Modelling the long QT syndrome with induced pluripotent stem cells</span></div><div class="casAuthors">Itzhaki, Ilanit; Maizels, Leonid; Huber, Irit; Zwi-Dantsis, Limor; Caspi, Oren; Winterstern, Aaron; Feldman, Oren; Gepstein, Amira; Arbel, Gil; Hammerman, Haim; Boulos, Monther; Gepstein, Lior</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">471</span>
        (<span class="NLM_cas:issue">7337</span>),
    <span class="NLM_cas:pages">225-229</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The ability to generate patient-specific human induced pluripotent stem cells (iPSCs) offers a new paradigm for modeling human disease and for individualizing drug testing.  Congenital long QT syndrome (LQTS) is a familial arrhythmogenic syndrome characterized by abnormal ion channel function and sudden cardiac death.  Here we report the development of a patient/disease-specific human iPSC line from a patient with type-2 LQTS (which is due to the A614V missense mutation in the KCNH2 gene).  The generated iPSCs were coaxed to differentiate into the cardiac lineage.  Detailed whole-cell patch-clamp and extracellular multielectrode recordings revealed significant prolongation of the action-potential duration in LQTS human iPSC-derived cardiomyocytes (the characteristic LQTS phenotype) when compared to healthy control cells.  Voltage-clamp studies confirmed that this action-potential-duration prolongation stems from a significant redn. of the cardiac potassium current IKr.  Importantly, LQTS-derived cells also showed marked arrhythmogenicity, characterized by early-after depolarizations and triggered arrhythmias.  We then used the LQTS human iPSC-derived cardiac-tissue model to evaluate the potency of existing and novel pharmacol. agents that may either aggravate (potassium-channel blockers) or ameliorate (calcium-channel blockers, KATP-channel openers and late sodium-channel blockers) the disease phenotype.  Our study illustrates the ability of human iPSC technol. to model the abnormal functional phenotype of an inherited cardiac disorder and to identify potential new therapeutic agents.  As such, it represents a promising paradigm to study disease mechanisms, optimize patient care (personalized medicine), and aid in the development of new therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0tlF6VEF72bVg90H21EOLACvtfcHk0lhXmlhSNFBmqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFCqug%253D%253D&md5=072452fdde50fce4055e1026c4436749</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fnature09747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09747%26sid%3Dliteratum%253Aachs%26aulast%3DItzhaki%26aufirst%3DI.%26aulast%3DMaizels%26aufirst%3DL.%26aulast%3DHuber%26aufirst%3DI.%26aulast%3DZwi-Dantsis%26aufirst%3DL.%26aulast%3DCaspi%26aufirst%3DO.%26aulast%3DWinterstern%26aufirst%3DA.%26aulast%3DFeldman%26aufirst%3DO.%26aulast%3DGepstein%26aufirst%3DA.%26aulast%3DArbel%26aufirst%3DG.%26aulast%3DHammerman%26aufirst%3DH.%26aulast%3DBoulos%26aufirst%3DM.%26aulast%3DGepstein%26aufirst%3DL.%26atitle%3DModelling%2520the%2520long%2520QT%2520syndrome%2520with%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DNature%26date%3D2011%26volume%3D471%26spage%3D225%26epage%3D229%26doi%3D10.1038%2Fnature09747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Terrenoire, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, K. W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pass, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotton, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kass, R. S.</span><span> </span><span class="NLM_article-title">Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics</span> <span class="citation_source-journal">J. Gen. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.1085/jgp.201210899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1085%2Fjgp.201210899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23277474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2013&pages=61-72&author=C.+Terrenoireauthor=K.+Wangauthor=K.+W.+C.+Tungauthor=W.+K.+Chungauthor=R.+H.+Passauthor=J.+T.+Luauthor=J.+C.+Jeanauthor=A.+Omariauthor=K.+J.+Sampsonauthor=D.+N.+Kottonauthor=G.+Kellerauthor=R.+S.+Kass&title=Induced+pluripotent+stem+cells+used+to+reveal+drug+actions+in+a+long+QT+syndrome+family+with+complex+genetics&doi=10.1085%2Fjgp.201210899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics</span></div><div class="casAuthors">Terrenoire, Cecile; Wang, Kai; Tung, Kelvin W. Chan; Chung, Wendy K.; Pass, Robert H.; Lu, Jonathan T.; Jean, Jyh-Chang; Omari, Amel; Sampson, Kevin J.; Kotton, Darrell N.; Keller, Gordon; Kass, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Physiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-72</span>CODEN:
                <span class="NLM_cas:coden">JGPLAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-1295</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Understanding the basis for differential responses to drug therapies remains a challenge despite advances in genetics and genomics.  Induced pluripotent stem cells (iPSCs) offer an unprecedented opportunity to investigate the pharmacol. of disease processes in therapeutically and genetically relevant primary cell types in vitro and to interweave clin. and basic mol. data.  We report here the derivation of iPSCs from a long QT syndrome patient with complex genetics.  The proband was found to have a de novo SCN5A LQT-3 mutation (F1473C) and a polymorphism (K897T) in KCNH2, the gene for LQT-2.  Anal. of the biophysics and mol. pharmacol. of ion channels expressed in cardiomyocytes (CMs) differentiated from these iPSCs (iPSC-CMs) demonstrates a primary LQT-3 (Na+ channel) defect responsible for the arrhythmias not influenced by the KCNH2 polymorphism.  The F1473C mutation occurs in the channel inactivation gate and enhances late Na+ channel current (INaL) that is carried by channels that fail to inactivate completely and conduct increased inward current during prolonged depolarization, resulting in delayed repolarization, a prolonged QT interval, and increased risk of fatal arrhythmia.  We find a very pronounced rate dependence of INaL such that increasing the pacing rate markedly reduces INaL and, in addn., increases its inhibition by the Na+ channel blocker mexiletine.  These rate-dependent properties and drug interactions, unique to the proband's iPSC-CMs, correlate with improved management of arrhythmias in the patient and provide support for this approach in developing patient-specific clin. regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXHxUVKmw7m7Vg90H21EOLACvtfcHk0lhXmlhSNFBmqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKhu7g%253D&md5=fcd46a1fb62eeddae5723c0ea93bd34e</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1085%2Fjgp.201210899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1085%252Fjgp.201210899%26sid%3Dliteratum%253Aachs%26aulast%3DTerrenoire%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DTung%26aufirst%3DK.%2BW.%2BC.%26aulast%3DChung%26aufirst%3DW.%2BK.%26aulast%3DPass%26aufirst%3DR.%2BH.%26aulast%3DLu%26aufirst%3DJ.%2BT.%26aulast%3DJean%26aufirst%3DJ.%2BC.%26aulast%3DOmari%26aufirst%3DA.%26aulast%3DSampson%26aufirst%3DK.%2BJ.%26aulast%3DKotton%26aufirst%3DD.%2BN.%26aulast%3DKeller%26aufirst%3DG.%26aulast%3DKass%26aufirst%3DR.%2BS.%26atitle%3DInduced%2520pluripotent%2520stem%2520cells%2520used%2520to%2520reveal%2520drug%2520actions%2520in%2520a%2520long%2520QT%2520syndrome%2520family%2520with%2520complex%2520genetics%26jtitle%3DJ.%2520Gen.%2520Physiol.%26date%3D2013%26volume%3D141%26spage%3D61%26epage%3D72%26doi%3D10.1085%2Fjgp.201210899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Ma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahib, N. B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liew, R.</span><span> </span><span class="NLM_article-title">Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells</span> <span class="citation_source-journal">Int. J. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">5277</span><span class="NLM_x">–</span> <span class="NLM_lpage">5286</span><span class="refDoi"> DOI: 10.1016/j.ijcard.2013.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.ijcard.2013.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23998552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A280%3ADC%252BC3sbks1yitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2013&pages=5277-5286&author=D.+Maauthor=H.+Weiauthor=Y.+Zhaoauthor=J.+Luauthor=G.+Liauthor=N.+B.+E.+Sahibauthor=T.+H.+Tanauthor=K.+Y.+Wongauthor=W.+Shimauthor=P.+Wongauthor=S.+A.+Cookauthor=R.+Liew&title=Modeling+type+3+long+QT+syndrome+with+cardiomyocytes+derived+from+patient-specific+induced+pluripotent+stem+cells&doi=10.1016%2Fj.ijcard.2013.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells</span></div><div class="casAuthors">Ma Dongrui; Wei Heming; Zhao Yongxing; Lu Jun; Li Guang; Sahib Norliza Binte Esmail; Tan Teng Hong; Wong Keng Yean; Shim Winston; Wong Philip; Cook Stuart A; Liew Reginald</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cardiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">5277-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Type 3 long QT syndrome (LQT3) is the third most common form of LQT syndrome and is characterized by QT-interval prolongation resulting from a gain-of-function mutation in SCN5A.  We aimed to establish a patient-specific human induced pluripotent stem cell (hiPSC) model of LQT3, which could be used for future drug testing and development of novel treatments for this inherited disorder.  METHODS AND RESULTS:  Dermal fibroblasts obtained from a patient with LQT3 harboring a SCN5A mutation (c.5287G>A; p.V1763M) were reprogrammed to hiPSCs via repeated transfection of mRNA encoding OCT-4, SOX-2, KLF-4, C-MYC and LIN-28. hiPSC-derived cardiomyocytes (hiPSC-CMs) were obtained via cardiac differentiation. hiPSC-CMs derived from the patient's healthy sister were used as a control.  Compared to the control, patient hiPSC-CMs exhibited dominant mutant SCN5A allele gene expression, significantly prolonged action potential duration or APD (paced CMs of control vs. patient: 226.50 ± 17.89 ms vs. 536.59 ± 37.1 ms; mean ± SEM, p < 0.005), an increased tetrodotoxin (TTX)-sensitive late or persistent Na(+) current (control vs. patient: 0.65 ± 0.11 vs. 3.16 ± 0.27 pA/pF; n = 9, p < 0.01), a positive shift of steady state inactivation and a faster recovery from inactivation.  Mexiletine, a NaV1.5 blocker, reversed the elevated late Na(+) current and prolonged APD in LQT3 hiPSC-CMs.  CONCLUSIONS:  We demonstrate that hiPSC-CMs derived from a LQT3 patient recapitulate the biophysical abnormalities that define LQT3.  The clinical significance of such an in vitro model is in the development of novel therapeutic strategies and a more personalized approach in testing drugs on patients with LQT3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaf57RHX2Q3EloaUqgkFHkfW6udTcc2eYk6quOBfuAq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbks1yitw%253D%253D&md5=19fe9b0c398af3a2a0816bc0df27fb9a</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.ijcard.2013.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijcard.2013.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DD.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DSahib%26aufirst%3DN.%2BB.%2BE.%26aulast%3DTan%26aufirst%3DT.%2BH.%26aulast%3DWong%26aufirst%3DK.%2BY.%26aulast%3DShim%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DP.%26aulast%3DCook%26aufirst%3DS.%2BA.%26aulast%3DLiew%26aufirst%3DR.%26atitle%3DModeling%2520type%25203%2520long%2520QT%2520syndrome%2520with%2520cardiomyocytes%2520derived%2520from%2520patient-specific%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DInt.%2520J.%2520Cardiol.%26date%3D2013%26volume%3D168%26spage%3D5277%26epage%3D5286%26doi%3D10.1016%2Fj.ijcard.2013.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Splawski, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timothy, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpe, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decher, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloise, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napolitano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condouris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tager-Flusberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priori, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, M. T.</span><span> </span><span class="NLM_article-title">Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span><span class="refDoi"> DOI: 10.1016/j.cell.2004.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.cell.2004.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=15454078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlyqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2004&pages=19-31&author=I.+Splawskiauthor=K.+W.+Timothyauthor=L.+M.+Sharpeauthor=N.+Decherauthor=P.+Kumarauthor=R.+Bloiseauthor=C.+Napolitanoauthor=P.+J.+Schwartzauthor=R.+M.+Josephauthor=K.+Condourisauthor=H.+Tager-Flusbergauthor=S.+G.+Prioriauthor=M.+C.+Sanguinettiauthor=M.+T.+Keating&title=Ca%28V%291.2+calcium+channel+dysfunction+causes+a+multisystem+disorder+including+arrhythmia+and+autism&doi=10.1016%2Fj.cell.2004.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">CaV1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism</span></div><div class="casAuthors">Splawski, Igor; Timothy, Katherine W.; Sharpe, Leah M.; Decher, Niels; Kumar, Pradeep; Bloise, Raffaella; Napolitano, Carlo; Schwartz, Peter J.; Joseph, Robert M.; Condouris, Karen; Tager-Flusberg, Helen; Priori, Silvia G.; Sanguinetti, Michael C.; Keating, Mark T.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-31</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cav1.2, the cardiac L-type calcium channel, is important for excitation and contraction of the heart.  Its role in other tissues is unclear.  Here the authors present Timothy syndrome, a novel disorder characterized by multiorgan dysfunction including lethal arrhythmias, webbing of fingers and toes, congenital heart disease, immune deficiency, intermittent hypoglycemia, cognitive abnormalities, and autism.  In every case, Timothy syndrome results from the identical, de novo Cav1.2 missense mutation G406R.  Cav1.2 is expressed in all affected tissues.  Functional expression reveals that G406R produces maintained inward Ca2+ currents by causing nearly complete loss of voltage-dependent channel inactivation.  This likely induces intracellular Ca2+ overload in multiple cell types.  In the heart, prolonged Ca2+ current delays cardiomyocyte repolarization and increases risk of arrhythmia, the ultimate cause of death in this disorder.  These discoveries establish the importance of Cav1.2 in human physiol. and development and implicate Ca2+ signaling in autism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps04snarO1XLVg90H21EOLACvtfcHk0li3_pgA1gr3_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlyqurk%253D&md5=8000a3a4517872224787864fd130b766</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2004.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2004.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DSplawski%26aufirst%3DI.%26aulast%3DTimothy%26aufirst%3DK.%2BW.%26aulast%3DSharpe%26aufirst%3DL.%2BM.%26aulast%3DDecher%26aufirst%3DN.%26aulast%3DKumar%26aufirst%3DP.%26aulast%3DBloise%26aufirst%3DR.%26aulast%3DNapolitano%26aufirst%3DC.%26aulast%3DSchwartz%26aufirst%3DP.%2BJ.%26aulast%3DJoseph%26aufirst%3DR.%2BM.%26aulast%3DCondouris%26aufirst%3DK.%26aulast%3DTager-Flusberg%26aufirst%3DH.%26aulast%3DPriori%26aufirst%3DS.%2BG.%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DKeating%26aufirst%3DM.%2BT.%26atitle%3DCa%2528V%25291.2%2520calcium%2520channel%2520dysfunction%2520causes%2520a%2520multisystem%2520disorder%2520including%2520arrhythmia%2520and%2520autism%26jtitle%3DCell%26date%3D2004%26volume%3D119%26spage%3D19%26epage%3D31%26doi%3D10.1016%2Fj.cell.2004.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Yazawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsueh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasca, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallmayer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolmetsch, R. E.</span><span> </span><span class="NLM_article-title">Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">471</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span><span class="refDoi"> DOI: 10.1038/nature09855</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature09855" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21307850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12ntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=471&publication_year=2011&pages=230-234&author=M.+Yazawaauthor=B.+Hsuehauthor=X.+Jiaauthor=A.+M.+Pascaauthor=J.+A.+Bernsteinauthor=J.+Hallmayerauthor=R.+E.+Dolmetsch&title=Using+induced+pluripotent+stem+cells+to+investigate+cardiac+phenotypes+in+Timothy+syndrome&doi=10.1038%2Fnature09855"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome</span></div><div class="casAuthors">Yazawa, Masayuki; Hsueh, Brian; Jia, Xiaolin; Pasca, Anca M.; Bernstein, Jonathan A.; Hallmayer, Joachim; Dolmetsch, Ricardo E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">471</span>
        (<span class="NLM_cas:issue">7337</span>),
    <span class="NLM_cas:pages">230-234</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Individuals with congenital or acquired prolongation of the QT interval, or long QT syndrome (LQTS), are at risk of life-threatening ventricular arrhythmia.  LQTS is commonly genetic in origin but can also be caused or exacerbated by environmental factors.  A missense mutation in the L-type calcium channel CaV1.2 leads to LQTS in patients with Timothy syndrome.  To explore the effect of the Timothy syndrome mutation on the elec. activity and contraction of human cardiomyocytes, we reprogrammed human skin cells from Timothy syndrome patients to generate induced pluripotent stem cells, and differentiated these cells into cardiomyocytes.  Electrophysiol. recording and calcium (Ca2+) imaging studies of these cells revealed irregular contraction, excess Ca2+ influx, prolonged action potentials, irregular elec. activity and abnormal calcium transients in ventricular-like cells.  We found that roscovitine, a compd. that increases the voltage-dependent inactivation of CaV1.2 (refs. 6-8), restored the elec. and Ca2+ signaling properties of cardiomyocytes from Timothy syndrome patients.  This study provides new opportunities for studying the mol. and cellular mechanisms of cardiac arrhythmias in humans, and provides a robust assay for developing new drugs to treat these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmADo-VbfG_LVg90H21EOLACvtfcHk0li3_pgA1gr3_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12ntr0%253D&md5=7f46402be8962c3b9d9e2706a6e48598</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1038%2Fnature09855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09855%26sid%3Dliteratum%253Aachs%26aulast%3DYazawa%26aufirst%3DM.%26aulast%3DHsueh%26aufirst%3DB.%26aulast%3DJia%26aufirst%3DX.%26aulast%3DPasca%26aufirst%3DA.%2BM.%26aulast%3DBernstein%26aufirst%3DJ.%2BA.%26aulast%3DHallmayer%26aufirst%3DJ.%26aulast%3DDolmetsch%26aufirst%3DR.%2BE.%26atitle%3DUsing%2520induced%2520pluripotent%2520stem%2520cells%2520to%2520investigate%2520cardiac%2520phenotypes%2520in%2520Timothy%2520syndrome%26jtitle%3DNature%26date%3D2011%26volume%3D471%26spage%3D230%26epage%3D234%26doi%3D10.1038%2Fnature09855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Jung, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mederos y Schnitzler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iop, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruppenthal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirschinger, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyfarth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinnecker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudermann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipp, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laugwitz, K. L.</span><span> </span><span class="NLM_article-title">Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.1002/emmm.201100194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1002%2Femmm.201100194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22174035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsVSqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=180-191&author=C.+B.+Jungauthor=A.+Morettiauthor=M.+Mederos+y+Schnitzlerauthor=L.+Iopauthor=U.+Storchauthor=M.+Bellinauthor=T.+Dornauthor=S.+Ruppenthalauthor=S.+Pfeifferauthor=A.+Goedelauthor=R.+J.+Dirschingerauthor=M.+Seyfarthauthor=J.+T.+Lamauthor=D.+Sinneckerauthor=T.+Gudermannauthor=P.+Lippauthor=K.+L.+Laugwitz&title=Dantrolene+rescues+arrhythmogenic+RYR2+defect+in+a+patient-specific+stem+cell+model+of+catecholaminergic+polymorphic+ventricular+tachycardia&doi=10.1002%2Femmm.201100194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia</span></div><div class="casAuthors">Jung, Christian B.; Moretti, Alessandra; Mederos y Schnitzler, Michael; Iop, Laura; Storch, Ursula; Bellin, Milena; Dorn, Tatjana; Ruppenthal, Sandra; Pfeiffer, Sarah; Goedel, Alexander; Dirschinger, Ralf J.; Seyfarth, Melchior; Lam, Jason T.; Sinnecker, Daniel; Gudermann, Thomas; Lipp, Peter; Laugwitz, Karl-Ludwig</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">180-191</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Coordinated release of calcium (Ca2+) from the sarcoplasmic reticulum (SR) through cardiac ryanodine receptor (RYR2) channels is essential for cardiomyocyte function.  In catecholaminergic polymorphic ventricular tachycardia (CPVT), an inherited disease characterized by stress-induced ventricular arrhythmias in young patients with structurally normal hearts, autosomal dominant mutations in RYR2 or recessive mutations in calsequestrin lead to aberrant diastolic Ca2+ release from the SR causing arrhythmogenic delayed after depolarizations (DADs).  Here, we report the generation of induced pluripotent stem cells (iPSCs) from a CPVT patient carrying a novel RYR2 S406L mutation.  In patient iPSC-derived cardiomyocytes, catecholaminergic stress led to elevated diastolic Ca2+ concns., a reduced SR Ca2+ content and an increased susceptibility to DADs and arrhythmia as compared to control myocytes.  This was due to increased frequency and duration of elementary Ca2+ release events (Ca2+ sparks).  Dantrolene, a drug effective on malignant hyperthermia, restored normal Ca2+ spark properties and rescued the arrhythmogenic phenotype.  This suggests defective inter-domain interactions within the RYR2 channel as the pathomechanism of the S406L mutation.  Our work provides a new in vitro model to study the pathogenesis of human cardiac arrhythmias and develop novel therapies for CPVT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQRKsXLyXJq7Vg90H21EOLACvtfcHk0ljJfckYY-iQ_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsVSqs7c%253D&md5=0e2eeafcbaf583a7bb267f483a28431c</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1002%2Femmm.201100194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201100194%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DC.%2BB.%26aulast%3DMoretti%26aufirst%3DA.%26aulast%3DMederos%2By%2BSchnitzler%26aufirst%3DM.%26aulast%3DIop%26aufirst%3DL.%26aulast%3DStorch%26aufirst%3DU.%26aulast%3DBellin%26aufirst%3DM.%26aulast%3DDorn%26aufirst%3DT.%26aulast%3DRuppenthal%26aufirst%3DS.%26aulast%3DPfeiffer%26aufirst%3DS.%26aulast%3DGoedel%26aufirst%3DA.%26aulast%3DDirschinger%26aufirst%3DR.%2BJ.%26aulast%3DSeyfarth%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DJ.%2BT.%26aulast%3DSinnecker%26aufirst%3DD.%26aulast%3DGudermann%26aufirst%3DT.%26aulast%3DLipp%26aufirst%3DP.%26aulast%3DLaugwitz%26aufirst%3DK.%2BL.%26atitle%3DDantrolene%2520rescues%2520arrhythmogenic%2520RYR2%2520defect%2520in%2520a%2520patient-specific%2520stem%2520cell%2520model%2520of%2520catecholaminergic%2520polymorphic%2520ventricular%2520tachycardia%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D180%26epage%3D191%26doi%3D10.1002%2Femmm.201100194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Itzhaki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maizels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gepstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belhassen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nof, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glikson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gepstein, L.</span><span> </span><span class="NLM_article-title">Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">990</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span><span class="refDoi"> DOI: 10.1016/j.jacc.2012.02.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.jacc.2012.02.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22749309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtlams77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=990-1000&author=I.+Itzhakiauthor=L.+Maizelsauthor=I.+Huberauthor=A.+Gepsteinauthor=G.+Arbelauthor=O.+Caspiauthor=L.+Millerauthor=B.+Belhassenauthor=E.+Nofauthor=M.+Gliksonauthor=L.+Gepstein&title=Modeling+of+catecholaminergic+polymorphic+ventricular+tachycardia+with+patient-specific+human-induced+pluripotent+stem+cells&doi=10.1016%2Fj.jacc.2012.02.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling of Catecholaminergic Polymorphic Ventricular Tachycardia With Patient-Specific Human-Induced Pluripotent Stem Cells</span></div><div class="casAuthors">Itzhaki, Ilanit; Maizels, Leonid; Huber, Irit; Gepstein, Amira; Arbel, Gil; Caspi, Oren; Miller, Liron; Belhassen, Bernard; Nof, Eyal; Glikson, Michael; Gepstein, Lior</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">990-1000</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Objectives: The goal of this study was to establish a patient-specific human-induced pluripotent stem cells (hiPSCs) model of catecholaminergic polymorphic ventricular tachycardia (CPVT).  Background: CPVT is a familial arrhythmogenic syndrome characterized by abnormal calcium (Ca2+) handling, ventricular arrhythmias, and sudden cardiac death.  Methods: Dermal fibroblasts were obtained from a CPVT patient due to the M4109R heterozygous point RYR2 mutation and reprogrammed to generate the CPVT-hiPSCs.  The patient-specific hiPSCs were coaxed to differentiate into the cardiac lineage and compared with healthy control hiPSCs-derived cardiomyocytes (hiPSCs-CMs).  Results: Intracellular electrophysiol. recordings demonstrated the development of delayed afterdepolarizations in 69% of the CPVT-hiPSCs-CMs compared with 11% in healthy control cardiomyocytes.  Adrenergic stimulation by isoproterenol (1 μM) or forskolin (5 μM) increased the frequency and magnitude of afterdepolarizations and also led to development of triggered activity in the CPVT-hiPSCs-CMs.  In contrast, flecainide (10 μM) and thapsigargin (10 μM) eliminated all afterdepolarizations in these cells.  The latter finding suggests an important role for internal Ca2+ stores in the pathogenesis of delayed afterdepolarizations.  Laser-confocal Ca2+ imaging revealed significant whole-cell [Ca2+] transient irregularities (frequent local and large-storage Ca2+-release events, broad and double-humped transients, and triggered activity) in the CPVT cardiomyocytes that worsened with adrenergic stimulation and Ca2+ overload and improved with beta-blockers.  Store-overload-induced Ca2+ release was also identified in the hiPSCs-CMs and the threshold for such events was significantly reduced in the CPVT cells.  Conclusions: This study highlights the potential of hiPSCs for studying inherited arrhythmogenic syndromes, in general, and CPVT specifically.  As such, it represents a promising paradigm to study disease mechanisms, optimize patient care, and aid in the development of new therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiKTJkTROOebVg90H21EOLACvtfcHk0ljJfckYY-iQ_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtlams77P&md5=7d828d7836d499600a2764b7fd194cf1</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2012.02.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2012.02.066%26sid%3Dliteratum%253Aachs%26aulast%3DItzhaki%26aufirst%3DI.%26aulast%3DMaizels%26aufirst%3DL.%26aulast%3DHuber%26aufirst%3DI.%26aulast%3DGepstein%26aufirst%3DA.%26aulast%3DArbel%26aufirst%3DG.%26aulast%3DCaspi%26aufirst%3DO.%26aulast%3DMiller%26aufirst%3DL.%26aulast%3DBelhassen%26aufirst%3DB.%26aulast%3DNof%26aufirst%3DE.%26aulast%3DGlikson%26aufirst%3DM.%26aulast%3DGepstein%26aufirst%3DL.%26atitle%3DModeling%2520of%2520catecholaminergic%2520polymorphic%2520ventricular%2520tachycardia%2520with%2520patient-specific%2520human-induced%2520pluripotent%2520stem%2520cells%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2012%26volume%3D60%26spage%3D990%26epage%3D1000%26doi%3D10.1016%2Fj.jacc.2012.02.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Maron, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Towbin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiene, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antzelevitch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrado, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidman, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. B.</span><span> </span><span class="NLM_article-title">Contemporary definitions and classification of the cardiomyopathies. An American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">1807</span><span class="NLM_x">–</span> <span class="NLM_lpage">1816</span><span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.106.174287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1161%2FCIRCULATIONAHA.106.174287" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2006&pages=1807-1816&author=B.+J.+Maronauthor=J.+A.+Towbinauthor=G.+Thieneauthor=C.+Antzelevitchauthor=D.+Corradoauthor=D.+Arnettauthor=A.+J.+Mossauthor=C.+E.+Seidmanauthor=J.+B.+Young&title=Contemporary+definitions+and+classification+of+the+cardiomyopathies.+An+American+Heart+Association+scientific+statement+from+the+Council+on+Clinical+Cardiology%2C+Heart+Failure+and+Transplantation+Committee%3B+Quality+of+Care+and+Outcomes+Research+and+Functional+Genomics+and+Translational+Biology+Interdisciplinary+Working+Groups%3B+and+Council+on+Epidemiology+and+Prevention&doi=10.1161%2FCIRCULATIONAHA.106.174287"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.106.174287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.106.174287%26sid%3Dliteratum%253Aachs%26aulast%3DMaron%26aufirst%3DB.%2BJ.%26aulast%3DTowbin%26aufirst%3DJ.%2BA.%26aulast%3DThiene%26aufirst%3DG.%26aulast%3DAntzelevitch%26aufirst%3DC.%26aulast%3DCorrado%26aufirst%3DD.%26aulast%3DArnett%26aufirst%3DD.%26aulast%3DMoss%26aufirst%3DA.%2BJ.%26aulast%3DSeidman%26aufirst%3DC.%2BE.%26aulast%3DYoung%26aufirst%3DJ.%2BB.%26atitle%3DContemporary%2520definitions%2520and%2520classification%2520of%2520the%2520cardiomyopathies.%2520An%2520American%2520Heart%2520Association%2520scientific%2520statement%2520from%2520the%2520Council%2520on%2520Clinical%2520Cardiology%252C%2520Heart%2520Failure%2520and%2520Transplantation%2520Committee%253B%2520Quality%2520of%2520Care%2520and%2520Outcomes%2520Research%2520and%2520Functional%2520Genomics%2520and%2520Translational%2520Biology%2520Interdisciplinary%2520Working%2520Groups%253B%2520and%2520Council%2520on%2520Epidemiology%2520and%2520Prevention%26jtitle%3DCirculation%26date%3D2006%26volume%3D113%26spage%3D1807%26epage%3D1816%26doi%3D10.1161%2FCIRCULATIONAHA.106.174287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Sun, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yazawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Freire, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abilez, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarrete, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlovic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajjar, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolmetsch, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butte, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashley, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longaker, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span> </span><span class="NLM_article-title">Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">130ra47</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3003552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1126%2Fscitranslmed.3003552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22517884" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=130ra47&author=N.+Sunauthor=M.+Yazawaauthor=J.+Liuauthor=L.+Hanauthor=V.+Sanchez-Freireauthor=O.+J.+Abilezauthor=E.+G.+Navarreteauthor=S.+Huauthor=L.+Wangauthor=A.+Leeauthor=A.+Pavlovicauthor=S.+Linauthor=R.+Chenauthor=R.+J.+Hajjarauthor=M.+P.+Snyderauthor=R.+E.+Dolmetschauthor=M.+J.+Butteauthor=E.+A.+Ashleyauthor=M.+T.+Longakerauthor=R.+C.+Robbinsauthor=J.+C.+Wu&title=Patient-specific+induced+pluripotent+stem+cells+as+a+model+for+familial+dilated+cardiomyopathy&doi=10.1126%2Fscitranslmed.3003552"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003552%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DN.%26aulast%3DYazawa%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DSanchez-Freire%26aufirst%3DV.%26aulast%3DAbilez%26aufirst%3DO.%2BJ.%26aulast%3DNavarrete%26aufirst%3DE.%2BG.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DPavlovic%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DHajjar%26aufirst%3DR.%2BJ.%26aulast%3DSnyder%26aufirst%3DM.%2BP.%26aulast%3DDolmetsch%26aufirst%3DR.%2BE.%26aulast%3DButte%26aufirst%3DM.%2BJ.%26aulast%3DAshley%26aufirst%3DE.%2BA.%26aulast%3DLongaker%26aufirst%3DM.%2BT.%26aulast%3DRobbins%26aufirst%3DR.%2BC.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26atitle%3DPatient-specific%2520induced%2520pluripotent%2520stem%2520cells%2520as%2520a%2520model%2520for%2520familial%2520dilated%2520cardiomyopathy%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D130ra47%26doi%3D10.1126%2Fscitranslmed.3003552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Maron, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flack, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gidding, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurosaki, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bild, D. E.</span><span> </span><span class="NLM_article-title">Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">785</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span><span class="refDoi"> DOI: 10.1161/01.CIR.92.4.785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1161%2F01.CIR.92.4.785" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=785-789&author=B.+J.+Maronauthor=J.+M.+Gardinauthor=J.+M.+Flackauthor=S.+S.+Giddingauthor=T.+T.+Kurosakiauthor=D.+E.+Bild&title=Prevalence+of+hypertrophic+cardiomyopathy+in+a+general+population+of+young+adults.+Echocardiographic+analysis+of+4111+subjects+in+the+CARDIA+Study.+Coronary+Artery+Risk+Development+in+%28Young%29+Adults&doi=10.1161%2F01.CIR.92.4.785"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.92.4.785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.92.4.785%26sid%3Dliteratum%253Aachs%26aulast%3DMaron%26aufirst%3DB.%2BJ.%26aulast%3DGardin%26aufirst%3DJ.%2BM.%26aulast%3DFlack%26aufirst%3DJ.%2BM.%26aulast%3DGidding%26aufirst%3DS.%2BS.%26aulast%3DKurosaki%26aufirst%3DT.%2BT.%26aulast%3DBild%26aufirst%3DD.%2BE.%26atitle%3DPrevalence%2520of%2520hypertrophic%2520cardiomyopathy%2520in%2520a%2520general%2520population%2520of%2520young%2520adults.%2520Echocardiographic%2520analysis%2520of%25204111%2520subjects%2520in%2520the%2520CARDIA%2520Study.%2520Coronary%2520Artery%2520Risk%2520Development%2520in%2520%2528Young%2529%2520Adults%26jtitle%3DCirculation%26date%3D1995%26volume%3D92%26spage%3D785%26epage%3D789%26doi%3D10.1161%2F01.CIR.92.4.785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Seidman, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidman, C.</span><span> </span><span class="NLM_article-title">The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span><span class="refDoi"> DOI: 10.1016/S0092-8674(01)00242-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2FS0092-8674%2801%2900242-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=11239412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD3MXis1Kks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=557-567&author=J.+G.+Seidmanauthor=C.+Seidman&title=The+genetic+basis+for+cardiomyopathy%3A+from+mutation+identification+to+mechanistic+paradigms&doi=10.1016%2FS0092-8674%2801%2900242-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms</span></div><div class="casAuthors">Seidman, J. G.; Seidman, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">557-567</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with 65 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqknf4bycp-LbVg90H21EOLACvtfcHk0lhN3q0MI4hEnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXis1Kks70%253D&md5=93f19640f7d7b5462203bb5185b09ecb</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2801%2900242-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252801%252900242-2%26sid%3Dliteratum%253Aachs%26aulast%3DSeidman%26aufirst%3DJ.%2BG.%26aulast%3DSeidman%26aufirst%3DC.%26atitle%3DThe%2520genetic%2520basis%2520for%2520cardiomyopathy%253A%2520from%2520mutation%2520identification%2520to%2520mechanistic%2520paradigms%26jtitle%3DCell%26date%3D2001%26volume%3D104%26spage%3D557%26epage%3D567%26doi%3D10.1016%2FS0092-8674%2801%2900242-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Lan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Freire, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abilez, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarrete, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashley, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bers, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longaker, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span> </span><span class="NLM_article-title">Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1016/j.stem.2012.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.stem.2012.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23290139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvFSgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=101-113&author=F.+Lanauthor=A.+S.+Leeauthor=P.+Liangauthor=V.+Sanchez-Freireauthor=P.+K.+Nguyenauthor=L.+Wangauthor=L.+Hanauthor=M.+Yenauthor=Y.+Wangauthor=N.+Sunauthor=O.+J.+Abilezauthor=S.+Huauthor=A.+D.+Ebertauthor=E.+G.+Navarreteauthor=C.+S.+Simmonsauthor=M.+Wheelerauthor=B.+Pruittauthor=R.+Lewisauthor=Y.+Yamaguchiauthor=E.+A.+Ashleyauthor=D.+M.+Bersauthor=R.+C.+Robbinsauthor=M.+T.+Longakerauthor=J.+C.+Wu&title=Abnormal+calcium+handling+properties+underlie+familial+hypertrophic+cardiomyopathy+pathology+in+patient-specific+induced+pluripotent+stem+cells&doi=10.1016%2Fj.stem.2012.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells</span></div><div class="casAuthors">Lan, Feng; Lee, Andrew S.; Liang, Ping; Sanchez-Freire, Veronica; Nguyen, Patricia K.; Wang, Li; Han, Leng; Yen, Michelle; Wang, Yongming; Sun, Ning; Abilez, Oscar J.; Hu, Shijun; Ebert, Antje D.; Navarrete, Enrique G.; Simmons, Chelsey S.; Wheeler, Matthew; Pruitt, Beth; Lewis, Richard; Yamaguchi, Yoshinori; Ashley, Euan A.; Bers, Donald M.; Robbins, Robert C.; Longaker, Michael T.; Wu, Joseph C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stem Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-113</span>CODEN:
                <span class="NLM_cas:coden">CSCEC4</span>;
        ISSN:<span class="NLM_cas:issn">1875-9777</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Familial hypertrophic cardiomyopathy (HCM) is a prevalent hereditary cardiac disorder linked to arrhythmia and sudden cardiac death.  While the causes of HCM have been identified as genetic mutations in the cardiac sarcomere, the pathways by which sarcomeric mutations engender myocyte hypertrophy and electrophysiol. abnormalities are not understood.  To elucidate the mechanisms underlying HCM development, we generated patient-specific induced pluripotent stem cell cardiomyocytes (iPSC-CMs) from a ten-member family cohort carrying a hereditary HCM missense mutation (Arg663His) in the MYH7 gene.  Diseased iPSC-CMs recapitulated numerous aspects of the HCM phenotype including cellular enlargement and contractile arrhythmia at the single-cell level.  Calcium (Ca2+) imaging indicated dysregulation of Ca2+ cycling and elevation in intracellular Ca2+ ([Ca2+]i) are central mechanisms for disease pathogenesis.  Pharmacol. restoration of Ca2+ homeostasis prevented development of hypertrophy and electrophysiol. irregularities.  We anticipate that these findings will help elucidate the mechanisms underlying HCM development and identify novel therapies for the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk0LUjCaJ0srVg90H21EOLACvtfcHk0ljmxNWHtCl6ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvFSgug%253D%253D&md5=0d963482b3ed3f5e954401d4005b3bca</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2012.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2012.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DA.%2BS.%26aulast%3DLiang%26aufirst%3DP.%26aulast%3DSanchez-Freire%26aufirst%3DV.%26aulast%3DNguyen%26aufirst%3DP.%2BK.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DN.%26aulast%3DAbilez%26aufirst%3DO.%2BJ.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DEbert%26aufirst%3DA.%2BD.%26aulast%3DNavarrete%26aufirst%3DE.%2BG.%26aulast%3DSimmons%26aufirst%3DC.%2BS.%26aulast%3DWheeler%26aufirst%3DM.%26aulast%3DPruitt%26aufirst%3DB.%26aulast%3DLewis%26aufirst%3DR.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DAshley%26aufirst%3DE.%2BA.%26aulast%3DBers%26aufirst%3DD.%2BM.%26aulast%3DRobbins%26aufirst%3DR.%2BC.%26aulast%3DLongaker%26aufirst%3DM.%2BT.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26atitle%3DAbnormal%2520calcium%2520handling%2520properties%2520underlie%2520familial%2520hypertrophic%2520cardiomyopathy%2520pathology%2520in%2520patient-specific%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2013%26volume%3D12%26spage%3D101%26epage%3D113%26doi%3D10.1016%2Fj.stem.2012.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Clarke, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groves, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newbury-Ecob, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai-Goodman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garratt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damin, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steward, C. G.</span><span> </span><span class="NLM_article-title">Barth syndrome</span> <span class="citation_source-journal">Orphanet J. Rare Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="refDoi"> DOI: 10.1186/1750-1172-8-23</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1186%2F1750-1172-8-23" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23398819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A280%3ADC%252BC3sznt1ykuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=23&author=S.+L.+Clarkeauthor=A.+Bowronauthor=I.+L.+Gonzalezauthor=S.+J.+Grovesauthor=R.+Newbury-Ecobauthor=N.+Claytonauthor=R.+P.+Martinauthor=B.+Tsai-Goodmanauthor=V.+Garrattauthor=M.+Ashworthauthor=V.+M.+Bowenauthor=K.+R.+McCurdyauthor=M.+K.+Daminauthor=C.+T.+Spencerauthor=M.+J.+Tothauthor=R.+I.+Kelleyauthor=C.+G.+Steward&title=Barth+syndrome&doi=10.1186%2F1750-1172-8-23"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Barth syndrome</span></div><div class="casAuthors">Clarke Sarah L N; Bowron Ann; Gonzalez Iris L; Groves Sarah J; Newbury-Ecob Ruth; Clayton Nicol; Martin Robin P; Tsai-Goodman Beverly; Garratt Vanessa; Ashworth Michael; Bowen Valerie M; McCurdy Katherine R; Damin Michaela K; Spencer Carolyn T; Toth Matthew J; Kelley Richard I; Steward Colin G</div><div class="citationInfo"><span class="NLM_cas:title">Orphanet journal of rare diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> First described in 1983, Barth syndrome (BTHS) is widely regarded as a rare X-linked genetic disease characterised by cardiomyopathy (CM), skeletal myopathy, growth delay, neutropenia and increased urinary excretion of 3-methylglutaconic acid (3-MGCA).  Fewer than 200 living males are known worldwide, but evidence is accumulating that the disorder is substantially under-diagnosed.  Clinical features include variable combinations of the following wide spectrum: dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), endocardial fibroelastosis (EFE), left ventricular non-compaction (LVNC), ventricular arrhythmia, sudden cardiac death, prolonged QTc interval, delayed motor milestones, proximal myopathy, lethargy and fatigue, neutropenia (absent to severe; persistent, intermittent or perfectly cyclical), compensatory monocytosis, recurrent bacterial infection, hypoglycaemia, lactic acidosis, growth and pubertal delay, feeding problems, failure to thrive, episodic diarrhoea, characteristic facies, and X-linked family history.  Historically regarded as a cardiac disease, BTHS is now considered a multi-system disorder which may be first seen by many different specialists or generalists.  Phenotypic breadth and variability present a major challenge to the diagnostician: some children with BTHS have never been neutropenic, whereas others lack increased 3-MGCA and a minority has occult or absent CM.  Furthermore, BTHS was first described in 2010 as an unrecognised cause of fetal death.  Disabling mutations or deletions of the tafazzin (TAZ) gene, located at Xq28, cause the disorder by reducing remodeling of cardiolipin, a principal phospholipid of the inner mitochondrial membrane.  A definitive biochemical test, based on detecting abnormal ratios of different cardiolipin species, was first described in 2008.  Key areas of differential diagnosis include metabolic and viral cardiomyopathies, mitochondrial diseases, and many causes of neutropenia and recurrent male miscarriage and stillbirth.  Cardiolipin testing and TAZ sequencing now provide relatively rapid diagnostic testing, both prospectively and retrospectively, from a range of fresh or stored tissues, blood or neonatal bloodspots.  TAZ sequencing also allows female carrier detection and antenatal screening.  Management of BTHS includes medical therapy of CM, cardiac transplantation (in 14% of patients), antibiotic prophylaxis and granulocyte colony-stimulating factor (G-CSF) therapy.  Multidisciplinary teams/clinics are essential for minimising hospital attendances and allowing many more individuals with BTHS to live into adulthood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTvqpUSzxD09H6oPH0mYWL1fW6udTcc2eaNQVZtSW8Ngbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sznt1ykuw%253D%253D&md5=116e6ea66b01eb3e16adbfd1670ebbbd</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1186%2F1750-1172-8-23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1172-8-23%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DS.%2BL.%26aulast%3DBowron%26aufirst%3DA.%26aulast%3DGonzalez%26aufirst%3DI.%2BL.%26aulast%3DGroves%26aufirst%3DS.%2BJ.%26aulast%3DNewbury-Ecob%26aufirst%3DR.%26aulast%3DClayton%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DR.%2BP.%26aulast%3DTsai-Goodman%26aufirst%3DB.%26aulast%3DGarratt%26aufirst%3DV.%26aulast%3DAshworth%26aufirst%3DM.%26aulast%3DBowen%26aufirst%3DV.%2BM.%26aulast%3DMcCurdy%26aufirst%3DK.%2BR.%26aulast%3DDamin%26aufirst%3DM.%2BK.%26aulast%3DSpencer%26aufirst%3DC.%2BT.%26aulast%3DToth%26aufirst%3DM.%2BJ.%26aulast%3DKelley%26aufirst%3DR.%2BI.%26aulast%3DSteward%26aufirst%3DC.%2BG.%26atitle%3DBarth%2520syndrome%26jtitle%3DOrphanet%2520J.%2520Rare%2520Dis.%26date%3D2013%26volume%3D8%26spage%3D23%26doi%3D10.1186%2F1750-1172-8-23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Chicco, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparagna, G. C.</span><span> </span><span class="NLM_article-title">Role of cardiolipin alterations in mitochondrial dysfunction and disease</span> <span class="citation_source-journal">Am. J. Physiol.: Cell Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">C33</span><span class="NLM_x">–</span> <span class="NLM_lpage">C44</span><span class="refDoi"> DOI: 10.1152/ajpcell.00243.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1152%2Fajpcell.00243.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=16899548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisFCrtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2007&pages=C33-C44&author=A.+J.+Chiccoauthor=G.+C.+Sparagna&title=Role+of+cardiolipin+alterations+in+mitochondrial+dysfunction+and+disease&doi=10.1152%2Fajpcell.00243.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Role of cardiolipin alterations in mitochondrial dysfunction and disease</span></div><div class="casAuthors">Chicco, Adam J.; Sparagna, Genevieve C.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">1, Pt. 1</span>),
    <span class="NLM_cas:pages">C33-C44</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Cardiolipin (CL) is a structurally unique dimeric phospholipid localized in the inner mitochondrial membrane where it is required for optimal mitochondrial function.  In addn. to its role in maintaining membrane potential and architecture, CL is known to provide essential structural and functional support to several proteins involved in mitochondrial bioenergetics.  A loss of CL content, alterations in its acyl chain compn., and/or CL peroxidn. have been assocd. with mitochondrial dysfunction in multiple tissues in a variety of pathol. conditions, including ischemia, hypothyroidism, aging, and heart failure.  Recently, aberrations in CL metab. have been implicated as a primary causative factor in the cardioskeletal myopathy known as Barth syndrome, underscoring an important role of CL in human health and disease.  The purpose of this review is to provide an overview of evidence that has linked changes in the CL profile to mitochondrial dysfunction in various pathol. conditions.  In addn., a brief overview of CL function and biosynthesis, and a discussion of methods used to examine CL in biol. tissues are provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOa1v_OV2Lk7Vg90H21EOLACvtfcHk0ljmxNWHtCl6ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisFCrtLo%253D&md5=285ac00edecb0847edafc891c984c550</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00243.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00243.2006%26sid%3Dliteratum%253Aachs%26aulast%3DChicco%26aufirst%3DA.%2BJ.%26aulast%3DSparagna%26aufirst%3DG.%2BC.%26atitle%3DRole%2520of%2520cardiolipin%2520alterations%2520in%2520mitochondrial%2520dysfunction%2520and%2520disease%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Cell%2520Physiol.%26date%3D2007%26volume%3D292%26spage%3DC33%26epage%3DC44%26doi%3D10.1152%2Fajpcell.00243.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCain, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasqualini, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zangi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geva, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanders, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulik, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laflamme, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murry, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Church, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, W. T.</span><span> </span><span class="NLM_article-title">Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span><span class="refDoi"> DOI: 10.1038/nm.3545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnm.3545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24813252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslGksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=616-623&author=G.+Wangauthor=M.+L.+McCainauthor=L.+Yangauthor=A.+Heauthor=F.+S.+Pasqualiniauthor=A.+Agarwalauthor=H.+Yuanauthor=D.+Jiangauthor=D.+Zhangauthor=L.+Zangiauthor=J.+Gevaauthor=A.+E.+Robertsauthor=Q.+Maauthor=J.+Dingauthor=J.+Chenauthor=D.+Z.+Wangauthor=K.+Liauthor=J.+Wangauthor=R.+J.+Wandersauthor=W.+Kulikauthor=F.+M.+Vazauthor=M.+A.+Laflammeauthor=C.+E.+Murryauthor=K.+R.+Chienauthor=R.+I.+Kelleyauthor=G.+M.+Churchauthor=K.+K.+Parkerauthor=W.+T.+Pu&title=Modeling+the+mitochondrial+cardiomyopathy+of+Barth+syndrome+with+induced+pluripotent+stem+cell+and+heart-on-chip+technologies&doi=10.1038%2Fnm.3545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies</span></div><div class="casAuthors">Wang, Gang; McCain, Megan L.; Yang, Luhan; He, Aibin; Pasqualini, Francesco Silvio; Agarwal, Ashutosh; Yuan, Hongyan; Jiang, Dawei; Zhang, Donghui; Zangi, Lior; Geva, Judith; Roberts, Amy E.; Ma, Qing; Ding, Jian; Chen, Jinghai; Wang, Da-Zhi; Li, Kai; Wang, Jiwu; Wanders, Ronald J. A.; Kulik, Wim; Vaz, Frederic M.; Laflamme, Michael A.; Murry, Charles E.; Chien, Kenneth R.; Kelley, Richard I.; Church, George M.; Parker, Kevin Kit; Pu, William T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">616-623</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Study of monogenic mitochondrial cardiomyopathies may yield insights into mitochondrial roles in cardiac development and disease.  Here, the authors combined patient-derived and genetically engineered induced pluripotent stem cells (iPSCs) with tissue engineering to elucidate the pathophysiol. underlying the cardiomyopathy of Barth syndrome (BTHS), a mitochondrial disorder caused by mutation of the gene encoding tafazzin (TAZ).  Using BTHS iPSC-derived cardiomyocytes (iPSC-CMs), the authors defined metabolic, structural and functional abnormalities assocd. with TAZ mutation.  BTHS iPSC-CMs assembled sparse and irregular sarcomeres, and engineered BTHS 'heart-on-chip' tissues contracted weakly.  Gene replacement and genome editing demonstrated that TAZ mutation is necessary and sufficient for these phenotypes.  Sarcomere assembly and myocardial contraction abnormalities occurred in the context of normal whole-cell ATP levels.  Excess levels of reactive oxygen species mechanistically linked TAZ mutation to impaired cardiomyocyte function.  The authors' study provides new insights into the pathogenesis of Barth syndrome, suggests new treatment strategies and advances iPSC-based in vitro modeling of cardiomyopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTOrzLZKI7VLVg90H21EOLACvtfcHk0lhZ1vpJIM67sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslGksrs%253D&md5=75baa7830e2c6bb709d99897575e9e1d</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1038%2Fnm.3545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3545%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%26aulast%3DMcCain%26aufirst%3DM.%2BL.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DA.%26aulast%3DPasqualini%26aufirst%3DF.%2BS.%26aulast%3DAgarwal%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DZangi%26aufirst%3DL.%26aulast%3DGeva%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DA.%2BE.%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DD.%2BZ.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWanders%26aufirst%3DR.%2BJ.%26aulast%3DKulik%26aufirst%3DW.%26aulast%3DVaz%26aufirst%3DF.%2BM.%26aulast%3DLaflamme%26aufirst%3DM.%2BA.%26aulast%3DMurry%26aufirst%3DC.%2BE.%26aulast%3DChien%26aufirst%3DK.%2BR.%26aulast%3DKelley%26aufirst%3DR.%2BI.%26aulast%3DChurch%26aufirst%3DG.%2BM.%26aulast%3DParker%26aufirst%3DK.%2BK.%26aulast%3DPu%26aufirst%3DW.%2BT.%26atitle%3DModeling%2520the%2520mitochondrial%2520cardiomyopathy%2520of%2520Barth%2520syndrome%2520with%2520induced%2520pluripotent%2520stem%2520cell%2520and%2520heart-on-chip%2520technologies%26jtitle%3DNat.%2520Med.%26date%3D2014%26volume%3D20%26spage%3D616%26epage%3D623%26doi%3D10.1038%2Fnm.3545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Drawnel, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boccardo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prummer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delobel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gérard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kam-Thong, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoflack, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiialainen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeworutzki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burcin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gromo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehringer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnone, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaja, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacone, R.</span><span> </span><span class="NLM_article-title">Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">810</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span><span class="refDoi"> DOI: 10.1016/j.celrep.2014.09.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.celrep.2014.09.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=25437537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslGnsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=810-821&author=F.+M.+Drawnelauthor=S.+Boccardoauthor=M.+Prummerauthor=F.+Delobelauthor=A.+Graffauthor=M.+Weberauthor=R.+G%C3%A9rardauthor=L.+Badiauthor=T.+Kam-Thongauthor=L.+Buauthor=X.+Jiangauthor=J.+C.+Hoflackauthor=A.+Kiialainenauthor=E.+Jeworutzkiauthor=N.+Aoyamaauthor=C.+Carlsonauthor=M.+Burcinauthor=G.+Gromoauthor=M.+Boehringerauthor=H.+Stahlbergauthor=B.+J.+Hallauthor=M.+C.+Magnoneauthor=K.+Kolajaauthor=K.+R.+Chienauthor=J.+Baillyauthor=R.+Iacone&title=Disease+modeling+and+phenotypic+drug+screening+for+diabetic+cardiomyopathy+using+human+induced+pluripotent+stem+cells&doi=10.1016%2Fj.celrep.2014.09.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Disease Modeling and Phenotypic Drug Screening for Diabetic Cardiomyopathy using Human Induced Pluripotent Stem Cells</span></div><div class="casAuthors">Drawnel, Faye M.; Boccardo, Stefano; Prummer, Michael; Delobel, Frederic; Graff, Alexandra; Weber, Michael; Gerard, Regine; Badi, Laura; Kam-Thong, Tony; Bu, Lei; Jiang, Xin; Hoflack, Jean-Christophe; Kiialainen, Anna; Jeworutzki, Elena; Aoyama, Natsuyo; Carlson, Coby; Burcin, Mark; Gromo, Gianni; Boehringer, Markus; Stahlberg, Henning; Hall, Benjamin J.; Magnone, Maria Chiara; Kolaja, Kyle; Chien, Kenneth R.; Bailly, Jacques; Iacone, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">810-820</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Diabetic cardiomyopathy is a complication of type 2 diabetes, with known contributions of lifestyle and genetics.  We develop environmentally and genetically driven in vitro models of the condition using human-induced-pluripotent-stem-cell-derived cardiomyocytes.  First, we mimic diabetic clin. chem. to induce a phenotypic surrogate of diabetic cardiomyopathy, observing structural and functional disarray.  Next, we consider genetic effects by deriving cardiomyocytes from two diabetic patients with variable disease progression.  The cardiomyopathic phenotype is recapitulated in the patient-specific cells basally, with a severity dependent on their original clin. status.  These models are incorporated into successive levels of a screening platform, identifying drugs that preserve cardiomyocyte phenotype in vitro during diabetic stress.  In this work, we present a patient-specific induced pluripotent stem cell (iPSC) model of a complex metabolic condition, showing the power of this technique for discovery and testing of therapeutic strategies for a disease with ever-increasing clin. significance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOPqKgXN3X7LVg90H21EOLACvtfcHk0lhZ1vpJIM67sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslGnsbnF&md5=3d2a3fcc6ab844cf3017ecac5e06e4b1</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.09.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.09.055%26sid%3Dliteratum%253Aachs%26aulast%3DDrawnel%26aufirst%3DF.%2BM.%26aulast%3DBoccardo%26aufirst%3DS.%26aulast%3DPrummer%26aufirst%3DM.%26aulast%3DDelobel%26aufirst%3DF.%26aulast%3DGraff%26aufirst%3DA.%26aulast%3DWeber%26aufirst%3DM.%26aulast%3DG%25C3%25A9rard%26aufirst%3DR.%26aulast%3DBadi%26aufirst%3DL.%26aulast%3DKam-Thong%26aufirst%3DT.%26aulast%3DBu%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DHoflack%26aufirst%3DJ.%2BC.%26aulast%3DKiialainen%26aufirst%3DA.%26aulast%3DJeworutzki%26aufirst%3DE.%26aulast%3DAoyama%26aufirst%3DN.%26aulast%3DCarlson%26aufirst%3DC.%26aulast%3DBurcin%26aufirst%3DM.%26aulast%3DGromo%26aufirst%3DG.%26aulast%3DBoehringer%26aufirst%3DM.%26aulast%3DStahlberg%26aufirst%3DH.%26aulast%3DHall%26aufirst%3DB.%2BJ.%26aulast%3DMagnone%26aufirst%3DM.%2BC.%26aulast%3DKolaja%26aufirst%3DK.%26aulast%3DChien%26aufirst%3DK.%2BR.%26aulast%3DBailly%26aufirst%3DJ.%26aulast%3DIacone%26aufirst%3DR.%26atitle%3DDisease%2520modeling%2520and%2520phenotypic%2520drug%2520screening%2520for%2520diabetic%2520cardiomyopathy%2520using%2520human%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D9%26spage%3D810%26epage%3D821%26doi%3D10.1016%2Fj.celrep.2014.09.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Yi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izpisúa Belmonte, J. C.</span><span> </span><span class="NLM_article-title">Human induced pluripotent stem cells derived hepatocytes: rising promise for disease modeling, drug development and cell therapy</span> <span class="citation_source-journal">Protein Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span><span class="refDoi"> DOI: 10.1007/s13238-012-2918-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1007%2Fs13238-012-2918-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22441839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFOgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=246-250&author=F.+Yiauthor=G.+H.+Liuauthor=J.+C.+Izpis%C3%BAa+Belmonte&title=Human+induced+pluripotent+stem+cells+derived+hepatocytes%3A+rising+promise+for+disease+modeling%2C+drug+development+and+cell+therapy&doi=10.1007%2Fs13238-012-2918-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Human induced pluripotent stem cells derived hepatocytes: rising promise for disease modeling, drug development and cell therapy</span></div><div class="casAuthors">Yi, Fei; Liu, Guang-Hui; Belmonte, Juan Carlos Izpisua</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">246-250</span>CODEN:
                <span class="NLM_cas:coden">PCREFB</span>;
        ISSN:<span class="NLM_cas:issn">1674-800X</span>.
    
            (<span class="NLM_cas:orgname">Higher Education Press</span>)
        </div><div class="casAbstract">A review.  Recent advances in the study of human hepatocytes derived from induced pluripotent stem cells (iPSC) represent new promises for liver disease study and drug discovery.  Human hepatocytes or hepatocyte-like cells differentiated from iPSC recapitulate many functional properties of primary human hepatocytes and have been demonstrated as a powerful and efficient tool to model human liver metabolic diseases and facilitate drug development process.  In this review, we summarize the recent progress in this field and discuss the future perspective of the application of human iPSC derived hepatocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQWm76F8KwlbVg90H21EOLACvtfcHk0lhZ1vpJIM67sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFOgs7g%253D&md5=5ff89e08bf3e3267fc1567abe21fb16e</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1007%2Fs13238-012-2918-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13238-012-2918-4%26sid%3Dliteratum%253Aachs%26aulast%3DYi%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DG.%2BH.%26aulast%3DIzpis%25C3%25BAa%2BBelmonte%26aufirst%3DJ.%2BC.%26atitle%3DHuman%2520induced%2520pluripotent%2520stem%2520cells%2520derived%2520hepatocytes%253A%2520rising%2520promise%2520for%2520disease%2520modeling%252C%2520drug%2520development%2520and%2520cell%2520therapy%26jtitle%3DProtein%2520Cell%26date%3D2012%26volume%3D3%26spage%3D246%26epage%3D250%26doi%3D10.1007%2Fs13238-012-2918-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Ala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashkan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dooley, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilsky, M. L.</span><span> </span><span class="NLM_article-title">Wilson’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span><span class="refDoi"> DOI: 10.1016/S0140-6736(07)60196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2FS0140-6736%2807%2960196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=17276780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1OrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2007&pages=397-408&author=A.+Alaauthor=A.+P.+Walkerauthor=K.+Ashkanauthor=J.+S.+Dooleyauthor=M.+L.+Schilsky&title=Wilson%E2%80%99s+disease&doi=10.1016%2FS0140-6736%2807%2960196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Wilson's disease</span></div><div class="casAuthors">Ala, Aftab; Walker, Ann P.; Ashkan, Keyoumars; Dooley, James S.; Schilsky, Michael L.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">9559</span>),
    <span class="NLM_cas:pages">397-408</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Progressive hepatolenticular degeneration, or Wilson's disease, is a genetic disorder of copper metab.  Knowledge of the clin. presentations and treatment of the disease are important both to the generalist and to specialists in gastroenterol. and hepatol., neurol., psychiatry, and pediatrics.  Wilson's disease invariably results in severe disability and death if untreated.  The diagnosis is easily overlooked but if discovered early, effective treatments are available that will prevent or reverse many manifestations of this disorder.  Studies have identified the role of copper in disease pathogenesis and clin., biochem., and genetic markers that can be useful in diagnosis.  There are several chelating agents and zinc salts for medical therapy.  Liver transplantation corrects the underlying pathophysiol. and can be lifesaving.  The discovery of the Wilson's disease gene has opened up a new mol. diagnostic approach, and could form the basis of future gene therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJRW6UzoX5a7Vg90H21EOLACvtfcHk0ljtVYGLzLkCaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1OrsLc%253D&md5=ed4e35ca24f1b4803cbbc6086e6c92e9</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2807%2960196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252807%252960196-2%26sid%3Dliteratum%253Aachs%26aulast%3DAla%26aufirst%3DA.%26aulast%3DWalker%26aufirst%3DA.%2BP.%26aulast%3DAshkan%26aufirst%3DK.%26aulast%3DDooley%26aufirst%3DJ.%2BS.%26aulast%3DSchilsky%26aufirst%3DM.%2BL.%26atitle%3DWilson%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2007%26volume%3D369%26spage%3D397%26epage%3D408%26doi%3D10.1016%2FS0140-6736%2807%2960196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zychlinski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schambach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, M. A.</span><span> </span><span class="NLM_article-title">Rescue of ATP7B function in hepatocyte-like cells from Wilson’s disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3176</span><span class="NLM_x">–</span> <span class="NLM_lpage">3187</span><span class="refDoi"> DOI: 10.1093/hmg/ddr223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1093%2Fhmg%2Fddr223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21593220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpt1Ohtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=3176-3187&author=S.+Zhangauthor=S.+Chenauthor=W.+Liauthor=X.+Guoauthor=P.+Zhaoauthor=J.+Xuauthor=Y.+Chenauthor=Q.+Panauthor=X.+Liuauthor=D.+Zychlinskiauthor=H.+Luauthor=M.+D.+Tortorellaauthor=A.+Schambachauthor=Y.+Wangauthor=D.+Peiauthor=M.+A.+Esteban&title=Rescue+of+ATP7B+function+in+hepatocyte-like+cells+from+Wilson%E2%80%99s+disease+induced+pluripotent+stem+cells+using+gene+therapy+or+the+chaperone+drug+curcumin&doi=10.1093%2Fhmg%2Fddr223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin</span></div><div class="casAuthors">Zhang, Shiqiang; Chen, Shen; Li, Wen; Guo, Xiangpeng; Zhao, Ping; Xu, Jianyong; Chen, Yan; Pan, Qiong; Liu, Xiaorong; Zychlinski, Daniela; Lu, Hai; Tortorella, Micky D.; Schambach, Axel; Wang, Yan; Pei, Duanqing; Esteban, Miguel A.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3176-3187</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Directed hepatocyte differentiation from human induced pluripotent stem cells (iPSCs) potentially provides a unique platform for modeling liver genetic diseases and performing drug-toxicity screening in vitro.  Wilson's disease is a genetic disease caused by mutations in the ATP7B gene, whose product is a liver transporter protein responsible for coordinated copper export into bile and blood.  Interestingly, the spectrum of ATP7B mutations is vast and can influence clin. presentation (a variable spectrum of hepatic and neural manifestations), though the reason is not well understood.  We describe the generation of iPSCs from a Chinese patient with Wilson's disease that bears the R778L Chinese hotspot mutation in the ATP7B gene.  These iPSCs were pluripotent and could be readily differentiated into hepatocyte-like cells that displayed abnormal cytoplasmic localization of mutated ATP7B and defective copper transport.  Moreover, gene correction using a self-inactivating lentiviral vector that expresses codon optimized-ATP7B or treatment with the chaperone drug curcumin could reverse the functional defect in vitro.  Hence, our work describes an attractive model for studying the pathogenesis of Wilson's disease that is valuable for screening compds. or gene therapy approaches aimed to correct the abnormality.  In the future, once relevant safety concerns (including the stability of the mature liver-like phenotype) and tech. issues for the transplantation procedure are solved, hepatocyte-like cells from similarly genetically cor. iPSCs could be an option for autologous transplantation in Wilson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGUsPwdAWBLrVg90H21EOLACvtfcHk0ljtVYGLzLkCaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpt1Ohtbk%253D&md5=d90a243069742a99272d258dca7d76bd</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddr223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddr223%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZychlinski%26aufirst%3DD.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DTortorella%26aufirst%3DM.%2BD.%26aulast%3DSchambach%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPei%26aufirst%3DD.%26aulast%3DEsteban%26aufirst%3DM.%2BA.%26atitle%3DRescue%2520of%2520ATP7B%2520function%2520in%2520hepatocyte-like%2520cells%2520from%2520Wilson%25E2%2580%2599s%2520disease%2520induced%2520pluripotent%2520stem%2520cells%2520using%2520gene%2520therapy%2520or%2520the%2520chaperone%2520drug%2520curcumin%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2011%26volume%3D20%26spage%3D3176%26epage%3D3187%26doi%3D10.1093%2Fhmg%2Fddr223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Choi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, Y. Y.</span><span> </span><span class="NLM_article-title">Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2458</span><span class="NLM_x">–</span> <span class="NLM_lpage">2468</span><span class="refDoi"> DOI: 10.1002/hep.26237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1002%2Fhep.26237" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=2458-2468&author=S.+M.+Choiauthor=Y.+Kimauthor=J.+S.+Shimauthor=J.+T.+Parkauthor=R.+H.+Wangauthor=S.+D.+Leachauthor=J.+O.+Liuauthor=C.+Dengauthor=Z.+Yeauthor=Y.+Y.+Jang&title=Efficient+drug+screening+and+gene+correction+for+treating+liver+disease+using+patient-specific+stem+cells&doi=10.1002%2Fhep.26237"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1002%2Fhep.26237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.26237%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.%2BM.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DShim%26aufirst%3DJ.%2BS.%26aulast%3DPark%26aufirst%3DJ.%2BT.%26aulast%3DWang%26aufirst%3DR.%2BH.%26aulast%3DLeach%26aufirst%3DS.%2BD.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26aulast%3DDeng%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DZ.%26aulast%3DJang%26aufirst%3DY.%2BY.%26atitle%3DEfficient%2520drug%2520screening%2520and%2520gene%2520correction%2520for%2520treating%2520liver%2520disease%2520using%2520patient-specific%2520stem%2520cells%26jtitle%3DHepatology%26date%3D2013%26volume%3D57%26spage%3D2458%26epage%3D2468%26doi%3D10.1002%2Fhep.26237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Boocock, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popovic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durie, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommens, J. M.</span><span> </span><span class="NLM_article-title">Mutations in SBDS are associated with Shwachman-Diamond syndrome</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span><span class="refDoi"> DOI: 10.1038/ng1062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fng1062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=12496757" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2002&pages=97-101&author=G.+R.+Boocockauthor=J.+A.+Morrisonauthor=M.+Popovicauthor=N.+Richardsauthor=L.+Ellisauthor=P.+R.+Durieauthor=J.+M.+Rommens&title=Mutations+in+SBDS+are+associated+with+Shwachman-Diamond+syndrome&doi=10.1038%2Fng1062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1038%2Fng1062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1062%26sid%3Dliteratum%253Aachs%26aulast%3DBoocock%26aufirst%3DG.%2BR.%26aulast%3DMorrison%26aufirst%3DJ.%2BA.%26aulast%3DPopovic%26aufirst%3DM.%26aulast%3DRichards%26aufirst%3DN.%26aulast%3DEllis%26aufirst%3DL.%26aulast%3DDurie%26aufirst%3DP.%2BR.%26aulast%3DRommens%26aufirst%3DJ.%2BM.%26atitle%3DMutations%2520in%2520SBDS%2520are%2520associated%2520with%2520Shwachman-Diamond%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D2002%26volume%3D33%26spage%3D97%26epage%3D101%26doi%3D10.1038%2Fng1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Tulpule, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensch, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPherson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlaeger, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley, G. Q.</span><span> </span><span class="NLM_article-title">Pluripotent stem cell models of shwachman-diamond syndrome reveal a common mechanism for pancreatic and hematopoietic dysfunction</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span><span class="refDoi"> DOI: 10.1016/j.stem.2013.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.stem.2013.04.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=727-736&author=A.+Tulpuleauthor=J.+M.+Kelleyauthor=M.+W.+Lenschauthor=J.+McPhersonauthor=I.+H.+Parkauthor=O.+Hartungauthor=T.+Nakamuraauthor=T.+M.+Schlaegerauthor=A.+Shimamuraauthor=G.+Q.+Daley&title=Pluripotent+stem+cell+models+of+shwachman-diamond+syndrome+reveal+a+common+mechanism+for+pancreatic+and+hematopoietic+dysfunction&doi=10.1016%2Fj.stem.2013.04.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2013.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2013.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DTulpule%26aufirst%3DA.%26aulast%3DKelley%26aufirst%3DJ.%2BM.%26aulast%3DLensch%26aufirst%3DM.%2BW.%26aulast%3DMcPherson%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DI.%2BH.%26aulast%3DHartung%26aufirst%3DO.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DSchlaeger%26aufirst%3DT.%2BM.%26aulast%3DShimamura%26aufirst%3DA.%26aulast%3DDaley%26aufirst%3DG.%2BQ.%26atitle%3DPluripotent%2520stem%2520cell%2520models%2520of%2520shwachman-diamond%2520syndrome%2520reveal%2520a%2520common%2520mechanism%2520for%2520pancreatic%2520and%2520hematopoietic%2520dysfunction%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2013%26volume%3D12%26spage%3D727%26epage%3D736%26doi%3D10.1016%2Fj.stem.2013.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Liu, G.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montserrat, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarantino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plongthongkum, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nivet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsunekawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soligalla, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goebl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aizawa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Sol, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bueren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trujillo, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surralles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufour, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izpisúa Belmonte, J. C.</span><span> </span><span class="NLM_article-title">Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">4330</span><span class="refDoi"> DOI: 10.1038/ncomms5330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fncomms5330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24999918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2murjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=4330&author=G.-H.+Liuauthor=K.+Suzukiauthor=M.+Liauthor=J.+Quauthor=N.+Montserratauthor=C.+Tarantinoauthor=Y.+Guauthor=F.+Yiauthor=X.+Xuauthor=W.+Zhangauthor=S.+Ruizauthor=N.+Plongthongkumauthor=K.+Zhangauthor=S.+Masudaauthor=E.+Nivetauthor=Y.+Tsunekawaauthor=R.+D.+Soligallaauthor=A.+Goeblauthor=E.+Aizawaauthor=N.+Y.+Kimauthor=J.+Kimauthor=I.+Dubovaauthor=Y.+Liauthor=R.+Renauthor=C.+Bennerauthor=A.+del+Solauthor=J.+Buerenauthor=J.+P.+Trujilloauthor=J.+Surrallesauthor=E.+Cappelliauthor=C.+Dufourauthor=C.+R.+Estebanauthor=J.+C.+Izpis%C3%BAa+Belmonte&title=Modelling+Fanconi+anemia+pathogenesis+and+therapeutics+using+integration-free+patient-derived+iPSCs&doi=10.1038%2Fncomms5330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs</span></div><div class="casAuthors">Liu, Guang-Hui; Suzuki, Keiichiro; Li, Mo; Qu, Jing; Montserrat, Nuria; Tarantino, Carolina; Gu, Ying; Yi, Fei; Xu, Xiuling; Zhang, Weiqi; Ruiz, Sergio; Plongthongkum, Nongluk; Zhang, Kun; Masuda, Shigeo; Nivet, Emmanuel; Tsunekawa, Yuji; Soligalla, Rupa Devi; Goebl, April; Aizawa, Emi; Kim, Na Young; Kim, Jessica; Dubova, Ilir; Li, Ying; Ren, Ruotong; Benner, Chris; del Sol, Antonio; Bueren, Juan; Trujillo, Juan Pablo; Surralles, Jordi; Cappelli, Enrico; Dufour, Carlo; Esteban, Concepcion Rodriguez; Belmonte, Juan Carlos Izpisua</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4330</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Fanconi anemia (FA) is a recessive disorder characterized by genomic instability, congenital abnormalities, cancer predisposition and bone marrow (BM) failure.  However, the pathogenesis of FA is not fully understood partly due to the limitations of current disease models.  Here, we derive integration free-induced pluripotent stem cells (iPSCs) from an FA patient without genetic complementation and report in situ gene correction in FA-iPSCs as well as the generation of isogenic FANCA-deficient human embryonic stem cell (ESC) lines.  FA cellular phenotypes are recapitulated in iPSCs/ESCs and their adult stem/progenitor cell derivs.  By using isogenic pathogenic mutation-free controls as well as cellular and genomic tools, our model serves to facilitate the discovery of novel disease features.  We validate our model as a drug-screening platform by identifying several compds. that improve hematopoietic differentiation of FA-iPSCs.  These compds. are also able to rescue the hematopoietic phenotype of FA patient BM cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB0zFFN-FNULVg90H21EOLACvtfcHk0lhHvUJj8cS8zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2murjE&md5=3b5dfe68789a582e4b1a94acf32b992f</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1038%2Fncomms5330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms5330%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.-H.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DJ.%26aulast%3DMontserrat%26aufirst%3DN.%26aulast%3DTarantino%26aufirst%3DC.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DYi%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DRuiz%26aufirst%3DS.%26aulast%3DPlongthongkum%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DMasuda%26aufirst%3DS.%26aulast%3DNivet%26aufirst%3DE.%26aulast%3DTsunekawa%26aufirst%3DY.%26aulast%3DSoligalla%26aufirst%3DR.%2BD.%26aulast%3DGoebl%26aufirst%3DA.%26aulast%3DAizawa%26aufirst%3DE.%26aulast%3DKim%26aufirst%3DN.%2BY.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DDubova%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DR.%26aulast%3DBenner%26aufirst%3DC.%26aulast%3Ddel%2BSol%26aufirst%3DA.%26aulast%3DBueren%26aufirst%3DJ.%26aulast%3DTrujillo%26aufirst%3DJ.%2BP.%26aulast%3DSurralles%26aufirst%3DJ.%26aulast%3DCappelli%26aufirst%3DE.%26aulast%3DDufour%26aufirst%3DC.%26aulast%3DEsteban%26aufirst%3DC.%2BR.%26aulast%3DIzpis%25C3%25BAa%2BBelmonte%26aufirst%3DJ.%2BC.%26atitle%3DModelling%2520Fanconi%2520anemia%2520pathogenesis%2520and%2520therapeutics%2520using%2520integration-free%2520patient-derived%2520iPSCs%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D4330%26doi%3D10.1038%2Fncomms5330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Moldovan, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, A. D.</span><span> </span><span class="NLM_article-title">How the fanconi anemia pathway guards the genome</span> <span class="citation_source-journal">Annu. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.1146/annurev-genet-102108-134222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1146%2Fannurev-genet-102108-134222" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2009&pages=223-249&author=G.+L.+Moldovanauthor=A.+D.+D%E2%80%99Andrea&title=How+the+fanconi+anemia+pathway+guards+the+genome&doi=10.1146%2Fannurev-genet-102108-134222"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1146%2Fannurev-genet-102108-134222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-genet-102108-134222%26sid%3Dliteratum%253Aachs%26aulast%3DMoldovan%26aufirst%3DG.%2BL.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%2BD.%26atitle%3DHow%2520the%2520fanconi%2520anemia%2520pathway%2520guards%2520the%2520genome%26jtitle%3DAnnu.%2520Rev.%2520Genet.%26date%3D2009%26volume%3D43%26spage%3D223%26epage%3D249%26doi%3D10.1146%2Fannurev-genet-102108-134222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Muller, L. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milsom, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brumme, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schambach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strait, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlaeger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley, G. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. A.</span><span> </span><span class="NLM_article-title">Overcoming reprogramming resistance of Fanconi anemia cells</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">5449</span><span class="NLM_x">–</span> <span class="NLM_lpage">5457</span><span class="refDoi"> DOI: 10.1182/blood-2012-02-408674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1182%2Fblood-2012-02-408674" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=5449-5457&author=L.+U.+Mullerauthor=M.+D.+Milsomauthor=C.+E.+Harrisauthor=R.+Vyasauthor=K.+M.+Brummeauthor=K.+Parmarauthor=L.+A.+Moreauauthor=A.+Schambachauthor=I.+H.+Parkauthor=W.+B.+Londonauthor=K.+Straitauthor=T.+Schlaegerauthor=A.+L.+Devineauthor=E.+Grassmanauthor=A.+D%E2%80%99Andreaauthor=G.+Q.+Daleyauthor=D.+A.+Williams&title=Overcoming+reprogramming+resistance+of+Fanconi+anemia+cells&doi=10.1182%2Fblood-2012-02-408674"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1182%2Fblood-2012-02-408674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2012-02-408674%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DL.%2BU.%26aulast%3DMilsom%26aufirst%3DM.%2BD.%26aulast%3DHarris%26aufirst%3DC.%2BE.%26aulast%3DVyas%26aufirst%3DR.%26aulast%3DBrumme%26aufirst%3DK.%2BM.%26aulast%3DParmar%26aufirst%3DK.%26aulast%3DMoreau%26aufirst%3DL.%2BA.%26aulast%3DSchambach%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DI.%2BH.%26aulast%3DLondon%26aufirst%3DW.%2BB.%26aulast%3DStrait%26aufirst%3DK.%26aulast%3DSchlaeger%26aufirst%3DT.%26aulast%3DDevine%26aufirst%3DA.%2BL.%26aulast%3DGrassman%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%26aulast%3DDaley%26aufirst%3DG.%2BQ.%26aulast%3DWilliams%26aufirst%3DD.%2BA.%26atitle%3DOvercoming%2520reprogramming%2520resistance%2520of%2520Fanconi%2520anemia%2520cells%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26spage%3D5449%26epage%3D5457%26doi%3D10.1182%2Fblood-2012-02-408674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Pereira, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrikopoulos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keene, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biery, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, F.</span><span> </span><span class="NLM_article-title">Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span><span class="refDoi"> DOI: 10.1038/ng1097-218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fng1097-218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=9326947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADyaK2sXmsFantLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=218-222&author=L.+Pereiraauthor=K.+Andrikopoulosauthor=J.+Tianauthor=S.+Y.+Leeauthor=D.+R.+Keeneauthor=R.+Onoauthor=D.+P.+Reinhardtauthor=L.+Y.+Sakaiauthor=N.+J.+Bieryauthor=T.+Buntonauthor=H.+C.+Dietzauthor=F.+Ramirez&title=Targetting+of+the+gene+encoding+fibrillin-1+recapitulates+the+vascular+aspect+of+Marfan+syndrome&doi=10.1038%2Fng1097-218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome</span></div><div class="casAuthors">Pereira, Lygia; Andrikopoulos, Konstantinos; Tian, Jenny; Lee, Sui Ying; Keene, Douglas R.; Ono, Robert; Reinhardt, Dieter P.; Sakai, Lynn Y.; Biery, Nancy Jensen; Bunton, Tracie; Dietz, Harry C.; Ramirez, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">218-222</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Aortic aneurysm and dissection account for about 2% of all deaths in industrialized countries; they are also components of several genetic diseases, including Marfan syndrome (MFS).  The vascular phenotype of MFS results from mutations in fibrillin-1 (FBN1), the major constituent of extracellular microfibrils.  Microfibrils, either assocd. with or devoid of elastin, give rise to a variety of extracellular networks in elastic and non-elastic tissues.  It is believed that microfibrils regulate elastic fiber formation by guiding tropoelastin deposition during embryogenesis and early post-natal life.  Hence, vascular disease in MFS is thought to result when FBN1 mutations preclude elastic fiber maturation by disrupting microfibrillar assembly.  Here we report a gene-targetting expt. in mice that indicates that fibrillin-1 microfibrils are predominantly engaged in tissue homeostasis rather than elastic matrix assembly.  This finding, in turn, suggests that aortic dilation is due primarily to the failure by the microfibrillar array of the adventitia to sustain physiol. hemodynamic stress, and that disruption of the elastic network of the media is a secondary event.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx4BB6vczcsrVg90H21EOLACvtfcHk0ljdrhuWHFOnmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmsFantLY%253D&md5=a85abffeebe0e6680f55da88bbe310a3</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1038%2Fng1097-218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1097-218%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DL.%26aulast%3DAndrikopoulos%26aufirst%3DK.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DKeene%26aufirst%3DD.%2BR.%26aulast%3DOno%26aufirst%3DR.%26aulast%3DReinhardt%26aufirst%3DD.%2BP.%26aulast%3DSakai%26aufirst%3DL.%2BY.%26aulast%3DBiery%26aufirst%3DN.%2BJ.%26aulast%3DBunton%26aufirst%3DT.%26aulast%3DDietz%26aufirst%3DH.%2BC.%26aulast%3DRamirez%26aufirst%3DF.%26atitle%3DTargetting%2520of%2520the%2520gene%2520encoding%2520fibrillin-1%2520recapitulates%2520the%2520vascular%2520aspect%2520of%2520Marfan%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D1997%26volume%3D17%26spage%3D218%26epage%3D222%26doi%3D10.1038%2Fng1097-218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Quarto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francke, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reijo-Pera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longaker, M. T.</span><span> </span><span class="NLM_article-title">Skeletogenic phenotype of human Marfan embryonic stem cells faithfully phenocopied by patient-specific induced-pluripotent stem cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span><span class="refDoi"> DOI: 10.1073/pnas.1113442109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1073%2Fpnas.1113442109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=215-220&author=N.+Quartoauthor=B.+Leonardauthor=S.+Liauthor=M.+Marchandauthor=E.+Andersonauthor=B.+Behrauthor=U.+Franckeauthor=R.+Reijo-Peraauthor=E.+Chiaoauthor=M.+T.+Longaker&title=Skeletogenic+phenotype+of+human+Marfan+embryonic+stem+cells+faithfully+phenocopied+by+patient-specific+induced-pluripotent+stem+cells&doi=10.1073%2Fpnas.1113442109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1113442109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1113442109%26sid%3Dliteratum%253Aachs%26aulast%3DQuarto%26aufirst%3DN.%26aulast%3DLeonard%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DMarchand%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DE.%26aulast%3DBehr%26aufirst%3DB.%26aulast%3DFrancke%26aufirst%3DU.%26aulast%3DReijo-Pera%26aufirst%3DR.%26aulast%3DChiao%26aufirst%3DE.%26aulast%3DLongaker%26aufirst%3DM.%2BT.%26atitle%3DSkeletogenic%2520phenotype%2520of%2520human%2520Marfan%2520embryonic%2520stem%2520cells%2520faithfully%2520phenocopied%2520by%2520patient-specific%2520induced-pluripotent%2520stem%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D215%26epage%3D220%26doi%3D10.1073%2Fpnas.1113442109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Shore, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenstermacher, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeMerrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morhart, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triffitt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urtizberea, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zasloff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, F. S.</span><span> </span><span class="NLM_article-title">A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span><span class="refDoi"> DOI: 10.1038/ng1783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fng1783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=16642017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvVGktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=525-527&author=E.+M.+Shoreauthor=M.+Xuauthor=G.+J.+Feldmanauthor=D.+A.+Fenstermacherauthor=T.+J.+Choauthor=I.+H.+Choiauthor=J.+M.+Connorauthor=P.+Delaiauthor=D.+L.+Glaserauthor=M.+LeMerrerauthor=R.+Morhartauthor=J.+G.+Rogersauthor=R.+Smithauthor=J.+T.+Triffittauthor=J.+A.+Urtizbereaauthor=M.+Zasloffauthor=M.+A.+Brownauthor=F.+S.+Kaplan&title=A+recurrent+mutation+in+the+BMP+type+I+receptor+ACVR1+causes+inherited+and+sporadic+fibrodysplasia+ossificans+progressiva&doi=10.1038%2Fng1783"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva</span></div><div class="casAuthors">Shore, Eileen M.; Xu, Meiqi; Feldman, George J.; Fenstermacher, David A.; Brown, Matthew A.; Kaplan, Frederick S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">525-527</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder of skeletal malformations and progressive extraskeletal ossification.  We mapped FOP to chromosome 2q23-24 by linkage anal. and identified an identical heterozygous mutation (617G → A; R206H) in the glycine-serine (GS) activation domain of ACVR1, a BMP type I receptor, in all affected individuals examd.  Protein modeling predicts destabilization of the GS domain, consistent with constitutive activation of ACVR1 as the underlying cause of the ectopic chondrogenesis, osteogenesis and joint fusions seen in FOP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJCMFDulIw-LVg90H21EOLACvtfcHk0ljdrhuWHFOnmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvVGktrk%253D&md5=24f4dce60f3073f2c621326d3c146601</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1038%2Fng1783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1783%26sid%3Dliteratum%253Aachs%26aulast%3DShore%26aufirst%3DE.%2BM.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DFeldman%26aufirst%3DG.%2BJ.%26aulast%3DFenstermacher%26aufirst%3DD.%2BA.%26aulast%3DCho%26aufirst%3DT.%2BJ.%26aulast%3DChoi%26aufirst%3DI.%2BH.%26aulast%3DConnor%26aufirst%3DJ.%2BM.%26aulast%3DDelai%26aufirst%3DP.%26aulast%3DGlaser%26aufirst%3DD.%2BL.%26aulast%3DLeMerrer%26aufirst%3DM.%26aulast%3DMorhart%26aufirst%3DR.%26aulast%3DRogers%26aufirst%3DJ.%2BG.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DTriffitt%26aufirst%3DJ.%2BT.%26aulast%3DUrtizberea%26aufirst%3DJ.%2BA.%26aulast%3DZasloff%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DM.%2BA.%26aulast%3DKaplan%26aufirst%3DF.%2BS.%26atitle%3DA%2520recurrent%2520mutation%2520in%2520the%2520BMP%2520type%2520I%2520receptor%2520ACVR1%2520causes%2520inherited%2520and%2520sporadic%2520fibrodysplasia%2520ossificans%2520progressiva%26jtitle%3DNat.%2520Genet.%26date%3D2006%26volume%3D38%26spage%3D525%26epage%3D527%26doi%3D10.1038%2Fng1783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Matsumoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlieve, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barruet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asaka, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toguchida, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, E. C.</span><span> </span><span class="NLM_article-title">Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation</span> <span class="citation_source-journal">Orphanet J. Rare Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="refDoi"> DOI: 10.1186/1750-1172-8-190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1186%2F1750-1172-8-190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24321451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A280%3ADC%252BC2c3kvVSmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=190&author=Y.+Matsumotoauthor=Y.+Hayashiauthor=C.+R.+Schlieveauthor=M.+Ikeyaauthor=H.+Kimauthor=T.+D.+Nguyenauthor=S.+Samiauthor=S.+Babaauthor=E.+Barruetauthor=A.+Nasuauthor=I.+Asakaauthor=T.+Otsukaauthor=S.+Yamanakaauthor=B.+R.+Conklinauthor=J.+Toguchidaauthor=E.+C.+Hsiao&title=Induced+pluripotent+stem+cells+from+patients+with+human+fibrodysplasia+ossificans+progressiva+show+increased+mineralization+and+cartilage+formation&doi=10.1186%2F1750-1172-8-190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation</span></div><div class="casAuthors">Matsumoto Yoshihisa; Hayashi Yohei; Schlieve Christopher R; Kim Hannah; Nguyen Trieu D; Sami Salma; Baba Shiro; Barruet Emilie; Nasu Akira; Asaka Isao; Otsuka Takanobu; Yamanaka Shinya; Conklin Bruce R; Toguchida Junya; Hsiao Edward C; Ikeya Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Orphanet journal of rare diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">190</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Abnormal activation of endochondral bone formation in soft tissues causes significant medical diseases associated with disability and pain.  Hyperactive mutations in the bone morphogenetic protein (BMP) type 1 receptor ACVR1 lead to fibrodysplasia ossificans progressiva (FOP), a rare genetic disorder characterized by progressive ossification in soft tissues.  However, the specific cellular mechanisms are unclear.  In addition, the difficulty obtaining tissue samples from FOP patients and the limitations in mouse models of FOP hamper our ability to dissect the pathogenesis of FOP.  METHODS:  To address these challenges and develop a "disease model in a dish", we created human induced pluripotent stem cells (iPS cells) derived from normal and FOP dermal fibroblasts by two separate methods, retroviral integration or integration-free episomal vectors.  We tested if the ability to contribute to different steps of endochondral bone formation was different in FOP vs. control iPS cells.  RESULTS:  Remarkably, FOP iPS cells showed increased mineralization and enhanced chondrogenesis in vitro.  The mineralization phenotypes could be suppressed with a small-molecule inhibitor of BMP signaling, DMH1.  Our results indicate that the FOP ACVR1 R206H mutation favors chondrogenesis and increases mineral deposition in vitro.  CONCLUSIONS:  Our findings establish a FOP disease cell model for in vitro experimentation and provide a proof-of-concept for using human iPS cell models to understand human skeletal disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTeIixu_Bu9JnO4gDb7JggCfW6udTcc2ebXz5fj8G70Fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3kvVSmuw%253D%253D&md5=6ad22b7ccae35e24e2eaa70fd3dcc9f7</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1186%2F1750-1172-8-190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1172-8-190%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DSchlieve%26aufirst%3DC.%2BR.%26aulast%3DIkeya%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%2BD.%26aulast%3DSami%26aufirst%3DS.%26aulast%3DBaba%26aufirst%3DS.%26aulast%3DBarruet%26aufirst%3DE.%26aulast%3DNasu%26aufirst%3DA.%26aulast%3DAsaka%26aufirst%3DI.%26aulast%3DOtsuka%26aufirst%3DT.%26aulast%3DYamanaka%26aufirst%3DS.%26aulast%3DConklin%26aufirst%3DB.%2BR.%26aulast%3DToguchida%26aufirst%3DJ.%26aulast%3DHsiao%26aufirst%3DE.%2BC.%26atitle%3DInduced%2520pluripotent%2520stem%2520cells%2520from%2520patients%2520with%2520human%2520fibrodysplasia%2520ossificans%2520progressiva%2520show%2520increased%2520mineralization%2520and%2520cartilage%2520formation%26jtitle%3DOrphanet%2520J.%2520Rare%2520Dis.%26date%3D2013%26volume%3D8%26spage%3D190%26doi%3D10.1186%2F1750-1172-8-190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Yamashita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yahara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikegawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumaki, N.</span><span> </span><span class="NLM_article-title">Statin treatment rescues FGFR3 skeletal dysplasia phenotypes</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">513</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span><span class="refDoi"> DOI: 10.1038/nature13775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature13775" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2014&pages=507-511&author=A.+Yamashitaauthor=M.+Moriokaauthor=H.+Kishiauthor=T.+Kimuraauthor=Y.+Yaharaauthor=M.+Okadaauthor=K.+Fujitaauthor=H.+Sawaiauthor=S.+Ikegawaauthor=N.+Tsumaki&title=Statin+treatment+rescues+FGFR3+skeletal+dysplasia+phenotypes&doi=10.1038%2Fnature13775"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1038%2Fnature13775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13775%26sid%3Dliteratum%253Aachs%26aulast%3DYamashita%26aufirst%3DA.%26aulast%3DMorioka%26aufirst%3DM.%26aulast%3DKishi%26aufirst%3DH.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DYahara%26aufirst%3DY.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DFujita%26aufirst%3DK.%26aulast%3DSawai%26aufirst%3DH.%26aulast%3DIkegawa%26aufirst%3DS.%26aulast%3DTsumaki%26aufirst%3DN.%26atitle%3DStatin%2520treatment%2520rescues%2520FGFR3%2520skeletal%2520dysplasia%2520phenotypes%26jtitle%3DNature%26date%3D2014%26volume%3D513%26spage%3D507%26epage%3D511%26doi%3D10.1038%2Fnature13775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Vajo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francomano, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkin, D. J.</span><span> </span><span class="NLM_article-title">The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1210/edrv.21.1.0387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1210%2Fedrv.21.1.0387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10696568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhs12hurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=23-39&author=Z.+Vajoauthor=C.+A.+Francomanoauthor=D.+J.+Wilkin&title=The+molecular+and+genetic+basis+of+fibroblast+growth+factor+receptor+3+disorders%3A+the+achondroplasia+family+of+skeletal+dysplasias%2C+Muenke+craniosynostosis%2C+and+Crouzon+syndrome+with+acanthosis+nigricans&doi=10.1210%2Fedrv.21.1.0387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans</span></div><div class="casAuthors">Vajo, Zoltan; Francomano, Clair A.; Wilkin, Douglas J.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-39</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review, with 149 refs.  Achondroplasia, the most common form of short-limbed dwarfism in humans, occurs between 1 in 15,000 and 40,000 live births.  More than 90% of cases are sporadic and there is, on av., an increased paternal age at the time of conception of affected individuals.  More then 97% of persons with achondroplasia have a Gly380Arg mutation in the transmembrane domain of the fibroblast growth factor receptor (FGFR) 3 gene.  Mutations in the FGFR3 gene also result in hypochondroplasia, the lethal thanatophoric dysplasias, the recently described SADDAN (severe achondroplasia with developmental delay and acanthosis nigricans) dysplasia, and two craniosynostosis disorders: Muenke coronal craniosynostosis and Crouzon syndrome with acanthosis nigricans.  Recent evidence suggests that the phenotypic differences may be due to specific alleles with varying degrees of ligand-independent activation, allowing the receptor to be constitutively active.  Since the Gly380Arg achondroplasia mutation was recognized, similar observations regarding the conserved nature of FGFR mutations and resulting phenotype have been made regarding other skeletal phenotypes, including hypochondroplasia, thanatophoric dysplasia, and Muenke coronal craniosynostosis.  These specific genotype-phenotype correlations in the FGFR disorders seem to be unprecedented in the study of human disease.  The explanation for this high degree of mutability at specific bases remains an intriguing question.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPf8IBwDCf07Vg90H21EOLACvtfcHk0ljsoPxWGkr1fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhs12hurc%253D&md5=373fb19253c7f8c4a819f8917050250c</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1210%2Fedrv.21.1.0387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fedrv.21.1.0387%26sid%3Dliteratum%253Aachs%26aulast%3DVajo%26aufirst%3DZ.%26aulast%3DFrancomano%26aufirst%3DC.%2BA.%26aulast%3DWilkin%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520molecular%2520and%2520genetic%2520basis%2520of%2520fibroblast%2520growth%2520factor%2520receptor%25203%2520disorders%253A%2520the%2520achondroplasia%2520family%2520of%2520skeletal%2520dysplasias%252C%2520Muenke%2520craniosynostosis%252C%2520and%2520Crouzon%2520syndrome%2520with%2520acanthosis%2520nigricans%26jtitle%3DEndocr.%2520Rev.%26date%3D2000%26volume%3D21%26spage%3D23%26epage%3D39%26doi%3D10.1210%2Fedrv.21.1.0387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Bayart, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Haguenauer, O.</span><span> </span><span class="NLM_article-title">Technological overview of iPS induction from human adult somatic cells</span> <span class="citation_source-journal">Curr. Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span><span class="refDoi"> DOI: 10.2174/1566523211313020002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.2174%2F1566523211313020002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23320476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1ynsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=73-92&author=E.+Bayartauthor=O.+Cohen-Haguenauer&title=Technological+overview+of+iPS+induction+from+human+adult+somatic+cells&doi=10.2174%2F1566523211313020002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Technological overview of iPS induction from human adult somatic cells</span></div><div class="casAuthors">Bayart, Emilie; Cohen-Haguenauer, Odile</div><div class="citationInfo"><span class="NLM_cas:title">Current Gene Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">73-92</span>CODEN:
                <span class="NLM_cas:coden">CGTUAH</span>;
        ISSN:<span class="NLM_cas:issn">1566-5232</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The unlimited proliferation capacity of embryonic stem cells (ESCs) combined with their pluripotent differentiation potential in various lineages raised great interest in both the scientific community and the public at large with hope for future prospects of regenerative medicine.  However, since ESCs are derived from human embryos, their use is assocd. with significant ethical issues preventing broad studies and therapeutic applications.  To get around this bottleneck, Takahashi and Yamanaka have recently achieved the conversion of adult somatic cells into ES-like cells via the forced expression of 4 transcription factors: Oct3/4, Sox2, Klf4 and c-Myc.  This first demonstration attracted public attention and opened a new field of stem cells research with both cognitive - such as disease modeling - and therapeutic prospects.  This pioneer work just received the 2012 Nobel Prize in Physiol. or Medicine.  Many methods were reported since 2006, for the generation of induced pluripotent stem (iPS) cells.  Most strategies currently under use are based on gene delivery via gamma-retroviral or lentiviral vectors; some expts. were also successful using plasmids or transposons- based systems and few with adenovirus.  However, most expts. involve integration in the host cell genome with an identified risk for insertional mutagenesis and oncogenic transformation.  To circumvent such risks which are deemed incompatible with therapeutic prospects, significant progress was made with transgene-free reprogramming methods based on e.g.: sendai virus or direct mRNA or protein delivery to achieve conversion of adult cells into iPS.  In this review the authors aim to cover current knowledge relating to both delivery systems and combinations of inducing factors including chems. which are used to generate human iPS cells.  Finally, genetic instability resulting from the reprogramming process is also being considered as a safety bottleneck for future clin. translation and stem cell-therapy prospects based on iPS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnf8DhExBwCbVg90H21EOLACvtfcHk0ljsoPxWGkr1fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1ynsbg%253D&md5=e4cea44c1d7126cdc66912becb38c12e</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.2174%2F1566523211313020002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1566523211313020002%26sid%3Dliteratum%253Aachs%26aulast%3DBayart%26aufirst%3DE.%26aulast%3DCohen-Haguenauer%26aufirst%3DO.%26atitle%3DTechnological%2520overview%2520of%2520iPS%2520induction%2520from%2520human%2520adult%2520somatic%2520cells%26jtitle%3DCurr.%2520Gene%2520Ther.%26date%3D2013%26volume%3D13%26spage%3D73%26epage%3D92%26doi%3D10.2174%2F1566523211313020002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Engle, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puppala, D.</span><span> </span><span class="NLM_article-title">Integrating human pluripotent stem cells into drug development</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span><span class="refDoi"> DOI: 10.1016/j.stem.2013.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.stem.2013.05.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=669-677&author=S.+J.+Engleauthor=D.+Puppala&title=Integrating+human+pluripotent+stem+cells+into+drug+development&doi=10.1016%2Fj.stem.2013.05.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2013.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2013.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DEngle%26aufirst%3DS.%2BJ.%26aulast%3DPuppala%26aufirst%3DD.%26atitle%3DIntegrating%2520human%2520pluripotent%2520stem%2520cells%2520into%2520drug%2520development%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2013%26volume%3D12%26spage%3D669%26epage%3D677%26doi%3D10.1016%2Fj.stem.2013.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pabon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murry, C. E.</span><span> </span><span class="NLM_article-title">Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span><span class="refDoi"> DOI: 10.1161/CIRCRESAHA.114.300558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1161%2FCIRCRESAHA.114.300558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24481842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=511-523&author=X.+Yangauthor=L.+Pabonauthor=C.+E.+Murry&title=Engineering+adolescence%3A+maturation+of+human+pluripotent+stem+cell-derived+cardiomyocytes&doi=10.1161%2FCIRCRESAHA.114.300558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Engineering Adolescence: Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes</span></div><div class="casAuthors">Yang, Xiulan; Pabon, Lil; Murry, Charles E.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">511-523</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  The discovery of human pluripotent stem cells (hPSCs), including both human embryonic stem cells and human-induced pluripotent stem cells, has opened up novel paths for a wide range of scientific studies.  The capability to direct the differentiation of hPSCs into functional cardiomyocytes has provided a platform for regenerative medicine, development, tissue engineering, disease modeling, and drug toxicity testing.  Despite exciting progress, achieving the optimal benefits has been hampered by the immature nature of these cardiomyocytes.  Cardiac maturation has long been studied in vivo using animal models; however, finding ways to mature hPSC cardiomyocytes is only in its initial stages.  In this review, we discuss progress in promoting the maturation of the hPSC cardiomyocytes, in the context of our current knowledge of developmental cardiac maturation and in relation to in vitro model systems such as rodent ventricular myocytes.  Promising approaches that have begun to be examd. in hPSC cardiomyocytes include long-term culturing, 3-dimensional tissue engineering, mech. loading, elec. stimulation, modulation of substrate stiffness, and treatment with neurohormonal factors.  Future studies will benefit from the combinatorial use of different approaches that more closely mimic nature's diverse cues, which may result in broader changes in structure, function, and therapeutic applicability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFZvY_Y_H1R7Vg90H21EOLACvtfcHk0liacObihFsLlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yhsbs%253D&md5=14b79ca4775b01d25d516cd8f7453fed</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.114.300558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.114.300558%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DPabon%26aufirst%3DL.%26aulast%3DMurry%26aufirst%3DC.%2BE.%26atitle%3DEngineering%2520adolescence%253A%2520maturation%2520of%2520human%2520pluripotent%2520stem%2520cell-derived%2520cardiomyocytes%26jtitle%3DCirc.%2520Res.%26date%3D2014%26volume%3D114%26spage%3D511%26epage%3D523%26doi%3D10.1161%2FCIRCRESAHA.114.300558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Burridge, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churko, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diecke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordwinkin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plews, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abilez, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span> </span><span class="NLM_article-title">Chemically defined generation of human cardiomyocytes</span> <span class="citation_source-journal">Nat. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">860</span><span class="refDoi"> DOI: 10.1038/nmeth.2999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnmeth.2999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24930130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslGis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=855-860&author=P.+W.+Burridgeauthor=E.+Matsaauthor=P.+Shuklaauthor=Z.+C.+Linauthor=J.+M.+Churkoauthor=A.+D.+Ebertauthor=F.+Lanauthor=S.+Dieckeauthor=B.+Huberauthor=N.+M.+Mordwinkinauthor=J.+R.+Plewsauthor=O.+J.+Abilezauthor=B.+Cuiauthor=J.+D.+Goldauthor=J.+C.+Wu&title=Chemically+defined+generation+of+human+cardiomyocytes&doi=10.1038%2Fnmeth.2999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Chemically defined generation of human cardiomyocytes</span></div><div class="casAuthors">Burridge, Paul W.; Matsa, Elena; Shukla, Praveen; Lin, Ziliang C.; Churko, Jared M.; Ebert, Antje D.; Lan, Feng; Diecke, Sebastian; Huber, Bruno; Mordwinkin, Nicholas M.; Plews, Jordan R.; Abilez, Oscar J.; Cui, Bianxiao; Gold, Joseph D.; Wu, Joseph C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">855-860</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Existing methods for human induced pluripotent stem cell (hiPSC) cardiac differentiation are efficient but require complex, undefined medium constituents that hinder further elucidation of the mol. mechanisms of cardiomyogenesis.  Using hiPSCs derived under chem. defined conditions on synthetic matrixes, we systematically developed an optimized cardiac differentiation strategy, using a chem. defined medium consisting of just three components: the basal medium RPMI 1640, L-ascorbic acid 2-phosphate and rice-derived recombinant human albumin.  Along with small mol.-based induction of differentiation, this protocol produced contractile sheets of up to 95% TNNT2+ cardiomyocytes at a yield of up to 100 cardiomyocytes for every input pluripotent cell and was effective in 11 hiPSC lines tested.  This chem. defined platform for cardiac specification of hiPSCs will allow the elucidation of cardiomyocyte macromol. and metabolic requirements and will provide a minimal system for the study of maturation and subtype specification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI4kKlfNA1fLVg90H21EOLACvtfcHk0liacObihFsLlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslGis7c%253D&md5=153be90e038f00ce022ac16e9919cfcc</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.2999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.2999%26sid%3Dliteratum%253Aachs%26aulast%3DBurridge%26aufirst%3DP.%2BW.%26aulast%3DMatsa%26aufirst%3DE.%26aulast%3DShukla%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DZ.%2BC.%26aulast%3DChurko%26aufirst%3DJ.%2BM.%26aulast%3DEbert%26aufirst%3DA.%2BD.%26aulast%3DLan%26aufirst%3DF.%26aulast%3DDiecke%26aufirst%3DS.%26aulast%3DHuber%26aufirst%3DB.%26aulast%3DMordwinkin%26aufirst%3DN.%2BM.%26aulast%3DPlews%26aufirst%3DJ.%2BR.%26aulast%3DAbilez%26aufirst%3DO.%2BJ.%26aulast%3DCui%26aufirst%3DB.%26aulast%3DGold%26aufirst%3DJ.%2BD.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26atitle%3DChemically%2520defined%2520generation%2520of%2520human%2520cardiomyocytes%26jtitle%3DNat.%2520Methods%26date%3D2014%26volume%3D11%26spage%3D855%26epage%3D860%26doi%3D10.1038%2Fnmeth.2999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Musunuru, K.</span><span> </span><span class="NLM_article-title">Genome editing of human pluripotent stem cells to generate human cellular disease models</span> <span class="citation_source-journal">Dis. Models &amp; Mech.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">896</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span><span class="refDoi"> DOI: 10.1242/dmm.012054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1242%2Fdmm.012054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23751357" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=896-904&author=K.+Musunuru&title=Genome+editing+of+human+pluripotent+stem+cells+to+generate+human+cellular+disease+models&doi=10.1242%2Fdmm.012054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1242%2Fdmm.012054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdmm.012054%26sid%3Dliteratum%253Aachs%26aulast%3DMusunuru%26aufirst%3DK.%26atitle%3DGenome%2520editing%2520of%2520human%2520pluripotent%2520stem%2520cells%2520to%2520generate%2520human%2520cellular%2520disease%2520models%26jtitle%3DDis.%2520Models%2520%2526amp%253B%2520Mech.%26date%3D2013%26volume%3D6%26spage%3D896%26epage%3D904%26doi%3D10.1242%2Fdmm.012054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Vincent, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loria, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pregel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitching, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nocka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyonnas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steppan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peakman, M. C.</span><span> </span><span class="NLM_article-title">Developing predictive assays: The phenotypic screening "rule of 3"</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">293ps15</span><span class="refDoi"> DOI: 10.1126/scitranslmed.aab1201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1126%2Fscitranslmed.aab1201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=26109101" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=293ps15&author=F.+Vincentauthor=P.+Loriaauthor=M.+Pregelauthor=R.+Stantonauthor=L.+Kitchingauthor=K.+Nockaauthor=R.+Doyonnasauthor=C.+Steppanauthor=A.+Gilbertauthor=T.+Schroeterauthor=M.+C.+Peakman&title=Developing+predictive+assays%3A+The+phenotypic+screening+%22rule+of+3%22&doi=10.1126%2Fscitranslmed.aab1201"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aab1201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aab1201%26sid%3Dliteratum%253Aachs%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DLoria%26aufirst%3DP.%26aulast%3DPregel%26aufirst%3DM.%26aulast%3DStanton%26aufirst%3DR.%26aulast%3DKitching%26aufirst%3DL.%26aulast%3DNocka%26aufirst%3DK.%26aulast%3DDoyonnas%26aufirst%3DR.%26aulast%3DSteppan%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DA.%26aulast%3DSchroeter%26aufirst%3DT.%26aulast%3DPeakman%26aufirst%3DM.%2BC.%26atitle%3DDeveloping%2520predictive%2520assays%253A%2520The%2520phenotypic%2520screening%2520%2522rule%2520of%25203%2522%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D293ps15%26doi%3D10.1126%2Fscitranslmed.aab1201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Hynds, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giangreco, A.</span><span> </span><span class="NLM_article-title">Concise review: the relevance of human stem cell-derived organoid models for epithelial translational medicine</span> <span class="citation_source-journal">Stem Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span><span class="refDoi"> DOI: 10.1002/stem.1290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1002%2Fstem.1290" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=417-422&author=R.+E.+Hyndsauthor=A.+Giangreco&title=Concise+review%3A+the+relevance+of+human+stem+cell-derived+organoid+models+for+epithelial+translational+medicine&doi=10.1002%2Fstem.1290"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1002%2Fstem.1290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fstem.1290%26sid%3Dliteratum%253Aachs%26aulast%3DHynds%26aufirst%3DR.%2BE.%26aulast%3DGiangreco%26aufirst%3DA.%26atitle%3DConcise%2520review%253A%2520the%2520relevance%2520of%2520human%2520stem%2520cell-derived%2520organoid%2520models%2520for%2520epithelial%2520translational%2520medicine%26jtitle%3DStem%2520Cells%26date%3D2013%26volume%3D31%26spage%3D417%26epage%3D422%26doi%3D10.1002%2Fstem.1290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Mathur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loskill, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huebsch, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandegar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, K. E.</span><span> </span><span class="NLM_article-title">Human iPSC-based cardiac microphysiological system for drug screening applications</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">8883</span><span class="refDoi"> DOI: 10.1038/srep08883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fsrep08883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=25748532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKhur%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=8883&author=A.+Mathurauthor=P.+Loskillauthor=K.+Shaoauthor=N.+Huebschauthor=S.+Hongauthor=S.+G.+Marcusauthor=N.+Marksauthor=M.+Mandegarauthor=B.+R.+Conklinauthor=L.+P.+Leeauthor=K.+E.+Healy&title=Human+iPSC-based+cardiac+microphysiological+system+for+drug+screening+applications&doi=10.1038%2Fsrep08883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications</span></div><div class="casAuthors">Mathur, Anurag; Loskill, Peter; Shao, Kaifeng; Huebsch, Nathaniel; Hong, Soon Gweon; Marcus, Sivan G.; Marks, Natalie; Mandegar, Mohammad; Conklin, Bruce R.; Lee, Luke P.; Healy, Kevin E.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8883</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drug discovery and development are hampered by high failure rates attributed to the reliance on non-human animal models employed during safety and efficacy testing.  A fundamental problem in this inefficient process is that non-human animal models cannot adequately represent human biol.  Thus, there is an urgent need for high-content in vitro systems that can better predict drug-induced toxicity.  Systems that predict cardiotoxicity are of uppermost significance, as approx. one third of safety-based pharmaceutical withdrawals are due to cardiotoxicty.  Here, we present a cardiac microphysiol. system (MPS) with the attributes required for an ideal in vitro system to predict cardiotoxicity: i) cells with a human genetic background; ii) physiol. relevant tissue structure (e.g. aligned cells); iii) computationally predictable perfusion mimicking human vasculature; and, iv) multiple modes of anal. (e.g. biol., electrophysiol., and physiol.).  Our MPS is able to keep human induced pluripotent stem cell derived cardiac tissue viable and functional over multiple weeks.  Pharmacol. studies using the cardiac MPS show half maximal inhibitory/effective concn. values (IC50/EC50) that are more consistent with the data on tissue scale refs. compared to cellular scale studies.  We anticipate the widespread adoption of MPSs for drug screening and disease modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCeMW615OeRrVg90H21EOLACvtfcHk0ljfYvWknZiJpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKhur%252FE&md5=3ad2b2791b5f84e98a7eeba633376507</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1038%2Fsrep08883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep08883%26sid%3Dliteratum%253Aachs%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DLoskill%26aufirst%3DP.%26aulast%3DShao%26aufirst%3DK.%26aulast%3DHuebsch%26aufirst%3DN.%26aulast%3DHong%26aufirst%3DS.%26aulast%3DMarcus%26aufirst%3DS.%2BG.%26aulast%3DMarks%26aufirst%3DN.%26aulast%3DMandegar%26aufirst%3DM.%26aulast%3DConklin%26aufirst%3DB.%2BR.%26aulast%3DLee%26aufirst%3DL.%2BP.%26aulast%3DHealy%26aufirst%3DK.%2BE.%26atitle%3DHuman%2520iPSC-based%2520cardiac%2520microphysiological%2520system%2520for%2520drug%2520screening%2520applications%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D8883%26doi%3D10.1038%2Fsrep08883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Lancaster, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bicknell, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurles, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homfray, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penninger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoblich, J. A.</span><span> </span><span class="NLM_article-title">Cerebral organoids model human brain development and microcephaly</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">501</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span><span class="refDoi"> DOI: 10.1038/nature12517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature12517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23995685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlCntb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=501&publication_year=2013&pages=373-379&author=M.+A.+Lancasterauthor=M.+Rennerauthor=C.+A.+Martinauthor=D.+Wenzelauthor=L.+S.+Bicknellauthor=M.+E.+Hurlesauthor=T.+Homfrayauthor=J.+M.+Penningerauthor=A.+P.+Jacksonauthor=J.+A.+Knoblich&title=Cerebral+organoids+model+human+brain+development+and+microcephaly&doi=10.1038%2Fnature12517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebral organoids model human brain development and microcephaly</span></div><div class="casAuthors">Lancaster, Madeline A.; Renner, Magdalena; Martin, Carol-Anne; Wenzel, Daniel; Bicknell, Louise S.; Hurles, Matthew E.; Homfray, Tessa; Penninger, Josef M.; Jackson, Andrew P.; Knoblich, Juergen A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">501</span>
        (<span class="NLM_cas:issue">7467</span>),
    <span class="NLM_cas:pages">373-379</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The complexity of the human brain has made it difficult to study many brain disorders in model organisms, highlighting the need for an in vitro model of human brain development.  Here we have developed a human pluripotent stem cell-derived three-dimensional organoid culture system, termed cerebral organoids, that develop various discrete, although interdependent, brain regions.  These include a cerebral cortex contg. progenitor populations that organize and produce mature cortical neuron subtypes.  Furthermore, cerebral organoids are shown to recapitulate features of human cortical development, namely characteristic progenitor zone organization with abundant outer radial glial stem cells.  Finally, we use RNA interference and patient-specific induced pluripotent stem cells to model microcephaly, a disorder that has been difficult to recapitulate in mice.  We demonstrate premature neuronal differentiation in patient organoids, a defect that could help to explain the disease phenotype.  Together, these data show that three-dimensional organoids can recapitulate development and disease even in this most complex human tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1ooY8YMg5k7Vg90H21EOLACvtfcHk0ljfYvWknZiJpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlCntb3F&md5=96195248e51aa62a5a5d761aa56814a1</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1038%2Fnature12517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12517%26sid%3Dliteratum%253Aachs%26aulast%3DLancaster%26aufirst%3DM.%2BA.%26aulast%3DRenner%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DC.%2BA.%26aulast%3DWenzel%26aufirst%3DD.%26aulast%3DBicknell%26aufirst%3DL.%2BS.%26aulast%3DHurles%26aufirst%3DM.%2BE.%26aulast%3DHomfray%26aufirst%3DT.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26aulast%3DJackson%26aufirst%3DA.%2BP.%26aulast%3DKnoblich%26aufirst%3DJ.%2BA.%26atitle%3DCerebral%2520organoids%2520model%2520human%2520brain%2520development%2520and%2520microcephaly%26jtitle%3DNature%26date%3D2013%26volume%3D501%26spage%3D373%26epage%3D379%26doi%3D10.1038%2Fnature12517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Choi, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebisch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sliwinski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Avanzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asselin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muffat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klee, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainger, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovacs, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D. Y.</span><span> </span><span class="NLM_article-title">A three-dimensional human neural cell culture model of Alzheimer’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">515</span><span class="NLM_x">, </span> <span class="NLM_fpage">274</span><span class="NLM_x">–</span> <span class="NLM_lpage">278</span><span class="refDoi"> DOI: 10.1038/nature13800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature13800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=25307057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVemtr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=515&publication_year=2014&pages=274-278&author=S.+H.+Choiauthor=Y.+H.+Kimauthor=M.+Hebischauthor=C.+Sliwinskiauthor=S.+Leeauthor=C.+D%E2%80%99Avanzoauthor=H.+Chenauthor=B.+Hooliauthor=C.+Asselinauthor=J.+Muffatauthor=J.+B.+Kleeauthor=C.+Zhangauthor=B.+J.+Waingerauthor=M.+Peitzauthor=D.+M.+Kovacsauthor=C.+J.+Woolfauthor=S.+L.+Wagnerauthor=R.+E.+Tanziauthor=D.+Y.+Kim&title=A+three-dimensional+human+neural+cell+culture+model+of+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnature13800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">A three-dimensional human neural cell culture model of Alzheimer's disease</span></div><div class="casAuthors">Choi, Se Hoon; Kim, Young Hye; Hebisch, Matthias; Sliwinski, Christopher; Lee, Seungkyu; D'Avanzo, Carla; Chen, Hechao; Hooli, Basavaraj; Asselin, Caroline; Muffat, Julien; Klee, Justin B.; Zhang, Can; Wainger, Brian J.; Peitz, Michael; Kovacs, Dora M.; Woolf, Clifford J.; Wagner, Steven L.; Tanzi, Rudolph E.; Kim, Doo Yeon</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">515</span>
        (<span class="NLM_cas:issue">7526</span>),
    <span class="NLM_cas:pages">274-278</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer's disease is the most common form of dementia, characterized by two pathol. hallmarks: amyloid-β plaques and neurofibrillary tangles.  The amyloid hypothesis of Alzheimer's disease posits that the excessive accumulation of amyloid-β peptide leads to neurofibrillary tangles composed of aggregated hyperphosphorylated tau.  However, to date, no single disease model has serially linked these two pathol. events using human neuronal cells.  Mouse models with familial Alzheimer's disease (FAD) mutations exhibit amyloid-β-induced synaptic and memory deficits but they do not fully recapitulate other key pathol. events of Alzheimer's disease, including distinct neurofibrillary tangle pathol.  Human neurons derived from Alzheimer's disease patients have shown elevated levels of toxic amyloid-β species and phosphorylated tau but did not demonstrate amyloid-β plaques or neurofibrillary tangles.  Here we report that FAD mutations in β-amyloid precursor protein and presenilin 1 are able to induce robust extracellular deposition of amyloid-β, including amyloid-β plaques, in a human neural stem-cell-derived three-dimensional (3D) culture system.  More importantly, the 3D-differentiated neuronal cells expressing FAD mutations exhibited high levels of detergent-resistant, silver-pos. aggregates of phosphorylated tau in the soma and neurites, as well as filamentous tau, as detected by immunoelectron microscopy.  Inhibition of amyloid-β generation with β- or γ-secretase inhibitors not only decreased amyloid-β pathol., but also attenuated tauopathy.  We also found that glycogen synthase kinase 3 (GSK3) regulated amyloid-β-mediated tau phosphorylation.  We have successfully recapitulated amyloid-β and tau pathol. in a single 3D human neural cell culture system.  Our unique strategy for recapitulating Alzheimer's disease pathol. in a 3D neural cell culture model should also serve to facilitate the development of more precise human neural cell models of other neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3vp1KMszwpLVg90H21EOLACvtfcHk0ljfYvWknZiJpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVemtr3L&md5=491938dac75824c5d642891c660a8885</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1038%2Fnature13800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13800%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DHebisch%26aufirst%3DM.%26aulast%3DSliwinski%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DD%25E2%2580%2599Avanzo%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DHooli%26aufirst%3DB.%26aulast%3DAsselin%26aufirst%3DC.%26aulast%3DMuffat%26aufirst%3DJ.%26aulast%3DKlee%26aufirst%3DJ.%2BB.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWainger%26aufirst%3DB.%2BJ.%26aulast%3DPeitz%26aufirst%3DM.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26aulast%3DWagner%26aufirst%3DS.%2BL.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DKim%26aufirst%3DD.%2BY.%26atitle%3DA%2520three-dimensional%2520human%2520neural%2520cell%2520culture%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2014%26volume%3D515%26spage%3D274%26epage%3D278%26doi%3D10.1038%2Fnature13800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Matsusaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akashi, M.</span><span> </span><span class="NLM_article-title">Three-dimensional cell culture technique and pathophysiology</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span><span class="refDoi"> DOI: 10.1016/j.addr.2014.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.addr.2014.01.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=95-103&author=M.+Matsusakiauthor=C.+P.+Caseauthor=M.+Akashi&title=Three-dimensional+cell+culture+technique+and+pathophysiology&doi=10.1016%2Fj.addr.2014.01.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2014.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2014.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DMatsusaki%26aufirst%3DM.%26aulast%3DCase%26aufirst%3DC.%2BP.%26aulast%3DAkashi%26aufirst%3DM.%26atitle%3DThree-dimensional%2520cell%2520culture%2520technique%2520and%2520pathophysiology%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2014%26volume%3D74%26spage%3D95%26epage%3D103%26doi%3D10.1016%2Fj.addr.2014.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Wagner, B. K.; Tolliday, N. J.; Clemons, P. A.</span>, Eds.  <span class="citation_source-book">Cell-Based Assays for High-Throughput Screening: Methods and Protocols</span>; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=B.+K.+Wagner&author=N.+J.+Tolliday&author=P.+A.+Clemons&title=Cell-Based+Assays+for+High-Throughput+Screening%3A+Methods+and+Protocols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DB.%2BK.%26btitle%3DCell-Based%2520Assays%2520for%2520High-Throughput%2520Screening%253A%2520Methods%2520and%2520Protocols%26pub%3DHumana%2520Press%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Harrison, C.</span><span> </span><span class="NLM_article-title">Phenotypic screening: A more rapid route to target deconvolution</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span><span class="refDoi"> DOI: 10.1038/nrd4243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnrd4243" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=102-103&author=C.+Harrison&title=Phenotypic+screening%3A+A+more+rapid+route+to+target+deconvolution&doi=10.1038%2Fnrd4243"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1038%2Fnrd4243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4243%26sid%3Dliteratum%253Aachs%26aulast%3DHarrison%26aufirst%3DC.%26atitle%3DPhenotypic%2520screening%253A%2520A%2520more%2520rapid%2520route%2520to%2520target%2520deconvolution%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D102%26epage%3D103%26doi%3D10.1038%2Fnrd4243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 19 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Xie</span>, <span class="hlFld-ContribAuthor ">Shibing  Tang</span>, <span class="hlFld-ContribAuthor ">Ke  Li</span>, and <span class="hlFld-ContribAuthor ">Sheng  Ding</span>  . </span><span class="cited-content_cbyCitation_article-title">Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2017,</strong> <em>50 </em>
                                    (5)
                                     , 1202-1211. <a href="https://doi.org/10.1021/acs.accounts.7b00020" title="DOI URL">https://doi.org/10.1021/acs.accounts.7b00020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.7b00020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.7b00020%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DPharmacological%252BReprogramming%252Bof%252BSomatic%252BCells%252Bfor%252BRegenerative%252BMedicine%26aulast%3DXie%26aufirst%3DMin%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D08012017%26date%3D28042017%26date%3D16052017%26volume%3D50%26issue%3D5%26spage%3D1202%26epage%3D1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiang  Li</span>, <span class="hlFld-ContribAuthor ">Jia  Wang</span>, <span class="hlFld-ContribAuthor ">Qiang  Wu</span>, <span class="hlFld-ContribAuthor ">Nan  Cao</span>, <span class="hlFld-ContribAuthor ">Huang‐Tian  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Perspective on human pluripotent stem cell‐derived cardiomyocytes in heart disease modeling and repair. </span><span class="cited-content_cbyCitation_journal-name">STEM CELLS Translational Medicine</span><span> <strong>2020,</strong> <em>9 </em>
                                    (10)
                                     , 1121-1128. <a href="https://doi.org/10.1002/sctm.19-0340" title="DOI URL">https://doi.org/10.1002/sctm.19-0340</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/sctm.19-0340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fsctm.19-0340%26sid%3Dliteratum%253Aachs%26jtitle%3DSTEM%2520CELLS%2520Translational%2520Medicine%26atitle%3DPerspective%252Bon%252Bhuman%252Bpluripotent%252Bstem%252Bcell%2525E2%252580%252590derived%252Bcardiomyocytes%252Bin%252Bheart%252Bdisease%252Bmodeling%252Band%252Brepair%26aulast%3DLi%26aufirst%3DQiang%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D10%26spage%3D1121%26epage%3D1128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark A.  Fields</span>, <span class="hlFld-ContribAuthor ">Lucian V.  Del Priore</span>, <span class="hlFld-ContribAuthor ">Ron A.  Adelman</span>, <span class="hlFld-ContribAuthor ">Lawrence J.  Rizzolo</span>. </span><span class="cited-content_cbyCitation_article-title">Interactions of the choroid, Bruch's membrane, retinal pigment epithelium, and neurosensory retina collaborate to form the outer blood-retinal-barrier. </span><span class="cited-content_cbyCitation_journal-name">Progress in Retinal and Eye Research</span><span> <strong>2020,</strong> <em>76 </em>, 100803. <a href="https://doi.org/10.1016/j.preteyeres.2019.100803" title="DOI URL">https://doi.org/10.1016/j.preteyeres.2019.100803</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.preteyeres.2019.100803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.preteyeres.2019.100803%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Retinal%2520and%2520Eye%2520Research%26atitle%3DInteractions%252Bof%252Bthe%252Bchoroid%25252C%252BBruch%252527s%252Bmembrane%25252C%252Bretinal%252Bpigment%252Bepithelium%25252C%252Band%252Bneurosensory%252Bretina%252Bcollaborate%252Bto%252Bform%252Bthe%252Bouter%252Bblood-retinal-barrier%26aulast%3DFields%26aufirst%3DMark%2BA.%26date%3D2020%26volume%3D76%26spage%3D100803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Gong</span>, <span class="hlFld-ContribAuthor ">Hui  Cai</span>, , <span class="hlFld-ContribAuthor ">Scott  Noggle</span>, <span class="hlFld-ContribAuthor ">Daniel  Paull</span>, <span class="hlFld-ContribAuthor ">Lawrence J.  Rizzolo</span>, <span class="hlFld-ContribAuthor ">Lucian V.  Del Priore</span>, <span class="hlFld-ContribAuthor ">Mark A.  Fields</span>. </span><span class="cited-content_cbyCitation_article-title">Stem cell‐derived retinal pigment epithelium from patients with age‐related macular degeneration exhibit reduced metabolism and matrix interactions. </span><span class="cited-content_cbyCitation_journal-name">STEM CELLS Translational Medicine</span><span> <strong>2020,</strong> <em>9 </em>
                                    (3)
                                     , 364-376. <a href="https://doi.org/10.1002/sctm.19-0321" title="DOI URL">https://doi.org/10.1002/sctm.19-0321</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/sctm.19-0321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fsctm.19-0321%26sid%3Dliteratum%253Aachs%26jtitle%3DSTEM%2520CELLS%2520Translational%2520Medicine%26atitle%3DStem%252Bcell%2525E2%252580%252590derived%252Bretinal%252Bpigment%252Bepithelium%252Bfrom%252Bpatients%252Bwith%252Bage%2525E2%252580%252590related%252Bmacular%252Bdegeneration%252Bexhibit%252Breduced%252Bmetabolism%252Band%252Bmatrix%252Binteractions%26aulast%3DGong%26aufirst%3DJie%26date%3D2020%26date%3D2019%26volume%3D9%26issue%3D3%26spage%3D364%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sally  Esmail</span>, <span class="hlFld-ContribAuthor ">Wayne R.  Danter</span>. </span><span class="cited-content_cbyCitation_article-title">DeepNEU: Artificially Induced Stem Cell (aiPSC) and Differentiated Skeletal Muscle Cell (aiSkMC) Simulations of Infantile Onset POMPE Disease (IOPD) for Potential Biomarker Identification and Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cell and Developmental Biology</span><span> <strong>2019,</strong> <em>7 </em><a href="https://doi.org/10.3389/fcell.2019.00325" title="DOI URL">https://doi.org/10.3389/fcell.2019.00325</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcell.2019.00325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcell.2019.00325%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cell%2520and%2520Developmental%2520Biology%26atitle%3DDeepNEU%25253A%252BArtificially%252BInduced%252BStem%252BCell%252B%252528aiPSC%252529%252Band%252BDifferentiated%252BSkeletal%252BMuscle%252BCell%252B%252528aiSkMC%252529%252BSimulations%252Bof%252BInfantile%252BOnset%252BPOMPE%252BDisease%252B%252528IOPD%252529%252Bfor%252BPotential%252BBiomarker%252BIdentification%252Band%252BDrug%252BDiscovery%26aulast%3DEsmail%26aufirst%3DSally%26date%3D2019%26date%3D2019%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason H.  Karnes</span>, <span class="hlFld-ContribAuthor ">Matthew A.  Miller</span>, <span class="hlFld-ContribAuthor ">Katie D.  White</span>, <span class="hlFld-ContribAuthor ">Katherine C.  Konvinse</span>, <span class="hlFld-ContribAuthor ">Rebecca K.  Pavlos</span>, <span class="hlFld-ContribAuthor ">Alec J.  Redwood</span>, <span class="hlFld-ContribAuthor ">Jonathan G.  Peter</span>, <span class="hlFld-ContribAuthor ">Rannakoe  Lehloenya</span>, <span class="hlFld-ContribAuthor ">Simon A.  Mallal</span>, <span class="hlFld-ContribAuthor ">Elizabeth J.  Phillips</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Pharmacology and Toxicology</span><span> <strong>2019,</strong> <em>59 </em>
                                    (1)
                                     , 463-486. <a href="https://doi.org/10.1146/annurev-pharmtox-010818-021818" title="DOI URL">https://doi.org/10.1146/annurev-pharmtox-010818-021818</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-pharmtox-010818-021818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-pharmtox-010818-021818%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Pharmacology%2520and%2520Toxicology%26atitle%3DApplications%252Bof%252BImmunopharmacogenomics%25253A%252BPredicting%25252C%252BPreventing%25252C%252Band%252BUnderstanding%252BImmune-Mediated%252BAdverse%252BDrug%252BReactions%26aulast%3DKarnes%26aufirst%3DJason%2BH.%26date%3D2019%26volume%3D59%26issue%3D1%26spage%3D463%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Xu</span>, <span class="hlFld-ContribAuthor ">Alessandro  Magli</span>, <span class="hlFld-ContribAuthor ">Yoska  Anugrah</span>, <span class="hlFld-ContribAuthor ">Steven J.  Koester</span>, <span class="hlFld-ContribAuthor ">Rita C.R.  Perlingeiro</span>, <span class="hlFld-ContribAuthor ">Wei  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Nanotopography-responsive myotube alignment and orientation as a sensitive phenotypic biomarker for Duchenne Muscular Dystrophy. </span><span class="cited-content_cbyCitation_journal-name">Biomaterials</span><span> <strong>2018,</strong> <em>183 </em>, 54-66. <a href="https://doi.org/10.1016/j.biomaterials.2018.08.047" title="DOI URL">https://doi.org/10.1016/j.biomaterials.2018.08.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biomaterials.2018.08.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biomaterials.2018.08.047%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomaterials%26atitle%3DNanotopography-responsive%252Bmyotube%252Balignment%252Band%252Borientation%252Bas%252Ba%252Bsensitive%252Bphenotypic%252Bbiomarker%252Bfor%252BDuchenne%252BMuscular%252BDystrophy%26aulast%3DXu%26aufirst%3DBin%26date%3D2018%26volume%3D183%26spage%3D54%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashok  Vaidya</span>, <span class="hlFld-ContribAuthor ">Anuradha  Roy</span>, <span class="hlFld-ContribAuthor ">Rathnam  Chaguturu</span>. </span><span class="cited-content_cbyCitation_article-title">How to rekindle drug discovery process through integrative therapeutic targeting?. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2018,</strong> <em>13 </em>
                                    (10)
                                     , 893-898. <a href="https://doi.org/10.1080/17460441.2018.1514010" title="DOI URL">https://doi.org/10.1080/17460441.2018.1514010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2018.1514010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2018.1514010%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DHow%252Bto%252Brekindle%252Bdrug%252Bdiscovery%252Bprocess%252Bthrough%252Bintegrative%252Btherapeutic%252Btargeting%25253F%26aulast%3DVaidya%26aufirst%3DAshok%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D10%26spage%3D893%26epage%3D898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helen  Zhao</span>, <span class="hlFld-ContribAuthor ">Guy  Perkins</span>, <span class="hlFld-ContribAuthor ">Hang  Yao</span>, <span class="hlFld-ContribAuthor ">David  Callacondo</span>, <span class="hlFld-ContribAuthor ">Otto  Appenzeller</span>, <span class="hlFld-ContribAuthor ">Mark  Ellisman</span>, <span class="hlFld-ContribAuthor ">Albert R.  La Spada</span>, <span class="hlFld-ContribAuthor ">Gabriel G.  Haddad</span>. </span><span class="cited-content_cbyCitation_article-title">Mitochondrial dysfunction in iPSC-derived neurons of subjects with chronic mountain sickness. </span><span class="cited-content_cbyCitation_journal-name">Journal of Applied Physiology</span><span> <strong>2018,</strong> <em>125 </em>
                                    (3)
                                     , 832-840. <a href="https://doi.org/10.1152/japplphysiol.00689.2017" title="DOI URL">https://doi.org/10.1152/japplphysiol.00689.2017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/japplphysiol.00689.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fjapplphysiol.00689.2017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Applied%2520Physiology%26atitle%3DMitochondrial%252Bdysfunction%252Bin%252BiPSC-derived%252Bneurons%252Bof%252Bsubjects%252Bwith%252Bchronic%252Bmountain%252Bsickness%26aulast%3DZhao%26aufirst%3DHelen%26date%3D2018%26volume%3D125%26issue%3D3%26spage%3D832%26epage%3D840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiong  Ke</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Xin  Yao</span>, <span class="hlFld-ContribAuthor ">Xingqiang  Lai</span>, <span class="hlFld-ContribAuthor ">Bing  Cai</span>, <span class="hlFld-ContribAuthor ">Hong  Chen</span>, <span class="hlFld-ContribAuthor ">Rui  Chen</span>, <span class="hlFld-ContribAuthor ">Zhichen  Zhai</span>, <span class="hlFld-ContribAuthor ">Lihua  Huang</span>, <span class="hlFld-ContribAuthor ">Kai  Li</span>, <span class="hlFld-ContribAuthor ">Anbin  Hu</span>, <span class="hlFld-ContribAuthor ">Frank Fuxiang  Mao</span>, <span class="hlFld-ContribAuthor ">Andy Peng  Xiang</span>, <span class="hlFld-ContribAuthor ">Liang  Tao</span>, <span class="hlFld-ContribAuthor ">Weiqiang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced generation of human induced pluripotent stem cells by ectopic expression of Connexin 45. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-00523-y" title="DOI URL">https://doi.org/10.1038/s41598-017-00523-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-00523-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-00523-y%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DEnhanced%252Bgeneration%252Bof%252Bhuman%252Binduced%252Bpluripotent%252Bstem%252Bcells%252Bby%252Bectopic%252Bexpression%252Bof%252BConnexin%252B45%26aulast%3DKe%26aufirst%3DQiong%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisa  Uliassi</span>, <span class="hlFld-ContribAuthor ">Annachiara  Gandini</span>, <span class="hlFld-ContribAuthor ">Rosaria Carmela  Perone</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">Neuroregeneration versus neurodegeneration: toward a paradigm shift in Alzheimer's disease drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (10)
                                     , 995-1013. <a href="https://doi.org/10.4155/fmc-2017-0038" title="DOI URL">https://doi.org/10.4155/fmc-2017-0038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0038%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DNeuroregeneration%252Bversus%252Bneurodegeneration%25253A%252Btoward%252Ba%252Bparadigm%252Bshift%252Bin%252BAlzheimer%252527s%252Bdisease%252Bdrug%252Bdiscovery%26aulast%3DUliassi%26aufirst%3DElisa%26date%3D2017%26volume%3D9%26issue%3D10%26spage%3D995%26epage%3D1013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isotta  Chimenti</span>, <span class="hlFld-ContribAuthor ">Diana  Massai</span>, <span class="hlFld-ContribAuthor ">Umberto  Morbiducci</span>, <span class="hlFld-ContribAuthor ">Antonio Paolo  Beltrami</span>, <span class="hlFld-ContribAuthor ">Maurizio  Pesce</span>, <span class="hlFld-ContribAuthor ">Elisa  Messina</span>. </span><span class="cited-content_cbyCitation_article-title">Stem Cell Spheroids and Ex Vivo Niche Modeling: Rationalization and Scaling-Up. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cardiovascular Translational Research</span><span> <strong>2017,</strong> <em>10 </em>
                                    (2)
                                     , 150-166. <a href="https://doi.org/10.1007/s12265-017-9741-5" title="DOI URL">https://doi.org/10.1007/s12265-017-9741-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12265-017-9741-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12265-017-9741-5%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cardiovascular%2520Translational%2520Research%26atitle%3DStem%252BCell%252BSpheroids%252Band%252BEx%252BVivo%252BNiche%252BModeling%25253A%252BRationalization%252Band%252BScaling-Up%26aulast%3DChimenti%26aufirst%3DIsotta%26date%3D2017%26date%3D2017%26volume%3D10%26issue%3D2%26spage%3D150%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masaki  Hosoya</span>, <span class="hlFld-ContribAuthor ">Katherine  Czysz</span>. </span><span class="cited-content_cbyCitation_article-title">Translational Prospects and Challenges in Human Induced Pluripotent Stem Cell Research in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2016,</strong> <em>5 </em>
                                    (4)
                                     , 46. <a href="https://doi.org/10.3390/cells5040046" title="DOI URL">https://doi.org/10.3390/cells5040046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells5040046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells5040046%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DTranslational%252BProspects%252Band%252BChallenges%252Bin%252BHuman%252BInduced%252BPluripotent%252BStem%252BCell%252BResearch%252Bin%252BDrug%252BDiscovery%26aulast%3DHosoya%26aufirst%3DMasaki%26date%3D2016%26date%3D2016%26volume%3D5%26issue%3D4%26spage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Liu</span>, <span class="hlFld-ContribAuthor ">Chen  Yu</span>, <span class="hlFld-ContribAuthor ">Min  Xie</span>, <span class="hlFld-ContribAuthor ">Ke  Li</span>, <span class="hlFld-ContribAuthor ">Sheng  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Modulation of Cell Fate in Stem Cell Therapeutics and Regenerative Medicine. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2016,</strong> <em>23 </em>
                                    (8)
                                     , 893-916. <a href="https://doi.org/10.1016/j.chembiol.2016.07.007" title="DOI URL">https://doi.org/10.1016/j.chembiol.2016.07.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2016.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2016.07.007%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DChemical%252BModulation%252Bof%252BCell%252BFate%252Bin%252BStem%252BCell%252BTherapeutics%252Band%252BRegenerative%252BMedicine%26aulast%3DLiu%26aufirst%3DKai%26date%3D2016%26volume%3D23%26issue%3D8%26spage%3D893%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Bibliography. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 229-246. <a href="https://doi.org/10.1002/9781119330141.biblio" title="DOI URL">https://doi.org/10.1002/9781119330141.biblio</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119330141.biblio&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119330141.biblio%26sid%3Dliteratum%253Aachs%26atitle%3DBibliography%26date%3D2016%26date%3D2016%26spage%3D229%26epage%3D246%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DLive%252BCell%252BAssays%26aulast%3DFurger%26aufirst%3DChristophe%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dido  Carrero</span>, <span class="hlFld-ContribAuthor ">Clara  Soria-Valles</span>, <span class="hlFld-ContribAuthor ">Carlos  López-Otín</span>. </span><span class="cited-content_cbyCitation_article-title">Hallmarks of progeroid syndromes: lessons from mice and reprogrammed cells. </span><span class="cited-content_cbyCitation_journal-name">Disease Models & Mechanisms</span><span> <strong>2016,</strong> <em>9 </em>
                                    (7)
                                     , 719-735. <a href="https://doi.org/10.1242/dmm.024711" title="DOI URL">https://doi.org/10.1242/dmm.024711</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1242/dmm.024711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1242%2Fdmm.024711%26sid%3Dliteratum%253Aachs%26jtitle%3DDisease%2520Models%2520%2526%2520Mechanisms%26atitle%3DHallmarks%252Bof%252Bprogeroid%252Bsyndromes%25253A%252Blessons%252Bfrom%252Bmice%252Band%252Breprogrammed%252Bcells%26aulast%3DCarrero%26aufirst%3DDido%26date%3D2016%26volume%3D9%26issue%3D7%26spage%3D719%26epage%3D735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Prati</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>, <span class="hlFld-ContribAuthor ">Maria  Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">Navigating the Chemical Space of Multitarget-Directed Ligands: From Hybrids to Fragments in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (4)
                                     , 466. <a href="https://doi.org/10.3390/molecules21040466" title="DOI URL">https://doi.org/10.3390/molecules21040466</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21040466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21040466%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNavigating%252Bthe%252BChemical%252BSpace%252Bof%252BMultitarget-Directed%252BLigands%25253A%252BFrom%252BHybrids%252Bto%252BFragments%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPrati%26aufirst%3DFederica%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D4%26spage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles H.  Williams</span>, <span class="hlFld-ContribAuthor ">Charles C.  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Zebrafish small molecule screens: Taking the phenotypic plunge. </span><span class="cited-content_cbyCitation_journal-name">Computational and Structural Biotechnology Journal</span><span> <strong>2016,</strong> <em>14 </em>, 350-356. <a href="https://doi.org/10.1016/j.csbj.2016.09.001" title="DOI URL">https://doi.org/10.1016/j.csbj.2016.09.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.csbj.2016.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.csbj.2016.09.001%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Structural%2520Biotechnology%2520Journal%26atitle%3DZebrafish%252Bsmall%252Bmolecule%252Bscreens%25253A%252BTaking%252Bthe%252Bphenotypic%252Bplunge%26aulast%3DWilliams%26aufirst%3DCharles%2BH.%26date%3D2016%26volume%3D14%26spage%3D350%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuliana E.  Salazar-Noratto</span>, <span class="hlFld-ContribAuthor ">Frank P.  Barry</span>, <span class="hlFld-ContribAuthor ">Robert E.  Guldberg</span>. </span><span class="cited-content_cbyCitation_article-title">Application of biomaterials to in vitro pluripotent stem cell disease modeling of the skeletal system. </span><span class="cited-content_cbyCitation_journal-name">Journal of Materials Chemistry B</span><span> <strong>2016,</strong> <em>4 </em>
                                    (20)
                                     , 3482-3489. <a href="https://doi.org/10.1039/C5TB02645H" title="DOI URL">https://doi.org/10.1039/C5TB02645H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5TB02645H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5TB02645H%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Materials%2520Chemistry%2520B%26atitle%3DApplication%252Bof%252Bbiomaterials%252Bto%252Bin%252Bvitro%252Bpluripotent%252Bstem%252Bcell%252Bdisease%252Bmodeling%252Bof%252Bthe%252Bskeletal%252Bsystem%26aulast%3DSalazar-Noratto%26aufirst%3DGiuliana%2BE.%26date%3D2016%26date%3D2016%26volume%3D4%26issue%3D20%26spage%3D3482%26epage%3D3489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b00789/20160804/images/medium/jm-2015-00789q_0002.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b00789/20160804/images/large/jm-2015-00789q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00789&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b00789/20160804/images/medium/jm-2015-00789q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b00789/20160804/images/large/jm-2015-00789q_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Process for generating induced pluripotent stem cells derived from patients and using them for disease modeling and phenotypic drug discovery. Induced pluripotent stem cells (iPSCs) can be generated from patient-specific somatic cells and then transformed into desired cell types by directed differentiation. Control cells can be either derived from healthy donors or generated by genetically correcting patient-specific iPSCs through targeted genome editing. These model cells can be used to study and compare phenotypes between control and diseased cells in a dish and to perform screening assays for phenotypic drug discovery. These approaches can enrich our knowledge of diseases and reveal drugs that effectively benefit patients.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b00789/20160804/images/large/jm-2015-00789q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00789&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b00789/20160804/images/medium/jm-2015-00789q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b00789/20160804/images/large/jm-2015-00789q_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b00789/20160804/images/large/jm-2015-00789q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00789&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05568" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05568" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 113 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Anighoro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rastelli, G.</span><span> </span><span class="NLM_article-title">Polypharmacology: challenges and opportunities in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7874</span><span class="NLM_x">–</span> <span class="NLM_lpage">7887</span><span class="refDoi"> DOI: 10.1021/jm5006463</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5006463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7874-7887&author=A.+Anighoroauthor=J.+Bajorathauthor=G.+Rastelli&title=Polypharmacology%3A+challenges+and+opportunities+in+drug+discovery&doi=10.1021%2Fjm5006463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology: Challenges and Opportunities in Drug Discovery</span></div><div class="casAuthors">Anighoro, Andrew; Bajorath, Jurgen; Rastelli, Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7874-7887</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  At present, the legendary magic bullet, i.e., a drug with high potency and selectivity toward a specific biol. target, shares the spotlight with an emerging and alternative polypharmacol. approach.  Polypharmacol. suggests that more effective drugs can be developed by specifically modulating multiple targets.  It is generally thought that complex diseases such as cancer and central nervous system diseases may require complex therapeutic approaches.  In this respect, a drug that "hits" multiple sensitive nodes belonging to a network of interacting targets offers the potential for higher efficacy and may limit drawbacks generally arising from the use of a single-target drug or a combination of multiple drugs.  In this review, we will compare advantages and disadvantages of multitarget vs. combination therapies, discuss potential drug promiscuity arising from off-target effects, comment on drug repurposing, and introduce approaches to the computational design of multitarget drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFOTyEu80AZrVg90H21EOLACvtfcHk0ljcUp3qiA1-3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I&md5=5ab36c961a84462d90bc25130d90a281</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm5006463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5006463%26sid%3Dliteratum%253Aachs%26aulast%3DAnighoro%26aufirst%3DA.%26aulast%3DBajorath%26aufirst%3DJ.%26aulast%3DRastelli%26aufirst%3DG.%26atitle%3DPolypharmacology%253A%2520challenges%2520and%2520opportunities%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7874%26epage%3D7887%26doi%3D10.1021%2Fjm5006463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Swinney, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, J.</span><span> </span><span class="NLM_article-title">How were new medicines discovered?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span><span class="refDoi"> DOI: 10.1038/nrd3480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnrd3480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21701501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlCmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=507-519&author=D.+C.+Swinneyauthor=J.+Anthony&title=How+were+new+medicines+discovered%3F&doi=10.1038%2Fnrd3480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">How were new medicines discovered?</span></div><div class="casAuthors">Swinney, David C.; Anthony, Jason</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">507-519</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Preclin. strategies that are used to identify potential drug candidates include target-based screening, phenotypic screening, modification of natural substances and biol.-based approaches.  To investigate whether some strategies have been more successful than others in the discovery of new drugs, we analyzed the discovery strategies and the mol. mechanism of action (MMOA) for new mol. entities and new biologics that were approved by the US Food and Drug Administration between 1999 and 2008.  Out of the 259 agents that were approved, 75 were first-in-class drugs with new MMOAs, and out of these, 50 (67%) were small mols. and 25 (33%) were biologics.  The results also show that the contribution of phenotypic screening to the discovery of first-in-class small-mol. drugs exceeded that of target-based approaches - with 28 and 17 of these drugs coming from the two approaches, resp. - in an era in which the major focus was on target-based approaches.  We postulate that a target-centric approach for first-in-class drugs, without consideration of an optimal MMOA, may contribute to the current high attrition rates and low productivity in pharmaceutical research and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE8Ah1iNz76bVg90H21EOLACvtfcHk0liDpUtjIndYDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlCmsbs%253D&md5=7503620f8fbadb0a829f6ea2029936a2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd3480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3480%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26aulast%3DAnthony%26aufirst%3DJ.%26atitle%3DHow%2520were%2520new%2520medicines%2520discovered%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D507%26epage%3D519%26doi%3D10.1038%2Fnrd3480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Wilding, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodmer, W. F.</span><span> </span><span class="NLM_article-title">Cancer cell lines for drug discovery and development</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">2377</span><span class="NLM_x">–</span> <span class="NLM_lpage">2384</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-2971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1158%2F0008-5472.CAN-13-2971" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=2377-2384&author=J.+L.+Wildingauthor=W.+F.+Bodmer&title=Cancer+cell+lines+for+drug+discovery+and+development&doi=10.1158%2F0008-5472.CAN-13-2971"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-2971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-2971%26sid%3Dliteratum%253Aachs%26aulast%3DWilding%26aufirst%3DJ.%2BL.%26aulast%3DBodmer%26aufirst%3DW.%2BF.%26atitle%3DCancer%2520cell%2520lines%2520for%2520drug%2520discovery%2520and%2520development%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D2377%26epage%3D2384%26doi%3D10.1158%2F0008-5472.CAN-13-2971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichisaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomoda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, S.</span><span> </span><span class="NLM_article-title">Induction of pluripotent stem cells from adult human fibroblasts by defined factors</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">861</span><span class="NLM_x">–</span> <span class="NLM_lpage">872</span><span class="refDoi"> DOI: 10.1016/j.cell.2007.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.cell.2007.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=18035408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCntbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=861-872&author=K.+Takahashiauthor=K.+Tanabeauthor=M.+Ohnukiauthor=M.+Naritaauthor=T.+Ichisakaauthor=K.+Tomodaauthor=S.+Yamanaka&title=Induction+of+pluripotent+stem+cells+from+adult+human+fibroblasts+by+defined+factors&doi=10.1016%2Fj.cell.2007.11.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of pluripotent stem cells from adult human fibroblasts by defined factors</span></div><div class="casAuthors">Takahashi, Kazutoshi; Tanabe, Koji; Ohnuki, Mari; Narita, Megumi; Ichisaka, Tomoko; Tomoda, Kiichiro; Yamanaka, Shinya</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">861-872</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Successful reprogramming of differentiated human somatic cells into a pluripotent state would allow creation of patient- and disease-specific stem cells.  The authors previously reported generation of induced pluripotent stem (iPS) cells, capable of germline transmission, from mouse somatic cells by transduction of four defined transcription factors.  Here, the authors demonstrate the generation of iPS cells from adult human dermal fibroblasts with the same four factors: Oct3/4, Sox2, Klf4, and c-Myc.  Human iPS cells were similar to human embryonic stem (ES) cells in morphol., proliferation, surface antigens, gene expression, epigenetic status of pluripotent cell-specific genes, and telomerase activity.  Furthermore, these cells could differentiate into cell types of the three germ layers in vitro and in teratomas.  These findings demonstrate that iPS cells can be generated from adult human fibroblasts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1iQxQ2EQuJbVg90H21EOLACvtfcHk0liDpUtjIndYDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCntbbK&md5=da3902c033f131a8cf28032cbeff1e24</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DTanabe%26aufirst%3DK.%26aulast%3DOhnuki%26aufirst%3DM.%26aulast%3DNarita%26aufirst%3DM.%26aulast%3DIchisaka%26aufirst%3DT.%26aulast%3DTomoda%26aufirst%3DK.%26aulast%3DYamanaka%26aufirst%3DS.%26atitle%3DInduction%2520of%2520pluripotent%2520stem%2520cells%2520from%2520adult%2520human%2520fibroblasts%2520by%2520defined%2520factors%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D861%26epage%3D872%26doi%3D10.1016%2Fj.cell.2007.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vodyanik, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smuga-Otto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antosiewicz-Bourget, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frane, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsdottir, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruotti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slukvin, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span> </span><span class="NLM_article-title">Induced pluripotent stem cell lines derived from human somatic cells</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1917</span><span class="NLM_x">–</span> <span class="NLM_lpage">1920</span><span class="refDoi"> DOI: 10.1126/science.1151526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1126%2Fscience.1151526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=18029452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGjsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=1917-1920&author=J.+Yuauthor=M.+A.+Vodyanikauthor=K.+Smuga-Ottoauthor=J.+Antosiewicz-Bourgetauthor=J.+L.+Franeauthor=S.+Tianauthor=J.+Nieauthor=G.+A.+Jonsdottirauthor=V.+Ruottiauthor=R.+Stewartauthor=I.+I.+Slukvinauthor=J.+A.+Thomson&title=Induced+pluripotent+stem+cell+lines+derived+from+human+somatic+cells&doi=10.1126%2Fscience.1151526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells</span></div><div class="casAuthors">Yu, Junying; Vodyanik, Maxim A.; Smuga-Otto, Kim; Antosiewicz-Bourget, Jessica; Frane, Jennifer L.; Tian, Shulan; Nie, Jeff; Jonsdottir, Gudrun A.; Ruotti, Victor; Stewart, Ron; Slukvin, Igor I.; Thomson, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">5858</span>),
    <span class="NLM_cas:pages">1917-1920</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Somatic cell nuclear transfer allows trans-acting factors present in the mammalian oocyte to reprogram somatic cell nuclei to an undifferentiated state.  We show that four factors (OCT4, SOX2, NANOG, and LIN28) are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells.  These induced pluripotent human stem cells have normal karyotypes, express telomerase activity, express cell surface markers and genes that characterize human ES cells, and maintain the developmental potential to differentiate into advanced derivs. of all three primary germ layers.  Such induced pluripotent human cell lines should be useful in the prodn. of new disease models and in drug development, as well as for applications in transplantation medicine, once tech. limitations (for example, mutation through viral integration) are eliminated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwgDWKSXh3QLVg90H21EOLACvtfcHk0liDpUtjIndYDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGjsLbN&md5=5bef3593837787a32e44303837d6444d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1151526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1151526%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DVodyanik%26aufirst%3DM.%2BA.%26aulast%3DSmuga-Otto%26aufirst%3DK.%26aulast%3DAntosiewicz-Bourget%26aufirst%3DJ.%26aulast%3DFrane%26aufirst%3DJ.%2BL.%26aulast%3DTian%26aufirst%3DS.%26aulast%3DNie%26aufirst%3DJ.%26aulast%3DJonsdottir%26aufirst%3DG.%2BA.%26aulast%3DRuotti%26aufirst%3DV.%26aulast%3DStewart%26aufirst%3DR.%26aulast%3DSlukvin%26aufirst%3DI.%2BI.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26atitle%3DInduced%2520pluripotent%2520stem%2520cell%2520lines%2520derived%2520from%2520human%2520somatic%2520cells%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D1917%26epage%3D1920%26doi%3D10.1126%2Fscience.1151526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">González, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boué, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izpisúa Belmonte, J. C.</span><span> </span><span class="NLM_article-title">Methods for making induced pluripotent stem cells: reprogramming à la carte</span> <span class="citation_source-journal">Nat. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1038/nrg2937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnrg2937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21339765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVGkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=231-242&author=F.+Gonz%C3%A1lezauthor=S.+Bou%C3%A9author=J.+C.+Izpis%C3%BAa+Belmonte&title=Methods+for+making+induced+pluripotent+stem+cells%3A+reprogramming+%C3%A0+la+carte&doi=10.1038%2Fnrg2937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Methods for making induced pluripotent stem cells: reprogramming a la carte</span></div><div class="casAuthors">Gonzalez, Federico; Boue, Stephanie; Belmonte, Juan Carlos Izpisua</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">231-242</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There are now myriad variations on techniques to reprogramme somatic cells into pluripotent stem cells, but which options should researchers choose This Review sets out the choices, focusing on how the desired downstream application should guide the reprogramming strategy.  Pluripotent stem-cell lines can be obtained through the reprogramming of somatic cells from different tissues and species by ectopic expression of defined factors.  In theory, these cells - known as induced pluripotent stem cells (iPSCs) - are suitable for various purposes, including disease modeling, autologous cell therapy, drug or toxicity screening and basic research.  Recent methodol. improvements are increasing the ease and efficiency of reprogramming, and reducing the genomic modifications required to complete the process.  However, depending on the downstream applications, certain technologies have advantages over others.  Here, we provide a comprehensive overview of the existing reprogramming approaches with the aim of providing readers with a better understanding of the reprogramming process and a basis for selecting the most suitable method for basic or clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraFE8Fhchm_LVg90H21EOLACvtfcHk0lh7dVkhpr9qKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVGkt7c%253D&md5=8802267a97cc92950b7190eac5650874</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrg2937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg2937%26sid%3Dliteratum%253Aachs%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DF.%26aulast%3DBou%25C3%25A9%26aufirst%3DS.%26aulast%3DIzpis%25C3%25BAa%2BBelmonte%26aufirst%3DJ.%2BC.%26atitle%3DMethods%2520for%2520making%2520induced%2520pluripotent%2520stem%2520cells%253A%2520reprogramming%2520%25C3%25A0%2520la%2520carte%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2011%26volume%3D12%26spage%3D231%26epage%3D242%26doi%3D10.1038%2Fnrg2937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Kim, D.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaslavsky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J.</span><span> </span><span class="NLM_article-title">Optimizing neuronal differentiation from induced pluripotent stem cells to model ASD</span> <span class="citation_source-journal">Front. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="refDoi"> DOI: 10.3389/fncel.2014.00109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.3389%2Ffncel.2014.00109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24782713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGnsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=109&author=D.-S.+Kimauthor=P.+J.+Rossauthor=K.+Zaslavskyauthor=J.+Ellis&title=Optimizing+neuronal+differentiation+from+induced+pluripotent+stem+cells+to+model+ASD&doi=10.3389%2Ffncel.2014.00109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing neuronal differentiation from induced pluripotent stem cells to model ASD</span></div><div class="casAuthors">Kim, Dae-Sung; Ross, P. Joel; Zaslavsky, Kirill; Ellis, James</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109/1-109/16, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Autism spectrum disorder (ASD) is an early-onset neurodevelopmental disorder characterized by deficits in social communication, and restricted and repetitive patterns of behavior.  Despite its high prevalence, discovery of pathophysiol. mechanisms underlying ASD has lagged due to a lack of appropriate model systems.  Recent advances in induced pluripotent stem cell (iPSC) technol. and neural differentiation techniques allow for detailed functional analyses of neurons generated from living individuals with ASD.  Refinement of cortical neuron differentiation methods from iPSCs will enable mechanistic studies of specific neuronal subpopulations that may be preferentially impaired in ASD.  In this review, we summarize recent accomplishments in differentiation of cortical neurons from human pluripotent stems cells and efforts to establish in vitro model systems to study ASD using personalized neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp12Pr3jSLWzrVg90H21EOLACvtfcHk0lh7dVkhpr9qKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGnsbvE&md5=2bbe40bee0e974e63ba8e0a220c851b8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2014.00109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2014.00109%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.-S.%26aulast%3DRoss%26aufirst%3DP.%2BJ.%26aulast%3DZaslavsky%26aufirst%3DK.%26aulast%3DEllis%26aufirst%3DJ.%26atitle%3DOptimizing%2520neuronal%2520differentiation%2520from%2520induced%2520pluripotent%2520stem%2520cells%2520to%2520model%2520ASD%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D109%26doi%3D10.3389%2Ffncel.2014.00109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Lian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azarin, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazeltine, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamp, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palecek, S. P.</span><span> </span><span class="NLM_article-title">Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">162</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span><span class="refDoi"> DOI: 10.1038/nprot.2012.150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnprot.2012.150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23257984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1KisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=162-175&author=X.+Lianauthor=J.+Zhangauthor=S.+M.+Azarinauthor=K.+Zhuauthor=L.+B.+Hazeltineauthor=X.+Baoauthor=C.+Hsiaoauthor=T.+J.+Kampauthor=S.+P.+Palecek&title=Directed+cardiomyocyte+differentiation+from+human+pluripotent+stem+cells+by+modulating+Wnt%2F%CE%B2-catenin+signaling+under+fully+defined+conditions&doi=10.1038%2Fnprot.2012.150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions</span></div><div class="casAuthors">Lian, Xiaojun; Zhang, Jianhua; Azarin, Samira M.; Zhu, Kexian; Hazeltine, Laurie B.; Bao, Xiaoping; Hsiao, Cheston; Kamp, Timothy J.; Palecek, Sean P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">162-175</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The protocol described here efficiently directs human pluripotent stem cells (hPSCs) to functional cardiomyocytes in a completely defined, growth factor- and serum-free system by temporal modulation of regulators of canonical Wnt signaling.  Appropriate temporal application of a glycogen synthase kinase 3 (GSK3) inhibitor combined with the expression of β-catenin shRNA or a chem. Wnt inhibitor is sufficient to produce a high yield (0.8-1.3 million cardiomyocytes per cm2) of virtually pure (80-98%) functional cardiomyocytes in 14 d from multiple hPSC lines without cell sorting or selection.  Qual. (immunostaining) and quant. (flow cytometry) characterization of differentiated cells is described to assess the expression of cardiac transcription factors and myofilament proteins.  Flow cytometry of BrdU incorporation or Ki67 expression in conjunction with cardiac sarcomere myosin protein expression can be used to det. the proliferative capacity of hPSC-derived cardiomyocytes.  Functional human cardiomyocytes differentiated via these protocols may constitute a potential cell source for heart disease modeling, drug screening and cell-based therapeutic applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKfgKIeSpJybVg90H21EOLACvtfcHk0ljyImWsLTkQWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1KisLk%253D&md5=e8a8e7f0ab41ce99452cb8c4562129e7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2012.150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2012.150%26sid%3Dliteratum%253Aachs%26aulast%3DLian%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAzarin%26aufirst%3DS.%2BM.%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DHazeltine%26aufirst%3DL.%2BB.%26aulast%3DBao%26aufirst%3DX.%26aulast%3DHsiao%26aufirst%3DC.%26aulast%3DKamp%26aufirst%3DT.%2BJ.%26aulast%3DPalecek%26aufirst%3DS.%2BP.%26atitle%3DDirected%2520cardiomyocyte%2520differentiation%2520from%2520human%2520pluripotent%2520stem%2520cells%2520by%2520modulating%2520Wnt%252F%25CE%25B2-catenin%2520signaling%2520under%2520fully%2520defined%2520conditions%26jtitle%3DNat.%2520Protoc.%26date%3D2013%26volume%3D8%26spage%3D162%26epage%3D175%26doi%3D10.1038%2Fnprot.2012.150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschudy-Seney, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roll, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behbahan, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahuja, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolstikov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khoobyari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolta, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willenbring, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zern, M. A.</span><span> </span><span class="NLM_article-title">Highly efficient differentiation of functional hepatocytes from human induced pluripotent stem cells</span> <span class="citation_source-journal">Stem Cells Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.5966/sctm.2012-0160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.5966%2Fsctm.2012-0160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23681950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVOktbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=409-419&author=X.+Maauthor=Y.+Duanauthor=B.+Tschudy-Seneyauthor=G.+Rollauthor=I.+S.+Behbahanauthor=T.+P.+Ahujaauthor=V.+Tolstikovauthor=C.+Wangauthor=J.+McGeeauthor=S.+Khoobyariauthor=J.+A.+Noltaauthor=H.+Willenbringauthor=M.+A.+Zern&title=Highly+efficient+differentiation+of+functional+hepatocytes+from+human+induced+pluripotent+stem+cells&doi=10.5966%2Fsctm.2012-0160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Highly efficient differentiation of functional hepatocytes from human induced pluripotent stem cells</span></div><div class="casAuthors">Ma, Xiaocui; Duan, Yuyou; Tschudy-Seney, Benjamin; Roll, Garrett; Behbahan, Iman Saramipoor; Ahuja, Tuess P.; Tolstikov, Vladimir; Wang, Charles; McGee, Jeannine; Khoobyari, Shiva; Nolta, Jan A.; Willenbring, Holger; Zern, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cells Translational Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">409-419</span>CODEN:
                <span class="NLM_cas:coden">SCTMC7</span>;
        ISSN:<span class="NLM_cas:issn">2157-6564</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">Human induced pluripotent stem cells (hiPSCs) hold great potential for use in regenerative medicine, novel drug development, and disease progression/developmental studies.  Here, we report highly efficient differentiation of hiPSCs toward a relatively homogeneous population of functional hepatocytes.  HiPSC-derived hepatocytes (hiHs) not only showed a high expression of hepatocyte-specific proteins and liver-specific functions, but they also developed a functional biotransformation system including phase I and II metabolizing enzymes and phase III transporters.  Nuclear receptors, which are crit. for regulating the expression of metabolizing enzymes, were also expressed in hiHs.  HiHs also responded to different compds./inducers of cytochrome P 450 as mature hepatocytes do.  To follow up on this observation, we analyzed the drug metabolizing capacity of hiHs in real time using a novel ultraperformance liq. chromatog.-tandem mass spectrometry.  We found that, like freshly isolated primary human hepatocytes, the seven major metabolic pathways of the drug bufuralol were found in hiHs.  In addn., transplanted hiHs engrafted, integrated, and proliferated in livers of an immune-deficient mouse model, and secreted human albumin, indicating that hiHs also function in vivo.  In conclusion, we have generated a method for the efficient generation of hepatocytes from induced pluripotent stem cells in vitro and in vivo, and it appears that the cells function similarly to primary human hepatocytes, including developing a complete metabolic function.  These results represent a significant step toward using patient/disease-specific hepatocytes for cell-based therapeutics as well as for pharmacol. and toxicol. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5XXj8lY8uArVg90H21EOLACvtfcHk0ljyImWsLTkQWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVOktbvN&md5=6b9582854d52592d09b4f21654e15704</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.5966%2Fsctm.2012-0160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5966%252Fsctm.2012-0160%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DDuan%26aufirst%3DY.%26aulast%3DTschudy-Seney%26aufirst%3DB.%26aulast%3DRoll%26aufirst%3DG.%26aulast%3DBehbahan%26aufirst%3DI.%2BS.%26aulast%3DAhuja%26aufirst%3DT.%2BP.%26aulast%3DTolstikov%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DMcGee%26aufirst%3DJ.%26aulast%3DKhoobyari%26aufirst%3DS.%26aulast%3DNolta%26aufirst%3DJ.%2BA.%26aulast%3DWillenbring%26aufirst%3DH.%26aulast%3DZern%26aufirst%3DM.%2BA.%26atitle%3DHighly%2520efficient%2520differentiation%2520of%2520functional%2520hepatocytes%2520from%2520human%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DStem%2520Cells%2520Transl.%2520Med.%26date%3D2013%26volume%3D2%26spage%3D409%26epage%3D419%26doi%3D10.5966%2Fsctm.2012-0160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Diekman, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoforou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willard, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leong, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilak, F.</span><span> </span><span class="NLM_article-title">Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">19172</span><span class="NLM_x">–</span> <span class="NLM_lpage">19177</span><span class="refDoi"> DOI: 10.1073/pnas.1210422109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1073%2Fpnas.1210422109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23115336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVagtrjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=19172-19177&author=B.+O.+Diekmanauthor=N.+Christoforouauthor=V.+P.+Willardauthor=H.+Sunauthor=J.+Sanchez-Adamsauthor=K.+W.+Leongauthor=F.+Guilak&title=Cartilage+tissue+engineering+using+differentiated+and+purified+induced+pluripotent+stem+cells&doi=10.1073%2Fpnas.1210422109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells</span></div><div class="casAuthors">Diekman, Brian O.; Christoforou, Nicolas; Willard, Vincent P.; Sun, Haosi; Sanchez-Adams, Johannah; Leong, Kam W.; Guilak, Farshid</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">19172-19177, S19172/1-S19172/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The development of regenerative therapies for cartilage injury has been greatly aided by recent advances in stem cell biol.  Induced pluripotent stem cells (iPSCs) have the potential to provide an abundant cell source for tissue engineering, as well as generating patient-matched in vitro models to study genetic and environmental factors in cartilage repair and osteoarthritis.  However, both cell therapy and modeling approaches require a purified and uniformly differentiated cell population to predictably recapitulate the physiol. characteristics of cartilage.  Here, iPSCs derived from adult mouse fibroblasts were chondrogenically differentiated and purified by type II collagen (Col2)-driven green fluorescent protein (GFP) expression.  Col2 and aggrecan gene expression levels were significantly up-regulated in GFP+ cells compared with GFP- cells and decreased with monolayer expansion.  An in vitro cartilage defect model was used to demonstrate integrative repair by GFP+ cells seeded in agarose, supporting their potential use in cartilage therapies.  In chondrogenic pellet culture, cells synthesized cartilage-specific matrix as indicated by high levels of glycosaminoglycans and type II collagen and low levels of type I and type X collagen.  The feasibility of cell expansion after initial differentiation was illustrated by homogenous matrix deposition in pellets from twice-passaged GFP+ cells.  Finally, at. force microscopy anal. showed increased microscale elastic moduli assocd. with collagen alignment at the periphery of pellets, mimicking zonal variation in native cartilage.  This study demonstrates the potential use of iPSCs for cartilage defect repair and for creating tissue models of cartilage that can be matched to specific genetic backgrounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI2gcVQL1I9bVg90H21EOLACvtfcHk0ljyImWsLTkQWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVagtrjO&md5=f888cdf3556d11efd0ce1938871e8e7f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1210422109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1210422109%26sid%3Dliteratum%253Aachs%26aulast%3DDiekman%26aufirst%3DB.%2BO.%26aulast%3DChristoforou%26aufirst%3DN.%26aulast%3DWillard%26aufirst%3DV.%2BP.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DSanchez-Adams%26aufirst%3DJ.%26aulast%3DLeong%26aufirst%3DK.%2BW.%26aulast%3DGuilak%26aufirst%3DF.%26atitle%3DCartilage%2520tissue%2520engineering%2520using%2520differentiated%2520and%2520purified%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D19172%26epage%3D19177%26doi%3D10.1073%2Fpnas.1210422109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Merkle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggan, K.</span><span> </span><span class="NLM_article-title">Modeling human disease with pluripotent stem cells: from genome association to function</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">656</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span><span class="refDoi"> DOI: 10.1016/j.stem.2013.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.stem.2013.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23746975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFOjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=656-668&author=F.+T.+Merkleauthor=K.+Eggan&title=Modeling+human+disease+with+pluripotent+stem+cells%3A+from+genome+association+to+function&doi=10.1016%2Fj.stem.2013.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling Human Disease with Pluripotent Stem Cells: from Genome Association to Function</span></div><div class="casAuthors">Merkle, Florian T.; Eggan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stem Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">656-668</span>CODEN:
                <span class="NLM_cas:coden">CSCEC4</span>;
        ISSN:<span class="NLM_cas:issn">1875-9777</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Mechanistic insights into human disease may enable the development of treatments that are effective in broad patient populations.  The confluence of gene-editing technologies, induced pluripotent stem cells, and genome-wide assocn. as well as DNA sequencing studies is enabling new approaches for illuminating the mol. basis of human disease.  We discuss the opportunities and challenges of combining these technologies and provide a workflow for interrogating the contribution of disease-assocd. candidate genetic variants to disease-relevant phenotypes.  Finally, we discuss the potential utility of human pluripotent stem cells for placing disease-assocd. genetic variants into mol. pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnjRzBTuEcZbVg90H21EOLACvtfcHk0lja21Wf_rXHFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFOjtrs%253D&md5=d35abcd12c26d92b17aa52585e5fc50c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2013.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2013.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DMerkle%26aufirst%3DF.%2BT.%26aulast%3DEggan%26aufirst%3DK.%26atitle%3DModeling%2520human%2520disease%2520with%2520pluripotent%2520stem%2520cells%253A%2520from%2520genome%2520association%2520to%2520function%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2013%26volume%3D12%26spage%3D656%26epage%3D668%26doi%3D10.1016%2Fj.stem.2013.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Sterneckert, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schöler, H. R.</span><span> </span><span class="NLM_article-title">Investigating human disease using stem cell models</span> <span class="citation_source-journal">Nat. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span><span class="refDoi"> DOI: 10.1038/nrg3764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnrg3764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=25069490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ams7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=625-639&author=J.+L.+Sterneckertauthor=P.+Reinhardtauthor=H.+R.+Sch%C3%B6ler&title=Investigating+human+disease+using+stem+cell+models&doi=10.1038%2Fnrg3764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Investigating human disease using stem cell models</span></div><div class="casAuthors">Sterneckert, Jared L.; Reinhardt, Peter; Schoeler, Hans R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">625-639</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tractable and accurate disease models are essential for understanding disease pathogenesis and for developing new therapeutics.  As stem cells are capable of self-renewal and differentiation, they are ideally suited both for generating these models and for obtaining the large quantities of cells required for drug development and transplantation therapies.  Although proof of principle for the use of adult stem cells and embryonic stem cells in disease modeling has been established, induced pluripotent stem cells (iPSCs) have demonstrated the greatest utility for modeling human diseases.  Furthermore, combining gene editing with iPSCs enables the generation of models of genetically complex disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof-24iJeeEtbVg90H21EOLACvtfcHk0lja21Wf_rXHFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ams7zN&md5=488855da74e86cae153c693c82e23e8a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrg3764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg3764%26sid%3Dliteratum%253Aachs%26aulast%3DSterneckert%26aufirst%3DJ.%2BL.%26aulast%3DReinhardt%26aufirst%3DP.%26aulast%3DSch%25C3%25B6ler%26aufirst%3DH.%2BR.%26atitle%3DInvestigating%2520human%2520disease%2520using%2520stem%2520cell%2520models%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2014%26volume%3D15%26spage%3D625%26epage%3D639%26doi%3D10.1038%2Fnrg3764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Zeng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunsberger, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeonov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, M.</span><span> </span><span class="NLM_article-title">Concise review: modeling central nervous system diseases using induced pluripotent stem cells</span> <span class="citation_source-journal">Stem Cells Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1418</span><span class="NLM_x">–</span> <span class="NLM_lpage">1428</span><span class="refDoi"> DOI: 10.5966/sctm.2014-0102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.5966%2Fsctm.2014-0102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=25368377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGis74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=1418-1428&author=X.+Zengauthor=J.+G.+Hunsbergerauthor=A.+Simeonovauthor=N.+Malikauthor=Y.+Peiauthor=M.+Rao&title=Concise+review%3A+modeling+central+nervous+system+diseases+using+induced+pluripotent+stem+cells&doi=10.5966%2Fsctm.2014-0102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Concise review: modeling central nervous system diseases using induced pluripotent stem cells</span></div><div class="casAuthors">Zeng, Xianmin; Hunsberger, Joshua G.; Simeonov, Anton; Malik, Nasir; Pei, Ying; Rao, Mahendra</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cells Translational Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1418-1428</span>CODEN:
                <span class="NLM_cas:coden">SCTMC7</span>;
        ISSN:<span class="NLM_cas:issn">2157-6564</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">A review.  Induced pluripotent stem cells (iPSCs) offer an opportunity to delve into the mechanisms underlying development while also affording the potential to take advantage of a no. of naturally occurring mutations that contribute to either disease susceptibility or resistance.  Just as with any new field, several models of screening are being explored, and innovators are working on the most efficient methods to overcome the inherent limitations of primary cell screens using iPSCs.  In the present review, we provide a background regarding why iPSCs represent a paradigm shift for central nervous system (CNS) disease modeling.  We describe the efforts in the field to develop more biol. relevant CNS disease models, which should provide screening assays useful for the pharmaceutical industry.  We also provide some examples of successful uses for iPSC-based screens and suggest that addnl. development could revolutionize the field of drug discovery.  The development and implementation of these advanced iPSC-based screens will create a more efficient disease-specific process underpinned by the biol. mechanism in a patient- and disease-specific manner rather than by trial-and-error.  Moreover, with careful and strategic planning, shared resources can be developed that will enable exponential advances in the field.  This will undoubtedly lead to more sensitive and accurate screens for early diagnosis and allow the identification of patient-specific therapies, thus, paving the way to personalized medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDVaYKRANkJrVg90H21EOLACvtfcHk0lja21Wf_rXHFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGis74%253D&md5=9fde9588bb07918b193a699e1e29e31f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.5966%2Fsctm.2014-0102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5966%252Fsctm.2014-0102%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DX.%26aulast%3DHunsberger%26aufirst%3DJ.%2BG.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DMalik%26aufirst%3DN.%26aulast%3DPei%26aufirst%3DY.%26aulast%3DRao%26aufirst%3DM.%26atitle%3DConcise%2520review%253A%2520modeling%2520central%2520nervous%2520system%2520diseases%2520using%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DStem%2520Cells%2520Transl.%2520Med.%26date%3D2014%26volume%3D3%26spage%3D1418%26epage%3D1428%26doi%3D10.5966%2Fsctm.2014-0102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Qiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeliovich, A.</span><span> </span><span class="NLM_article-title">Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">957</span><span class="NLM_x">–</span> <span class="NLM_lpage">969</span><span class="refDoi"> DOI: 10.1016/j.neuron.2013.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.neuron.2013.06.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=957-969&author=L.+Qiangauthor=R.+Fujitaauthor=A.+Abeliovich&title=Remodeling+neurodegeneration%3A+somatic+cell+reprogramming-based+models+of+adult+neurological+disorders&doi=10.1016%2Fj.neuron.2013.06.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2013.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2013.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DQiang%26aufirst%3DL.%26aulast%3DFujita%26aufirst%3DR.%26aulast%3DAbeliovich%26aufirst%3DA.%26atitle%3DRemodeling%2520neurodegeneration%253A%2520somatic%2520cell%2520reprogramming-based%2520models%2520of%2520adult%2520neurological%2520disorders%26jtitle%3DNeuron%26date%3D2013%26volume%3D78%26spage%3D957%26epage%3D969%26doi%3D10.1016%2Fj.neuron.2013.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ross, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akimov, S. S.</span><span> </span><span class="NLM_article-title">Human-induced pluripotent stem cells: potential for neurodegenerative diseases</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">R17</span><span class="NLM_x">–</span> <span class="NLM_lpage">R26</span><span class="refDoi"> DOI: 10.1093/hmg/ddu204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1093%2Fhmg%2Fddu204" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=R17-R26&author=C.+A.+Rossauthor=S.+S.+Akimov&title=Human-induced+pluripotent+stem+cells%3A+potential+for+neurodegenerative+diseases&doi=10.1093%2Fhmg%2Fddu204"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddu204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddu204%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DC.%2BA.%26aulast%3DAkimov%26aufirst%3DS.%2BS.%26atitle%3DHuman-induced%2520pluripotent%2520stem%2520cells%253A%2520potential%2520for%2520neurodegenerative%2520diseases%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2014%26volume%3D23%26spage%3DR17%26epage%3DR26%26doi%3D10.1093%2Fhmg%2Fddu204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Anderson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kichula, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rork, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, B. Y.</span><span> </span><span class="NLM_article-title">Familial Dysautonomia is caused by mutations of the IKAP gene</span> <span class="citation_source-journal">Am. J. Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">758</span><span class="refDoi"> DOI: 10.1086/318808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1086%2F318808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=11179021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD3MXit1aks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2001&pages=753-758&author=S.+L.+Andersonauthor=R.+Coliauthor=I.+W.+Dalyauthor=E.+A.+Kichulaauthor=M.+J.+Rorkauthor=S.+A.+Volpiauthor=J.+Eksteinauthor=B.+Y.+Rubin&title=Familial+Dysautonomia+is+caused+by+mutations+of+the+IKAP+gene&doi=10.1086%2F318808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Familial dysautonomia is caused by mutations of the IKAP gene</span></div><div class="casAuthors">Anderson, Sylvia L.; Coli, Rocco; Daly, Ira W.; Kichula, Elizabeth A.; Rork, Matthew J.; Volpi, Sabrina A.; Ekstein, Josef; Rubin, Berish Y.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">753-758</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">The defective gene DYS, which is responsible for familial dysautonomia (FD) and has been mapped to a 0.5-cM region on chromosome 9q31, has eluded identification.  The authors identified and characterized the RNAs encoded by this region of chromosome 9 in cell lines derived from individuals homozygous for the major FD haplotype, and the authors obsd. that the RNA encoding the IκB kinase complex-assocd. protein (IKAP) lacks exon 20 and, as a result of a frameshift, encodes a truncated protein.  Sequence anal. reveals a T→C transition in the donor splice site of intron 20.  In individuals bearing a minor FD haplotype, a missense mutation in exon 19 disrupts a consensus serine/threonine kinase phosphorylation site.  This mutation results in defective phosphorylation of IKAP.  These mutations were obsd. to be present in a random sample of Ashkenazi Jewish individuals, at approx. the predicted carrier frequency of FD.  These findings demonstrate that mutations in the gene encoding IKAP are responsible for FD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjF98Tj8RQbrVg90H21EOLACvtfcHk0liOYYIfvJTI_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXit1aks74%253D&md5=d0727b5f21efa7541c8289d09266b7d5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1086%2F318808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F318808%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DS.%2BL.%26aulast%3DColi%26aufirst%3DR.%26aulast%3DDaly%26aufirst%3DI.%2BW.%26aulast%3DKichula%26aufirst%3DE.%2BA.%26aulast%3DRork%26aufirst%3DM.%2BJ.%26aulast%3DVolpi%26aufirst%3DS.%2BA.%26aulast%3DEkstein%26aufirst%3DJ.%26aulast%3DRubin%26aufirst%3DB.%2BY.%26atitle%3DFamilial%2520Dysautonomia%2520is%2520caused%2520by%2520mutations%2520of%2520the%2520IKAP%2520gene%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2001%26volume%3D68%26spage%3D753%26epage%3D758%26doi%3D10.1086%2F318808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Lee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papapetrou, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomishima, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fasano, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganat, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadelain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studer, L.</span><span> </span><span class="NLM_article-title">Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">461</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span><span class="refDoi"> DOI: 10.1038/nature08320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature08320" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=402-406&author=G.+Leeauthor=E.+P.+Papapetrouauthor=H.+Kimauthor=S.+M.+Chambersauthor=M.+J.+Tomishimaauthor=C.+A.+Fasanoauthor=Y.+M.+Ganatauthor=J.+Menonauthor=F.+Shimizuauthor=A.+Vialeauthor=V.+Tabarauthor=M.+Sadelainauthor=L.+Studer&title=Modelling+pathogenesis+and+treatment+of+familial+dysautonomia+using+patient-specific+iPSCs&doi=10.1038%2Fnature08320"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature08320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08320%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DG.%26aulast%3DPapapetrou%26aufirst%3DE.%2BP.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DChambers%26aufirst%3DS.%2BM.%26aulast%3DTomishima%26aufirst%3DM.%2BJ.%26aulast%3DFasano%26aufirst%3DC.%2BA.%26aulast%3DGanat%26aufirst%3DY.%2BM.%26aulast%3DMenon%26aufirst%3DJ.%26aulast%3DShimizu%26aufirst%3DF.%26aulast%3DViale%26aufirst%3DA.%26aulast%3DTabar%26aufirst%3DV.%26aulast%3DSadelain%26aufirst%3DM.%26aulast%3DStuder%26aufirst%3DL.%26atitle%3DModelling%2520pathogenesis%2520and%2520treatment%2520of%2520familial%2520dysautonomia%2520using%2520patient-specific%2520iPSCs%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D402%26epage%3D406%26doi%3D10.1038%2Fnature08320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Lee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeltner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhinder, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee-Clavin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djaballah, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studer, L.</span><span> </span><span class="NLM_article-title">Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1244</span><span class="NLM_x">–</span> <span class="NLM_lpage">1248</span><span class="refDoi"> DOI: 10.1038/nbt.2435</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnbt.2435" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=1244-1248&author=G.+Leeauthor=C.+N.+Ramirezauthor=H.+Kimauthor=N.+Zeltnerauthor=B.+Liuauthor=C.+Raduauthor=B.+Bhinderauthor=Y.+J.+Kimauthor=I.+Y.+Choiauthor=B.+Mukherjee-Clavinauthor=H.+Djaballahauthor=L.+Studer&title=Large-scale+screening+using+familial+dysautonomia+induced+pluripotent+stem+cells+identifies+compounds+that+rescue+IKBKAP+expression&doi=10.1038%2Fnbt.2435"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2435%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DG.%26aulast%3DRamirez%26aufirst%3DC.%2BN.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DZeltner%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DRadu%26aufirst%3DC.%26aulast%3DBhinder%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DY.%2BJ.%26aulast%3DChoi%26aufirst%3DI.%2BY.%26aulast%3DMukherjee-Clavin%26aufirst%3DB.%26aulast%3DDjaballah%26aufirst%3DH.%26aulast%3DStuder%26aufirst%3DL.%26atitle%3DLarge-scale%2520screening%2520using%2520familial%2520dysautonomia%2520induced%2520pluripotent%2520stem%2520cells%2520identifies%2520compounds%2520that%2520rescue%2520IKBKAP%2520expression%26jtitle%3DNat.%2520Biotechnol.%26date%3D2012%26volume%3D30%26spage%3D1244%26epage%3D1248%26doi%3D10.1038%2Fnbt.2435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kolb, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissel, J. T.</span><span> </span><span class="NLM_article-title">Spinal muscular atrophy: a timely review</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">984</span><span class="refDoi"> DOI: 10.1001/archneurol.2011.74</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1001%2Farchneurol.2011.74" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21482919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A280%3ADC%252BC3MjksVKjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2011&pages=979-984&author=S.+J.+Kolbauthor=J.+T.+Kissel&title=Spinal+muscular+atrophy%3A+a+timely+review&doi=10.1001%2Farchneurol.2011.74"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Spinal muscular atrophy: a timely review</span></div><div class="casAuthors">Kolb Stephen J; Kissel John T</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">979-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Spinal muscular atrophy (SMA) is a neurodegenerative disease characterized by loss of motor neurons in the anterior horn of the spinal cord and resultant weakness.  The most common form of SMA, accounting for 95% of cases, is autosomal recessive proximal SMA associated with mutations in the survival of motor neurons (SMN1) gene.  Relentless progress during the past 15 years in the understanding of the molecular genetics and pathophysiology of SMA has resulted in a unique opportunity for rational, effective therapeutic trials.  The goal of SMA therapy is to increase the expression levels of the SMN protein in the correct cells at the right time.  With this target in sight, investigators can now effectively screen potential therapies in vitro, test them in accurate, reliable animal models, move promising agents forward to clinical trials, and accurately diagnose patients at an early or presymptomatic stage of disease.  A major challenge for the SMA community will be to prioritize and develop the most promising therapies in an efficient, timely, and safe manner with the guidance of the appropriate regulatory agencies.  This review will take a historical perspective to highlight important milestones on the road to developing effective therapies for SMA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQy90kBbekgJf69nzq6467DfW6udTcc2eaNlLAc1R9IMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjksVKjsA%253D%253D&md5=0dca2120de923052563b6d2f3905a87d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1001%2Farchneurol.2011.74&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneurol.2011.74%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DS.%2BJ.%26aulast%3DKissel%26aufirst%3DJ.%2BT.%26atitle%3DSpinal%2520muscular%2520atrophy%253A%2520a%2520timely%2520review%26jtitle%3DArch.%2520Neurol.%26date%3D2011%26volume%3D68%26spage%3D979%26epage%3D984%26doi%3D10.1001%2Farchneurol.2011.74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Ebert, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, F. F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattis, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorson, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svendsen, C. N.</span><span> </span><span class="NLM_article-title">Induced pluripotent stem cells from a spinal muscular atrophy patient</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">457</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span><span class="refDoi"> DOI: 10.1038/nature07677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature07677" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=19098894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFWnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2009&pages=277-280&author=A.+D.+Ebertauthor=J.+Yuauthor=F.+F.+Roseauthor=V.+B.+Mattisauthor=C.+L.+Lorsonauthor=J.+A.+Thomsonauthor=C.+N.+Svendsen&title=Induced+pluripotent+stem+cells+from+a+spinal+muscular+atrophy+patient&doi=10.1038%2Fnature07677"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Induced pluripotent stem cells from a spinal muscular atrophy patient</span></div><div class="casAuthors">Ebert, Allison D.; Yu, Junying; Rose, Ferrill F., Jr.; Mattis, Virginia B.; Lorson, Christian L.; Thomson, James A.; Svendsen, Clive N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">457</span>
        (<span class="NLM_cas:issue">7227</span>),
    <span class="NLM_cas:pages">277-280</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Spinal muscular atrophy is one of the most common inherited forms of neurol. disease leading to infant mortality.  Patients have selective loss of lower motor neurons resulting in muscle weakness, paralysis and often death.  Although patient fibroblasts have been used extensively to study spinal muscular atrophy, motor neurons have a unique anatomy and physiol. which may underlie their vulnerability to the disease process.  Here the authors report the generation of induced pluripotent stem cells from skin fibroblast samples taken from a child with spinal muscular atrophy.  These cells expanded robustly in culture, maintained the disease genotype and generated motor neurons that showed selective deficits compared to those derived from the child's unaffected mother.  This is the first study to show that human induced pluripotent stem cells can be used to model the specific pathol. seen in a genetically inherited disease.  As such, it represents a promising resource to study disease mechanisms, screen new drug compds. and develop new therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpITfd6GqT6_bVg90H21EOLACvtfcHk0lgb8oZgkmphYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFWnsw%253D%253D&md5=0763383c1a78f8279ec939cc13da4b18</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature07677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07677%26sid%3Dliteratum%253Aachs%26aulast%3DEbert%26aufirst%3DA.%2BD.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DRose%26aufirst%3DF.%2BF.%26aulast%3DMattis%26aufirst%3DV.%2BB.%26aulast%3DLorson%26aufirst%3DC.%2BL.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DSvendsen%26aufirst%3DC.%2BN.%26atitle%3DInduced%2520pluripotent%2520stem%2520cells%2520from%2520a%2520spinal%2520muscular%2520atrophy%2520patient%26jtitle%3DNature%26date%3D2009%26volume%3D457%26spage%3D277%26epage%3D280%26doi%3D10.1038%2Fnature07677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Amir, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Veyver, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francke, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, H. Y.</span><span> </span><span class="NLM_article-title">Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span><span class="refDoi"> DOI: 10.1038/13810</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2F13810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10508514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlOhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1999&pages=185-188&author=R.+E.+Amirauthor=I.+B.+Van+den+Veyverauthor=M.+Wanauthor=C.+Q.+Tranauthor=U.+Franckeauthor=H.+Y.+Zoghbi&title=Rett+syndrome+is+caused+by+mutations+in+X-linked+MECP2%2C+encoding+methyl-CpG-binding+protein+2&doi=10.1038%2F13810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</span></div><div class="casAuthors">Amir, Ruthie E.; Van den Veyver, Ignatia B.; Wan, Mimi; Tran, Charles Q.; Francke, Uta; Zoghbi, Huda Y.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-188</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Rett syndrome (RTT, MIM 312750) is a progressive neurodevelopmental disorder and one of the most common causes of mental retardation in females, with an incidence of 1 in 10,000-15,000.  Patients with classic RTT appear to develop normally until 6-18 mo of age, then gradually lose speech and purposeful hand use, and develop microcephaly, seizures, autism, ataxia, intermittent hyperventilation and stereotypic hand movements.  After initial regression, the condition stabilizes and patients usually survive into adulthood.  As RTT occurs almost exclusively in females, it has been proposed that RTT is caused by an X-linked dominant mutation with lethality in hemizygous males.  Previous exclusion mapping studies using RTT families mapped the locus to Xq28.  Using a systematic gene screening approach, the authors have identified mutations in the gene (MECP2) encoding X-linked methyl-CpG-binding protein 2 (MeCP2) as the cause of some cases of RTT.  MeCP2 selectively binds CpG dinucleotides in the mammalian genome and mediates transcriptional repression through interaction with histone deacetylase and the corepressor SIN3A.  In 5 of 21 sporadic patients, the authors found 3 de novo missense mutations in the region encoding the highly conserved methyl-binding domain (MBD) as well as a de novo frameshift and a de novo nonsense mutation, both of which disrupt the transcription repression domain (TRD).  In two affected half-sisters of a RTT family, the authors found segregation of an addnl. missense mutation not detected in their obligate carrier mother.  This suggests that the mother is a germline mosaic for this mutation.  The authors' study reports the first disease-causing mutations in RTT and points to abnormal epigenetic regulation as the mechanism underlying the pathogenesis of RTT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7yw7uglP4ErVg90H21EOLACvtfcHk0lgb8oZgkmphYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlOhtbo%253D&md5=ca0a168eb91cd1514c38058a1955c289</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2F13810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F13810%26sid%3Dliteratum%253Aachs%26aulast%3DAmir%26aufirst%3DR.%2BE.%26aulast%3DVan%2Bden%2BVeyver%26aufirst%3DI.%2BB.%26aulast%3DWan%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DC.%2BQ.%26aulast%3DFrancke%26aufirst%3DU.%26aulast%3DZoghbi%26aufirst%3DH.%2BY.%26atitle%3DRett%2520syndrome%2520is%2520caused%2520by%2520mutations%2520in%2520X-linked%2520MECP2%252C%2520encoding%2520methyl-CpG-binding%2520protein%25202%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D23%26spage%3D185%26epage%3D188%26doi%3D10.1038%2F13810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Chao, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenmund, C.</span><span> </span><span class="NLM_article-title">MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span><span class="refDoi"> DOI: 10.1016/j.neuron.2007.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.neuron.2007.08.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=58-65&author=H.+T.+Chaoauthor=H.+Y.+Zoghbiauthor=C.+Rosenmund&title=MeCP2+controls+excitatory+synaptic+strength+by+regulating+glutamatergic+synapse+number&doi=10.1016%2Fj.neuron.2007.08.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2007.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2007.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DChao%26aufirst%3DH.%2BT.%26aulast%3DZoghbi%26aufirst%3DH.%2BY.%26aulast%3DRosenmund%26aufirst%3DC.%26atitle%3DMeCP2%2520controls%2520excitatory%2520synaptic%2520strength%2520by%2520regulating%2520glutamatergic%2520synapse%2520number%26jtitle%3DNeuron%26date%3D2007%26volume%3D56%26spage%3D58%26epage%3D65%26doi%3D10.1016%2Fj.neuron.2007.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Marchetto, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carromeu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acab, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muotri, A. R.</span><span> </span><span class="NLM_article-title">A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">539</span><span class="refDoi"> DOI: 10.1016/j.cell.2010.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.cell.2010.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21074045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahtbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2010&pages=527-539&author=M.+C.+Marchettoauthor=C.+Carromeuauthor=A.+Acabauthor=D.+Yuauthor=G.+W.+Yeoauthor=Y.+Muauthor=G.+Chenauthor=F.+H.+Gageauthor=A.+R.+Muotri&title=A+model+for+neural+development+and+treatment+of+Rett+syndrome+using+human+induced+pluripotent+stem+cells&doi=10.1016%2Fj.cell.2010.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells</span></div><div class="casAuthors">Marchetto, Maria C. N.; Carromeu, Cassiano; Acab, Allan; Yu, Diana; Yeo, Gene W.; Mu, Yangling; Chen, Gong; Gage, Fred H.; Muotri, Alysson R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-539</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Autism spectrum disorders (ASD) are complex neurodevelopmental diseases in which different combinations of genetic mutations may contribute to the phenotype.  Using Rett syndrome (RTT) as an ASD genetic model, we developed a culture system using induced pluripotent stem cells (iPSCs) from RTT patients' fibroblasts.  RTT patients' iPSCs are able to undergo X-inactivation and generate functional neurons.  Neurons derived from RTT-iPSCs had fewer synapses, reduced spine d., smaller soma size, altered calcium signaling and electrophysiol. defects when compared to controls.  Our data uncovered early alterations in developing human RTT neurons.  Finally, we used RTT neurons to test the effects of drugs in rescuing synaptic defects.  Our data provide evidence of an unexplored developmental window, before disease onset, in RTT syndrome where potential therapies could be successfully employed.  Our model recapitulates early stages of a human neurodevelopmental disease and represents a promising cellular tool for drug screening, diagnosis and personalized treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVs6bKz90wyLVg90H21EOLACvtfcHk0lins15Dewdv5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahtbrE&md5=e65138528f9ad3678f5c8e0e0cf2d162</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetto%26aufirst%3DM.%2BC.%26aulast%3DCarromeu%26aufirst%3DC.%26aulast%3DAcab%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DYeo%26aufirst%3DG.%2BW.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGage%26aufirst%3DF.%2BH.%26aulast%3DMuotri%26aufirst%3DA.%2BR.%26atitle%3DA%2520model%2520for%2520neural%2520development%2520and%2520treatment%2520of%2520Rett%2520syndrome%2520using%2520human%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DCell%26date%3D2010%26volume%3D143%26spage%3D527%26epage%3D539%26doi%3D10.1016%2Fj.cell.2010.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Koch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breuer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jungverdorben, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesavan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poppe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladewig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tüting, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klockgether, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evert, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wüllner, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brüstle, O.</span><span> </span><span class="NLM_article-title">Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">480</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span><span class="refDoi"> DOI: 10.1038/nature10671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature10671" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=480&publication_year=2011&pages=543-546&author=P.+Kochauthor=P.+Breuerauthor=M.+Peitzauthor=J.+Jungverdorbenauthor=J.+Kesavanauthor=D.+Poppeauthor=J.+Doerrauthor=J.+Ladewigauthor=J.+Mertensauthor=T.+T%C3%BCtingauthor=P.+Hoffmannauthor=T.+Klockgetherauthor=B.+O.+Evertauthor=U.+W%C3%BCllnerauthor=O.+Br%C3%BCstle&title=Excitation-induced+ataxin-3+aggregation+in+neurons+from+patients+with+Machado-Joseph+disease&doi=10.1038%2Fnature10671"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnature10671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10671%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DP.%26aulast%3DBreuer%26aufirst%3DP.%26aulast%3DPeitz%26aufirst%3DM.%26aulast%3DJungverdorben%26aufirst%3DJ.%26aulast%3DKesavan%26aufirst%3DJ.%26aulast%3DPoppe%26aufirst%3DD.%26aulast%3DDoerr%26aufirst%3DJ.%26aulast%3DLadewig%26aufirst%3DJ.%26aulast%3DMertens%26aufirst%3DJ.%26aulast%3DT%25C3%25BCting%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DP.%26aulast%3DKlockgether%26aufirst%3DT.%26aulast%3DEvert%26aufirst%3DB.%2BO.%26aulast%3DW%25C3%25BCllner%26aufirst%3DU.%26aulast%3DBr%25C3%25BCstle%26aufirst%3DO.%26atitle%3DExcitation-induced%2520ataxin-3%2520aggregation%2520in%2520neurons%2520from%2520patients%2520with%2520Machado-Joseph%2520disease%26jtitle%3DNature%26date%3D2011%26volume%3D480%26spage%3D543%26epage%3D546%26doi%3D10.1038%2Fnature10671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Camp, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuhausen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiobech, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polloi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myles-Worsley, M.</span><span> </span><span class="NLM_article-title">Genomewide multipoint linkage analysis of seven extended Palauan pedigrees with schizophrenia, by a Markov-chain Monte Carlo method</span> <span class="citation_source-journal">Am. J. Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1278</span><span class="NLM_x">–</span> <span class="NLM_lpage">1289</span><span class="refDoi"> DOI: 10.1086/324590</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1086%2F324590" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=11668428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD38XhslShug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2001&pages=1278-1289&author=N.+J.+Campauthor=S.+L.+Neuhausenauthor=J.+Tiobechauthor=A.+Polloiauthor=H.+Coonauthor=M.+Myles-Worsley&title=Genomewide+multipoint+linkage+analysis+of+seven+extended+Palauan+pedigrees+with+schizophrenia%2C+by+a+Markov-chain+Monte+Carlo+method&doi=10.1086%2F324590"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Genomewide multipoint linkage analysis of seven extended Palauan pedigrees with schizophrenia, by a Markov-chain Monte Carlo method</span></div><div class="casAuthors">Camp, Nicola J.; Neuhausen, Susan L.; Tiobech, Josepha; Polloi, Anthony; Coon, Hilary; Myles-Worsley, Marina</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1278-1289</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Palauans are an isolated population in Micronesia with lifetime prevalence of schizophrenia (SCZD) of 2%, compared to the world rate of ∼1%.  The possible enrichment for SCZD genes, in conjunction with the potential for reduced etiol. heterogeneity and the opportunity to ascertain statistically powerful extended pedigrees, makes Palauans a population of choice for the mapping of SCZD genes.  We have used a Markov-chain Monte Carlo method to perform a genome wide multipoint anal. in 7 extended pedigrees from Palau.  Robust multipoint parametric and nonparametric linkage (NPL) analyses were performed under three nested diagnostic classifications-core, spectrum, and broad.  We obsd. four regions of interest across the genome.  Two of these regions-on chromosomes 2p13-14 (for which, under core diagnostic classification, NPL = 6.5 and parametric LOD = 4.8) and 13q12-22 (for which, under broad diagnostic classification, parametric LOD = 3.6, and, under spectrum diagnostic classification, parametric LOD = 3.5)-had evidence for linkage with genome wide significance, after correction for multiple testing; with the current pedigree resource and genotyping, these regions are estd. to be 4.3 cM and 19.75 cM in size, resp.  A 3rd region, with intermediate evidence for linkage, was identified on chromosome 5q22-qterd (for which, under broad diagnostic classification, parametric LOD = 2.5).  The fourth region of interest had only borderline suggestive evidence for linkage (on 3q24-28; for this region, under broad diagnostic classification, parametric LOD = 2.0).  All regions exhibited evidence for genetic heterogeneity.  Our findings provide significant evidence for susceptibility loci on chromosomes 2p13-14 and 13q12-22 and support both a model of genetic heterogeneity and the utility of a broader set of diagnostic classifications in the population from Palau.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa1bBLf6V0pbVg90H21EOLACvtfcHk0lins15Dewdv5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhslShug%253D%253D&md5=651209dd80bc69dfaf047bc297964768</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1086%2F324590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F324590%26sid%3Dliteratum%253Aachs%26aulast%3DCamp%26aufirst%3DN.%2BJ.%26aulast%3DNeuhausen%26aufirst%3DS.%2BL.%26aulast%3DTiobech%26aufirst%3DJ.%26aulast%3DPolloi%26aufirst%3DA.%26aulast%3DCoon%26aufirst%3DH.%26aulast%3DMyles-Worsley%26aufirst%3DM.%26atitle%3DGenomewide%2520multipoint%2520linkage%2520analysis%2520of%2520seven%2520extended%2520Palauan%2520pedigrees%2520with%2520schizophrenia%252C%2520by%2520a%2520Markov-chain%2520Monte%2520Carlo%2520method%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2001%26volume%3D69%26spage%3D1278%26epage%3D1289%26doi%3D10.1086%2F324590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Miyamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarskog, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleischhacker, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberman, J. A.</span><span> </span><span class="NLM_article-title">Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1206</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span><span class="refDoi"> DOI: 10.1038/mp.2012.47</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fmp.2012.47" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22584864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslahtrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=1206-1227&author=S.+Miyamotoauthor=N.+Miyakeauthor=L.+F.+Jarskogauthor=W.+W.+Fleischhackerauthor=J.+A.+Lieberman&title=Pharmacological+treatment+of+schizophrenia%3A+a+critical+review+of+the+pharmacology+and+clinical+effects+of+current+and+future+therapeutic+agents&doi=10.1038%2Fmp.2012.47"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents</span></div><div class="casAuthors">Miyamoto, S.; Miyake, N.; Jarskog, L. F.; Fleischhacker, W. W.; Lieberman, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1206-1227</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the introduction of chlorpromazine and throughout the development of the new-generation antipsychotic drugs (APDs) beginning with clozapine, the D2 receptor has been the target for the development of APDs.  Pharmacol. actions to reduce neurotransmission through the D2 receptor have been the only proven therapeutic mechanism for psychoses.  A no. of novel non-D2 mechanisms of action of APDs have been explored over the past 40 years but none has definitively been proven effective.  At the same time, the effectiveness of treatments and range of outcomes for patients are far from satisfactory.  The relative success of antipsychotics in treating pos. symptoms is limited by the fact that a substantial no. of patients are refractory to current medications and by their lack of efficacy for neg. and cognitive symptoms, which often det. the level of functional impairment.  In addn., while the newer antipsychotics produce fewer motor side effects, safety and tolerability concerns about wt. gain and endocrinopathies have emerged.  Consequently, there is an urgent need for more effective and better-tolerated antipsychotic agents, and to identify new mol. targets and develop mechanistically novel compds. that can address the various symptom dimensions of schizophrenia.  In recent years, a variety of new exptl. pharmacol. approaches have emerged, including compds. acting on targets other than the dopamine D2 receptor.  However, there is still an ongoing debate as to whether drugs selective for singe mol. targets (i.e., magic bullets') or drugs selectively non-selective for several mol. targets (i.e., magic shotguns', multifunctional drugs' or intramol. polypharmacy') will lead to more effective new medications for schizophrenia.  In this context, current and future drug development strategies can be seen to fall into three categories: (1) refinement of precedented mechanisms of action to provide drugs of comparable or superior efficacy and side-effect profiles to existing APDs; (2) development of novel (and presumably non-D2) mechanism APDs; (3) development of compds. to be used as adjuncts to APDs to augment efficacy by targeting specific symptom dimensions of schizophrenia and particularly those not responsive to traditional APD treatment.  In addn., efforts are being made to det. if the products of susceptibility genes in schizophrenia, identified by genetic linkage and assocn. studies, may be viable targets for drug development.  Finally, a focus on early detection and early intervention aimed at halting or reversing progressive pathophysiol. processes in schizophrenia has gained great influence.  This has encouraged future drug development and therapeutic strategies that are neuroprotective.  This article provides an update and crit. review of the pharmacol. and clin. profiles of current APDs and drugs acting on novel targets with potential to be therapeutic agents in the future.  Mol. Psychiatry (2012) 17, 1206-1227; doi:10.1038/mp.2012.47; published online 15 May 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8qXbq8buMvLVg90H21EOLACvtfcHk0lhmJ2MjJvOBkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslahtrbI&md5=f0240f40a88e012daaebd216efc438b1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fmp.2012.47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2012.47%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DS.%26aulast%3DMiyake%26aufirst%3DN.%26aulast%3DJarskog%26aufirst%3DL.%2BF.%26aulast%3DFleischhacker%26aufirst%3DW.%2BW.%26aulast%3DLieberman%26aufirst%3DJ.%2BA.%26atitle%3DPharmacological%2520treatment%2520of%2520schizophrenia%253A%2520a%2520critical%2520review%2520of%2520the%2520pharmacology%2520and%2520clinical%2520effects%2520of%2520current%2520and%2520future%2520therapeutic%2520agents%26jtitle%3DMol.%2520Psychiatry%26date%3D2012%26volume%3D17%26spage%3D1206%26epage%3D1227%26doi%3D10.1038%2Fmp.2012.47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Karlsgodt, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutkenhoff, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willhite, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Erp, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, T. D.</span><span> </span><span class="NLM_article-title">Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia</span> <span class="citation_source-journal">Dev. Psychopathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1297</span><span class="NLM_x">–</span> <span class="NLM_lpage">1327</span><span class="refDoi"> DOI: 10.1017/S095457940800062X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1017%2FS095457940800062X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=18838043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A280%3ADC%252BD1cnksFyhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2008&pages=1297-1327&author=K.+H.+Karlsgodtauthor=D.+Sunauthor=A.+M.+Jimenezauthor=E.+S.+Lutkenhoffauthor=R.+Willhiteauthor=T.+G.+Van+Erpauthor=T.+D.+Cannon&title=Developmental+disruptions+in+neural+connectivity+in+the+pathophysiology+of+schizophrenia&doi=10.1017%2FS095457940800062X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia</span></div><div class="casAuthors">Karlsgodt Katherine H; Sun Daqiang; Jimenez Amy M; Lutkenhoff Evan S; Willhite Rachael; van Erp Theo G M; Cannon Tyrone D</div><div class="citationInfo"><span class="NLM_cas:title">Development and psychopathology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1297-327</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Schizophrenia has been thought of as a disorder of reduced functional and structural connectivity.  Recent advances in neuroimaging techniques such as functional magnetic resonance imaging, structural magnetic resonance imaging, diffusion tensor imaging, and small animal imaging have advanced our ability to investigate this hypothesis.  Moreover, the power of longitudinal designs possible with these noninvasive techniques enable the study of not just how connectivity is disrupted in schizophrenia, but when this disruption emerges during development.  This article reviews genetic and neurodevelopmental influences on structural and functional connectivity in human populations with or at risk for schizophrenia and in animal models of the disorder.  We conclude that the weight of evidence across these diverse lines of inquiry points to a developmental disruption of neural connectivity in schizophrenia and that this disrupted connectivity likely involves susceptibility genes that affect processes involved in establishing intra- and interregional connectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTeIDy8YQwcWZdYoSR9eyvsfW6udTcc2eZ-UwmnUGqqH7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cnksFyhtw%253D%253D&md5=2fe8f6ad2b69d487ddc11f48f3eaed09</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1017%2FS095457940800062X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS095457940800062X%26sid%3Dliteratum%253Aachs%26aulast%3DKarlsgodt%26aufirst%3DK.%2BH.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DJimenez%26aufirst%3DA.%2BM.%26aulast%3DLutkenhoff%26aufirst%3DE.%2BS.%26aulast%3DWillhite%26aufirst%3DR.%26aulast%3DVan%2BErp%26aufirst%3DT.%2BG.%26aulast%3DCannon%26aufirst%3DT.%2BD.%26atitle%3DDevelopmental%2520disruptions%2520in%2520neural%2520connectivity%2520in%2520the%2520pathophysiology%2520of%2520schizophrenia%26jtitle%3DDev.%2520Psychopathol.%26date%3D2008%26volume%3D20%26spage%3D1297%26epage%3D1327%26doi%3D10.1017%2FS095457940800062X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Brennand, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelboin-Burkhart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sangar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, F. H.</span><span> </span><span class="NLM_article-title">Modelling schizophrenia using human induced pluripotent stem cells</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">473</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span><span class="refDoi"> DOI: 10.1038/nature09915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature09915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21490598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslCmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=473&publication_year=2011&pages=221-225&author=K.+J.+Brennandauthor=A.+Simoneauthor=J.+Jouauthor=C.+Gelboin-Burkhartauthor=N.+Tranauthor=S.+Sangarauthor=Y.+Liauthor=Y.+Muauthor=G.+Chenauthor=D.+Yuauthor=S.+McCarthyauthor=J.+Sebatauthor=F.+H.+Gage&title=Modelling+schizophrenia+using+human+induced+pluripotent+stem+cells&doi=10.1038%2Fnature09915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling schizophrenia using human induced pluripotent stem cells</span></div><div class="casAuthors">Brennand, Kristen J.; Simone, Anthony; Jou, Jessica; Gelboin-Burkhart, Chelsea; Tran, Ngoc; Sangar, Sarah; Li, Yan; Mu, Yang-Ling; Chen, Gong; Yu, Diana; McCarthy, Shane; Sebat, Jonathan; Gage, Fred H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">473</span>
        (<span class="NLM_cas:issue">7346</span>),
    <span class="NLM_cas:pages">221-225</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Schizophrenia (SCZD) is a debilitating neurol. disorder with a world-wide prevalence of 1%; there is a strong genetic component, with an estd. heritability of 80-85%.  Although post-mortem studies have revealed reduced brain vol., cell size, spine d. and abnormal neural distribution in the prefrontal cortex and hippocampus of SCZD brain tissue and neuropharmacol. studies have implicated dopaminergic, glutamatergic and GABAergic activity in SCZD, the cell types affected in SCZD and the mol. mechanisms underlying the disease state remain unclear.  To elucidate the cellular and mol. defects of SCZD, we directly reprogrammed fibroblasts from SCZD patients into human induced pluripotent stem cells (hiPSCs) and subsequently differentiated these disorder-specific hiPSCs into neurons (Supplementary Fig. 1).  SCZD hiPSC neurons showed diminished neuronal connectivity in conjunction with decreased neurite no., PSD95-protein levels and glutamate receptor expression.  Gene expression profiles of SCZD hiPSC neurons identified altered expression of many components of the cAMP and WNT signaling pathways.  Key cellular and mol. elements of the SCZD phenotype were ameliorated following treatment of SCZD hiPSC neurons with the antipsychotic loxapine.  To date, hiPSC neuronal pathol. has only been demonstrated in diseases characterized by both the loss of function of a single gene product and rapid disease progression in early childhood.  We now report hiPSC neuronal phenotypes and gene expression changes assocd. with SCZD, a complex genetic psychiatric disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjnAfLsN16LbVg90H21EOLACvtfcHk0lhmJ2MjJvOBkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslCmtbk%253D&md5=dcdd5cf2036e4ba0334693c21dd21a28</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnature09915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09915%26sid%3Dliteratum%253Aachs%26aulast%3DBrennand%26aufirst%3DK.%2BJ.%26aulast%3DSimone%26aufirst%3DA.%26aulast%3DJou%26aufirst%3DJ.%26aulast%3DGelboin-Burkhart%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DN.%26aulast%3DSangar%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DMcCarthy%26aufirst%3DS.%26aulast%3DSebat%26aufirst%3DJ.%26aulast%3DGage%26aufirst%3DF.%2BH.%26atitle%3DModelling%2520schizophrenia%2520using%2520human%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DNature%26date%3D2011%26volume%3D473%26spage%3D221%26epage%3D225%26doi%3D10.1038%2Fnature09915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Rodriguez-Murillo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogos, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karayiorgou, M.</span><span> </span><span class="NLM_article-title">The genetic architecture of schizophrenia: new mutations and emerging paradigms</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span><span class="refDoi"> DOI: 10.1146/annurev-med-072010-091100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1146%2Fannurev-med-072010-091100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2012&pages=63-80&author=L.+Rodriguez-Murilloauthor=J.+A.+Gogosauthor=M.+Karayiorgou&title=The+genetic+architecture+of+schizophrenia%3A+new+mutations+and+emerging+paradigms&doi=10.1146%2Fannurev-med-072010-091100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1146%2Fannurev-med-072010-091100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-med-072010-091100%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Murillo%26aufirst%3DL.%26aulast%3DGogos%26aufirst%3DJ.%2BA.%26aulast%3DKarayiorgou%26aufirst%3DM.%26atitle%3DThe%2520genetic%2520architecture%2520of%2520schizophrenia%253A%2520new%2520mutations%2520and%2520emerging%2520paradigms%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2012%26volume%3D63%26spage%3D63%26epage%3D80%26doi%3D10.1146%2Fannurev-med-072010-091100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Robberecht, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philips, T.</span><span> </span><span class="NLM_article-title">The changing scene of amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span><span class="refDoi"> DOI: 10.1038/nrn3430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnrn3430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23463272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsVOiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=248-264&author=W.+Robberechtauthor=T.+Philips&title=The+changing+scene+of+amyotrophic+lateral+sclerosis&doi=10.1038%2Fnrn3430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The changing scene of amyotrophic lateral sclerosis</span></div><div class="casAuthors">Robberecht, Wim; Philips, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">248-264</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Several recent breakthroughs have provided notable insights into the pathogenesis of amyotrophic lateral sclerosis (ALS), with some even shifting our thinking about this neurodegenerative disease and raising the question as to whether this disorder is a proteinopathy, a ribonucleopathy or both.  In addn., these breakthroughs have revealed mechanistic links between ALS and frontotemporal dementia, as well as between ALS and other neurodegenerative diseases, such as the cerebellar atrophies, myotonic dystrophy and inclusion body myositis.  Here, we summarize the new findings in ALS research, discuss what they have taught us about this disease and examine issues that are still outstanding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUCWEu29GwdLVg90H21EOLACvtfcHk0liepi1TBDBsGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsVOiur4%253D&md5=def3da74cf76bde78ecc1fa9eed87a74</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrn3430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3430%26sid%3Dliteratum%253Aachs%26aulast%3DRobberecht%26aufirst%3DW.%26aulast%3DPhilips%26aufirst%3DT.%26atitle%3DThe%2520changing%2520scene%2520of%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D248%26epage%3D264%26doi%3D10.1038%2Fnrn3430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigio, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesulam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fushimi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. Y.</span><span> </span><span class="NLM_article-title">An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">822</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span><span class="refDoi"> DOI: 10.1038/nsmb.2053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnsmb.2053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21666678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVWqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=822-830&author=W.+Guoauthor=Y.+Chenauthor=X.+Zhouauthor=A.+Karauthor=P.+Rayauthor=X.+Chenauthor=E.+J.+Raoauthor=M.+Yangauthor=H.+Yeauthor=L.+Zhuauthor=J.+Liuauthor=M.+Xuauthor=Y.+Yangauthor=C.+Wangauthor=D.+Zhangauthor=E.+H.+Bigioauthor=M.+Mesulamauthor=Y.+Shenauthor=Q.+Xuauthor=K.+Fushimiauthor=J.+Y.+Wu&title=An+ALS-associated+mutation+affecting+TDP-43+enhances+protein+aggregation%2C+fibril+formation+and+neurotoxicity&doi=10.1038%2Fnsmb.2053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity</span></div><div class="casAuthors">Guo, Weirui; Chen, Yanbo; Zhou, Xiaohong; Kar, Amar; Ray, Payal; Chen, Xiaoping; Rao, Elizabeth J.; Yang, Mengxue; Ye, Haihong; Zhu, Li; Liu, Jianghong; Xu, Meng; Yang, Yanlian; Wang, Chen; Zhang, David; Bigio, Eileen H.; Mesulam, Marsel; Shen, Yan; Xu, Qi; Fushimi, Kazuo; Wu, Jane Y.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">822-830</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in TARDBP, encoding TAR DNA-binding protein-43 (TDP-43), are assocd. with TDP-43 proteinopathies, including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD).  We compared wild-type TDP-43 and an ALS-assocd. mutant TDP-43 in vitro and in vivo.  The A315T mutant enhances neurotoxicity and the formation of aberrant TDP-43 species, including protease-resistant fragments.  The C-terminus of TDP-43 shows sequence similarity to prion proteins.  Synthetic peptides flanking residue 315 form amyloid fibrils in vitro and cause neuronal death in primary cultures.  These data provide evidence for biochem. similarities between TDP-43 and prion proteins, raising the possibility that TDP-43 derivs. may cause spreading of the disease phenotype among neighboring neurons.  Our work also suggests that decreasing the abundance of neurotoxic TDP-43 species, enhancing degrdn. or clearance of such TDP-43 derivs. and blocking the spread of the disease phenotype may have therapeutic potential for TDP-43 proteinopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs0RuzmtnWW7Vg90H21EOLACvtfcHk0liepi1TBDBsGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVWqtLY%253D&md5=d0e763411d1402b6da1e2f596e50bdc9</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2053%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DKar%26aufirst%3DA.%26aulast%3DRay%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DRao%26aufirst%3DE.%2BJ.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DBigio%26aufirst%3DE.%2BH.%26aulast%3DMesulam%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DFushimi%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DJ.%2BY.%26atitle%3DAn%2520ALS-associated%2520mutation%2520affecting%2520TDP-43%2520enhances%2520protein%2520aggregation%252C%2520fibril%2520formation%2520and%2520neurotoxicity%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D822%26epage%3D830%26doi%3D10.1038%2Fnsmb.2053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Egawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitaoka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naitoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asaka, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morizane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamawaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hioki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamaoka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakahata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetto, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, H.</span><span> </span><span class="NLM_article-title">Drug screening for ALS using patient-specific induced pluripotent stem cells</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">145ra104</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3004052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1126%2Fscitranslmed.3004052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22855461" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=145ra104&author=N.+Egawaauthor=S.+Kitaokaauthor=K.+Tsukitaauthor=M.+Naitohauthor=K.+Takahashiauthor=T.+Yamamotoauthor=F.+Adachiauthor=T.+Kondoauthor=K.+Okitaauthor=I.+Asakaauthor=T.+Aoiauthor=A.+Watanabeauthor=Y.+Yamadaauthor=A.+Morizaneauthor=J.+Takahashiauthor=T.+Ayakiauthor=H.+Itoauthor=K.+Yoshikawaauthor=S.+Yamawakiauthor=S.+Suzukiauthor=D.+Watanabeauthor=H.+Hiokiauthor=T.+Kanekoauthor=K.+Makiokaauthor=K.+Okamotoauthor=H.+Takumaauthor=A.+Tamaokaauthor=K.+Hasegawaauthor=T.+Nonakaauthor=M.+Hasegawaauthor=A.+Kawataauthor=M.+Yoshidaauthor=T.+Nakahataauthor=R.+Takahashiauthor=M.+C.+Marchettoauthor=F.+H.+Gageauthor=S.+Yamanakaauthor=H.+Inoue&title=Drug+screening+for+ALS+using+patient-specific+induced+pluripotent+stem+cells&doi=10.1126%2Fscitranslmed.3004052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3004052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3004052%26sid%3Dliteratum%253Aachs%26aulast%3DEgawa%26aufirst%3DN.%26aulast%3DKitaoka%26aufirst%3DS.%26aulast%3DTsukita%26aufirst%3DK.%26aulast%3DNaitoh%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DAdachi%26aufirst%3DF.%26aulast%3DKondo%26aufirst%3DT.%26aulast%3DOkita%26aufirst%3DK.%26aulast%3DAsaka%26aufirst%3DI.%26aulast%3DAoi%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DMorizane%26aufirst%3DA.%26aulast%3DTakahashi%26aufirst%3DJ.%26aulast%3DAyaki%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DYoshikawa%26aufirst%3DK.%26aulast%3DYamawaki%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DD.%26aulast%3DHioki%26aufirst%3DH.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DMakioka%26aufirst%3DK.%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DTakuma%26aufirst%3DH.%26aulast%3DTamaoka%26aufirst%3DA.%26aulast%3DHasegawa%26aufirst%3DK.%26aulast%3DNonaka%26aufirst%3DT.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DKawata%26aufirst%3DA.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DNakahata%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DMarchetto%26aufirst%3DM.%2BC.%26aulast%3DGage%26aufirst%3DF.%2BH.%26aulast%3DYamanaka%26aufirst%3DS.%26aulast%3DInoue%26aufirst%3DH.%26atitle%3DDrug%2520screening%2520for%2520ALS%2520using%2520patient-specific%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D145ra104%26doi%3D10.1126%2Fscitranslmed.3004052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Strong, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesavapany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pant, H. C.</span><span> </span><span class="NLM_article-title">The pathobiology of amyotrophic lateral sclerosis: a proteinopathy?</span> <span class="citation_source-journal">J. Neuropathol. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">649</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span><span class="refDoi"> DOI: 10.1097/01.jnen.0000173889.71434.ea</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1097%2F01.jnen.0000173889.71434.ea" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=16106213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVemsL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2005&pages=649-664&author=M.+J.+Strongauthor=S.+Kesavapanyauthor=H.+C.+Pant&title=The+pathobiology+of+amyotrophic+lateral+sclerosis%3A+a+proteinopathy%3F&doi=10.1097%2F01.jnen.0000173889.71434.ea"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The pathobiology of amyotrophic lateral sclerosis: a proteinopathy?</span></div><div class="casAuthors">Strong, Michael J.; Kesavapany, Sashi; Pant, Harish C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology & Experimental Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">649-664</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Amyotrophic lateral sclerosis (ALS) is increasingly considered to be a disorder of multiple etiologies that have in common progressive degeneration of both upper and lower motor neurons, ultimately giving rise to a relentless loss of muscle function.  This progressive degeneration is assocd. with heightened levels of oxidative injury, excitotoxicity, and mitochondrial dysfunction-all occurring concurrently.  In this article, we review the evidence that suggests, in common with other age-dependent neurodegenerative disorders, that ALS can be considered a disorder of protein aggregation.  Morphol., this is evident as Bunina bodies, ubiquitin-immunoreactive fibrils or aggregates, neurofilamentous aggregates, mutant copper/zinc superoxide dismutase (SOD1) aggregates in familial ALS variants harboring mutations in SOD1, peripherin-immunoreactive aggregates within spinal motor neurons and as neuroaxonal spheroids, and in an increasingly greater population of patients with ALS with cognitive impairment, both intra- and extraneuronal tau aggregates.  We review the evidence that somatotopically specific patterns of altered kinase and phosphatase activity are assocd. with alterations in the phosphorylation state of these proteins, altering either soly. or assembly characteristics.  The role of nonneuronal cells in mediating motor neuronal injury is discussed in the context of alterations in tyrosine kinase activity and enhanced protein phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWAmzTh9eWX7Vg90H21EOLACvtfcHk0lgJJ9TVsKPbBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVemsL3K&md5=af483a63c7b9cadd240094ad93eea93e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1097%2F01.jnen.0000173889.71434.ea&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.jnen.0000173889.71434.ea%26sid%3Dliteratum%253Aachs%26aulast%3DStrong%26aufirst%3DM.%2BJ.%26aulast%3DKesavapany%26aufirst%3DS.%26aulast%3DPant%26aufirst%3DH.%2BC.%26atitle%3DThe%2520pathobiology%2520of%2520amyotrophic%2520lateral%2520sclerosis%253A%2520a%2520proteinopathy%253F%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2005%26volume%3D64%26spage%3D649%26epage%3D664%26doi%3D10.1097%2F01.jnen.0000173889.71434.ea" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Yang, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerqueira, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainger, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosowski, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schein, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackeifi, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arvanites, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidow, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, L. L.</span><span> </span><span class="NLM_article-title">A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">713</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span><span class="refDoi"> DOI: 10.1016/j.stem.2013.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.stem.2013.04.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=713-726&author=Y.+M.+Yangauthor=S.+K.+Guptaauthor=K.+J.+Kimauthor=B.+E.+Powersauthor=A.+Cerqueiraauthor=B.+J.+Waingerauthor=H.+D.+Ngoauthor=K.+A.+Rosowskiauthor=P.+A.+Scheinauthor=C.+A.+Ackeifiauthor=A.+C.+Arvanitesauthor=L.+S.+Davidowauthor=C.+J.+Woolfauthor=L.+L.+Rubin&title=A+small+molecule+screen+in+stem-cell-derived+motor+neurons+identifies+a+kinase+inhibitor+as+a+candidate+therapeutic+for+ALS&doi=10.1016%2Fj.stem.2013.04.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2013.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2013.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%2BM.%26aulast%3DGupta%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DK.%2BJ.%26aulast%3DPowers%26aufirst%3DB.%2BE.%26aulast%3DCerqueira%26aufirst%3DA.%26aulast%3DWainger%26aufirst%3DB.%2BJ.%26aulast%3DNgo%26aufirst%3DH.%2BD.%26aulast%3DRosowski%26aufirst%3DK.%2BA.%26aulast%3DSchein%26aufirst%3DP.%2BA.%26aulast%3DAckeifi%26aufirst%3DC.%2BA.%26aulast%3DArvanites%26aufirst%3DA.%2BC.%26aulast%3DDavidow%26aufirst%3DL.%2BS.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26atitle%3DA%2520small%2520molecule%2520screen%2520in%2520stem-cell-derived%2520motor%2520neurons%2520identifies%2520a%2520kinase%2520inhibitor%2520as%2520a%2520candidate%2520therapeutic%2520for%2520ALS%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2013%26volume%3D12%26spage%3D713%26epage%3D726%26doi%3D10.1016%2Fj.stem.2013.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Burkhardt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volfson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lievers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoukat-Mumtaz, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grskovic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irion, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bright, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griswold-Prenner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javaherian, A.</span><span> </span><span class="NLM_article-title">A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1016/j.mcn.2013.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.mcn.2013.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23891805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCit7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=355-364&author=M.+F.+Burkhardtauthor=F.+J.+Martinezauthor=S.+Wrightauthor=C.+Ramosauthor=D.+Volfsonauthor=M.+Masonauthor=J.+Garnesauthor=V.+Dangauthor=J.+Lieversauthor=U.+Shoukat-Mumtazauthor=R.+Martinezauthor=H.+Gaiauthor=R.+Blakeauthor=E.+Vaisbergauthor=M.+Grskovicauthor=C.+Johnsonauthor=S.+Irionauthor=J.+Brightauthor=B.+Cooperauthor=L.+Nguyenauthor=I.+Griswold-Prennerauthor=A.+Javaherian&title=A+cellular+model+for+sporadic+ALS+using+patient-derived+induced+pluripotent+stem+cells&doi=10.1016%2Fj.mcn.2013.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells</span></div><div class="casAuthors">Burkhardt, Matthew F.; Martinez, Fernando J.; Wright, Sarah; Ramos, Carla; Volfson, Dmitri; Mason, Michael; Garnes, Jeff; Dang, Vu; Lievers, Jeffery; Shoukat-Mumtaz, Uzma; Martinez, Rita; Gai, Hui; Blake, Robert; Vaisberg, Eugeni; Grskovic, Marica; Johnson, Charles; Irion, Stefan; Bright, Jessica; Cooper, Bonnie; Nguyen, Leane; Griswold-Prenner, Irene; Javaherian, Ashkan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">355-364</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Development of therapeutics for genetically complex neurodegenerative diseases such as sporadic amyotrophic lateral sclerosis (ALS) has largely been hampered by lack of relevant disease models.  Reprogramming of sporadic ALS patients' fibroblasts into induced pluripotent stem cells (iPSC) and differentiation into affected neurons that show a disease phenotype could provide a cellular model for disease mechanism studies and drug discovery.  Here we report the reprogramming to pluripotency of fibroblasts from a large cohort of healthy controls and ALS patients and their differentiation into motor neurons.  We demonstrate that motor neurons derived from three sALS patients show de novo TDP-43 aggregation and that the aggregates recapitulate pathol. in postmortem tissue from one of the same patients from which the iPSC were derived.  We configured a high-content chem. screen using the TDP-43 aggregate endpoint both in lower motor neurons and upper motor neuron like cells and identified FDA-approved small mol. modulators including Digoxin demonstrating the feasibility of patient-derived iPSC-based disease modeling for drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-15aZvERjwbVg90H21EOLACvtfcHk0ligcMPjAFUiUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCit7vE&md5=fabc97dd02cb4c29d33e8fbee1b7c882</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2013.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2013.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DBurkhardt%26aufirst%3DM.%2BF.%26aulast%3DMartinez%26aufirst%3DF.%2BJ.%26aulast%3DWright%26aufirst%3DS.%26aulast%3DRamos%26aufirst%3DC.%26aulast%3DVolfson%26aufirst%3DD.%26aulast%3DMason%26aufirst%3DM.%26aulast%3DGarnes%26aufirst%3DJ.%26aulast%3DDang%26aufirst%3DV.%26aulast%3DLievers%26aufirst%3DJ.%26aulast%3DShoukat-Mumtaz%26aufirst%3DU.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DGai%26aufirst%3DH.%26aulast%3DBlake%26aufirst%3DR.%26aulast%3DVaisberg%26aufirst%3DE.%26aulast%3DGrskovic%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DC.%26aulast%3DIrion%26aufirst%3DS.%26aulast%3DBright%26aufirst%3DJ.%26aulast%3DCooper%26aufirst%3DB.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DGriswold-Prenner%26aufirst%3DI.%26aulast%3DJavaherian%26aufirst%3DA.%26atitle%3DA%2520cellular%2520model%2520for%2520sporadic%2520ALS%2520using%2520patient-derived%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2013%26volume%3D56%26spage%3D355%26epage%3D364%26doi%3D10.1016%2Fj.mcn.2013.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Pasinelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. H.</span><span> </span><span class="NLM_article-title">Molecular biology of amyotrophic lateral sclerosis: insights from genetics</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span><span class="refDoi"> DOI: 10.1038/nrn1971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnrn1971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=16924260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlCgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=710-723&author=P.+Pasinelliauthor=R.+H.+Brown&title=Molecular+biology+of+amyotrophic+lateral+sclerosis%3A+insights+from+genetics&doi=10.1038%2Fnrn1971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular biology of amyotrophic lateral sclerosis: insights from genetics</span></div><div class="casAuthors">Pasinelli, Piera; Brown, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">710-723</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Amyotrophic lateral sclerosis (ALS) is a paralytic disorder caused by motor neuron degeneration.  Mutations in more than 50 human genes cause diverse types of motor neuron pathol.  Moreover, defects in five Mendelian genes lead to motor neuron disease, with two mutations reproducing the ALS phenotype.  Analyses of these genetic effects have generated new insights into the diverse mol. pathways involved in ALS pathogenesis.  Here, we present an overview of the mechanisms for motor neuron death and of the role of non-neuronal cells in ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGeL8ButRoa7Vg90H21EOLACvtfcHk0ligcMPjAFUiUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlCgtro%253D&md5=0c023f607f81378751f0b2c3cd8310f7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnrn1971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1971%26sid%3Dliteratum%253Aachs%26aulast%3DPasinelli%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DR.%2BH.%26atitle%3DMolecular%2520biology%2520of%2520amyotrophic%2520lateral%2520sclerosis%253A%2520insights%2520from%2520genetics%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D710%26epage%3D723%26doi%3D10.1038%2Fnrn1971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Cleveland, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothstein, J. D.</span><span> </span><span class="NLM_article-title">From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">806</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span><span class="refDoi"> DOI: 10.1038/35097565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2F35097565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=11715057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmt1WitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=806-819&author=D.+W.+Clevelandauthor=J.+D.+Rothstein&title=From+Charcot+to+Lou+Gehrig%3A+deciphering+selective+motor+neuron+death+in+ALS&doi=10.1038%2F35097565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS</span></div><div class="casAuthors">Cleveland, Don W.; Rothstein, Jeffrey D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">806-819</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since its description by Charcot more than 130 yr ago, the mechanism underlying the characteristic selective degeneration and death of motor neurons in amyotrophic lateral sclerosis has remained a mystery.  Modern genetics has now identified mutations in two genes, SOD1 and ALS2, as primary causes of the disease, and has implicated others as potential contributors.  Insights into these abnormalities, together with errors in the handling of synaptic glutamate and the potential excitotoxic response that this alteration provokes, have provided leads for the development of new strategies to identify an as yet elusive remedy for this progressive, fatal disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprMhUigZJiOLVg90H21EOLACvtfcHk0ligcMPjAFUiUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmt1WitLs%253D&md5=503e3cc792616168c18f412977475664</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2F35097565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35097565%26sid%3Dliteratum%253Aachs%26aulast%3DCleveland%26aufirst%3DD.%2BW.%26aulast%3DRothstein%26aufirst%3DJ.%2BD.%26atitle%3DFrom%2520Charcot%2520to%2520Lou%2520Gehrig%253A%2520deciphering%2520selective%2520motor%2520neuron%2520death%2520in%2520ALS%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2001%26volume%3D2%26spage%3D806%26epage%3D819%26doi%3D10.1038%2F35097565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Wainger, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiskinis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiskow, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandoe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulting, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cudkowicz, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bean, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, C. J.</span><span> </span><span class="NLM_article-title">Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1016/j.celrep.2014.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.celrep.2014.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24703839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1egsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=1-11&author=B.+J.+Waingerauthor=E.+Kiskinisauthor=C.+Mellinauthor=O.+Wiskowauthor=S.+S.+Hanauthor=J.+Sandoeauthor=N.+P.+Perezauthor=L.+A.+Williamsauthor=S.+Leeauthor=G.+Boultingauthor=J.+D.+Berryauthor=R.+H.+Brownauthor=M.+E.+Cudkowiczauthor=B.+P.+Beanauthor=K.+Egganauthor=C.+J.+Woolf&title=Intrinsic+membrane+hyperexcitability+of+amyotrophic+lateral+sclerosis+patient-derived+motor+neurons&doi=10.1016%2Fj.celrep.2014.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons</span></div><div class="casAuthors">Wainger, Brian J.; Kiskinis, Evangelos; Mellin, Cassidy; Wiskow, Ole; Han, Steve S. W.; Sandoe, Jackson; Perez, Numa P.; Williams, Luis A.; Lee, Seungkyu; Boulting, Gabriella; Berry, James D.; Brown, Robert H.; Cudkowicz, Merit E.; Bean, Bruce P.; Eggan, Kevin; Woolf, Clifford J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease of the motor nervous system.  We show using multielectrode array and patch-clamp recordings that hyperexcitability detected by clin. neurophysiol. studies of ALS patients is recapitulated in induced pluripotent stem cell-derived motor neurons from ALS patients harboring superoxide dismutase 1 (SOD1), C9orf72, and fused-in-sarcoma mutations.  Motor neurons produced from a genetically cor. but otherwise isogenic SOD1+/+ stem cell line do not display the hyperexcitability phenotype.  SOD1A4V/+ ALS patient-derived motor neurons have reduced delayed-rectifier potassium current amplitudes relative to control-derived motor neurons, a deficit that may underlie their hyperexcitability.  The Kv7 channel activator retigabine both blocks the hyperexcitability and improves motor neuron survival in vitro when tested in SOD1 mutant ALS cases.  Therefore, electrophysiol. characterization of human stem cell-derived neurons can reveal disease-related mechanisms and identify therapeutic candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhZaC_0cXv57Vg90H21EOLACvtfcHk0lj_pFl5qsldrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1egsbk%253D&md5=aaf70b5f2825003ddd049a13840e64a5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DWainger%26aufirst%3DB.%2BJ.%26aulast%3DKiskinis%26aufirst%3DE.%26aulast%3DMellin%26aufirst%3DC.%26aulast%3DWiskow%26aufirst%3DO.%26aulast%3DHan%26aufirst%3DS.%2BS.%26aulast%3DSandoe%26aufirst%3DJ.%26aulast%3DPerez%26aufirst%3DN.%2BP.%26aulast%3DWilliams%26aufirst%3DL.%2BA.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DBoulting%26aufirst%3DG.%26aulast%3DBerry%26aufirst%3DJ.%2BD.%26aulast%3DBrown%26aufirst%3DR.%2BH.%26aulast%3DCudkowicz%26aufirst%3DM.%2BE.%26aulast%3DBean%26aufirst%3DB.%2BP.%26aulast%3DEggan%26aufirst%3DK.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26atitle%3DIntrinsic%2520membrane%2520hyperexcitability%2520of%2520amyotrophic%2520lateral%2520sclerosis%2520patient-derived%2520motor%2520neurons%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D7%26spage%3D1%26epage%3D11%26doi%3D10.1016%2Fj.celrep.2014.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">de Lau, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breteler, M. M.</span><span> </span><span class="NLM_article-title">Epidemiology of Parkinson’s disease</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">535</span><span class="refDoi"> DOI: 10.1016/S1474-4422(06)70471-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2FS1474-4422%2806%2970471-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=16713924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A280%3ADC%252BD283osVehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=525-535&author=L.+M.+de+Lauauthor=M.+M.+Breteler&title=Epidemiology+of+Parkinson%E2%80%99s+disease&doi=10.1016%2FS1474-4422%2806%2970471-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology of Parkinson's disease</span></div><div class="casAuthors">de Lau Lonneke M L; Breteler Monique M B</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">525-35</span>
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    </div><div class="casAbstract">The causes of Parkinson's disease (PD), the second most common neurodegenerative disorder, are still largely unknown.  Current thinking is that major gene mutations cause only a small proportion of all cases and that in most cases, non-genetic factors play a part, probably in interaction with susceptibility genes.  Numerous epidemiological studies have been done to identify such non-genetic risk factors, but most were small and methodologically limited.  Larger, well-designed prospective cohort studies have only recently reached a stage at which they have enough incident patients and person-years of follow-up to investigate possible risk factors and their interactions.  In this article, we review what is known about the prevalence, incidence, risk factors, and prognosis of PD from epidemiological studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcREGHHqwISPvJVVjGoY74BafW6udTcc2eZiZ1sE0Zbce7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD283osVehtg%253D%253D&md5=2c22b5eb8ff98db0a23d568123adea4b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2806%2970471-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252806%252970471-9%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLau%26aufirst%3DL.%2BM.%26aulast%3DBreteler%26aufirst%3DM.%2BM.%26atitle%3DEpidemiology%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DLancet%2520Neurol.%26date%3D2006%26volume%3D5%26spage%3D525%26epage%3D535%26doi%3D10.1016%2FS1474-4422%2806%2970471-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Connolly, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, A. E.</span><span> </span><span class="NLM_article-title">Pharmacological treatment of Parkinson disease: a review</span> <span class="citation_source-journal">J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">1670</span><span class="NLM_x">–</span> <span class="NLM_lpage">1683</span><span class="refDoi"> DOI: 10.1001/jama.2014.3654</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1001%2Fjama.2014.3654" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24756517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFems7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2014&pages=1670-1683&author=B.+S.+Connollyauthor=A.+E.+Lang&title=Pharmacological+treatment+of+Parkinson+disease%3A+a+review&doi=10.1001%2Fjama.2014.3654"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological treatment of Parkinson disease: a review</span></div><div class="casAuthors">Connolly, Barbara S.; Lang, Anthony E.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1670-1683, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">1538-3598</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">A review.  Importance: Parkinson disease is the second most common neurodegenerative disease worldwide.  Although no available therapies alter the underlying neurodegenerative process, symptomatic therapies can improve patient quality of life.  Objective: To provide an evidence-based review of the initial pharmacol. management of the classic motor symptoms of Parkinson disease; describe management of medication-related motor complications (such as motor fluctuations and dyskinesia), and other medication adverse effects (nausea, psychosis, and impulse control disorders and related behaviors); and discuss the management of selected nonmotor symptoms of Parkinson disease, including rapid eye movement sleep behavior disorder, cognitive impairment, depression, orthostatic hypotension, and sialorrhea.  Evidence Review: Refs. were identified using searches of PubMed between Jan. 1985 and Feb. 2014 for English-language human studies and the full database of the Cochrane Library.  The classification of studies by quality (classes I-IV) was assessed using the levels of evidence guidelines from the American Academy of Neurol. and the highest-quality data for each topic.  Results: Although levodopa is the most effective medication available for treating the motor symptoms of Parkinson disease, in certain instances (eg, mild symptoms, tremor as the only or most prominent symptom, aged <60 years) other medications (eg, monoamine oxidase type B inhibitors [MAOBIs], amantadine, anticholinergics, β-blockers, or dopamine agonists) may be initiated first to avoid levodopa-related motor complications.  Motor fluctuations may be managed by modifying the levodopa dosing regimen or by adding several other medications, such as MAOBIs, catechol-O-methyltransferase inhibitors, or dopamine agonists.  Impulse control disorders are typically managed by reducing or withdrawing dopaminergic medication, particularly dopamine agonists.  Evidence-based management of some nonmotor symptoms is limited by a paucity of high-quality pos. studies.  Conclusions and Relevance: Strong evidence supports using levodopa and dopamine agonists for motor symptoms at all stages of Parkinson disease.  Dopamine agonists and drugs that block dopamine metab. are effective for motor fluctuations and clozapine is effective for hallucinations.  Cholinesterase inhibitors may improve symptoms of dementia and antidepressants and pramipexole may improve depression.  Evidence supporting other therapies for motor and nonmotor features is less well established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq4bHOyyI7XrVg90H21EOLACvtfcHk0lj_pFl5qsldrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFems7rP&md5=a3faf879f5febdfc11a8992db89f2e67</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1001%2Fjama.2014.3654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2014.3654%26sid%3Dliteratum%253Aachs%26aulast%3DConnolly%26aufirst%3DB.%2BS.%26aulast%3DLang%26aufirst%3DA.%2BE.%26atitle%3DPharmacological%2520treatment%2520of%2520Parkinson%2520disease%253A%2520a%2520review%26jtitle%3DJ.%2520Am.%2520Med.%2520Assoc.%26date%3D2014%26volume%3D311%26spage%3D1670%26epage%3D1683%26doi%3D10.1001%2Fjama.2014.3654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Hall, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landeck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bye, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leanza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Double, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halliday, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirik, D.</span><span> </span><span class="NLM_article-title">Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson’s disease</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">2493</span><span class="NLM_x">–</span> <span class="NLM_lpage">2508</span><span class="refDoi"> DOI: 10.1093/brain/awu193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1093%2Fbrain%2Fawu193" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2014&pages=2493-2508&author=H.+Hallauthor=S.+Reyesauthor=N.+Landeckauthor=C.+Byeauthor=G.+Leanzaauthor=K.+Doubleauthor=L.+Thompsonauthor=G.+Hallidayauthor=D.+Kirik&title=Hippocampal+Lewy+pathology+and+cholinergic+dysfunction+are+associated+with+dementia+in+Parkinson%E2%80%99s+disease&doi=10.1093%2Fbrain%2Fawu193"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawu193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawu193%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DH.%26aulast%3DReyes%26aufirst%3DS.%26aulast%3DLandeck%26aufirst%3DN.%26aulast%3DBye%26aufirst%3DC.%26aulast%3DLeanza%26aufirst%3DG.%26aulast%3DDouble%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DL.%26aulast%3DHalliday%26aufirst%3DG.%26aulast%3DKirik%26aufirst%3DD.%26atitle%3DHippocampal%2520Lewy%2520pathology%2520and%2520cholinergic%2520dysfunction%2520are%2520associated%2520with%2520dementia%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBrain%26date%3D2014%26volume%3D137%26spage%3D2493%26epage%3D2508%26doi%3D10.1093%2Fbrain%2Fawu193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Exner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutz, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winklhofer, K. F.</span><span> </span><span class="NLM_article-title">Mitochondrial dysfunction in Parkinson’s disease: molecular mechanisms and pathophysiological consequences</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">3038</span><span class="NLM_x">–</span> <span class="NLM_lpage">3062</span><span class="refDoi"> DOI: 10.1038/emboj.2012.170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Femboj.2012.170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22735187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpt1SgsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=3038-3062&author=N.+Exnerauthor=A.+K.+Lutzauthor=C.+Haassauthor=K.+F.+Winklhofer&title=Mitochondrial+dysfunction+in+Parkinson%E2%80%99s+disease%3A+molecular+mechanisms+and+pathophysiological+consequences&doi=10.1038%2Femboj.2012.170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences</span></div><div class="casAuthors">Exner, Nicole; Lutz, Anne Kathrin; Haass, Christian; Winklhofer, Konstanze F.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3038-3062</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Neurons are critically dependent on mitochondrial integrity based on specific morphol., biochem., and physiol. features.  They are characterized by high rates of metabolic activity and need to respond promptly to activity-dependent fluctuations in bioenergetic demand.  The dimensions and polarity of neurons require efficient transport of mitochondria to hot spots of energy consumption, such as presynaptic and postsynaptic sites.  Moreover, the postmitotic state of neurons in combination with their exposure to intrinsic and extrinsic neuronal stress factors call for a high fidelity of mitochondrial quality control systems.  Consequently, it is not surprising that mitochondrial alterations can promote neuronal dysfunction and degeneration.  In particular, mitochondrial dysfunction has long been implicated in the etiopathogenesis of Parkinson's disease (PD), based on the observation that mitochondrial toxins can cause parkinsonism in humans and animal models.  Substantial progress towards understanding the role of mitochondria in the disease process has been made by the identification and characterization of genes causing familial variants of PD.  Studies on the function and dysfunction of these genes revealed that various aspects of mitochondrial biol. appear to be affected in PD, comprising mitochondrial biogenesis, bioenergetics, dynamics, transport, and quality control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH4-kE75wmUbVg90H21EOLACvtfcHk0ljPEwp1yJey5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpt1SgsL8%253D&md5=82274488828864faa56ec1d6b875c476</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Femboj.2012.170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2012.170%26sid%3Dliteratum%253Aachs%26aulast%3DExner%26aufirst%3DN.%26aulast%3DLutz%26aufirst%3DA.%2BK.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DWinklhofer%26aufirst%3DK.%2BF.%26atitle%3DMitochondrial%2520dysfunction%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520molecular%2520mechanisms%2520and%2520pathophysiological%2520consequences%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26spage%3D3038%26epage%3D3062%26doi%3D10.1038%2Femboj.2012.170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Henchcliffe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis</span> <span class="citation_source-journal">Nat. Clin. Pract. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">600</span><span class="NLM_x">–</span> <span class="NLM_lpage">609</span><span class="refDoi"> DOI: 10.1038/ncpneuro0924</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fncpneuro0924" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=18978800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWktbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=600-609&author=C.+Henchcliffeauthor=M.+F.+Beal&title=Mitochondrial+biology+and+oxidative+stress+in+Parkinson+disease+pathogenesis&doi=10.1038%2Fncpneuro0924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis</span></div><div class="casAuthors">Henchcliffe, Claire; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">600-609</span>CODEN:
                <span class="NLM_cas:coden">NCPND4</span>;
        ISSN:<span class="NLM_cas:issn">1745-834X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mitochondrial dysfunction and oxidative stress have been strongly implicated in the pathogenesis of Parkinson disease (PD), and the products of several PD-assocd. genes become localized to the mitochondria under certain conditions.  In this article, Henchcliffe and Beal review recent developments in mitochondrial biol. that have contributed to our understanding of the disease process in PD, and they discuss how this knowledge might aid in the development of 'mitochondrial therapies' for PD.  Parkinson disease (PD) is assocd. with progressive loss of dopaminergic neurons in the substantia nigra, as well as with more-widespread neuronal changes that cause complex and variable motor and nonmotor symptoms.  Recent rapid advances in PD genetics have revealed a prominent role for mitochondrial dysfunction in the pathogenesis of the disease, and the products of several PD-assocd. genes, including SNCA, Parkin, PINK1, DJ-1, LRRK2 and HTR2A, show a degree of localization to the mitochondria under certain conditions.  Impaired mitochondrial function is likely to increase oxidative stress and might render cells more vulnerable to this and other related processes, including excitotoxicity.  The mitochondria, therefore, represent a highly promising target for the development of disease biomarkers by use of genetic, biochem. and bioimaging approaches.  Novel therapeutic interventions that modify mitochondrial function are currently under development, and a large phase III clin. trial is underway to examine whether high-dose oral coenzyme Q10 will slow disease progression.  In this Review, we examine evidence for the roles of mitochondrial dysfunction and increased oxidative stress in the neuronal loss that leads to PD and discuss how this knowledge might further improve patient management and aid in the development of 'mitochondrial therapy' for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqneg1PjpRmGrVg90H21EOLACvtfcHk0ljPEwp1yJey5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWktbnM&md5=699436613ceae22565abf37aa4dfd9f9</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fncpneuro0924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncpneuro0924%26sid%3Dliteratum%253Aachs%26aulast%3DHenchcliffe%26aufirst%3DC.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DMitochondrial%2520biology%2520and%2520oxidative%2520stress%2520in%2520Parkinson%2520disease%2520pathogenesis%26jtitle%3DNat.%2520Clin.%2520Pract.%2520Neurol.%26date%3D2008%26volume%3D4%26spage%3D600%26epage%3D609%26doi%3D10.1038%2Fncpneuro0924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Shulman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Jager, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feany, M. B.</span><span> </span><span class="NLM_article-title">Parkinson’s disease: genetics and pathogenesis</span> <span class="citation_source-journal">Annu. Rev. Pathol.: Mech. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span><span class="refDoi"> DOI: 10.1146/annurev-pathol-011110-130242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1146%2Fannurev-pathol-011110-130242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21034221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtVWrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=193-222&author=J.+M.+Shulmanauthor=P.+L.+De+Jagerauthor=M.+B.+Feany&title=Parkinson%E2%80%99s+disease%3A+genetics+and+pathogenesis&doi=10.1146%2Fannurev-pathol-011110-130242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Parkinson's disease: genetics and pathogenesis</span></div><div class="casAuthors">Shulman, Joshua M.; De Jager, Philip L.; Feany, Mel B.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pathology: Mechanisms of Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">193-222</span>CODEN:
                <span class="NLM_cas:coden">ARPMCU</span>;
        ISSN:<span class="NLM_cas:issn">1553-4006</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Recent investigation into the mechanisms of Parkinson's disease (PD) has generated remarkable insight while simultaneously challenging traditional conceptual frameworks.  Although the disease remains defined clin. by its cardinal motor manifestations and pathol. by midbrain dopaminergic cell loss in assocn. with Lewy bodies, it is now recognized that PD has substantially more widespread impact, causing a host of nonmotor symptoms and assocd. pathol. in multiple regions throughout the nervous system.  Further, the discovery and validation of PD-susceptibility genes contradict the historical view that environmental factors predominate, and blur distinctions between familial and sproadic disease.  Genetic advances have also promoted the development of improved animal models, highlighted responsible mol. pathways, and revealed mechanistic overlap with other neurodegenerative disorders.  In this review, we synthesize emerging lessons on PD pathogenesis from clin., pathol., and genetic studies toward a unified concept of the disorder that may accelerate the design and testing of the next generation of PD therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiywhYI9S77LVg90H21EOLACvtfcHk0ljPEwp1yJey5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtVWrsrg%253D&md5=bcef535a4b0e9b7cda6932dc9eb3b685</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pathol-011110-130242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pathol-011110-130242%26sid%3Dliteratum%253Aachs%26aulast%3DShulman%26aufirst%3DJ.%2BM.%26aulast%3DDe%2BJager%26aufirst%3DP.%2BL.%26aulast%3DFeany%26aufirst%3DM.%2BB.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%253A%2520genetics%2520and%2520pathogenesis%26jtitle%3DAnnu.%2520Rev.%2520Pathol.%253A%2520Mech.%2520Dis.%26date%3D2011%26volume%3D6%26spage%3D193%26epage%3D222%26doi%3D10.1146%2Fannurev-pathol-011110-130242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Cooper, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrabi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guardia-Laguarta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziotto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo-Reid, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargus, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deleidi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogetofte, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Torres, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskowitz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzulli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpicelli-Daley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uitti, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opala, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarffe, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marder, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surmeier, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wszolek, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przedborski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krainc, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacson, O.</span><span> </span><span class="NLM_article-title">Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson’s disease</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">141ra90</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3003985</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1126%2Fscitranslmed.3003985" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22764206" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=141ra90&author=O.+Cooperauthor=H.+Seoauthor=S.+Andrabiauthor=C.+Guardia-Laguartaauthor=J.+Graziottoauthor=M.+Sundbergauthor=J.+R.+McLeanauthor=L.+Carrillo-Reidauthor=Z.+Xieauthor=T.+Osbornauthor=G.+Hargusauthor=M.+Deleidiauthor=T.+Lawsonauthor=H.+Bogetofteauthor=E.+Perez-Torresauthor=L.+Clarkauthor=C.+Moskowitzauthor=J.+Mazzulliauthor=L.+Chenauthor=L.+Volpicelli-Daleyauthor=N.+Romeroauthor=H.+Jiangauthor=R.+J.+Uittiauthor=Z.+Huangauthor=G.+Opalaauthor=L.+A.+Scarffeauthor=V.+L.+Dawsonauthor=C.+Kleinauthor=J.+Fengauthor=O.+A.+Rossauthor=J.+Q.+Trojanowskiauthor=V.+M.+Leeauthor=K.+Marderauthor=D.+J.+Surmeierauthor=Z.+K.+Wszolekauthor=S.+Przedborskiauthor=D.+Kraincauthor=T.+M.+Dawsonauthor=O.+Isacson&title=Pharmacological+rescue+of+mitochondrial+deficits+in+iPSC-derived+neural+cells+from+patients+with+familial+Parkinson%E2%80%99s+disease&doi=10.1126%2Fscitranslmed.3003985"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003985%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DO.%26aulast%3DSeo%26aufirst%3DH.%26aulast%3DAndrabi%26aufirst%3DS.%26aulast%3DGuardia-Laguarta%26aufirst%3DC.%26aulast%3DGraziotto%26aufirst%3DJ.%26aulast%3DSundberg%26aufirst%3DM.%26aulast%3DMcLean%26aufirst%3DJ.%2BR.%26aulast%3DCarrillo-Reid%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DOsborn%26aufirst%3DT.%26aulast%3DHargus%26aufirst%3DG.%26aulast%3DDeleidi%26aufirst%3DM.%26aulast%3DLawson%26aufirst%3DT.%26aulast%3DBogetofte%26aufirst%3DH.%26aulast%3DPerez-Torres%26aufirst%3DE.%26aulast%3DClark%26aufirst%3DL.%26aulast%3DMoskowitz%26aufirst%3DC.%26aulast%3DMazzulli%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DVolpicelli-Daley%26aufirst%3DL.%26aulast%3DRomero%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DUitti%26aufirst%3DR.%2BJ.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DOpala%26aufirst%3DG.%26aulast%3DScarffe%26aufirst%3DL.%2BA.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DRoss%26aufirst%3DO.%2BA.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DMarder%26aufirst%3DK.%26aulast%3DSurmeier%26aufirst%3DD.%2BJ.%26aulast%3DWszolek%26aufirst%3DZ.%2BK.%26aulast%3DPrzedborski%26aufirst%3DS.%26aulast%3DKrainc%26aufirst%3DD.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DIsacson%26aufirst%3DO.%26atitle%3DPharmacological%2520rescue%2520of%2520mitochondrial%2520deficits%2520in%2520iPSC-derived%2520neural%2520cells%2520from%2520patients%2520with%2520familial%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D141ra90%26doi%3D10.1126%2Fscitranslmed.3003985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Reinhardt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burbulla, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schöndorf, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glatza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höing, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargus, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhingra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brockmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maisel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krüger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsytsyura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiel, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Psathaki, O. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klingauf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhlmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klewin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schöler, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterneckert, J.</span><span> </span><span class="NLM_article-title">Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">354</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1016/j.stem.2013.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.stem.2013.01.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=354-367&author=P.+Reinhardtauthor=B.+Schmidauthor=L.+F.+Burbullaauthor=D.+C.+Sch%C3%B6ndorfauthor=L.+Wagnerauthor=M.+Glatzaauthor=S.+H%C3%B6ingauthor=G.+Hargusauthor=S.+A.+Heckauthor=A.+Dhingraauthor=G.+Wuauthor=S.+M%C3%BCllerauthor=K.+Brockmannauthor=T.+Klubaauthor=M.+Maiselauthor=R.+Kr%C3%BCgerauthor=D.+Bergauthor=Y.+Tsytsyuraauthor=C.+S.+Thielauthor=O.+E.+Psathakiauthor=J.+Klingaufauthor=T.+Kuhlmannauthor=M.+Klewinauthor=H.+M%C3%BCllerauthor=T.+Gasserauthor=H.+R.+Sch%C3%B6lerauthor=J.+Sterneckert&title=Genetic+correction+of+a+LRRK2+mutation+in+human+iPSCs+links+parkinsonian+neurodegeneration+to+ERK-dependent+changes+in+gene+expression&doi=10.1016%2Fj.stem.2013.01.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2013.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2013.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DReinhardt%26aufirst%3DP.%26aulast%3DSchmid%26aufirst%3DB.%26aulast%3DBurbulla%26aufirst%3DL.%2BF.%26aulast%3DSch%25C3%25B6ndorf%26aufirst%3DD.%2BC.%26aulast%3DWagner%26aufirst%3DL.%26aulast%3DGlatza%26aufirst%3DM.%26aulast%3DH%25C3%25B6ing%26aufirst%3DS.%26aulast%3DHargus%26aufirst%3DG.%26aulast%3DHeck%26aufirst%3DS.%2BA.%26aulast%3DDhingra%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DBrockmann%26aufirst%3DK.%26aulast%3DKluba%26aufirst%3DT.%26aulast%3DMaisel%26aufirst%3DM.%26aulast%3DKr%25C3%25BCger%26aufirst%3DR.%26aulast%3DBerg%26aufirst%3DD.%26aulast%3DTsytsyura%26aufirst%3DY.%26aulast%3DThiel%26aufirst%3DC.%2BS.%26aulast%3DPsathaki%26aufirst%3DO.%2BE.%26aulast%3DKlingauf%26aufirst%3DJ.%26aulast%3DKuhlmann%26aufirst%3DT.%26aulast%3DKlewin%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DGasser%26aufirst%3DT.%26aulast%3DSch%25C3%25B6ler%26aufirst%3DH.%2BR.%26aulast%3DSterneckert%26aufirst%3DJ.%26atitle%3DGenetic%2520correction%2520of%2520a%2520LRRK2%2520mutation%2520in%2520human%2520iPSCs%2520links%2520parkinsonian%2520neurodegeneration%2520to%2520ERK-dependent%2520changes%2520in%2520gene%2520expression%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2013%26volume%3D12%26spage%3D354%26epage%3D367%26doi%3D10.1016%2Fj.stem.2013.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Irwin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Parkinson’s disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">626</span><span class="NLM_x">–</span> <span class="NLM_lpage">636</span><span class="refDoi"> DOI: 10.1038/nrn3549</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnrn3549" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23900411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=626-636&author=D.+J.+Irwinauthor=V.+M.+Y.+Leeauthor=J.+Q.+Trojanowski&title=Parkinson%E2%80%99s+disease+dementia%3A+convergence+of+%CE%B1-synuclein%2C+tau+and+amyloid-%CE%B2+pathologies&doi=10.1038%2Fnrn3549"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies</span></div><div class="casAuthors">Irwin, David J.; Lee, Virginia M.-Y.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">626-636</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Dementia is increasingly being recognized in cases of Parkinson's disease (PD); such cases are termed PD dementia (PDD).  The spread of fibrillar α-synuclein (α-syn) pathol. from the brainstem to limbic and neocortical structures seems to be the strongest neuropathol. correlate of emerging dementia in PD.  In addn., up to 50% of patients with PDD also develop sufficient nos. of amyloid-β plaques and tau-contg. neurofibrillary tangles for a secondary diagnosis of Alzheimer's disease, and these pathologies may act synergistically with α-syn pathol. to confer a worse prognosis.  An understanding of the relationships between these three distinct pathologies and their resultant clin. phenotypes is crucial for the development of effective disease-modifying treatments for PD and PDD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQHKxvVpPusLVg90H21EOLACvtfcHk0lh7UUW_HUPgkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7bN&md5=e8de266b3d41136269251f1857ec72db</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnrn3549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3549%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DD.%2BJ.%26aulast%3DLee%26aufirst%3DV.%2BM.%2BY.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%2520dementia%253A%2520convergence%2520of%2520%25CE%25B1-synuclein%252C%2520tau%2520and%2520amyloid-%25CE%25B2%2520pathologies%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D626%26epage%3D636%26doi%3D10.1038%2Fnrn3549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Wilkaniec, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strosznajder, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamczyk, A.</span><span> </span><span class="NLM_article-title">Toxicity of extracellular secreted α-synuclein: Its role in nitrosative stress and neurodegeneration</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">776</span><span class="NLM_x">–</span> <span class="NLM_lpage">783</span><span class="refDoi"> DOI: 10.1016/j.neuint.2013.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.neuint.2013.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23416621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjt1aisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=776-783&author=A.+Wilkaniecauthor=J.+B.+Strosznajderauthor=A.+Adamczyk&title=Toxicity+of+extracellular+secreted+%CE%B1-synuclein%3A+Its+role+in+nitrosative+stress+and+neurodegeneration&doi=10.1016%2Fj.neuint.2013.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity of extracellular secreted alpha-synuclein: Its role in nitrosative stress and neurodegeneration</span></div><div class="casAuthors">Wilkaniec, Anna; Strosznajder, Joanna B.; Adamczyk, Agata</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">776-783</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  It has been demonstrated that both oligomerization and accumulation of α-synuclein (ASN) are the key mol. processes involved in the pathophysiol. of neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease and other synucleinopathies.  Alterations of ASN expression and impairment of its degrdn. can lead to the formation of intracellular deposits of this protein, called Lewy bodies.  Overexpressed or misfolded ASN could be secreted to the extracellular space.  Today the prion-like transmission of ASN oligomers to neighboring cells is believed to be responsible for protein modification and propagation of neurodegeneration in the brain.  It was presented that oxidative/nitrosative stress may play a key role in ASN secretion and spread of ASN pathol.  Moreover, ASN-evoked protein oxidn., nitration and nitrosylation lead to disturbances in synaptic transmission and cell death.  The interaction of secreted ASN with other amyloidogenic proteins and its involvement in irreversible mitochondrial disturbances and oxidative stress were also described.  A better understanding of the mechanisms of ASN secretion and dysfunction may help to explain the mol. mechanisms of neurodegeneration and may be the basis for the development of novel therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4XNGYKhjAzrVg90H21EOLACvtfcHk0ljktLCNJPmCqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjt1aisrc%253D&md5=91abc3f2f1916850d48e44de5b6cc432</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2013.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2013.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DWilkaniec%26aufirst%3DA.%26aulast%3DStrosznajder%26aufirst%3DJ.%2BB.%26aulast%3DAdamczyk%26aufirst%3DA.%26atitle%3DToxicity%2520of%2520extracellular%2520secreted%2520%25CE%25B1-synuclein%253A%2520Its%2520role%2520in%2520nitrosative%2520stress%2520and%2520neurodegeneration%26jtitle%3DNeurochem.%2520Int.%26date%3D2013%26volume%3D62%26spage%3D776%26epage%3D783%26doi%3D10.1016%2Fj.neuint.2013.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Chung, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khurana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auluck, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardiff, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzulli, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soldner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baru, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freyzon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mungenast, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muffat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitalipova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pluth, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jui, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schüle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krainc, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaenisch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, S.</span><span> </span><span class="NLM_article-title">Identification and rescue of α-synuclein toxicity in parkinson patient-derived neurons</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">983</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span><span class="refDoi"> DOI: 10.1126/science.1245296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1126%2Fscience.1245296" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2013&pages=983-987&author=C.+Y.+Chungauthor=V.+Khuranaauthor=P.+K.+Auluckauthor=D.+F.+Tardiffauthor=J.+R.+Mazzulliauthor=F.+Soldnerauthor=V.+Baruauthor=Y.+Louauthor=Y.+Freyzonauthor=S.+Choauthor=A.+E.+Mungenastauthor=J.+Muffatauthor=M.+Mitalipovaauthor=M.+D.+Pluthauthor=N.+T.+Juiauthor=B.+Sch%C3%BCleauthor=S.+J.+Lippardauthor=L.+H.+Tsaiauthor=D.+Kraincauthor=S.+L.+Buchwaldauthor=R.+Jaenischauthor=S.+Lindquist&title=Identification+and+rescue+of+%CE%B1-synuclein+toxicity+in+parkinson+patient-derived+neurons&doi=10.1126%2Fscience.1245296"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1126%2Fscience.1245296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1245296%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.%2BY.%26aulast%3DKhurana%26aufirst%3DV.%26aulast%3DAuluck%26aufirst%3DP.%2BK.%26aulast%3DTardiff%26aufirst%3DD.%2BF.%26aulast%3DMazzulli%26aufirst%3DJ.%2BR.%26aulast%3DSoldner%26aufirst%3DF.%26aulast%3DBaru%26aufirst%3DV.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DFreyzon%26aufirst%3DY.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DMungenast%26aufirst%3DA.%2BE.%26aulast%3DMuffat%26aufirst%3DJ.%26aulast%3DMitalipova%26aufirst%3DM.%26aulast%3DPluth%26aufirst%3DM.%2BD.%26aulast%3DJui%26aufirst%3DN.%2BT.%26aulast%3DSch%25C3%25BCle%26aufirst%3DB.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26aulast%3DTsai%26aufirst%3DL.%2BH.%26aulast%3DKrainc%26aufirst%3DD.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26aulast%3DJaenisch%26aufirst%3DR.%26aulast%3DLindquist%26aufirst%3DS.%26atitle%3DIdentification%2520and%2520rescue%2520of%2520%25CE%25B1-synuclein%2520toxicity%2520in%2520parkinson%2520patient-derived%2520neurons%26jtitle%3DScience%26date%3D2013%26volume%3D342%26spage%3D983%26epage%3D987%26doi%3D10.1126%2Fscience.1245296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Tardiff, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jui, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khurana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tambe, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamadurai, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancaster, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, S.</span><span> </span><span class="NLM_article-title">Yeast reveal a "druggable" Rsp5/Nedd4 network that ameliorates α-synuclein toxicity in neurons</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">983</span><span class="refDoi"> DOI: 10.1126/science.1245321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1126%2Fscience.1245321" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2013&pages=979-983&author=D.+F.+Tardiffauthor=N.+T.+Juiauthor=V.+Khuranaauthor=M.+A.+Tambeauthor=M.+L.+Thompsonauthor=C.+Y.+Chungauthor=H.+B.+Kamaduraiauthor=H.+T.+Kimauthor=A.+K.+Lancasterauthor=K.+A.+Caldwellauthor=G.+A.+Caldwellauthor=J.+C.+Rochetauthor=S.+L.+Buchwaldauthor=S.+Lindquist&title=Yeast+reveal+a+%22druggable%22+Rsp5%2FNedd4+network+that+ameliorates+%CE%B1-synuclein+toxicity+in+neurons&doi=10.1126%2Fscience.1245321"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1126%2Fscience.1245321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1245321%26sid%3Dliteratum%253Aachs%26aulast%3DTardiff%26aufirst%3DD.%2BF.%26aulast%3DJui%26aufirst%3DN.%2BT.%26aulast%3DKhurana%26aufirst%3DV.%26aulast%3DTambe%26aufirst%3DM.%2BA.%26aulast%3DThompson%26aufirst%3DM.%2BL.%26aulast%3DChung%26aufirst%3DC.%2BY.%26aulast%3DKamadurai%26aufirst%3DH.%2BB.%26aulast%3DKim%26aufirst%3DH.%2BT.%26aulast%3DLancaster%26aufirst%3DA.%2BK.%26aulast%3DCaldwell%26aufirst%3DK.%2BA.%26aulast%3DCaldwell%26aufirst%3DG.%2BA.%26aulast%3DRochet%26aufirst%3DJ.%2BC.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26aulast%3DLindquist%26aufirst%3DS.%26atitle%3DYeast%2520reveal%2520a%2520%2522druggable%2522%2520Rsp5%252FNedd4%2520network%2520that%2520ameliorates%2520%25CE%25B1-synuclein%2520toxicity%2520in%2520neurons%26jtitle%3DScience%26date%3D2013%26volume%3D342%26spage%3D979%26epage%3D983%26doi%3D10.1126%2Fscience.1245321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Chiang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span> </span><span class="NLM_article-title">Emerging therapeutics for Alzheimer’s disease</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span><span class="refDoi"> DOI: 10.1146/annurev-pharmtox-011613-135932</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1146%2Fannurev-pharmtox-011613-135932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24392696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVSqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=381-405&author=K.+Chiangauthor=E.+H.+Koo&title=Emerging+therapeutics+for+Alzheimer%E2%80%99s+disease&doi=10.1146%2Fannurev-pharmtox-011613-135932"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging therapeutics for Alzheimer's disease</span></div><div class="casAuthors">Chiang, Karen; Koo, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">381-405</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Despite decades of intense research, therapeutics for Alzheimer's disease (AD) are still limited to symptomatic treatments that possess only short-term efficacy.  Recently, several large-scale Phase III trials targeting amyloid-β prodn. or clearance have failed to show efficacy, leading to a reexamn. of the amyloid hypothesis as well as highlighting the need to explore alternatives in both clin. testing strategies and drug discovery targets.  In this review, we discuss therapeutics currently being tested in clin. trials and up-and-coming interventions that have shown promise in animal models, devoting attention to the mechanisms that may underlie their ability to influence disease progression and placing particular emphasis on tau therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtr6-78RIRjLVg90H21EOLACvtfcHk0ljktLCNJPmCqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVSqt7s%253D&md5=2282a36b965704b1cfb3796f1a685eda</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-011613-135932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-011613-135932%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DK.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26atitle%3DEmerging%2520therapeutics%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2014%26volume%3D54%26spage%3D381%26epage%3D405%26doi%3D10.1146%2Fannurev-pharmtox-011613-135932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">Alzheimer mechanisms and therapeutic strategies</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">1204</span><span class="NLM_x">–</span> <span class="NLM_lpage">1222</span><span class="refDoi"> DOI: 10.1016/j.cell.2012.02.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.cell.2012.02.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22424230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1CqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2012&pages=1204-1222&author=Y.+Huangauthor=L.+Mucke&title=Alzheimer+mechanisms+and+therapeutic+strategies&doi=10.1016%2Fj.cell.2012.02.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer Mechanisms and Therapeutic Strategies</span></div><div class="casAuthors">Huang, Yadong; Mucke, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1204-1222</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  There are still no effective treatments to prevent, halt, or reverse Alzheimer's disease, but research advances over the past three decades could change this gloomy picture.  Genetic studies demonstrate that the disease has multiple causes.  Interdisciplinary approaches combining biochem., mol. and cell biol., and transgenic modeling have revealed some of its mol. mechanisms.  Progress in chem., radiol., and systems biol. is beginning to provide useful biomarkers, and the emergence of personalized medicine is poised to transform pharmaceutical development and clin. trials.  However, investigative and drug development efforts should be diversified to fully address the multifactoriality of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx4Jw1D9na57Vg90H21EOLACvtfcHk0lgxMVg1BRLRtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1CqurY%253D&md5=4f44f2d5019321a668029282777946d1</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.02.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.02.040%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DAlzheimer%2520mechanisms%2520and%2520therapeutic%2520strategies%26jtitle%3DCell%26date%3D2012%26volume%3D148%26spage%3D1204%26epage%3D1222%26doi%3D10.1016%2Fj.cell.2012.02.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Bertram, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lill, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span> </span><span class="NLM_article-title">The genetics of Alzheimer disease: back to the future</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1016/j.neuron.2010.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.neuron.2010.10.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2010&pages=270-281&author=L.+Bertramauthor=C.+M.+Lillauthor=R.+E.+Tanzi&title=The+genetics+of+Alzheimer+disease%3A+back+to+the+future&doi=10.1016%2Fj.neuron.2010.10.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2010.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2010.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DBertram%26aufirst%3DL.%26aulast%3DLill%26aufirst%3DC.%2BM.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26atitle%3DThe%2520genetics%2520of%2520Alzheimer%2520disease%253A%2520back%2520to%2520the%2520future%26jtitle%3DNeuron%26date%3D2010%26volume%3D68%26spage%3D270%26epage%3D281%26doi%3D10.1016%2Fj.neuron.2010.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Serrano-Pozo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frosch, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span> </span><span class="NLM_article-title">Neuropathological alterations in Alzheimer disease</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">a006189</span><span class="refDoi"> DOI: 10.1101/cshperspect.a006189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1101%2Fcshperspect.a006189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22229116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFWgt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=a006189&author=A.+Serrano-Pozoauthor=M.+P.+Froschauthor=E.+Masliahauthor=B.+T.+Hyman&title=Neuropathological+alterations+in+Alzheimer+disease&doi=10.1101%2Fcshperspect.a006189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathological alterations in Alzheimer disease</span></div><div class="casAuthors">Serrano-Pozo, Alberto; Frosch, Matthew P.; Masliah, Eliezer; Hyman, Bradley T.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">a006189/1-a006189/23</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  The neuropathol. hallmarks of Alzheimer disease (AD) include "pos." lesions such as amyloid plaques and cerebral amyloid angiopathy, neurofibrillary tangles, and glial responses, and "neg." lesions such as neuronal and synaptic loss.  Despite their inherently cross-sectional nature, postmortem studies have enabled the staging of the progression of both amyloid and tangle pathologies, and, consequently, the development of diagnostic criteria that are now used worldwide.  In addn., clinicopathol. correlation studies have been crucial to generate hypotheses about the pathophysiol. of the disease, by establishing that there is a continuum between "normal" aging and AD dementia, and that the amyloid plaque build-up occurs primarily before the onset of cognitive deficits, while neurofibrillary tangles, neuron loss, and particularly synaptic loss, parallel the progression of cognitive decline.  Importantly, these cross-sectional neuropathol. data have been largely validated by longitudinal in vivo studies using modern imaging biomarkers such as amyloid PET and volumetric MRI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohEFWLIBeaLrVg90H21EOLACvtfcHk0lgxMVg1BRLRtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFWgt7c%253D&md5=ac33eb37912f670122c03fda4a1d2162</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006189%26sid%3Dliteratum%253Aachs%26aulast%3DSerrano-Pozo%26aufirst%3DA.%26aulast%3DFrosch%26aufirst%3DM.%2BP.%26aulast%3DMasliah%26aufirst%3DE.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26atitle%3DNeuropathological%2520alterations%2520in%2520Alzheimer%2520disease%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2011%26volume%3D1%26spage%3Da006189%26doi%3D10.1101%2Fcshperspect.a006189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertram, L.</span><span> </span><span class="NLM_article-title">Twenty years of the Alzheimer’s disease amyloid hypothesis: a genetic perspective</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span><span class="refDoi"> DOI: 10.1016/j.cell.2005.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.cell.2005.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=15734686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVWnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2005&pages=545-555&author=R.+E.+Tanziauthor=L.+Bertram&title=Twenty+years+of+the+Alzheimer%E2%80%99s+disease+amyloid+hypothesis%3A+a+genetic+perspective&doi=10.1016%2Fj.cell.2005.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective</span></div><div class="casAuthors">Tanzi, Rudolph E.; Bertram, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">545-555</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  From Alois Alzheimer's description of Auguste D.'s brain in 1907 to George Glenner's biochem. dissection of β-amyloid in 1984, the "amyloid hypothesis" of Alzheimer's disease has continued to gain support over the past two decades, particularly from genetic studies.  Here we assess the amyloid hypothesis based on both known and putative Alzheimer's disease genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPVQvwUmMmXrVg90H21EOLACvtfcHk0lgxMVg1BRLRtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVWnu7k%253D&md5=3f88dc7dda6b726429789c61d5992493</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2005.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2005.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DBertram%26aufirst%3DL.%26atitle%3DTwenty%2520years%2520of%2520the%2520Alzheimer%25E2%2580%2599s%2520disease%2520amyloid%2520hypothesis%253A%2520a%2520genetic%2520perspective%26jtitle%3DCell%26date%3D2005%26volume%3D120%26spage%3D545%26epage%3D555%26doi%3D10.1016%2Fj.cell.2005.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Yagi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akamatsu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nihei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span> </span><span class="NLM_article-title">Modeling familial Alzheimer’s disease with induced pluripotent stem cells</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4530</span><span class="NLM_x">–</span> <span class="NLM_lpage">4539</span><span class="refDoi"> DOI: 10.1093/hmg/ddr394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1093%2Fhmg%2Fddr394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21900357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVGrsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=4530-4539&author=T.+Yagiauthor=D.+Itoauthor=Y.+Okadaauthor=W.+Akamatsuauthor=Y.+Niheiauthor=T.+Yoshizakiauthor=S.+Yamanakaauthor=H.+Okanoauthor=N.+Suzuki&title=Modeling+familial+Alzheimer%E2%80%99s+disease+with+induced+pluripotent+stem+cells&doi=10.1093%2Fhmg%2Fddr394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling familial Alzheimer's disease with induced pluripotent stem cells</span></div><div class="casAuthors">Yagi, Takuya; Ito, Daisuke; Okada, Yohei; Akamatsu, Wado; Nihei, Yoshihiro; Yoshizaki, Takahito; Yamanaka, Shinya; Okano, Hideyuki; Suzuki, Norihiro</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4530-4539</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most common form of age-related dementia, characterized by progressive memory loss and cognitive disturbance.  Mutations of presenilin 1 (PS1) and presenilin 2 (PS2) are causative factors for autosomal-dominant early-onset familial AD (FAD).  Induced pluripotent stem cell (iPSC) technol. can be used to model human disorders and provide novel opportunities to study cellular mechanisms and establish therapeutic strategies against various diseases, including neurodegenerative diseases.  Here we generate iPSCs from fibroblasts of FAD patients with mutations in PS1 (A246E) and PS2 (N141I), and characterize the differentiation of these cells into neurons.  We find that FAD-iPSC-derived differentiated neurons have increased amyloid β42 secretion, recapitulating the mol. pathogenesis of mutant presenilins.  Furthermore, secretion of amyloid β42 from these neurons sharply responds to γ-secretase inhibitors and modulators, indicating the potential for identification and validation of candidate drugs.  Our findings demonstrate that the FAD-iPSC-derived neuron is a valid model of AD and provides an innovative strategy for the study of age-related neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYj221SQsO-7Vg90H21EOLACvtfcHk0lhiehhB-Zsm1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVGrsbnF&md5=80193f43d2ebcf4e3a73c0c02a3739c5</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddr394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddr394%26sid%3Dliteratum%253Aachs%26aulast%3DYagi%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DD.%26aulast%3DOkada%26aufirst%3DY.%26aulast%3DAkamatsu%26aufirst%3DW.%26aulast%3DNihei%26aufirst%3DY.%26aulast%3DYoshizaki%26aufirst%3DT.%26aulast%3DYamanaka%26aufirst%3DS.%26aulast%3DOkano%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DN.%26atitle%3DModeling%2520familial%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2011%26volume%3D20%26spage%3D4530%26epage%3D4539%26doi%3D10.1093%2Fhmg%2Fddr394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Hampel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoessler, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Total and phosphorylated tau protein as biological markers of Alzheimer’s disease</span> <span class="citation_source-journal">Exp. Gerontol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1016/j.exger.2009.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.exger.2009.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=19853650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFynt7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=30-40&author=H.+Hampelauthor=K.+Blennowauthor=L.+M.+Shawauthor=Y.+C.+Hoesslerauthor=H.+Zetterbergauthor=J.+Q.+Trojanowski&title=Total+and+phosphorylated+tau+protein+as+biological+markers+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.exger.2009.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Total and phosphorylated tau protein as biological markers of Alzheimer's disease</span></div><div class="casAuthors">Hampel, Harald; Blennow, Kaj; Shaw, Leslie M.; Hoessler, Yvonne C.; Zetterberg, Henrik; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Gerontology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-40</span>CODEN:
                <span class="NLM_cas:coden">EXGEAB</span>;
        ISSN:<span class="NLM_cas:issn">0531-5565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Advances in our understanding of tau-mediated neurodegeneration in Alzheimer's disease (AD) are moving this disease pathway to center stage for the development of biomarkers and disease modifying drug discovery efforts.  Immunoassays were developed detecting total (t-tau) and tau phosphorylated at specific epitopes (p-tauX) in cerebrospinal fluid (CSF), methods to analyze tau in blood are at the exptl. beginning.  Clin. research consistently demonstrated CSF t- and p-tau increased in AD compared to controls.  Measuring these tau species proved informative for classifying AD from relevant differential diagnoses.  Tau phosphorylated at threonine 231 (p-tau231) differentiated between AD and frontotemporal dementia, tau phosphorylated at serine 181 (p-tau181) enhanced classification between AD and dementia with Lewy bodies.  T- and p-tau are considered "core" AD biomarkers that have been successfully validated by controlled large-scale multi-center studies.  Tau biomarkers are implemented in clin. trials to reflect biol. activity, mechanisms of action of compds., support enrichment of target populations, provide endpoints for proof-of-concept and confirmatory trials on disease modification.  World-wide quality control initiatives are underway to set required methodol. and protocol stds.  Discussions with regulatory authorities gain momentum defining the role of tau biomarkers for trial designs and how they may be further qualified for surrogate marker status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhPszOrNFIc7Vg90H21EOLACvtfcHk0lhiehhB-Zsm1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFynt7nN&md5=96851e57d604016c581d4723b21a545f</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.exger.2009.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exger.2009.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DHampel%26aufirst%3DH.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DHoessler%26aufirst%3DY.%2BC.%26aulast%3DZetterberg%26aufirst%3DH.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DTotal%2520and%2520phosphorylated%2520tau%2520protein%2520as%2520biological%2520markers%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExp.%2520Gerontol.%26date%3D2010%26volume%3D45%26spage%3D30%26epage%3D40%26doi%3D10.1016%2Fj.exger.2009.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Israel, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyna, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hefferan, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gorp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazor, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boscolo, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remes, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, L. S.</span><span> </span><span class="NLM_article-title">Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">482</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span><span class="refDoi"> DOI: 10.1038/nature10821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature10821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22278060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ejsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2012&pages=216-220&author=M.+A.+Israelauthor=S.+H.+Yuanauthor=C.+Bardyauthor=S.+M.+Reynaauthor=Y.+Muauthor=C.+Herreraauthor=M.+P.+Hefferanauthor=S.+Van+Gorpauthor=K.+L.+Nazorauthor=F.+S.+Boscoloauthor=C.+T.+Carsonauthor=L.+C.+Laurentauthor=M.+Marsalaauthor=F.+H.+Gageauthor=A.+M.+Remesauthor=E.+H.+Kooauthor=L.+S.+Goldstein&title=Probing+sporadic+and+familial+Alzheimer%E2%80%99s+disease+using+induced+pluripotent+stem+cells&doi=10.1038%2Fnature10821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells</span></div><div class="casAuthors">Israel, Mason A.; Yuan, Shauna H.; Bardy, Cedric; Reyna, Sol M.; Mu, Yangling; Herrera, Cheryl; Hefferan, Michael P.; Van Gorp, Sebastiaan; Nazor, Kristopher L.; Boscolo, Francesca S.; Carson, Christian T.; Laurent, Louise C.; Marsala, Martin; Gage, Fred H.; Remes, Anne M.; Koo, Edward H.; Goldstein, Lawrence S. B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">482</span>
        (<span class="NLM_cas:issue">7384</span>),
    <span class="NLM_cas:pages">216-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Induced pluripotent stem cells are shown to be useful for studying phenotypes relevant to familial and sporadic Alzheimer's disease, even though it can take decades for the disease to manifest in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe7GR8O1bN17Vg90H21EOLACvtfcHk0lhiehhB-Zsm1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ejsrY%253D&md5=6ca7f428574f0aa547066fc0879cbe1b</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fnature10821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10821%26sid%3Dliteratum%253Aachs%26aulast%3DIsrael%26aufirst%3DM.%2BA.%26aulast%3DYuan%26aufirst%3DS.%2BH.%26aulast%3DBardy%26aufirst%3DC.%26aulast%3DReyna%26aufirst%3DS.%2BM.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DHerrera%26aufirst%3DC.%26aulast%3DHefferan%26aufirst%3DM.%2BP.%26aulast%3DVan%2BGorp%26aufirst%3DS.%26aulast%3DNazor%26aufirst%3DK.%2BL.%26aulast%3DBoscolo%26aufirst%3DF.%2BS.%26aulast%3DCarson%26aufirst%3DC.%2BT.%26aulast%3DLaurent%26aufirst%3DL.%2BC.%26aulast%3DMarsala%26aufirst%3DM.%26aulast%3DGage%26aufirst%3DF.%2BH.%26aulast%3DRemes%26aufirst%3DA.%2BM.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DGoldstein%26aufirst%3DL.%2BS.%26atitle%3DProbing%2520sporadic%2520and%2520familial%2520Alzheimer%25E2%2580%2599s%2520disease%2520using%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DNature%26date%3D2012%26volume%3D482%26spage%3D216%26epage%3D220%26doi%3D10.1038%2Fnature10821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Kondo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutoku, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohsawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yahata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asaka, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadoya, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choshi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakahata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hioki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naitoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamawaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, H.</span><span> </span><span class="NLM_article-title">Modeling Alzheimer’s disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">487</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1016/j.stem.2013.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.stem.2013.01.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=487-496&author=T.+Kondoauthor=M.+Asaiauthor=K.+Tsukitaauthor=Y.+Kutokuauthor=Y.+Ohsawaauthor=Y.+Sunadaauthor=K.+Imamuraauthor=N.+Egawaauthor=N.+Yahataauthor=K.+Okitaauthor=K.+Takahashiauthor=I.+Asakaauthor=T.+Aoiauthor=A.+Watanabeauthor=K.+Watanabeauthor=C.+Kadoyaauthor=R.+Nakanoauthor=D.+Watanabeauthor=K.+Maruyamaauthor=O.+Horiauthor=S.+Hibinoauthor=T.+Choshiauthor=T.+Nakahataauthor=H.+Hiokiauthor=T.+Kanekoauthor=M.+Naitohauthor=K.+Yoshikawaauthor=S.+Yamawakiauthor=S.+Suzukiauthor=R.+Hataauthor=S.+Uenoauthor=T.+Sekiauthor=K.+Kobayashiauthor=T.+Todaauthor=K.+Murakamiauthor=K.+Irieauthor=W.+L.+Kleinauthor=H.+Moriauthor=T.+Asadaauthor=R.+Takahashiauthor=N.+Iwataauthor=S.+Yamanakaauthor=H.+Inoue&title=Modeling+Alzheimer%E2%80%99s+disease+with+iPSCs+reveals+stress+phenotypes+associated+with+intracellular+A%CE%B2+and+differential+drug+responsiveness&doi=10.1016%2Fj.stem.2013.01.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2013.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2013.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DKondo%26aufirst%3DT.%26aulast%3DAsai%26aufirst%3DM.%26aulast%3DTsukita%26aufirst%3DK.%26aulast%3DKutoku%26aufirst%3DY.%26aulast%3DOhsawa%26aufirst%3DY.%26aulast%3DSunada%26aufirst%3DY.%26aulast%3DImamura%26aufirst%3DK.%26aulast%3DEgawa%26aufirst%3DN.%26aulast%3DYahata%26aufirst%3DN.%26aulast%3DOkita%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DAsaka%26aufirst%3DI.%26aulast%3DAoi%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DKadoya%26aufirst%3DC.%26aulast%3DNakano%26aufirst%3DR.%26aulast%3DWatanabe%26aufirst%3DD.%26aulast%3DMaruyama%26aufirst%3DK.%26aulast%3DHori%26aufirst%3DO.%26aulast%3DHibino%26aufirst%3DS.%26aulast%3DChoshi%26aufirst%3DT.%26aulast%3DNakahata%26aufirst%3DT.%26aulast%3DHioki%26aufirst%3DH.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DNaitoh%26aufirst%3DM.%26aulast%3DYoshikawa%26aufirst%3DK.%26aulast%3DYamawaki%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DHata%26aufirst%3DR.%26aulast%3DUeno%26aufirst%3DS.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DToda%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DK.%26aulast%3DIrie%26aufirst%3DK.%26aulast%3DKlein%26aufirst%3DW.%2BL.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DAsada%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DIwata%26aufirst%3DN.%26aulast%3DYamanaka%26aufirst%3DS.%26aulast%3DInoue%26aufirst%3DH.%26atitle%3DModeling%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520iPSCs%2520reveals%2520stress%2520phenotypes%2520associated%2520with%2520intracellular%2520A%25CE%25B2%2520and%2520differential%2520drug%2520responsiveness%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2013%26volume%3D12%26spage%3D487%26epage%3D496%26doi%3D10.1016%2Fj.stem.2013.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Mummery, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elefanty, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamp, T. J.</span><span> </span><span class="NLM_article-title">Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span><span class="refDoi"> DOI: 10.1161/CIRCRESAHA.110.227512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1161%2FCIRCRESAHA.110.227512" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2012&pages=344-358&author=C.+L.+Mummeryauthor=J.+Zhangauthor=E.+S.+Ngauthor=D.+A.+Elliottauthor=A.+G.+Elefantyauthor=T.+J.+Kamp&title=Differentiation+of+human+embryonic+stem+cells+and+induced+pluripotent+stem+cells+to+cardiomyocytes%3A+a+methods+overview&doi=10.1161%2FCIRCRESAHA.110.227512"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.110.227512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.110.227512%26sid%3Dliteratum%253Aachs%26aulast%3DMummery%26aufirst%3DC.%2BL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DNg%26aufirst%3DE.%2BS.%26aulast%3DElliott%26aufirst%3DD.%2BA.%26aulast%3DElefanty%26aufirst%3DA.%2BG.%26aulast%3DKamp%26aufirst%3DT.%2BJ.%26atitle%3DDifferentiation%2520of%2520human%2520embryonic%2520stem%2520cells%2520and%2520induced%2520pluripotent%2520stem%2520cells%2520to%2520cardiomyocytes%253A%2520a%2520methods%2520overview%26jtitle%3DCirc.%2520Res.%26date%3D2012%26volume%3D111%26spage%3D344%26epage%3D358%26doi%3D10.1161%2FCIRCRESAHA.110.227512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Matsa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burridge, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span> </span><span class="NLM_article-title">Human stem cells for modeling heart disease and for drug discovery</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">239ps6</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3008921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1126%2Fscitranslmed.3008921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24898747" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=239ps6&author=E.+Matsaauthor=P.+W.+Burridgeauthor=J.+C.+Wu&title=Human+stem+cells+for+modeling+heart+disease+and+for+drug+discovery&doi=10.1126%2Fscitranslmed.3008921"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3008921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3008921%26sid%3Dliteratum%253Aachs%26aulast%3DMatsa%26aufirst%3DE.%26aulast%3DBurridge%26aufirst%3DP.%2BW.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26atitle%3DHuman%2520stem%2520cells%2520for%2520modeling%2520heart%2520disease%2520and%2520for%2520drug%2520discovery%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D239ps6%26doi%3D10.1126%2Fscitranslmed.3008921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Carvajal-Vergara, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sevilla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Souza, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ang, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaniel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edelmann, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waghray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenbelt, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemischka, I. R.</span><span> </span><span class="NLM_article-title">Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">808</span><span class="NLM_x">–</span> <span class="NLM_lpage">812</span><span class="refDoi"> DOI: 10.1038/nature09005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature09005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=808-812&author=X.+Carvajal-Vergaraauthor=A.+Sevillaauthor=S.+L.+D%E2%80%99Souzaauthor=Y.+S.+Angauthor=C.+Schanielauthor=D.+F.+Leeauthor=L.+Yangauthor=A.+D.+Kaplanauthor=E.+D.+Adlerauthor=R.+Rozovauthor=Y.+Geauthor=N.+Cohenauthor=L.+J.+Edelmannauthor=B.+Changauthor=A.+Waghrayauthor=J.+Suauthor=S.+Pardoauthor=K.+D.+Lichtenbeltauthor=M.+Tartagliaauthor=B.+D.+Gelbauthor=I.+R.+Lemischka&title=Patient-specific+induced+pluripotent+stem-cell-derived+models+of+LEOPARD+syndrome&doi=10.1038%2Fnature09005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnature09005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09005%26sid%3Dliteratum%253Aachs%26aulast%3DCarvajal-Vergara%26aufirst%3DX.%26aulast%3DSevilla%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DS.%2BL.%26aulast%3DAng%26aufirst%3DY.%2BS.%26aulast%3DSchaniel%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DD.%2BF.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DKaplan%26aufirst%3DA.%2BD.%26aulast%3DAdler%26aufirst%3DE.%2BD.%26aulast%3DRozov%26aufirst%3DR.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DN.%26aulast%3DEdelmann%26aufirst%3DL.%2BJ.%26aulast%3DChang%26aufirst%3DB.%26aulast%3DWaghray%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DPardo%26aufirst%3DS.%26aulast%3DLichtenbelt%26aufirst%3DK.%2BD.%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26aulast%3DLemischka%26aufirst%3DI.%2BR.%26atitle%3DPatient-specific%2520induced%2520pluripotent%2520stem-cell-derived%2520models%2520of%2520LEOPARD%2520syndrome%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D808%26epage%3D812%26doi%3D10.1038%2Fnature09005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Mercola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willems, E.</span><span> </span><span class="NLM_article-title">Induced pluripotent stem cells in cardiovascular drug discovery</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span><span class="refDoi"> DOI: 10.1161/CIRCRESAHA.111.250266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1161%2FCIRCRESAHA.111.250266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23371902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2013&pages=534-548&author=M.+Mercolaauthor=A.+Colasauthor=E.+Willems&title=Induced+pluripotent+stem+cells+in+cardiovascular+drug+discovery&doi=10.1161%2FCIRCRESAHA.111.250266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Induced Pluripotent Stem Cells in Cardiovascular Drug Discovery</span></div><div class="casAuthors">Mercola, Mark; Colas, Alexandre; Willems, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">534-548</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The unexpected discovery that somatic cells can be reprogrammed to a pluripotent state yielding induced pluripotent stem cells has made it possible to produce cardiovascular cells exhibiting inherited traits and disorders.  Use of these cells in high throughput analyses should broaden our insight into fundamental disease mechanisms and provide many benefits for patients, including new therapeutics and individually tailored therapies.  Here we review recent progress in generating induced pluripotent stem cell-based models of cardiovascular disease and their multiple applications in drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFERiffTl3IrVg90H21EOLACvtfcHk0li5GNJqy5sAag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWgs7w%253D&md5=1bafac2daf2625f0cd8f40112d59e978</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.111.250266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.111.250266%26sid%3Dliteratum%253Aachs%26aulast%3DMercola%26aufirst%3DM.%26aulast%3DColas%26aufirst%3DA.%26aulast%3DWillems%26aufirst%3DE.%26atitle%3DInduced%2520pluripotent%2520stem%2520cells%2520in%2520cardiovascular%2520drug%2520discovery%26jtitle%3DCirc.%2520Res.%26date%3D2013%26volume%3D112%26spage%3D534%26epage%3D548%26doi%3D10.1161%2FCIRCRESAHA.111.250266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Sinnecker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laugwitz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, A.</span><span> </span><span class="NLM_article-title">Induced pluripotent stem cell-derived cardiomyocytes for drug development and toxicity testing</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2014.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.pharmthera.2014.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24657289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1eqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2014&pages=246-252&author=D.+Sinneckerauthor=K.+L.+Laugwitzauthor=A.+Moretti&title=Induced+pluripotent+stem+cell-derived+cardiomyocytes+for+drug+development+and+toxicity+testing&doi=10.1016%2Fj.pharmthera.2014.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Induced pluripotent stem cell-derived cardiomyocytes for drug development and toxicity testing</span></div><div class="casAuthors">Sinnecker, Daniel; Laugwitz, Karl-Ludwig; Moretti, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-252</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Induced pluripotent stem cell (iPSC) technol. is creating exciting new opportunities for cardiovascular research by providing platforms to study the mechanisms of disease pathogenesis that could lead to new therapies or reveal drug sensitivities.  In this review, the potential usefulness of iPSC-derived cardiomyocytes in drug development as well as in drug toxicity testing is discussed, with a focus on the achievements that have been already made in this regard.  Moreover, the crucial steps that have to be taken before this technol. can be broadly used in drug discovery and toxicol. assessments are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokJL-d2p89U7Vg90H21EOLACvtfcHk0lgitRvQYTQ49g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1eqtro%253D&md5=11862e0ca7ef5136686c0564361e4e8e</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DSinnecker%26aufirst%3DD.%26aulast%3DLaugwitz%26aufirst%3DK.%2BL.%26aulast%3DMoretti%26aufirst%3DA.%26atitle%3DInduced%2520pluripotent%2520stem%2520cell-derived%2520cardiomyocytes%2520for%2520drug%2520development%2520and%2520toxicity%2520testing%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D143%26spage%3D246%26epage%3D252%26doi%3D10.1016%2Fj.pharmthera.2014.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Mordwinkin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burridge, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span> </span><span class="NLM_article-title">A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards</span> <span class="citation_source-journal">J. Cardiovasc. Transl. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1007/s12265-012-9423-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1007%2Fs12265-012-9423-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23229562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A280%3ADC%252BC3s3gtF2itA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=22-30&author=N.+M.+Mordwinkinauthor=P.+W.+Burridgeauthor=J.+C.+Wu&title=A+review+of+human+pluripotent+stem+cell-derived+cardiomyocytes+for+high-throughput+drug+discovery%2C+cardiotoxicity+screening%2C+and+publication+standards&doi=10.1007%2Fs12265-012-9423-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards</span></div><div class="casAuthors">Mordwinkin Nicholas M; Burridge Paul W; Wu Joseph C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cardiovascular translational research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Drug attrition rates have increased in past years, resulting in growing costs for the pharmaceutical industry and consumers.  The reasons for this include the lack of in vitro models that correlate with clinical results and poor preclinical toxicity screening assays.  The in vitro production of human cardiac progenitor cells and cardiomyocytes from human pluripotent stem cells provides an amenable source of cells for applications in drug discovery, disease modeling, regenerative medicine, and cardiotoxicity screening.  In addition, the ability to derive human-induced pluripotent stem cells from somatic tissues, combined with current high-throughput screening and pharmacogenomics, may help realize the use of these cells to fulfill the potential of personalized medicine.  In this review, we discuss the use of pluripotent stem cell-derived cardiomyocytes for drug discovery and cardiotoxicity screening, as well as current hurdles that must be overcome for wider clinical applications of this promising approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0iX2-R-iDTY2y4bB4mnvYfW6udTcc2ebxog8FbTg7gLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3gtF2itA%253D%253D&md5=c64c5af61307d04247eee7a830f69946</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1007%2Fs12265-012-9423-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12265-012-9423-2%26sid%3Dliteratum%253Aachs%26aulast%3DMordwinkin%26aufirst%3DN.%2BM.%26aulast%3DBurridge%26aufirst%3DP.%2BW.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26atitle%3DA%2520review%2520of%2520human%2520pluripotent%2520stem%2520cell-derived%2520cardiomyocytes%2520for%2520high-throughput%2520drug%2520discovery%252C%2520cardiotoxicity%2520screening%252C%2520and%2520publication%2520standards%26jtitle%3DJ.%2520Cardiovasc.%2520Transl.%2520Res.%26date%3D2013%26volume%3D6%26spage%3D22%26epage%3D30%26doi%3D10.1007%2Fs12265-012-9423-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Goldenberg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, A. J.</span><span> </span><span class="NLM_article-title">Long QT syndrome</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2291</span><span class="NLM_x">–</span> <span class="NLM_lpage">2300</span><span class="refDoi"> DOI: 10.1016/j.jacc.2008.02.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.jacc.2008.02.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=18549912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A280%3ADC%252BD1czotFKrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2291-2300&author=I.+Goldenbergauthor=A.+J.+Moss&title=Long+QT+syndrome&doi=10.1016%2Fj.jacc.2008.02.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Long QT syndrome</span></div><div class="casAuthors">Goldenberg Ilan; Moss Arthur J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2291-300</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The hereditary long QT syndrome (LQTS) is a genetic channelopathy with variable penetrance that is associated with increased propensity to syncope, polymorphous ventricular tachycardia (torsades de pointes), and sudden arrhythmic death.  This inherited cardiac disorder constitutes an important cause of malignant ventricular arrhythmias and sudden cardiac death in young individuals with normal cardiac morphology.  Risk assessment in affected LQTS patients relies upon a constellation of electrocardiographic, clinical, and genetic factors.  Administration of beta-blockers is the mainstay therapy in affected patients, and primary prevention with an implantable cardioverter defibrillator or left cervicothoracic sympathetic denervation are therapeutic options in patients who remain symptomatic despite beta-blocker therapy.  Accumulating data from the International LQTS Registry have recently facilitated a comprehensive analysis of risk factors for aborted cardiac arrest or sudden cardiac death in pre-specified age groups, including the childhood, adolescence, adulthood, and post-40 periods.  These analyses have consistently indicated that the phenotypic expression of LQTS is time dependent and age specific, warranting continuous risk assessment in affected patients.  Furthermore, the biophysical function, type, and location of the ion-channel mutation are currently emerging as important determinants of outcome in genotyped patients.  These new data may be used to improve risk stratification and for the development of gene-specific therapies that may reduce the risk of life-threatening cardiac events in patients with this inherited cardiac disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnjRnC0qWXOrxanA7vODO6fW6udTcc2ebMRcFNwp6Sf7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czotFKrsg%253D%253D&md5=de93c414806e91dd3e5556b7839c20b4</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2008.02.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2008.02.068%26sid%3Dliteratum%253Aachs%26aulast%3DGoldenberg%26aufirst%3DI.%26aulast%3DMoss%26aufirst%3DA.%2BJ.%26atitle%3DLong%2520QT%2520syndrome%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2008%26volume%3D51%26spage%3D2291%26epage%3D2300%26doi%3D10.1016%2Fj.jacc.2008.02.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Moss, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kass, R. S.</span><span> </span><span class="NLM_article-title">Long QT syndrome: from channels to cardiac arrhythmias</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">2018</span><span class="NLM_x">–</span> <span class="NLM_lpage">2024</span><span class="refDoi"> DOI: 10.1172/JCI25537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1172%2FJCI25537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=16075042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntFCmt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=2018-2024&author=A.+J.+Mossauthor=R.+S.+Kass&title=Long+QT+syndrome%3A+from+channels+to+cardiac+arrhythmias&doi=10.1172%2FJCI25537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Long QT syndrome: From channels to cardiac arrhythmias</span></div><div class="casAuthors">Moss, Arthur J.; Kass, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2018-2024</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Long QT syndrome, a rare genetic disorder assocd. with life-threatening arrhythmias, has provided a wealth of information about fundamental mechanisms underlying human cardiac electrophysiol. that has come about because of truly collaborative interactions between clin. and basic scientists.  Our understanding of the mechanisms that control the crit. plateau and repolarization phases of the human ventricular action potential has been raised to new levels through these studies, which have clarified the manner in which both potassium and sodium channels regulate this crit. period of elec. activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVt_KGvZsuKrVg90H21EOLACvtfcHk0liypG8KnjEGYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntFCmt78%253D&md5=bb3b40480997574d10aa009eec8d51e0</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1172%2FJCI25537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI25537%26sid%3Dliteratum%253Aachs%26aulast%3DMoss%26aufirst%3DA.%2BJ.%26aulast%3DKass%26aufirst%3DR.%2BS.%26atitle%3DLong%2520QT%2520syndrome%253A%2520from%2520channels%2520to%2520cardiac%2520arrhythmias%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26spage%3D2018%26epage%3D2024%26doi%3D10.1172%2FJCI25537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Moretti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bott-Flügel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höhnke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyfarth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinnecker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schömig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laugwitz, K. L.</span><span> </span><span class="NLM_article-title">Patient-specific induced pluripotent stem-cell models for long-QT syndrome</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">1397</span><span class="NLM_x">–</span> <span class="NLM_lpage">1409</span><span class="refDoi"> DOI: 10.1056/NEJMoa0908679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1056%2FNEJMoa0908679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=20660394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGks73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1397-1409&author=A.+Morettiauthor=M.+Bellinauthor=A.+Wellingauthor=C.+B.+Jungauthor=J.+T.+Lamauthor=L.+Bott-Fl%C3%BCgelauthor=T.+Dornauthor=A.+Goedelauthor=C.+H%C3%B6hnkeauthor=F.+Hofmannauthor=M.+Seyfarthauthor=D.+Sinneckerauthor=A.+Sch%C3%B6migauthor=K.+L.+Laugwitz&title=Patient-specific+induced+pluripotent+stem-cell+models+for+long-QT+syndrome&doi=10.1056%2FNEJMoa0908679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Patient-specific induced pluripotent stem-cell models for long-QT syndrome</span></div><div class="casAuthors">Moretti, Alessandra; Bellin, Milena; Welling, Andrea; Jung, Christian Billy; Lam, Jason T.; Bott-Flugel, Lorenz; Dorn, Tatjana; Goedel, Alexander; Hohnke, Christian; Hofmann, Franz; Seyfarth, Melchior; Sinnecker, Daniel; Schomig, Albert; Laugwitz, Karl-Ludwig</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1397-1409</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Long-QT syndromes are heritable diseases assocd. with prolongation of the QT interval on an ECG and a high risk of sudden cardiac death due to ventricular tachyarrhythmia.  In long-QT syndrome type 1, mutations occur in the KCNQ1 gene, which encodes the repolarizing potassium channel mediating the delayed rectifier IKs current.  Methods: We screened a family affected by long-QT syndrome type 1 and identified an autosomal dominant missense mutation (R190Q) in the KCNQ1 gene.  We obtained dermal fibroblasts from two family members and two healthy controls and infected them with retroviral vectors encoding the human transcription factors OCT3/4, SOX2, KLF4, and c-MYC to generate pluripotent stem cells.  With the use of a specific protocol, these cells were then directed to differentiate into cardiac myocytes.  Results: Induced pluripotent stem cells maintained the disease genotype of long-QT syndrome type 1 and generated functional myocytes.  Individual cells showed a "ventricular," "atrial," or "nodal" phenotype, as evidenced by the expression of cell-type-specific markers and as seen in recordings of the action potentials in single cells.  The duration of the action potential was markedly prolonged in "ventricular" and "atrial" cells derived from patients with long-QT syndrome type 1, as compared with cells from control subjects.  Further characterization of the role of the R190Q-KCNQ1 mutation in the pathogenesis of long-QT syndrome type 1 revealed a dominant neg. trafficking defect assocd. with a 70 to 80% redn. in IKs current and altered channel activation and deactivation properties.  Moreover, we showed that myocytes derived from patients with long-QT syndrome type 1 had an increased susceptibility to catecholamine-induced tachyarrhythmia and that beta-blockade attenuated this phenotype.  Conclusions: We generated patient-specific pluripotent stem cells from members of a family affected by long-QT syndrome type 1 and induced them to differentiate into functional cardiac myocytes.  The patient-derived cells recapitulated the electrophysiol. features of the disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok8xgTGHQSe7Vg90H21EOLACvtfcHk0liypG8KnjEGYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGks73N&md5=871d9acee55cb2fc1e89a2752de0481d</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0908679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0908679%26sid%3Dliteratum%253Aachs%26aulast%3DMoretti%26aufirst%3DA.%26aulast%3DBellin%26aufirst%3DM.%26aulast%3DWelling%26aufirst%3DA.%26aulast%3DJung%26aufirst%3DC.%2BB.%26aulast%3DLam%26aufirst%3DJ.%2BT.%26aulast%3DBott-Fl%25C3%25BCgel%26aufirst%3DL.%26aulast%3DDorn%26aufirst%3DT.%26aulast%3DGoedel%26aufirst%3DA.%26aulast%3DH%25C3%25B6hnke%26aufirst%3DC.%26aulast%3DHofmann%26aufirst%3DF.%26aulast%3DSeyfarth%26aufirst%3DM.%26aulast%3DSinnecker%26aufirst%3DD.%26aulast%3DSch%25C3%25B6mig%26aufirst%3DA.%26aulast%3DLaugwitz%26aufirst%3DK.%2BL.%26atitle%3DPatient-specific%2520induced%2520pluripotent%2520stem-cell%2520models%2520for%2520long-QT%2520syndrome%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D1397%26epage%3D1409%26doi%3D10.1056%2FNEJMoa0908679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Matsa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamohan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staniforth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denning, C.</span><span> </span><span class="NLM_article-title">Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">952</span><span class="NLM_x">–</span> <span class="NLM_lpage">962</span><span class="refDoi"> DOI: 10.1093/eurheartj/ehr073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1093%2Feurheartj%2Fehr073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21367833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFaksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=952-962&author=E.+Matsaauthor=D.+Rajamohanauthor=E.+Dickauthor=L.+Youngauthor=I.+Mellorauthor=A.+Staniforthauthor=C.+Denning&title=Drug+evaluation+in+cardiomyocytes+derived+from+human+induced+pluripotent+stem+cells+carrying+a+long+QT+syndrome+type+2+mutation&doi=10.1093%2Feurheartj%2Fehr073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation</span></div><div class="casAuthors">Matsa, Elena; Rajamohan, Divya; Dick, Emily; Young, Lorraine; Mellor, Ian; Staniforth, Andrew; Denning, Chris</div><div class="citationInfo"><span class="NLM_cas:title">European Heart Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">952-962</span>CODEN:
                <span class="NLM_cas:coden">EHJODF</span>;
        ISSN:<span class="NLM_cas:issn">0195-668X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Aims: Congenital long QT syndromes (LQTSs) are assocd. with prolonged ventricular repolarization and sudden cardiac death.  Limitations to existing clin. therapeutic management strategies prompted us to develop a novel human in vitro drug-evaluation system for LQTS type 2 (LQT2) that will complement the existing in vitro and in vivo models.  Methods and results: Skin fibroblasts from a patient with a KCNH2 G1681A mutation (encodes IKr potassium ion channel) were reprogrammed to human induced pluripotent stem cells (hiPSCs), which were subsequently differentiated to functional cardiomyocytes.  Relative to controls (including the patient's mother), multi-electrode array and patch-clamp electrophysiol. of LQT2-hiPSC cardiomyocytes showed prolonged field/action potential duration.  When LQT2-hiPSC cardiomyocytes were exposed to E4031 (an IKr blocker), arrhythmias developed and these presented as early after depolarizations (EADs) in the action potentials.  In contrast to control cardiomyocytes, LQT2-hiPSC cardiomyocytes also developed EADs when challenged with the clin. used stressor, isoprenaline.  This effect was reversed by β-blockers, propranolol, and nadolol, the latter being used for the patient's therapy.  Treatment of cardiomyocytes with exptl. potassium channel enhancers, nicorandil and PD118057, caused action potential shortening and in some cases could abolish EADs.  Notably, combined treatment with isoprenaline (enhancers/isoprenaline) caused EADs, but this effect was reversed by nadolol.  Conclusions Findings: from this paper demonstrate that patient LQT2-hiPSC cardiomyocytes respond appropriately to clin. relevant pharmacol. and will be a valuable human in vitro model for testing exptl. drug combinations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoFWAzoN3q-bVg90H21EOLACvtfcHk0liypG8KnjEGYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFaksb0%253D&md5=37730314b1646fec879ce24aa17abf5e</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1093%2Feurheartj%2Fehr073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurheartj%252Fehr073%26sid%3Dliteratum%253Aachs%26aulast%3DMatsa%26aufirst%3DE.%26aulast%3DRajamohan%26aufirst%3DD.%26aulast%3DDick%26aufirst%3DE.%26aulast%3DYoung%26aufirst%3DL.%26aulast%3DMellor%26aufirst%3DI.%26aulast%3DStaniforth%26aufirst%3DA.%26aulast%3DDenning%26aufirst%3DC.%26atitle%3DDrug%2520evaluation%2520in%2520cardiomyocytes%2520derived%2520from%2520human%2520induced%2520pluripotent%2520stem%2520cells%2520carrying%2520a%2520long%2520QT%2520syndrome%2520type%25202%2520mutation%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2011%26volume%3D32%26spage%3D952%26epage%3D962%26doi%3D10.1093%2Feurheartj%2Fehr073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Itzhaki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maizels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwi-Dantsis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winterstern, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gepstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammerman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gepstein, L.</span><span> </span><span class="NLM_article-title">Modelling the long QT syndrome with induced pluripotent stem cells</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">471</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span><span class="refDoi"> DOI: 10.1038/nature09747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature09747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21240260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFCqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=471&publication_year=2011&pages=225-229&author=I.+Itzhakiauthor=L.+Maizelsauthor=I.+Huberauthor=L.+Zwi-Dantsisauthor=O.+Caspiauthor=A.+Wintersternauthor=O.+Feldmanauthor=A.+Gepsteinauthor=G.+Arbelauthor=H.+Hammermanauthor=M.+Boulosauthor=L.+Gepstein&title=Modelling+the+long+QT+syndrome+with+induced+pluripotent+stem+cells&doi=10.1038%2Fnature09747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Modelling the long QT syndrome with induced pluripotent stem cells</span></div><div class="casAuthors">Itzhaki, Ilanit; Maizels, Leonid; Huber, Irit; Zwi-Dantsis, Limor; Caspi, Oren; Winterstern, Aaron; Feldman, Oren; Gepstein, Amira; Arbel, Gil; Hammerman, Haim; Boulos, Monther; Gepstein, Lior</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">471</span>
        (<span class="NLM_cas:issue">7337</span>),
    <span class="NLM_cas:pages">225-229</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The ability to generate patient-specific human induced pluripotent stem cells (iPSCs) offers a new paradigm for modeling human disease and for individualizing drug testing.  Congenital long QT syndrome (LQTS) is a familial arrhythmogenic syndrome characterized by abnormal ion channel function and sudden cardiac death.  Here we report the development of a patient/disease-specific human iPSC line from a patient with type-2 LQTS (which is due to the A614V missense mutation in the KCNH2 gene).  The generated iPSCs were coaxed to differentiate into the cardiac lineage.  Detailed whole-cell patch-clamp and extracellular multielectrode recordings revealed significant prolongation of the action-potential duration in LQTS human iPSC-derived cardiomyocytes (the characteristic LQTS phenotype) when compared to healthy control cells.  Voltage-clamp studies confirmed that this action-potential-duration prolongation stems from a significant redn. of the cardiac potassium current IKr.  Importantly, LQTS-derived cells also showed marked arrhythmogenicity, characterized by early-after depolarizations and triggered arrhythmias.  We then used the LQTS human iPSC-derived cardiac-tissue model to evaluate the potency of existing and novel pharmacol. agents that may either aggravate (potassium-channel blockers) or ameliorate (calcium-channel blockers, KATP-channel openers and late sodium-channel blockers) the disease phenotype.  Our study illustrates the ability of human iPSC technol. to model the abnormal functional phenotype of an inherited cardiac disorder and to identify potential new therapeutic agents.  As such, it represents a promising paradigm to study disease mechanisms, optimize patient care (personalized medicine), and aid in the development of new therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0tlF6VEF72bVg90H21EOLACvtfcHk0lij8OPQxbaFXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFCqug%253D%253D&md5=072452fdde50fce4055e1026c4436749</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fnature09747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09747%26sid%3Dliteratum%253Aachs%26aulast%3DItzhaki%26aufirst%3DI.%26aulast%3DMaizels%26aufirst%3DL.%26aulast%3DHuber%26aufirst%3DI.%26aulast%3DZwi-Dantsis%26aufirst%3DL.%26aulast%3DCaspi%26aufirst%3DO.%26aulast%3DWinterstern%26aufirst%3DA.%26aulast%3DFeldman%26aufirst%3DO.%26aulast%3DGepstein%26aufirst%3DA.%26aulast%3DArbel%26aufirst%3DG.%26aulast%3DHammerman%26aufirst%3DH.%26aulast%3DBoulos%26aufirst%3DM.%26aulast%3DGepstein%26aufirst%3DL.%26atitle%3DModelling%2520the%2520long%2520QT%2520syndrome%2520with%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DNature%26date%3D2011%26volume%3D471%26spage%3D225%26epage%3D229%26doi%3D10.1038%2Fnature09747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Terrenoire, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, K. W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pass, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotton, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kass, R. S.</span><span> </span><span class="NLM_article-title">Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics</span> <span class="citation_source-journal">J. Gen. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.1085/jgp.201210899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1085%2Fjgp.201210899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23277474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2013&pages=61-72&author=C.+Terrenoireauthor=K.+Wangauthor=K.+W.+C.+Tungauthor=W.+K.+Chungauthor=R.+H.+Passauthor=J.+T.+Luauthor=J.+C.+Jeanauthor=A.+Omariauthor=K.+J.+Sampsonauthor=D.+N.+Kottonauthor=G.+Kellerauthor=R.+S.+Kass&title=Induced+pluripotent+stem+cells+used+to+reveal+drug+actions+in+a+long+QT+syndrome+family+with+complex+genetics&doi=10.1085%2Fjgp.201210899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics</span></div><div class="casAuthors">Terrenoire, Cecile; Wang, Kai; Tung, Kelvin W. Chan; Chung, Wendy K.; Pass, Robert H.; Lu, Jonathan T.; Jean, Jyh-Chang; Omari, Amel; Sampson, Kevin J.; Kotton, Darrell N.; Keller, Gordon; Kass, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Physiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-72</span>CODEN:
                <span class="NLM_cas:coden">JGPLAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-1295</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Understanding the basis for differential responses to drug therapies remains a challenge despite advances in genetics and genomics.  Induced pluripotent stem cells (iPSCs) offer an unprecedented opportunity to investigate the pharmacol. of disease processes in therapeutically and genetically relevant primary cell types in vitro and to interweave clin. and basic mol. data.  We report here the derivation of iPSCs from a long QT syndrome patient with complex genetics.  The proband was found to have a de novo SCN5A LQT-3 mutation (F1473C) and a polymorphism (K897T) in KCNH2, the gene for LQT-2.  Anal. of the biophysics and mol. pharmacol. of ion channels expressed in cardiomyocytes (CMs) differentiated from these iPSCs (iPSC-CMs) demonstrates a primary LQT-3 (Na+ channel) defect responsible for the arrhythmias not influenced by the KCNH2 polymorphism.  The F1473C mutation occurs in the channel inactivation gate and enhances late Na+ channel current (INaL) that is carried by channels that fail to inactivate completely and conduct increased inward current during prolonged depolarization, resulting in delayed repolarization, a prolonged QT interval, and increased risk of fatal arrhythmia.  We find a very pronounced rate dependence of INaL such that increasing the pacing rate markedly reduces INaL and, in addn., increases its inhibition by the Na+ channel blocker mexiletine.  These rate-dependent properties and drug interactions, unique to the proband's iPSC-CMs, correlate with improved management of arrhythmias in the patient and provide support for this approach in developing patient-specific clin. regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXHxUVKmw7m7Vg90H21EOLACvtfcHk0lij8OPQxbaFXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKhu7g%253D&md5=fcd46a1fb62eeddae5723c0ea93bd34e</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1085%2Fjgp.201210899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1085%252Fjgp.201210899%26sid%3Dliteratum%253Aachs%26aulast%3DTerrenoire%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DTung%26aufirst%3DK.%2BW.%2BC.%26aulast%3DChung%26aufirst%3DW.%2BK.%26aulast%3DPass%26aufirst%3DR.%2BH.%26aulast%3DLu%26aufirst%3DJ.%2BT.%26aulast%3DJean%26aufirst%3DJ.%2BC.%26aulast%3DOmari%26aufirst%3DA.%26aulast%3DSampson%26aufirst%3DK.%2BJ.%26aulast%3DKotton%26aufirst%3DD.%2BN.%26aulast%3DKeller%26aufirst%3DG.%26aulast%3DKass%26aufirst%3DR.%2BS.%26atitle%3DInduced%2520pluripotent%2520stem%2520cells%2520used%2520to%2520reveal%2520drug%2520actions%2520in%2520a%2520long%2520QT%2520syndrome%2520family%2520with%2520complex%2520genetics%26jtitle%3DJ.%2520Gen.%2520Physiol.%26date%3D2013%26volume%3D141%26spage%3D61%26epage%3D72%26doi%3D10.1085%2Fjgp.201210899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Ma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahib, N. B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liew, R.</span><span> </span><span class="NLM_article-title">Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells</span> <span class="citation_source-journal">Int. J. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">5277</span><span class="NLM_x">–</span> <span class="NLM_lpage">5286</span><span class="refDoi"> DOI: 10.1016/j.ijcard.2013.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.ijcard.2013.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23998552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A280%3ADC%252BC3sbks1yitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2013&pages=5277-5286&author=D.+Maauthor=H.+Weiauthor=Y.+Zhaoauthor=J.+Luauthor=G.+Liauthor=N.+B.+E.+Sahibauthor=T.+H.+Tanauthor=K.+Y.+Wongauthor=W.+Shimauthor=P.+Wongauthor=S.+A.+Cookauthor=R.+Liew&title=Modeling+type+3+long+QT+syndrome+with+cardiomyocytes+derived+from+patient-specific+induced+pluripotent+stem+cells&doi=10.1016%2Fj.ijcard.2013.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells</span></div><div class="casAuthors">Ma Dongrui; Wei Heming; Zhao Yongxing; Lu Jun; Li Guang; Sahib Norliza Binte Esmail; Tan Teng Hong; Wong Keng Yean; Shim Winston; Wong Philip; Cook Stuart A; Liew Reginald</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cardiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">5277-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Type 3 long QT syndrome (LQT3) is the third most common form of LQT syndrome and is characterized by QT-interval prolongation resulting from a gain-of-function mutation in SCN5A.  We aimed to establish a patient-specific human induced pluripotent stem cell (hiPSC) model of LQT3, which could be used for future drug testing and development of novel treatments for this inherited disorder.  METHODS AND RESULTS:  Dermal fibroblasts obtained from a patient with LQT3 harboring a SCN5A mutation (c.5287G>A; p.V1763M) were reprogrammed to hiPSCs via repeated transfection of mRNA encoding OCT-4, SOX-2, KLF-4, C-MYC and LIN-28. hiPSC-derived cardiomyocytes (hiPSC-CMs) were obtained via cardiac differentiation. hiPSC-CMs derived from the patient's healthy sister were used as a control.  Compared to the control, patient hiPSC-CMs exhibited dominant mutant SCN5A allele gene expression, significantly prolonged action potential duration or APD (paced CMs of control vs. patient: 226.50 ± 17.89 ms vs. 536.59 ± 37.1 ms; mean ± SEM, p < 0.005), an increased tetrodotoxin (TTX)-sensitive late or persistent Na(+) current (control vs. patient: 0.65 ± 0.11 vs. 3.16 ± 0.27 pA/pF; n = 9, p < 0.01), a positive shift of steady state inactivation and a faster recovery from inactivation.  Mexiletine, a NaV1.5 blocker, reversed the elevated late Na(+) current and prolonged APD in LQT3 hiPSC-CMs.  CONCLUSIONS:  We demonstrate that hiPSC-CMs derived from a LQT3 patient recapitulate the biophysical abnormalities that define LQT3.  The clinical significance of such an in vitro model is in the development of novel therapeutic strategies and a more personalized approach in testing drugs on patients with LQT3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaf57RHX2Q3EloaUqgkFHkfW6udTcc2eZwwJVU2YWeabntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbks1yitw%253D%253D&md5=19fe9b0c398af3a2a0816bc0df27fb9a</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.ijcard.2013.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijcard.2013.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DD.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DSahib%26aufirst%3DN.%2BB.%2BE.%26aulast%3DTan%26aufirst%3DT.%2BH.%26aulast%3DWong%26aufirst%3DK.%2BY.%26aulast%3DShim%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DP.%26aulast%3DCook%26aufirst%3DS.%2BA.%26aulast%3DLiew%26aufirst%3DR.%26atitle%3DModeling%2520type%25203%2520long%2520QT%2520syndrome%2520with%2520cardiomyocytes%2520derived%2520from%2520patient-specific%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DInt.%2520J.%2520Cardiol.%26date%3D2013%26volume%3D168%26spage%3D5277%26epage%3D5286%26doi%3D10.1016%2Fj.ijcard.2013.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Splawski, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timothy, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpe, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decher, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloise, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napolitano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condouris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tager-Flusberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priori, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, M. T.</span><span> </span><span class="NLM_article-title">Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span><span class="refDoi"> DOI: 10.1016/j.cell.2004.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.cell.2004.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=15454078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlyqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2004&pages=19-31&author=I.+Splawskiauthor=K.+W.+Timothyauthor=L.+M.+Sharpeauthor=N.+Decherauthor=P.+Kumarauthor=R.+Bloiseauthor=C.+Napolitanoauthor=P.+J.+Schwartzauthor=R.+M.+Josephauthor=K.+Condourisauthor=H.+Tager-Flusbergauthor=S.+G.+Prioriauthor=M.+C.+Sanguinettiauthor=M.+T.+Keating&title=Ca%28V%291.2+calcium+channel+dysfunction+causes+a+multisystem+disorder+including+arrhythmia+and+autism&doi=10.1016%2Fj.cell.2004.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">CaV1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism</span></div><div class="casAuthors">Splawski, Igor; Timothy, Katherine W.; Sharpe, Leah M.; Decher, Niels; Kumar, Pradeep; Bloise, Raffaella; Napolitano, Carlo; Schwartz, Peter J.; Joseph, Robert M.; Condouris, Karen; Tager-Flusberg, Helen; Priori, Silvia G.; Sanguinetti, Michael C.; Keating, Mark T.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-31</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cav1.2, the cardiac L-type calcium channel, is important for excitation and contraction of the heart.  Its role in other tissues is unclear.  Here the authors present Timothy syndrome, a novel disorder characterized by multiorgan dysfunction including lethal arrhythmias, webbing of fingers and toes, congenital heart disease, immune deficiency, intermittent hypoglycemia, cognitive abnormalities, and autism.  In every case, Timothy syndrome results from the identical, de novo Cav1.2 missense mutation G406R.  Cav1.2 is expressed in all affected tissues.  Functional expression reveals that G406R produces maintained inward Ca2+ currents by causing nearly complete loss of voltage-dependent channel inactivation.  This likely induces intracellular Ca2+ overload in multiple cell types.  In the heart, prolonged Ca2+ current delays cardiomyocyte repolarization and increases risk of arrhythmia, the ultimate cause of death in this disorder.  These discoveries establish the importance of Cav1.2 in human physiol. and development and implicate Ca2+ signaling in autism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps04snarO1XLVg90H21EOLACvtfcHk0ljqDzDnWBxmsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlyqurk%253D&md5=8000a3a4517872224787864fd130b766</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2004.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2004.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DSplawski%26aufirst%3DI.%26aulast%3DTimothy%26aufirst%3DK.%2BW.%26aulast%3DSharpe%26aufirst%3DL.%2BM.%26aulast%3DDecher%26aufirst%3DN.%26aulast%3DKumar%26aufirst%3DP.%26aulast%3DBloise%26aufirst%3DR.%26aulast%3DNapolitano%26aufirst%3DC.%26aulast%3DSchwartz%26aufirst%3DP.%2BJ.%26aulast%3DJoseph%26aufirst%3DR.%2BM.%26aulast%3DCondouris%26aufirst%3DK.%26aulast%3DTager-Flusberg%26aufirst%3DH.%26aulast%3DPriori%26aufirst%3DS.%2BG.%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DKeating%26aufirst%3DM.%2BT.%26atitle%3DCa%2528V%25291.2%2520calcium%2520channel%2520dysfunction%2520causes%2520a%2520multisystem%2520disorder%2520including%2520arrhythmia%2520and%2520autism%26jtitle%3DCell%26date%3D2004%26volume%3D119%26spage%3D19%26epage%3D31%26doi%3D10.1016%2Fj.cell.2004.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Yazawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsueh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasca, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallmayer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolmetsch, R. E.</span><span> </span><span class="NLM_article-title">Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">471</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span><span class="refDoi"> DOI: 10.1038/nature09855</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature09855" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21307850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12ntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=471&publication_year=2011&pages=230-234&author=M.+Yazawaauthor=B.+Hsuehauthor=X.+Jiaauthor=A.+M.+Pascaauthor=J.+A.+Bernsteinauthor=J.+Hallmayerauthor=R.+E.+Dolmetsch&title=Using+induced+pluripotent+stem+cells+to+investigate+cardiac+phenotypes+in+Timothy+syndrome&doi=10.1038%2Fnature09855"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome</span></div><div class="casAuthors">Yazawa, Masayuki; Hsueh, Brian; Jia, Xiaolin; Pasca, Anca M.; Bernstein, Jonathan A.; Hallmayer, Joachim; Dolmetsch, Ricardo E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">471</span>
        (<span class="NLM_cas:issue">7337</span>),
    <span class="NLM_cas:pages">230-234</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Individuals with congenital or acquired prolongation of the QT interval, or long QT syndrome (LQTS), are at risk of life-threatening ventricular arrhythmia.  LQTS is commonly genetic in origin but can also be caused or exacerbated by environmental factors.  A missense mutation in the L-type calcium channel CaV1.2 leads to LQTS in patients with Timothy syndrome.  To explore the effect of the Timothy syndrome mutation on the elec. activity and contraction of human cardiomyocytes, we reprogrammed human skin cells from Timothy syndrome patients to generate induced pluripotent stem cells, and differentiated these cells into cardiomyocytes.  Electrophysiol. recording and calcium (Ca2+) imaging studies of these cells revealed irregular contraction, excess Ca2+ influx, prolonged action potentials, irregular elec. activity and abnormal calcium transients in ventricular-like cells.  We found that roscovitine, a compd. that increases the voltage-dependent inactivation of CaV1.2 (refs. 6-8), restored the elec. and Ca2+ signaling properties of cardiomyocytes from Timothy syndrome patients.  This study provides new opportunities for studying the mol. and cellular mechanisms of cardiac arrhythmias in humans, and provides a robust assay for developing new drugs to treat these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmADo-VbfG_LVg90H21EOLACvtfcHk0ljqDzDnWBxmsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12ntr0%253D&md5=7f46402be8962c3b9d9e2706a6e48598</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1038%2Fnature09855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09855%26sid%3Dliteratum%253Aachs%26aulast%3DYazawa%26aufirst%3DM.%26aulast%3DHsueh%26aufirst%3DB.%26aulast%3DJia%26aufirst%3DX.%26aulast%3DPasca%26aufirst%3DA.%2BM.%26aulast%3DBernstein%26aufirst%3DJ.%2BA.%26aulast%3DHallmayer%26aufirst%3DJ.%26aulast%3DDolmetsch%26aufirst%3DR.%2BE.%26atitle%3DUsing%2520induced%2520pluripotent%2520stem%2520cells%2520to%2520investigate%2520cardiac%2520phenotypes%2520in%2520Timothy%2520syndrome%26jtitle%3DNature%26date%3D2011%26volume%3D471%26spage%3D230%26epage%3D234%26doi%3D10.1038%2Fnature09855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Jung, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mederos y Schnitzler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iop, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruppenthal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirschinger, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyfarth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinnecker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudermann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipp, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laugwitz, K. L.</span><span> </span><span class="NLM_article-title">Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.1002/emmm.201100194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1002%2Femmm.201100194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22174035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsVSqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=180-191&author=C.+B.+Jungauthor=A.+Morettiauthor=M.+Mederos+y+Schnitzlerauthor=L.+Iopauthor=U.+Storchauthor=M.+Bellinauthor=T.+Dornauthor=S.+Ruppenthalauthor=S.+Pfeifferauthor=A.+Goedelauthor=R.+J.+Dirschingerauthor=M.+Seyfarthauthor=J.+T.+Lamauthor=D.+Sinneckerauthor=T.+Gudermannauthor=P.+Lippauthor=K.+L.+Laugwitz&title=Dantrolene+rescues+arrhythmogenic+RYR2+defect+in+a+patient-specific+stem+cell+model+of+catecholaminergic+polymorphic+ventricular+tachycardia&doi=10.1002%2Femmm.201100194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia</span></div><div class="casAuthors">Jung, Christian B.; Moretti, Alessandra; Mederos y Schnitzler, Michael; Iop, Laura; Storch, Ursula; Bellin, Milena; Dorn, Tatjana; Ruppenthal, Sandra; Pfeiffer, Sarah; Goedel, Alexander; Dirschinger, Ralf J.; Seyfarth, Melchior; Lam, Jason T.; Sinnecker, Daniel; Gudermann, Thomas; Lipp, Peter; Laugwitz, Karl-Ludwig</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">180-191</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Coordinated release of calcium (Ca2+) from the sarcoplasmic reticulum (SR) through cardiac ryanodine receptor (RYR2) channels is essential for cardiomyocyte function.  In catecholaminergic polymorphic ventricular tachycardia (CPVT), an inherited disease characterized by stress-induced ventricular arrhythmias in young patients with structurally normal hearts, autosomal dominant mutations in RYR2 or recessive mutations in calsequestrin lead to aberrant diastolic Ca2+ release from the SR causing arrhythmogenic delayed after depolarizations (DADs).  Here, we report the generation of induced pluripotent stem cells (iPSCs) from a CPVT patient carrying a novel RYR2 S406L mutation.  In patient iPSC-derived cardiomyocytes, catecholaminergic stress led to elevated diastolic Ca2+ concns., a reduced SR Ca2+ content and an increased susceptibility to DADs and arrhythmia as compared to control myocytes.  This was due to increased frequency and duration of elementary Ca2+ release events (Ca2+ sparks).  Dantrolene, a drug effective on malignant hyperthermia, restored normal Ca2+ spark properties and rescued the arrhythmogenic phenotype.  This suggests defective inter-domain interactions within the RYR2 channel as the pathomechanism of the S406L mutation.  Our work provides a new in vitro model to study the pathogenesis of human cardiac arrhythmias and develop novel therapies for CPVT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQRKsXLyXJq7Vg90H21EOLACvtfcHk0ljqDzDnWBxmsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsVSqs7c%253D&md5=0e2eeafcbaf583a7bb267f483a28431c</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1002%2Femmm.201100194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201100194%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DC.%2BB.%26aulast%3DMoretti%26aufirst%3DA.%26aulast%3DMederos%2By%2BSchnitzler%26aufirst%3DM.%26aulast%3DIop%26aufirst%3DL.%26aulast%3DStorch%26aufirst%3DU.%26aulast%3DBellin%26aufirst%3DM.%26aulast%3DDorn%26aufirst%3DT.%26aulast%3DRuppenthal%26aufirst%3DS.%26aulast%3DPfeiffer%26aufirst%3DS.%26aulast%3DGoedel%26aufirst%3DA.%26aulast%3DDirschinger%26aufirst%3DR.%2BJ.%26aulast%3DSeyfarth%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DJ.%2BT.%26aulast%3DSinnecker%26aufirst%3DD.%26aulast%3DGudermann%26aufirst%3DT.%26aulast%3DLipp%26aufirst%3DP.%26aulast%3DLaugwitz%26aufirst%3DK.%2BL.%26atitle%3DDantrolene%2520rescues%2520arrhythmogenic%2520RYR2%2520defect%2520in%2520a%2520patient-specific%2520stem%2520cell%2520model%2520of%2520catecholaminergic%2520polymorphic%2520ventricular%2520tachycardia%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D180%26epage%3D191%26doi%3D10.1002%2Femmm.201100194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Itzhaki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maizels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gepstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belhassen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nof, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glikson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gepstein, L.</span><span> </span><span class="NLM_article-title">Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">990</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span><span class="refDoi"> DOI: 10.1016/j.jacc.2012.02.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.jacc.2012.02.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22749309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtlams77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=990-1000&author=I.+Itzhakiauthor=L.+Maizelsauthor=I.+Huberauthor=A.+Gepsteinauthor=G.+Arbelauthor=O.+Caspiauthor=L.+Millerauthor=B.+Belhassenauthor=E.+Nofauthor=M.+Gliksonauthor=L.+Gepstein&title=Modeling+of+catecholaminergic+polymorphic+ventricular+tachycardia+with+patient-specific+human-induced+pluripotent+stem+cells&doi=10.1016%2Fj.jacc.2012.02.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling of Catecholaminergic Polymorphic Ventricular Tachycardia With Patient-Specific Human-Induced Pluripotent Stem Cells</span></div><div class="casAuthors">Itzhaki, Ilanit; Maizels, Leonid; Huber, Irit; Gepstein, Amira; Arbel, Gil; Caspi, Oren; Miller, Liron; Belhassen, Bernard; Nof, Eyal; Glikson, Michael; Gepstein, Lior</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">990-1000</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Objectives: The goal of this study was to establish a patient-specific human-induced pluripotent stem cells (hiPSCs) model of catecholaminergic polymorphic ventricular tachycardia (CPVT).  Background: CPVT is a familial arrhythmogenic syndrome characterized by abnormal calcium (Ca2+) handling, ventricular arrhythmias, and sudden cardiac death.  Methods: Dermal fibroblasts were obtained from a CPVT patient due to the M4109R heterozygous point RYR2 mutation and reprogrammed to generate the CPVT-hiPSCs.  The patient-specific hiPSCs were coaxed to differentiate into the cardiac lineage and compared with healthy control hiPSCs-derived cardiomyocytes (hiPSCs-CMs).  Results: Intracellular electrophysiol. recordings demonstrated the development of delayed afterdepolarizations in 69% of the CPVT-hiPSCs-CMs compared with 11% in healthy control cardiomyocytes.  Adrenergic stimulation by isoproterenol (1 μM) or forskolin (5 μM) increased the frequency and magnitude of afterdepolarizations and also led to development of triggered activity in the CPVT-hiPSCs-CMs.  In contrast, flecainide (10 μM) and thapsigargin (10 μM) eliminated all afterdepolarizations in these cells.  The latter finding suggests an important role for internal Ca2+ stores in the pathogenesis of delayed afterdepolarizations.  Laser-confocal Ca2+ imaging revealed significant whole-cell [Ca2+] transient irregularities (frequent local and large-storage Ca2+-release events, broad and double-humped transients, and triggered activity) in the CPVT cardiomyocytes that worsened with adrenergic stimulation and Ca2+ overload and improved with beta-blockers.  Store-overload-induced Ca2+ release was also identified in the hiPSCs-CMs and the threshold for such events was significantly reduced in the CPVT cells.  Conclusions: This study highlights the potential of hiPSCs for studying inherited arrhythmogenic syndromes, in general, and CPVT specifically.  As such, it represents a promising paradigm to study disease mechanisms, optimize patient care, and aid in the development of new therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiKTJkTROOebVg90H21EOLACvtfcHk0ljRlvRoetVVHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtlams77P&md5=7d828d7836d499600a2764b7fd194cf1</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2012.02.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2012.02.066%26sid%3Dliteratum%253Aachs%26aulast%3DItzhaki%26aufirst%3DI.%26aulast%3DMaizels%26aufirst%3DL.%26aulast%3DHuber%26aufirst%3DI.%26aulast%3DGepstein%26aufirst%3DA.%26aulast%3DArbel%26aufirst%3DG.%26aulast%3DCaspi%26aufirst%3DO.%26aulast%3DMiller%26aufirst%3DL.%26aulast%3DBelhassen%26aufirst%3DB.%26aulast%3DNof%26aufirst%3DE.%26aulast%3DGlikson%26aufirst%3DM.%26aulast%3DGepstein%26aufirst%3DL.%26atitle%3DModeling%2520of%2520catecholaminergic%2520polymorphic%2520ventricular%2520tachycardia%2520with%2520patient-specific%2520human-induced%2520pluripotent%2520stem%2520cells%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2012%26volume%3D60%26spage%3D990%26epage%3D1000%26doi%3D10.1016%2Fj.jacc.2012.02.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Maron, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Towbin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiene, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antzelevitch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrado, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidman, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. B.</span><span> </span><span class="NLM_article-title">Contemporary definitions and classification of the cardiomyopathies. An American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">1807</span><span class="NLM_x">–</span> <span class="NLM_lpage">1816</span><span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.106.174287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1161%2FCIRCULATIONAHA.106.174287" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2006&pages=1807-1816&author=B.+J.+Maronauthor=J.+A.+Towbinauthor=G.+Thieneauthor=C.+Antzelevitchauthor=D.+Corradoauthor=D.+Arnettauthor=A.+J.+Mossauthor=C.+E.+Seidmanauthor=J.+B.+Young&title=Contemporary+definitions+and+classification+of+the+cardiomyopathies.+An+American+Heart+Association+scientific+statement+from+the+Council+on+Clinical+Cardiology%2C+Heart+Failure+and+Transplantation+Committee%3B+Quality+of+Care+and+Outcomes+Research+and+Functional+Genomics+and+Translational+Biology+Interdisciplinary+Working+Groups%3B+and+Council+on+Epidemiology+and+Prevention&doi=10.1161%2FCIRCULATIONAHA.106.174287"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.106.174287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.106.174287%26sid%3Dliteratum%253Aachs%26aulast%3DMaron%26aufirst%3DB.%2BJ.%26aulast%3DTowbin%26aufirst%3DJ.%2BA.%26aulast%3DThiene%26aufirst%3DG.%26aulast%3DAntzelevitch%26aufirst%3DC.%26aulast%3DCorrado%26aufirst%3DD.%26aulast%3DArnett%26aufirst%3DD.%26aulast%3DMoss%26aufirst%3DA.%2BJ.%26aulast%3DSeidman%26aufirst%3DC.%2BE.%26aulast%3DYoung%26aufirst%3DJ.%2BB.%26atitle%3DContemporary%2520definitions%2520and%2520classification%2520of%2520the%2520cardiomyopathies.%2520An%2520American%2520Heart%2520Association%2520scientific%2520statement%2520from%2520the%2520Council%2520on%2520Clinical%2520Cardiology%252C%2520Heart%2520Failure%2520and%2520Transplantation%2520Committee%253B%2520Quality%2520of%2520Care%2520and%2520Outcomes%2520Research%2520and%2520Functional%2520Genomics%2520and%2520Translational%2520Biology%2520Interdisciplinary%2520Working%2520Groups%253B%2520and%2520Council%2520on%2520Epidemiology%2520and%2520Prevention%26jtitle%3DCirculation%26date%3D2006%26volume%3D113%26spage%3D1807%26epage%3D1816%26doi%3D10.1161%2FCIRCULATIONAHA.106.174287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Sun, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yazawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Freire, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abilez, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarrete, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlovic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajjar, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolmetsch, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butte, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashley, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longaker, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span> </span><span class="NLM_article-title">Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">130ra47</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3003552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1126%2Fscitranslmed.3003552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22517884" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=130ra47&author=N.+Sunauthor=M.+Yazawaauthor=J.+Liuauthor=L.+Hanauthor=V.+Sanchez-Freireauthor=O.+J.+Abilezauthor=E.+G.+Navarreteauthor=S.+Huauthor=L.+Wangauthor=A.+Leeauthor=A.+Pavlovicauthor=S.+Linauthor=R.+Chenauthor=R.+J.+Hajjarauthor=M.+P.+Snyderauthor=R.+E.+Dolmetschauthor=M.+J.+Butteauthor=E.+A.+Ashleyauthor=M.+T.+Longakerauthor=R.+C.+Robbinsauthor=J.+C.+Wu&title=Patient-specific+induced+pluripotent+stem+cells+as+a+model+for+familial+dilated+cardiomyopathy&doi=10.1126%2Fscitranslmed.3003552"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003552%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DN.%26aulast%3DYazawa%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DSanchez-Freire%26aufirst%3DV.%26aulast%3DAbilez%26aufirst%3DO.%2BJ.%26aulast%3DNavarrete%26aufirst%3DE.%2BG.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DPavlovic%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DHajjar%26aufirst%3DR.%2BJ.%26aulast%3DSnyder%26aufirst%3DM.%2BP.%26aulast%3DDolmetsch%26aufirst%3DR.%2BE.%26aulast%3DButte%26aufirst%3DM.%2BJ.%26aulast%3DAshley%26aufirst%3DE.%2BA.%26aulast%3DLongaker%26aufirst%3DM.%2BT.%26aulast%3DRobbins%26aufirst%3DR.%2BC.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26atitle%3DPatient-specific%2520induced%2520pluripotent%2520stem%2520cells%2520as%2520a%2520model%2520for%2520familial%2520dilated%2520cardiomyopathy%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D130ra47%26doi%3D10.1126%2Fscitranslmed.3003552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Maron, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flack, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gidding, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurosaki, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bild, D. E.</span><span> </span><span class="NLM_article-title">Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">785</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span><span class="refDoi"> DOI: 10.1161/01.CIR.92.4.785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1161%2F01.CIR.92.4.785" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=785-789&author=B.+J.+Maronauthor=J.+M.+Gardinauthor=J.+M.+Flackauthor=S.+S.+Giddingauthor=T.+T.+Kurosakiauthor=D.+E.+Bild&title=Prevalence+of+hypertrophic+cardiomyopathy+in+a+general+population+of+young+adults.+Echocardiographic+analysis+of+4111+subjects+in+the+CARDIA+Study.+Coronary+Artery+Risk+Development+in+%28Young%29+Adults&doi=10.1161%2F01.CIR.92.4.785"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.92.4.785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.92.4.785%26sid%3Dliteratum%253Aachs%26aulast%3DMaron%26aufirst%3DB.%2BJ.%26aulast%3DGardin%26aufirst%3DJ.%2BM.%26aulast%3DFlack%26aufirst%3DJ.%2BM.%26aulast%3DGidding%26aufirst%3DS.%2BS.%26aulast%3DKurosaki%26aufirst%3DT.%2BT.%26aulast%3DBild%26aufirst%3DD.%2BE.%26atitle%3DPrevalence%2520of%2520hypertrophic%2520cardiomyopathy%2520in%2520a%2520general%2520population%2520of%2520young%2520adults.%2520Echocardiographic%2520analysis%2520of%25204111%2520subjects%2520in%2520the%2520CARDIA%2520Study.%2520Coronary%2520Artery%2520Risk%2520Development%2520in%2520%2528Young%2529%2520Adults%26jtitle%3DCirculation%26date%3D1995%26volume%3D92%26spage%3D785%26epage%3D789%26doi%3D10.1161%2F01.CIR.92.4.785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Seidman, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidman, C.</span><span> </span><span class="NLM_article-title">The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span><span class="refDoi"> DOI: 10.1016/S0092-8674(01)00242-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2FS0092-8674%2801%2900242-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=11239412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD3MXis1Kks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=557-567&author=J.+G.+Seidmanauthor=C.+Seidman&title=The+genetic+basis+for+cardiomyopathy%3A+from+mutation+identification+to+mechanistic+paradigms&doi=10.1016%2FS0092-8674%2801%2900242-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms</span></div><div class="casAuthors">Seidman, J. G.; Seidman, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">557-567</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with 65 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqknf4bycp-LbVg90H21EOLACvtfcHk0ljifgxZak0MBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXis1Kks70%253D&md5=93f19640f7d7b5462203bb5185b09ecb</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2801%2900242-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252801%252900242-2%26sid%3Dliteratum%253Aachs%26aulast%3DSeidman%26aufirst%3DJ.%2BG.%26aulast%3DSeidman%26aufirst%3DC.%26atitle%3DThe%2520genetic%2520basis%2520for%2520cardiomyopathy%253A%2520from%2520mutation%2520identification%2520to%2520mechanistic%2520paradigms%26jtitle%3DCell%26date%3D2001%26volume%3D104%26spage%3D557%26epage%3D567%26doi%3D10.1016%2FS0092-8674%2801%2900242-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Lan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Freire, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abilez, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarrete, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashley, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bers, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longaker, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span> </span><span class="NLM_article-title">Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1016/j.stem.2012.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.stem.2012.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23290139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvFSgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=101-113&author=F.+Lanauthor=A.+S.+Leeauthor=P.+Liangauthor=V.+Sanchez-Freireauthor=P.+K.+Nguyenauthor=L.+Wangauthor=L.+Hanauthor=M.+Yenauthor=Y.+Wangauthor=N.+Sunauthor=O.+J.+Abilezauthor=S.+Huauthor=A.+D.+Ebertauthor=E.+G.+Navarreteauthor=C.+S.+Simmonsauthor=M.+Wheelerauthor=B.+Pruittauthor=R.+Lewisauthor=Y.+Yamaguchiauthor=E.+A.+Ashleyauthor=D.+M.+Bersauthor=R.+C.+Robbinsauthor=M.+T.+Longakerauthor=J.+C.+Wu&title=Abnormal+calcium+handling+properties+underlie+familial+hypertrophic+cardiomyopathy+pathology+in+patient-specific+induced+pluripotent+stem+cells&doi=10.1016%2Fj.stem.2012.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells</span></div><div class="casAuthors">Lan, Feng; Lee, Andrew S.; Liang, Ping; Sanchez-Freire, Veronica; Nguyen, Patricia K.; Wang, Li; Han, Leng; Yen, Michelle; Wang, Yongming; Sun, Ning; Abilez, Oscar J.; Hu, Shijun; Ebert, Antje D.; Navarrete, Enrique G.; Simmons, Chelsey S.; Wheeler, Matthew; Pruitt, Beth; Lewis, Richard; Yamaguchi, Yoshinori; Ashley, Euan A.; Bers, Donald M.; Robbins, Robert C.; Longaker, Michael T.; Wu, Joseph C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stem Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-113</span>CODEN:
                <span class="NLM_cas:coden">CSCEC4</span>;
        ISSN:<span class="NLM_cas:issn">1875-9777</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Familial hypertrophic cardiomyopathy (HCM) is a prevalent hereditary cardiac disorder linked to arrhythmia and sudden cardiac death.  While the causes of HCM have been identified as genetic mutations in the cardiac sarcomere, the pathways by which sarcomeric mutations engender myocyte hypertrophy and electrophysiol. abnormalities are not understood.  To elucidate the mechanisms underlying HCM development, we generated patient-specific induced pluripotent stem cell cardiomyocytes (iPSC-CMs) from a ten-member family cohort carrying a hereditary HCM missense mutation (Arg663His) in the MYH7 gene.  Diseased iPSC-CMs recapitulated numerous aspects of the HCM phenotype including cellular enlargement and contractile arrhythmia at the single-cell level.  Calcium (Ca2+) imaging indicated dysregulation of Ca2+ cycling and elevation in intracellular Ca2+ ([Ca2+]i) are central mechanisms for disease pathogenesis.  Pharmacol. restoration of Ca2+ homeostasis prevented development of hypertrophy and electrophysiol. irregularities.  We anticipate that these findings will help elucidate the mechanisms underlying HCM development and identify novel therapies for the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk0LUjCaJ0srVg90H21EOLACvtfcHk0ljifgxZak0MBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvFSgug%253D%253D&md5=0d963482b3ed3f5e954401d4005b3bca</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2012.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2012.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DA.%2BS.%26aulast%3DLiang%26aufirst%3DP.%26aulast%3DSanchez-Freire%26aufirst%3DV.%26aulast%3DNguyen%26aufirst%3DP.%2BK.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DN.%26aulast%3DAbilez%26aufirst%3DO.%2BJ.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DEbert%26aufirst%3DA.%2BD.%26aulast%3DNavarrete%26aufirst%3DE.%2BG.%26aulast%3DSimmons%26aufirst%3DC.%2BS.%26aulast%3DWheeler%26aufirst%3DM.%26aulast%3DPruitt%26aufirst%3DB.%26aulast%3DLewis%26aufirst%3DR.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DAshley%26aufirst%3DE.%2BA.%26aulast%3DBers%26aufirst%3DD.%2BM.%26aulast%3DRobbins%26aufirst%3DR.%2BC.%26aulast%3DLongaker%26aufirst%3DM.%2BT.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26atitle%3DAbnormal%2520calcium%2520handling%2520properties%2520underlie%2520familial%2520hypertrophic%2520cardiomyopathy%2520pathology%2520in%2520patient-specific%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2013%26volume%3D12%26spage%3D101%26epage%3D113%26doi%3D10.1016%2Fj.stem.2012.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Clarke, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groves, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newbury-Ecob, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai-Goodman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garratt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damin, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steward, C. G.</span><span> </span><span class="NLM_article-title">Barth syndrome</span> <span class="citation_source-journal">Orphanet J. Rare Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="refDoi"> DOI: 10.1186/1750-1172-8-23</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1186%2F1750-1172-8-23" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23398819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A280%3ADC%252BC3sznt1ykuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=23&author=S.+L.+Clarkeauthor=A.+Bowronauthor=I.+L.+Gonzalezauthor=S.+J.+Grovesauthor=R.+Newbury-Ecobauthor=N.+Claytonauthor=R.+P.+Martinauthor=B.+Tsai-Goodmanauthor=V.+Garrattauthor=M.+Ashworthauthor=V.+M.+Bowenauthor=K.+R.+McCurdyauthor=M.+K.+Daminauthor=C.+T.+Spencerauthor=M.+J.+Tothauthor=R.+I.+Kelleyauthor=C.+G.+Steward&title=Barth+syndrome&doi=10.1186%2F1750-1172-8-23"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Barth syndrome</span></div><div class="casAuthors">Clarke Sarah L N; Bowron Ann; Gonzalez Iris L; Groves Sarah J; Newbury-Ecob Ruth; Clayton Nicol; Martin Robin P; Tsai-Goodman Beverly; Garratt Vanessa; Ashworth Michael; Bowen Valerie M; McCurdy Katherine R; Damin Michaela K; Spencer Carolyn T; Toth Matthew J; Kelley Richard I; Steward Colin G</div><div class="citationInfo"><span class="NLM_cas:title">Orphanet journal of rare diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> First described in 1983, Barth syndrome (BTHS) is widely regarded as a rare X-linked genetic disease characterised by cardiomyopathy (CM), skeletal myopathy, growth delay, neutropenia and increased urinary excretion of 3-methylglutaconic acid (3-MGCA).  Fewer than 200 living males are known worldwide, but evidence is accumulating that the disorder is substantially under-diagnosed.  Clinical features include variable combinations of the following wide spectrum: dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), endocardial fibroelastosis (EFE), left ventricular non-compaction (LVNC), ventricular arrhythmia, sudden cardiac death, prolonged QTc interval, delayed motor milestones, proximal myopathy, lethargy and fatigue, neutropenia (absent to severe; persistent, intermittent or perfectly cyclical), compensatory monocytosis, recurrent bacterial infection, hypoglycaemia, lactic acidosis, growth and pubertal delay, feeding problems, failure to thrive, episodic diarrhoea, characteristic facies, and X-linked family history.  Historically regarded as a cardiac disease, BTHS is now considered a multi-system disorder which may be first seen by many different specialists or generalists.  Phenotypic breadth and variability present a major challenge to the diagnostician: some children with BTHS have never been neutropenic, whereas others lack increased 3-MGCA and a minority has occult or absent CM.  Furthermore, BTHS was first described in 2010 as an unrecognised cause of fetal death.  Disabling mutations or deletions of the tafazzin (TAZ) gene, located at Xq28, cause the disorder by reducing remodeling of cardiolipin, a principal phospholipid of the inner mitochondrial membrane.  A definitive biochemical test, based on detecting abnormal ratios of different cardiolipin species, was first described in 2008.  Key areas of differential diagnosis include metabolic and viral cardiomyopathies, mitochondrial diseases, and many causes of neutropenia and recurrent male miscarriage and stillbirth.  Cardiolipin testing and TAZ sequencing now provide relatively rapid diagnostic testing, both prospectively and retrospectively, from a range of fresh or stored tissues, blood or neonatal bloodspots.  TAZ sequencing also allows female carrier detection and antenatal screening.  Management of BTHS includes medical therapy of CM, cardiac transplantation (in 14% of patients), antibiotic prophylaxis and granulocyte colony-stimulating factor (G-CSF) therapy.  Multidisciplinary teams/clinics are essential for minimising hospital attendances and allowing many more individuals with BTHS to live into adulthood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTvqpUSzxD09H6oPH0mYWL1fW6udTcc2eYWbI7OoPxGUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sznt1ykuw%253D%253D&md5=116e6ea66b01eb3e16adbfd1670ebbbd</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1186%2F1750-1172-8-23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1172-8-23%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DS.%2BL.%26aulast%3DBowron%26aufirst%3DA.%26aulast%3DGonzalez%26aufirst%3DI.%2BL.%26aulast%3DGroves%26aufirst%3DS.%2BJ.%26aulast%3DNewbury-Ecob%26aufirst%3DR.%26aulast%3DClayton%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DR.%2BP.%26aulast%3DTsai-Goodman%26aufirst%3DB.%26aulast%3DGarratt%26aufirst%3DV.%26aulast%3DAshworth%26aufirst%3DM.%26aulast%3DBowen%26aufirst%3DV.%2BM.%26aulast%3DMcCurdy%26aufirst%3DK.%2BR.%26aulast%3DDamin%26aufirst%3DM.%2BK.%26aulast%3DSpencer%26aufirst%3DC.%2BT.%26aulast%3DToth%26aufirst%3DM.%2BJ.%26aulast%3DKelley%26aufirst%3DR.%2BI.%26aulast%3DSteward%26aufirst%3DC.%2BG.%26atitle%3DBarth%2520syndrome%26jtitle%3DOrphanet%2520J.%2520Rare%2520Dis.%26date%3D2013%26volume%3D8%26spage%3D23%26doi%3D10.1186%2F1750-1172-8-23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Chicco, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparagna, G. C.</span><span> </span><span class="NLM_article-title">Role of cardiolipin alterations in mitochondrial dysfunction and disease</span> <span class="citation_source-journal">Am. J. Physiol.: Cell Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">C33</span><span class="NLM_x">–</span> <span class="NLM_lpage">C44</span><span class="refDoi"> DOI: 10.1152/ajpcell.00243.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1152%2Fajpcell.00243.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=16899548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisFCrtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2007&pages=C33-C44&author=A.+J.+Chiccoauthor=G.+C.+Sparagna&title=Role+of+cardiolipin+alterations+in+mitochondrial+dysfunction+and+disease&doi=10.1152%2Fajpcell.00243.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Role of cardiolipin alterations in mitochondrial dysfunction and disease</span></div><div class="casAuthors">Chicco, Adam J.; Sparagna, Genevieve C.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">1, Pt. 1</span>),
    <span class="NLM_cas:pages">C33-C44</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Cardiolipin (CL) is a structurally unique dimeric phospholipid localized in the inner mitochondrial membrane where it is required for optimal mitochondrial function.  In addn. to its role in maintaining membrane potential and architecture, CL is known to provide essential structural and functional support to several proteins involved in mitochondrial bioenergetics.  A loss of CL content, alterations in its acyl chain compn., and/or CL peroxidn. have been assocd. with mitochondrial dysfunction in multiple tissues in a variety of pathol. conditions, including ischemia, hypothyroidism, aging, and heart failure.  Recently, aberrations in CL metab. have been implicated as a primary causative factor in the cardioskeletal myopathy known as Barth syndrome, underscoring an important role of CL in human health and disease.  The purpose of this review is to provide an overview of evidence that has linked changes in the CL profile to mitochondrial dysfunction in various pathol. conditions.  In addn., a brief overview of CL function and biosynthesis, and a discussion of methods used to examine CL in biol. tissues are provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOa1v_OV2Lk7Vg90H21EOLACvtfcHk0lhYKH0rErttQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisFCrtLo%253D&md5=285ac00edecb0847edafc891c984c550</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00243.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00243.2006%26sid%3Dliteratum%253Aachs%26aulast%3DChicco%26aufirst%3DA.%2BJ.%26aulast%3DSparagna%26aufirst%3DG.%2BC.%26atitle%3DRole%2520of%2520cardiolipin%2520alterations%2520in%2520mitochondrial%2520dysfunction%2520and%2520disease%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Cell%2520Physiol.%26date%3D2007%26volume%3D292%26spage%3DC33%26epage%3DC44%26doi%3D10.1152%2Fajpcell.00243.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCain, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasqualini, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zangi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geva, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanders, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulik, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laflamme, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murry, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Church, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, W. T.</span><span> </span><span class="NLM_article-title">Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span><span class="refDoi"> DOI: 10.1038/nm.3545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnm.3545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24813252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslGksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=616-623&author=G.+Wangauthor=M.+L.+McCainauthor=L.+Yangauthor=A.+Heauthor=F.+S.+Pasqualiniauthor=A.+Agarwalauthor=H.+Yuanauthor=D.+Jiangauthor=D.+Zhangauthor=L.+Zangiauthor=J.+Gevaauthor=A.+E.+Robertsauthor=Q.+Maauthor=J.+Dingauthor=J.+Chenauthor=D.+Z.+Wangauthor=K.+Liauthor=J.+Wangauthor=R.+J.+Wandersauthor=W.+Kulikauthor=F.+M.+Vazauthor=M.+A.+Laflammeauthor=C.+E.+Murryauthor=K.+R.+Chienauthor=R.+I.+Kelleyauthor=G.+M.+Churchauthor=K.+K.+Parkerauthor=W.+T.+Pu&title=Modeling+the+mitochondrial+cardiomyopathy+of+Barth+syndrome+with+induced+pluripotent+stem+cell+and+heart-on-chip+technologies&doi=10.1038%2Fnm.3545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies</span></div><div class="casAuthors">Wang, Gang; McCain, Megan L.; Yang, Luhan; He, Aibin; Pasqualini, Francesco Silvio; Agarwal, Ashutosh; Yuan, Hongyan; Jiang, Dawei; Zhang, Donghui; Zangi, Lior; Geva, Judith; Roberts, Amy E.; Ma, Qing; Ding, Jian; Chen, Jinghai; Wang, Da-Zhi; Li, Kai; Wang, Jiwu; Wanders, Ronald J. A.; Kulik, Wim; Vaz, Frederic M.; Laflamme, Michael A.; Murry, Charles E.; Chien, Kenneth R.; Kelley, Richard I.; Church, George M.; Parker, Kevin Kit; Pu, William T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">616-623</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Study of monogenic mitochondrial cardiomyopathies may yield insights into mitochondrial roles in cardiac development and disease.  Here, the authors combined patient-derived and genetically engineered induced pluripotent stem cells (iPSCs) with tissue engineering to elucidate the pathophysiol. underlying the cardiomyopathy of Barth syndrome (BTHS), a mitochondrial disorder caused by mutation of the gene encoding tafazzin (TAZ).  Using BTHS iPSC-derived cardiomyocytes (iPSC-CMs), the authors defined metabolic, structural and functional abnormalities assocd. with TAZ mutation.  BTHS iPSC-CMs assembled sparse and irregular sarcomeres, and engineered BTHS 'heart-on-chip' tissues contracted weakly.  Gene replacement and genome editing demonstrated that TAZ mutation is necessary and sufficient for these phenotypes.  Sarcomere assembly and myocardial contraction abnormalities occurred in the context of normal whole-cell ATP levels.  Excess levels of reactive oxygen species mechanistically linked TAZ mutation to impaired cardiomyocyte function.  The authors' study provides new insights into the pathogenesis of Barth syndrome, suggests new treatment strategies and advances iPSC-based in vitro modeling of cardiomyopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTOrzLZKI7VLVg90H21EOLACvtfcHk0lhYKH0rErttQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslGksrs%253D&md5=75baa7830e2c6bb709d99897575e9e1d</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1038%2Fnm.3545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3545%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%26aulast%3DMcCain%26aufirst%3DM.%2BL.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DA.%26aulast%3DPasqualini%26aufirst%3DF.%2BS.%26aulast%3DAgarwal%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DZangi%26aufirst%3DL.%26aulast%3DGeva%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DA.%2BE.%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DD.%2BZ.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWanders%26aufirst%3DR.%2BJ.%26aulast%3DKulik%26aufirst%3DW.%26aulast%3DVaz%26aufirst%3DF.%2BM.%26aulast%3DLaflamme%26aufirst%3DM.%2BA.%26aulast%3DMurry%26aufirst%3DC.%2BE.%26aulast%3DChien%26aufirst%3DK.%2BR.%26aulast%3DKelley%26aufirst%3DR.%2BI.%26aulast%3DChurch%26aufirst%3DG.%2BM.%26aulast%3DParker%26aufirst%3DK.%2BK.%26aulast%3DPu%26aufirst%3DW.%2BT.%26atitle%3DModeling%2520the%2520mitochondrial%2520cardiomyopathy%2520of%2520Barth%2520syndrome%2520with%2520induced%2520pluripotent%2520stem%2520cell%2520and%2520heart-on-chip%2520technologies%26jtitle%3DNat.%2520Med.%26date%3D2014%26volume%3D20%26spage%3D616%26epage%3D623%26doi%3D10.1038%2Fnm.3545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Drawnel, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boccardo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prummer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delobel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gérard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kam-Thong, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoflack, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiialainen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeworutzki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burcin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gromo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehringer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnone, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaja, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacone, R.</span><span> </span><span class="NLM_article-title">Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">810</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span><span class="refDoi"> DOI: 10.1016/j.celrep.2014.09.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.celrep.2014.09.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=25437537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslGnsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=810-821&author=F.+M.+Drawnelauthor=S.+Boccardoauthor=M.+Prummerauthor=F.+Delobelauthor=A.+Graffauthor=M.+Weberauthor=R.+G%C3%A9rardauthor=L.+Badiauthor=T.+Kam-Thongauthor=L.+Buauthor=X.+Jiangauthor=J.+C.+Hoflackauthor=A.+Kiialainenauthor=E.+Jeworutzkiauthor=N.+Aoyamaauthor=C.+Carlsonauthor=M.+Burcinauthor=G.+Gromoauthor=M.+Boehringerauthor=H.+Stahlbergauthor=B.+J.+Hallauthor=M.+C.+Magnoneauthor=K.+Kolajaauthor=K.+R.+Chienauthor=J.+Baillyauthor=R.+Iacone&title=Disease+modeling+and+phenotypic+drug+screening+for+diabetic+cardiomyopathy+using+human+induced+pluripotent+stem+cells&doi=10.1016%2Fj.celrep.2014.09.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Disease Modeling and Phenotypic Drug Screening for Diabetic Cardiomyopathy using Human Induced Pluripotent Stem Cells</span></div><div class="casAuthors">Drawnel, Faye M.; Boccardo, Stefano; Prummer, Michael; Delobel, Frederic; Graff, Alexandra; Weber, Michael; Gerard, Regine; Badi, Laura; Kam-Thong, Tony; Bu, Lei; Jiang, Xin; Hoflack, Jean-Christophe; Kiialainen, Anna; Jeworutzki, Elena; Aoyama, Natsuyo; Carlson, Coby; Burcin, Mark; Gromo, Gianni; Boehringer, Markus; Stahlberg, Henning; Hall, Benjamin J.; Magnone, Maria Chiara; Kolaja, Kyle; Chien, Kenneth R.; Bailly, Jacques; Iacone, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">810-820</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Diabetic cardiomyopathy is a complication of type 2 diabetes, with known contributions of lifestyle and genetics.  We develop environmentally and genetically driven in vitro models of the condition using human-induced-pluripotent-stem-cell-derived cardiomyocytes.  First, we mimic diabetic clin. chem. to induce a phenotypic surrogate of diabetic cardiomyopathy, observing structural and functional disarray.  Next, we consider genetic effects by deriving cardiomyocytes from two diabetic patients with variable disease progression.  The cardiomyopathic phenotype is recapitulated in the patient-specific cells basally, with a severity dependent on their original clin. status.  These models are incorporated into successive levels of a screening platform, identifying drugs that preserve cardiomyocyte phenotype in vitro during diabetic stress.  In this work, we present a patient-specific induced pluripotent stem cell (iPSC) model of a complex metabolic condition, showing the power of this technique for discovery and testing of therapeutic strategies for a disease with ever-increasing clin. significance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOPqKgXN3X7LVg90H21EOLACvtfcHk0liTuTYvskCTQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslGnsbnF&md5=3d2a3fcc6ab844cf3017ecac5e06e4b1</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.09.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.09.055%26sid%3Dliteratum%253Aachs%26aulast%3DDrawnel%26aufirst%3DF.%2BM.%26aulast%3DBoccardo%26aufirst%3DS.%26aulast%3DPrummer%26aufirst%3DM.%26aulast%3DDelobel%26aufirst%3DF.%26aulast%3DGraff%26aufirst%3DA.%26aulast%3DWeber%26aufirst%3DM.%26aulast%3DG%25C3%25A9rard%26aufirst%3DR.%26aulast%3DBadi%26aufirst%3DL.%26aulast%3DKam-Thong%26aufirst%3DT.%26aulast%3DBu%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DHoflack%26aufirst%3DJ.%2BC.%26aulast%3DKiialainen%26aufirst%3DA.%26aulast%3DJeworutzki%26aufirst%3DE.%26aulast%3DAoyama%26aufirst%3DN.%26aulast%3DCarlson%26aufirst%3DC.%26aulast%3DBurcin%26aufirst%3DM.%26aulast%3DGromo%26aufirst%3DG.%26aulast%3DBoehringer%26aufirst%3DM.%26aulast%3DStahlberg%26aufirst%3DH.%26aulast%3DHall%26aufirst%3DB.%2BJ.%26aulast%3DMagnone%26aufirst%3DM.%2BC.%26aulast%3DKolaja%26aufirst%3DK.%26aulast%3DChien%26aufirst%3DK.%2BR.%26aulast%3DBailly%26aufirst%3DJ.%26aulast%3DIacone%26aufirst%3DR.%26atitle%3DDisease%2520modeling%2520and%2520phenotypic%2520drug%2520screening%2520for%2520diabetic%2520cardiomyopathy%2520using%2520human%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D9%26spage%3D810%26epage%3D821%26doi%3D10.1016%2Fj.celrep.2014.09.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Yi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izpisúa Belmonte, J. C.</span><span> </span><span class="NLM_article-title">Human induced pluripotent stem cells derived hepatocytes: rising promise for disease modeling, drug development and cell therapy</span> <span class="citation_source-journal">Protein Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span><span class="refDoi"> DOI: 10.1007/s13238-012-2918-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1007%2Fs13238-012-2918-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=22441839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFOgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=246-250&author=F.+Yiauthor=G.+H.+Liuauthor=J.+C.+Izpis%C3%BAa+Belmonte&title=Human+induced+pluripotent+stem+cells+derived+hepatocytes%3A+rising+promise+for+disease+modeling%2C+drug+development+and+cell+therapy&doi=10.1007%2Fs13238-012-2918-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Human induced pluripotent stem cells derived hepatocytes: rising promise for disease modeling, drug development and cell therapy</span></div><div class="casAuthors">Yi, Fei; Liu, Guang-Hui; Belmonte, Juan Carlos Izpisua</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">246-250</span>CODEN:
                <span class="NLM_cas:coden">PCREFB</span>;
        ISSN:<span class="NLM_cas:issn">1674-800X</span>.
    
            (<span class="NLM_cas:orgname">Higher Education Press</span>)
        </div><div class="casAbstract">A review.  Recent advances in the study of human hepatocytes derived from induced pluripotent stem cells (iPSC) represent new promises for liver disease study and drug discovery.  Human hepatocytes or hepatocyte-like cells differentiated from iPSC recapitulate many functional properties of primary human hepatocytes and have been demonstrated as a powerful and efficient tool to model human liver metabolic diseases and facilitate drug development process.  In this review, we summarize the recent progress in this field and discuss the future perspective of the application of human iPSC derived hepatocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQWm76F8KwlbVg90H21EOLACvtfcHk0liTuTYvskCTQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFOgs7g%253D&md5=5ff89e08bf3e3267fc1567abe21fb16e</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1007%2Fs13238-012-2918-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13238-012-2918-4%26sid%3Dliteratum%253Aachs%26aulast%3DYi%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DG.%2BH.%26aulast%3DIzpis%25C3%25BAa%2BBelmonte%26aufirst%3DJ.%2BC.%26atitle%3DHuman%2520induced%2520pluripotent%2520stem%2520cells%2520derived%2520hepatocytes%253A%2520rising%2520promise%2520for%2520disease%2520modeling%252C%2520drug%2520development%2520and%2520cell%2520therapy%26jtitle%3DProtein%2520Cell%26date%3D2012%26volume%3D3%26spage%3D246%26epage%3D250%26doi%3D10.1007%2Fs13238-012-2918-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Ala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashkan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dooley, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilsky, M. L.</span><span> </span><span class="NLM_article-title">Wilson’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span><span class="refDoi"> DOI: 10.1016/S0140-6736(07)60196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2FS0140-6736%2807%2960196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=17276780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1OrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2007&pages=397-408&author=A.+Alaauthor=A.+P.+Walkerauthor=K.+Ashkanauthor=J.+S.+Dooleyauthor=M.+L.+Schilsky&title=Wilson%E2%80%99s+disease&doi=10.1016%2FS0140-6736%2807%2960196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Wilson's disease</span></div><div class="casAuthors">Ala, Aftab; Walker, Ann P.; Ashkan, Keyoumars; Dooley, James S.; Schilsky, Michael L.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">9559</span>),
    <span class="NLM_cas:pages">397-408</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Progressive hepatolenticular degeneration, or Wilson's disease, is a genetic disorder of copper metab.  Knowledge of the clin. presentations and treatment of the disease are important both to the generalist and to specialists in gastroenterol. and hepatol., neurol., psychiatry, and pediatrics.  Wilson's disease invariably results in severe disability and death if untreated.  The diagnosis is easily overlooked but if discovered early, effective treatments are available that will prevent or reverse many manifestations of this disorder.  Studies have identified the role of copper in disease pathogenesis and clin., biochem., and genetic markers that can be useful in diagnosis.  There are several chelating agents and zinc salts for medical therapy.  Liver transplantation corrects the underlying pathophysiol. and can be lifesaving.  The discovery of the Wilson's disease gene has opened up a new mol. diagnostic approach, and could form the basis of future gene therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJRW6UzoX5a7Vg90H21EOLACvtfcHk0liTuTYvskCTQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1OrsLc%253D&md5=ed4e35ca24f1b4803cbbc6086e6c92e9</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2807%2960196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252807%252960196-2%26sid%3Dliteratum%253Aachs%26aulast%3DAla%26aufirst%3DA.%26aulast%3DWalker%26aufirst%3DA.%2BP.%26aulast%3DAshkan%26aufirst%3DK.%26aulast%3DDooley%26aufirst%3DJ.%2BS.%26aulast%3DSchilsky%26aufirst%3DM.%2BL.%26atitle%3DWilson%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2007%26volume%3D369%26spage%3D397%26epage%3D408%26doi%3D10.1016%2FS0140-6736%2807%2960196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zychlinski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schambach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, M. A.</span><span> </span><span class="NLM_article-title">Rescue of ATP7B function in hepatocyte-like cells from Wilson’s disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3176</span><span class="NLM_x">–</span> <span class="NLM_lpage">3187</span><span class="refDoi"> DOI: 10.1093/hmg/ddr223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1093%2Fhmg%2Fddr223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=21593220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpt1Ohtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=3176-3187&author=S.+Zhangauthor=S.+Chenauthor=W.+Liauthor=X.+Guoauthor=P.+Zhaoauthor=J.+Xuauthor=Y.+Chenauthor=Q.+Panauthor=X.+Liuauthor=D.+Zychlinskiauthor=H.+Luauthor=M.+D.+Tortorellaauthor=A.+Schambachauthor=Y.+Wangauthor=D.+Peiauthor=M.+A.+Esteban&title=Rescue+of+ATP7B+function+in+hepatocyte-like+cells+from+Wilson%E2%80%99s+disease+induced+pluripotent+stem+cells+using+gene+therapy+or+the+chaperone+drug+curcumin&doi=10.1093%2Fhmg%2Fddr223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin</span></div><div class="casAuthors">Zhang, Shiqiang; Chen, Shen; Li, Wen; Guo, Xiangpeng; Zhao, Ping; Xu, Jianyong; Chen, Yan; Pan, Qiong; Liu, Xiaorong; Zychlinski, Daniela; Lu, Hai; Tortorella, Micky D.; Schambach, Axel; Wang, Yan; Pei, Duanqing; Esteban, Miguel A.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3176-3187</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Directed hepatocyte differentiation from human induced pluripotent stem cells (iPSCs) potentially provides a unique platform for modeling liver genetic diseases and performing drug-toxicity screening in vitro.  Wilson's disease is a genetic disease caused by mutations in the ATP7B gene, whose product is a liver transporter protein responsible for coordinated copper export into bile and blood.  Interestingly, the spectrum of ATP7B mutations is vast and can influence clin. presentation (a variable spectrum of hepatic and neural manifestations), though the reason is not well understood.  We describe the generation of iPSCs from a Chinese patient with Wilson's disease that bears the R778L Chinese hotspot mutation in the ATP7B gene.  These iPSCs were pluripotent and could be readily differentiated into hepatocyte-like cells that displayed abnormal cytoplasmic localization of mutated ATP7B and defective copper transport.  Moreover, gene correction using a self-inactivating lentiviral vector that expresses codon optimized-ATP7B or treatment with the chaperone drug curcumin could reverse the functional defect in vitro.  Hence, our work describes an attractive model for studying the pathogenesis of Wilson's disease that is valuable for screening compds. or gene therapy approaches aimed to correct the abnormality.  In the future, once relevant safety concerns (including the stability of the mature liver-like phenotype) and tech. issues for the transplantation procedure are solved, hepatocyte-like cells from similarly genetically cor. iPSCs could be an option for autologous transplantation in Wilson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGUsPwdAWBLrVg90H21EOLACvtfcHk0lgpPPKns6rDLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpt1Ohtbk%253D&md5=d90a243069742a99272d258dca7d76bd</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddr223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddr223%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZychlinski%26aufirst%3DD.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DTortorella%26aufirst%3DM.%2BD.%26aulast%3DSchambach%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPei%26aufirst%3DD.%26aulast%3DEsteban%26aufirst%3DM.%2BA.%26atitle%3DRescue%2520of%2520ATP7B%2520function%2520in%2520hepatocyte-like%2520cells%2520from%2520Wilson%25E2%2580%2599s%2520disease%2520induced%2520pluripotent%2520stem%2520cells%2520using%2520gene%2520therapy%2520or%2520the%2520chaperone%2520drug%2520curcumin%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2011%26volume%3D20%26spage%3D3176%26epage%3D3187%26doi%3D10.1093%2Fhmg%2Fddr223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Choi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shim, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, Y. Y.</span><span> </span><span class="NLM_article-title">Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2458</span><span class="NLM_x">–</span> <span class="NLM_lpage">2468</span><span class="refDoi"> DOI: 10.1002/hep.26237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1002%2Fhep.26237" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=2458-2468&author=S.+M.+Choiauthor=Y.+Kimauthor=J.+S.+Shimauthor=J.+T.+Parkauthor=R.+H.+Wangauthor=S.+D.+Leachauthor=J.+O.+Liuauthor=C.+Dengauthor=Z.+Yeauthor=Y.+Y.+Jang&title=Efficient+drug+screening+and+gene+correction+for+treating+liver+disease+using+patient-specific+stem+cells&doi=10.1002%2Fhep.26237"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1002%2Fhep.26237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.26237%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.%2BM.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DShim%26aufirst%3DJ.%2BS.%26aulast%3DPark%26aufirst%3DJ.%2BT.%26aulast%3DWang%26aufirst%3DR.%2BH.%26aulast%3DLeach%26aufirst%3DS.%2BD.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26aulast%3DDeng%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DZ.%26aulast%3DJang%26aufirst%3DY.%2BY.%26atitle%3DEfficient%2520drug%2520screening%2520and%2520gene%2520correction%2520for%2520treating%2520liver%2520disease%2520using%2520patient-specific%2520stem%2520cells%26jtitle%3DHepatology%26date%3D2013%26volume%3D57%26spage%3D2458%26epage%3D2468%26doi%3D10.1002%2Fhep.26237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Boocock, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popovic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durie, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommens, J. M.</span><span> </span><span class="NLM_article-title">Mutations in SBDS are associated with Shwachman-Diamond syndrome</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span><span class="refDoi"> DOI: 10.1038/ng1062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fng1062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=12496757" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2002&pages=97-101&author=G.+R.+Boocockauthor=J.+A.+Morrisonauthor=M.+Popovicauthor=N.+Richardsauthor=L.+Ellisauthor=P.+R.+Durieauthor=J.+M.+Rommens&title=Mutations+in+SBDS+are+associated+with+Shwachman-Diamond+syndrome&doi=10.1038%2Fng1062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1038%2Fng1062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1062%26sid%3Dliteratum%253Aachs%26aulast%3DBoocock%26aufirst%3DG.%2BR.%26aulast%3DMorrison%26aufirst%3DJ.%2BA.%26aulast%3DPopovic%26aufirst%3DM.%26aulast%3DRichards%26aufirst%3DN.%26aulast%3DEllis%26aufirst%3DL.%26aulast%3DDurie%26aufirst%3DP.%2BR.%26aulast%3DRommens%26aufirst%3DJ.%2BM.%26atitle%3DMutations%2520in%2520SBDS%2520are%2520associated%2520with%2520Shwachman-Diamond%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D2002%26volume%3D33%26spage%3D97%26epage%3D101%26doi%3D10.1038%2Fng1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Tulpule, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensch, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPherson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlaeger, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley, G. Q.</span><span> </span><span class="NLM_article-title">Pluripotent stem cell models of shwachman-diamond syndrome reveal a common mechanism for pancreatic and hematopoietic dysfunction</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span><span class="refDoi"> DOI: 10.1016/j.stem.2013.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.stem.2013.04.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=727-736&author=A.+Tulpuleauthor=J.+M.+Kelleyauthor=M.+W.+Lenschauthor=J.+McPhersonauthor=I.+H.+Parkauthor=O.+Hartungauthor=T.+Nakamuraauthor=T.+M.+Schlaegerauthor=A.+Shimamuraauthor=G.+Q.+Daley&title=Pluripotent+stem+cell+models+of+shwachman-diamond+syndrome+reveal+a+common+mechanism+for+pancreatic+and+hematopoietic+dysfunction&doi=10.1016%2Fj.stem.2013.04.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2013.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2013.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DTulpule%26aufirst%3DA.%26aulast%3DKelley%26aufirst%3DJ.%2BM.%26aulast%3DLensch%26aufirst%3DM.%2BW.%26aulast%3DMcPherson%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DI.%2BH.%26aulast%3DHartung%26aufirst%3DO.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DSchlaeger%26aufirst%3DT.%2BM.%26aulast%3DShimamura%26aufirst%3DA.%26aulast%3DDaley%26aufirst%3DG.%2BQ.%26atitle%3DPluripotent%2520stem%2520cell%2520models%2520of%2520shwachman-diamond%2520syndrome%2520reveal%2520a%2520common%2520mechanism%2520for%2520pancreatic%2520and%2520hematopoietic%2520dysfunction%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2013%26volume%3D12%26spage%3D727%26epage%3D736%26doi%3D10.1016%2Fj.stem.2013.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Liu, G.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montserrat, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarantino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plongthongkum, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nivet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsunekawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soligalla, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goebl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aizawa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Sol, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bueren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trujillo, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surralles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufour, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izpisúa Belmonte, J. C.</span><span> </span><span class="NLM_article-title">Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">4330</span><span class="refDoi"> DOI: 10.1038/ncomms5330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fncomms5330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24999918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2murjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=4330&author=G.-H.+Liuauthor=K.+Suzukiauthor=M.+Liauthor=J.+Quauthor=N.+Montserratauthor=C.+Tarantinoauthor=Y.+Guauthor=F.+Yiauthor=X.+Xuauthor=W.+Zhangauthor=S.+Ruizauthor=N.+Plongthongkumauthor=K.+Zhangauthor=S.+Masudaauthor=E.+Nivetauthor=Y.+Tsunekawaauthor=R.+D.+Soligallaauthor=A.+Goeblauthor=E.+Aizawaauthor=N.+Y.+Kimauthor=J.+Kimauthor=I.+Dubovaauthor=Y.+Liauthor=R.+Renauthor=C.+Bennerauthor=A.+del+Solauthor=J.+Buerenauthor=J.+P.+Trujilloauthor=J.+Surrallesauthor=E.+Cappelliauthor=C.+Dufourauthor=C.+R.+Estebanauthor=J.+C.+Izpis%C3%BAa+Belmonte&title=Modelling+Fanconi+anemia+pathogenesis+and+therapeutics+using+integration-free+patient-derived+iPSCs&doi=10.1038%2Fncomms5330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs</span></div><div class="casAuthors">Liu, Guang-Hui; Suzuki, Keiichiro; Li, Mo; Qu, Jing; Montserrat, Nuria; Tarantino, Carolina; Gu, Ying; Yi, Fei; Xu, Xiuling; Zhang, Weiqi; Ruiz, Sergio; Plongthongkum, Nongluk; Zhang, Kun; Masuda, Shigeo; Nivet, Emmanuel; Tsunekawa, Yuji; Soligalla, Rupa Devi; Goebl, April; Aizawa, Emi; Kim, Na Young; Kim, Jessica; Dubova, Ilir; Li, Ying; Ren, Ruotong; Benner, Chris; del Sol, Antonio; Bueren, Juan; Trujillo, Juan Pablo; Surralles, Jordi; Cappelli, Enrico; Dufour, Carlo; Esteban, Concepcion Rodriguez; Belmonte, Juan Carlos Izpisua</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4330</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Fanconi anemia (FA) is a recessive disorder characterized by genomic instability, congenital abnormalities, cancer predisposition and bone marrow (BM) failure.  However, the pathogenesis of FA is not fully understood partly due to the limitations of current disease models.  Here, we derive integration free-induced pluripotent stem cells (iPSCs) from an FA patient without genetic complementation and report in situ gene correction in FA-iPSCs as well as the generation of isogenic FANCA-deficient human embryonic stem cell (ESC) lines.  FA cellular phenotypes are recapitulated in iPSCs/ESCs and their adult stem/progenitor cell derivs.  By using isogenic pathogenic mutation-free controls as well as cellular and genomic tools, our model serves to facilitate the discovery of novel disease features.  We validate our model as a drug-screening platform by identifying several compds. that improve hematopoietic differentiation of FA-iPSCs.  These compds. are also able to rescue the hematopoietic phenotype of FA patient BM cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB0zFFN-FNULVg90H21EOLACvtfcHk0ljfa3LO_zakYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2murjE&md5=3b5dfe68789a582e4b1a94acf32b992f</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1038%2Fncomms5330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms5330%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.-H.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DJ.%26aulast%3DMontserrat%26aufirst%3DN.%26aulast%3DTarantino%26aufirst%3DC.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DYi%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DRuiz%26aufirst%3DS.%26aulast%3DPlongthongkum%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DMasuda%26aufirst%3DS.%26aulast%3DNivet%26aufirst%3DE.%26aulast%3DTsunekawa%26aufirst%3DY.%26aulast%3DSoligalla%26aufirst%3DR.%2BD.%26aulast%3DGoebl%26aufirst%3DA.%26aulast%3DAizawa%26aufirst%3DE.%26aulast%3DKim%26aufirst%3DN.%2BY.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DDubova%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DR.%26aulast%3DBenner%26aufirst%3DC.%26aulast%3Ddel%2BSol%26aufirst%3DA.%26aulast%3DBueren%26aufirst%3DJ.%26aulast%3DTrujillo%26aufirst%3DJ.%2BP.%26aulast%3DSurralles%26aufirst%3DJ.%26aulast%3DCappelli%26aufirst%3DE.%26aulast%3DDufour%26aufirst%3DC.%26aulast%3DEsteban%26aufirst%3DC.%2BR.%26aulast%3DIzpis%25C3%25BAa%2BBelmonte%26aufirst%3DJ.%2BC.%26atitle%3DModelling%2520Fanconi%2520anemia%2520pathogenesis%2520and%2520therapeutics%2520using%2520integration-free%2520patient-derived%2520iPSCs%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D4330%26doi%3D10.1038%2Fncomms5330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Moldovan, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, A. D.</span><span> </span><span class="NLM_article-title">How the fanconi anemia pathway guards the genome</span> <span class="citation_source-journal">Annu. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.1146/annurev-genet-102108-134222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1146%2Fannurev-genet-102108-134222" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2009&pages=223-249&author=G.+L.+Moldovanauthor=A.+D.+D%E2%80%99Andrea&title=How+the+fanconi+anemia+pathway+guards+the+genome&doi=10.1146%2Fannurev-genet-102108-134222"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1146%2Fannurev-genet-102108-134222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-genet-102108-134222%26sid%3Dliteratum%253Aachs%26aulast%3DMoldovan%26aufirst%3DG.%2BL.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%2BD.%26atitle%3DHow%2520the%2520fanconi%2520anemia%2520pathway%2520guards%2520the%2520genome%26jtitle%3DAnnu.%2520Rev.%2520Genet.%26date%3D2009%26volume%3D43%26spage%3D223%26epage%3D249%26doi%3D10.1146%2Fannurev-genet-102108-134222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Muller, L. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milsom, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brumme, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schambach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strait, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlaeger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley, G. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. A.</span><span> </span><span class="NLM_article-title">Overcoming reprogramming resistance of Fanconi anemia cells</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">5449</span><span class="NLM_x">–</span> <span class="NLM_lpage">5457</span><span class="refDoi"> DOI: 10.1182/blood-2012-02-408674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1182%2Fblood-2012-02-408674" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=5449-5457&author=L.+U.+Mullerauthor=M.+D.+Milsomauthor=C.+E.+Harrisauthor=R.+Vyasauthor=K.+M.+Brummeauthor=K.+Parmarauthor=L.+A.+Moreauauthor=A.+Schambachauthor=I.+H.+Parkauthor=W.+B.+Londonauthor=K.+Straitauthor=T.+Schlaegerauthor=A.+L.+Devineauthor=E.+Grassmanauthor=A.+D%E2%80%99Andreaauthor=G.+Q.+Daleyauthor=D.+A.+Williams&title=Overcoming+reprogramming+resistance+of+Fanconi+anemia+cells&doi=10.1182%2Fblood-2012-02-408674"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1182%2Fblood-2012-02-408674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2012-02-408674%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DL.%2BU.%26aulast%3DMilsom%26aufirst%3DM.%2BD.%26aulast%3DHarris%26aufirst%3DC.%2BE.%26aulast%3DVyas%26aufirst%3DR.%26aulast%3DBrumme%26aufirst%3DK.%2BM.%26aulast%3DParmar%26aufirst%3DK.%26aulast%3DMoreau%26aufirst%3DL.%2BA.%26aulast%3DSchambach%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DI.%2BH.%26aulast%3DLondon%26aufirst%3DW.%2BB.%26aulast%3DStrait%26aufirst%3DK.%26aulast%3DSchlaeger%26aufirst%3DT.%26aulast%3DDevine%26aufirst%3DA.%2BL.%26aulast%3DGrassman%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%26aulast%3DDaley%26aufirst%3DG.%2BQ.%26aulast%3DWilliams%26aufirst%3DD.%2BA.%26atitle%3DOvercoming%2520reprogramming%2520resistance%2520of%2520Fanconi%2520anemia%2520cells%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26spage%3D5449%26epage%3D5457%26doi%3D10.1182%2Fblood-2012-02-408674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Pereira, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrikopoulos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keene, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biery, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, F.</span><span> </span><span class="NLM_article-title">Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span><span class="refDoi"> DOI: 10.1038/ng1097-218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fng1097-218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=9326947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADyaK2sXmsFantLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=218-222&author=L.+Pereiraauthor=K.+Andrikopoulosauthor=J.+Tianauthor=S.+Y.+Leeauthor=D.+R.+Keeneauthor=R.+Onoauthor=D.+P.+Reinhardtauthor=L.+Y.+Sakaiauthor=N.+J.+Bieryauthor=T.+Buntonauthor=H.+C.+Dietzauthor=F.+Ramirez&title=Targetting+of+the+gene+encoding+fibrillin-1+recapitulates+the+vascular+aspect+of+Marfan+syndrome&doi=10.1038%2Fng1097-218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome</span></div><div class="casAuthors">Pereira, Lygia; Andrikopoulos, Konstantinos; Tian, Jenny; Lee, Sui Ying; Keene, Douglas R.; Ono, Robert; Reinhardt, Dieter P.; Sakai, Lynn Y.; Biery, Nancy Jensen; Bunton, Tracie; Dietz, Harry C.; Ramirez, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">218-222</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Aortic aneurysm and dissection account for about 2% of all deaths in industrialized countries; they are also components of several genetic diseases, including Marfan syndrome (MFS).  The vascular phenotype of MFS results from mutations in fibrillin-1 (FBN1), the major constituent of extracellular microfibrils.  Microfibrils, either assocd. with or devoid of elastin, give rise to a variety of extracellular networks in elastic and non-elastic tissues.  It is believed that microfibrils regulate elastic fiber formation by guiding tropoelastin deposition during embryogenesis and early post-natal life.  Hence, vascular disease in MFS is thought to result when FBN1 mutations preclude elastic fiber maturation by disrupting microfibrillar assembly.  Here we report a gene-targetting expt. in mice that indicates that fibrillin-1 microfibrils are predominantly engaged in tissue homeostasis rather than elastic matrix assembly.  This finding, in turn, suggests that aortic dilation is due primarily to the failure by the microfibrillar array of the adventitia to sustain physiol. hemodynamic stress, and that disruption of the elastic network of the media is a secondary event.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx4BB6vczcsrVg90H21EOLACvtfcHk0ljfa3LO_zakYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmsFantLY%253D&md5=a85abffeebe0e6680f55da88bbe310a3</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1038%2Fng1097-218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1097-218%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DL.%26aulast%3DAndrikopoulos%26aufirst%3DK.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DKeene%26aufirst%3DD.%2BR.%26aulast%3DOno%26aufirst%3DR.%26aulast%3DReinhardt%26aufirst%3DD.%2BP.%26aulast%3DSakai%26aufirst%3DL.%2BY.%26aulast%3DBiery%26aufirst%3DN.%2BJ.%26aulast%3DBunton%26aufirst%3DT.%26aulast%3DDietz%26aufirst%3DH.%2BC.%26aulast%3DRamirez%26aufirst%3DF.%26atitle%3DTargetting%2520of%2520the%2520gene%2520encoding%2520fibrillin-1%2520recapitulates%2520the%2520vascular%2520aspect%2520of%2520Marfan%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D1997%26volume%3D17%26spage%3D218%26epage%3D222%26doi%3D10.1038%2Fng1097-218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Quarto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francke, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reijo-Pera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longaker, M. T.</span><span> </span><span class="NLM_article-title">Skeletogenic phenotype of human Marfan embryonic stem cells faithfully phenocopied by patient-specific induced-pluripotent stem cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span><span class="refDoi"> DOI: 10.1073/pnas.1113442109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1073%2Fpnas.1113442109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=215-220&author=N.+Quartoauthor=B.+Leonardauthor=S.+Liauthor=M.+Marchandauthor=E.+Andersonauthor=B.+Behrauthor=U.+Franckeauthor=R.+Reijo-Peraauthor=E.+Chiaoauthor=M.+T.+Longaker&title=Skeletogenic+phenotype+of+human+Marfan+embryonic+stem+cells+faithfully+phenocopied+by+patient-specific+induced-pluripotent+stem+cells&doi=10.1073%2Fpnas.1113442109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1113442109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1113442109%26sid%3Dliteratum%253Aachs%26aulast%3DQuarto%26aufirst%3DN.%26aulast%3DLeonard%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DMarchand%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DE.%26aulast%3DBehr%26aufirst%3DB.%26aulast%3DFrancke%26aufirst%3DU.%26aulast%3DReijo-Pera%26aufirst%3DR.%26aulast%3DChiao%26aufirst%3DE.%26aulast%3DLongaker%26aufirst%3DM.%2BT.%26atitle%3DSkeletogenic%2520phenotype%2520of%2520human%2520Marfan%2520embryonic%2520stem%2520cells%2520faithfully%2520phenocopied%2520by%2520patient-specific%2520induced-pluripotent%2520stem%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D215%26epage%3D220%26doi%3D10.1073%2Fpnas.1113442109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Shore, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenstermacher, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeMerrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morhart, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triffitt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urtizberea, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zasloff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, F. S.</span><span> </span><span class="NLM_article-title">A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span><span class="refDoi"> DOI: 10.1038/ng1783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fng1783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=16642017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvVGktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=525-527&author=E.+M.+Shoreauthor=M.+Xuauthor=G.+J.+Feldmanauthor=D.+A.+Fenstermacherauthor=T.+J.+Choauthor=I.+H.+Choiauthor=J.+M.+Connorauthor=P.+Delaiauthor=D.+L.+Glaserauthor=M.+LeMerrerauthor=R.+Morhartauthor=J.+G.+Rogersauthor=R.+Smithauthor=J.+T.+Triffittauthor=J.+A.+Urtizbereaauthor=M.+Zasloffauthor=M.+A.+Brownauthor=F.+S.+Kaplan&title=A+recurrent+mutation+in+the+BMP+type+I+receptor+ACVR1+causes+inherited+and+sporadic+fibrodysplasia+ossificans+progressiva&doi=10.1038%2Fng1783"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva</span></div><div class="casAuthors">Shore, Eileen M.; Xu, Meiqi; Feldman, George J.; Fenstermacher, David A.; Brown, Matthew A.; Kaplan, Frederick S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">525-527</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder of skeletal malformations and progressive extraskeletal ossification.  We mapped FOP to chromosome 2q23-24 by linkage anal. and identified an identical heterozygous mutation (617G → A; R206H) in the glycine-serine (GS) activation domain of ACVR1, a BMP type I receptor, in all affected individuals examd.  Protein modeling predicts destabilization of the GS domain, consistent with constitutive activation of ACVR1 as the underlying cause of the ectopic chondrogenesis, osteogenesis and joint fusions seen in FOP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJCMFDulIw-LVg90H21EOLACvtfcHk0lg-Ri_cKzLapg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvVGktrk%253D&md5=24f4dce60f3073f2c621326d3c146601</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1038%2Fng1783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1783%26sid%3Dliteratum%253Aachs%26aulast%3DShore%26aufirst%3DE.%2BM.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DFeldman%26aufirst%3DG.%2BJ.%26aulast%3DFenstermacher%26aufirst%3DD.%2BA.%26aulast%3DCho%26aufirst%3DT.%2BJ.%26aulast%3DChoi%26aufirst%3DI.%2BH.%26aulast%3DConnor%26aufirst%3DJ.%2BM.%26aulast%3DDelai%26aufirst%3DP.%26aulast%3DGlaser%26aufirst%3DD.%2BL.%26aulast%3DLeMerrer%26aufirst%3DM.%26aulast%3DMorhart%26aufirst%3DR.%26aulast%3DRogers%26aufirst%3DJ.%2BG.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DTriffitt%26aufirst%3DJ.%2BT.%26aulast%3DUrtizberea%26aufirst%3DJ.%2BA.%26aulast%3DZasloff%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DM.%2BA.%26aulast%3DKaplan%26aufirst%3DF.%2BS.%26atitle%3DA%2520recurrent%2520mutation%2520in%2520the%2520BMP%2520type%2520I%2520receptor%2520ACVR1%2520causes%2520inherited%2520and%2520sporadic%2520fibrodysplasia%2520ossificans%2520progressiva%26jtitle%3DNat.%2520Genet.%26date%3D2006%26volume%3D38%26spage%3D525%26epage%3D527%26doi%3D10.1038%2Fng1783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Matsumoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlieve, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barruet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asaka, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toguchida, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, E. C.</span><span> </span><span class="NLM_article-title">Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation</span> <span class="citation_source-journal">Orphanet J. Rare Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="refDoi"> DOI: 10.1186/1750-1172-8-190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1186%2F1750-1172-8-190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24321451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A280%3ADC%252BC2c3kvVSmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=190&author=Y.+Matsumotoauthor=Y.+Hayashiauthor=C.+R.+Schlieveauthor=M.+Ikeyaauthor=H.+Kimauthor=T.+D.+Nguyenauthor=S.+Samiauthor=S.+Babaauthor=E.+Barruetauthor=A.+Nasuauthor=I.+Asakaauthor=T.+Otsukaauthor=S.+Yamanakaauthor=B.+R.+Conklinauthor=J.+Toguchidaauthor=E.+C.+Hsiao&title=Induced+pluripotent+stem+cells+from+patients+with+human+fibrodysplasia+ossificans+progressiva+show+increased+mineralization+and+cartilage+formation&doi=10.1186%2F1750-1172-8-190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation</span></div><div class="casAuthors">Matsumoto Yoshihisa; Hayashi Yohei; Schlieve Christopher R; Kim Hannah; Nguyen Trieu D; Sami Salma; Baba Shiro; Barruet Emilie; Nasu Akira; Asaka Isao; Otsuka Takanobu; Yamanaka Shinya; Conklin Bruce R; Toguchida Junya; Hsiao Edward C; Ikeya Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Orphanet journal of rare diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">190</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Abnormal activation of endochondral bone formation in soft tissues causes significant medical diseases associated with disability and pain.  Hyperactive mutations in the bone morphogenetic protein (BMP) type 1 receptor ACVR1 lead to fibrodysplasia ossificans progressiva (FOP), a rare genetic disorder characterized by progressive ossification in soft tissues.  However, the specific cellular mechanisms are unclear.  In addition, the difficulty obtaining tissue samples from FOP patients and the limitations in mouse models of FOP hamper our ability to dissect the pathogenesis of FOP.  METHODS:  To address these challenges and develop a "disease model in a dish", we created human induced pluripotent stem cells (iPS cells) derived from normal and FOP dermal fibroblasts by two separate methods, retroviral integration or integration-free episomal vectors.  We tested if the ability to contribute to different steps of endochondral bone formation was different in FOP vs. control iPS cells.  RESULTS:  Remarkably, FOP iPS cells showed increased mineralization and enhanced chondrogenesis in vitro.  The mineralization phenotypes could be suppressed with a small-molecule inhibitor of BMP signaling, DMH1.  Our results indicate that the FOP ACVR1 R206H mutation favors chondrogenesis and increases mineral deposition in vitro.  CONCLUSIONS:  Our findings establish a FOP disease cell model for in vitro experimentation and provide a proof-of-concept for using human iPS cell models to understand human skeletal disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTeIixu_Bu9JnO4gDb7JggCfW6udTcc2eYG7FDLiRCFL7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3kvVSmuw%253D%253D&md5=6ad22b7ccae35e24e2eaa70fd3dcc9f7</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1186%2F1750-1172-8-190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1172-8-190%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DSchlieve%26aufirst%3DC.%2BR.%26aulast%3DIkeya%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%2BD.%26aulast%3DSami%26aufirst%3DS.%26aulast%3DBaba%26aufirst%3DS.%26aulast%3DBarruet%26aufirst%3DE.%26aulast%3DNasu%26aufirst%3DA.%26aulast%3DAsaka%26aufirst%3DI.%26aulast%3DOtsuka%26aufirst%3DT.%26aulast%3DYamanaka%26aufirst%3DS.%26aulast%3DConklin%26aufirst%3DB.%2BR.%26aulast%3DToguchida%26aufirst%3DJ.%26aulast%3DHsiao%26aufirst%3DE.%2BC.%26atitle%3DInduced%2520pluripotent%2520stem%2520cells%2520from%2520patients%2520with%2520human%2520fibrodysplasia%2520ossificans%2520progressiva%2520show%2520increased%2520mineralization%2520and%2520cartilage%2520formation%26jtitle%3DOrphanet%2520J.%2520Rare%2520Dis.%26date%3D2013%26volume%3D8%26spage%3D190%26doi%3D10.1186%2F1750-1172-8-190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Yamashita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yahara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikegawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumaki, N.</span><span> </span><span class="NLM_article-title">Statin treatment rescues FGFR3 skeletal dysplasia phenotypes</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">513</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span><span class="refDoi"> DOI: 10.1038/nature13775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature13775" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2014&pages=507-511&author=A.+Yamashitaauthor=M.+Moriokaauthor=H.+Kishiauthor=T.+Kimuraauthor=Y.+Yaharaauthor=M.+Okadaauthor=K.+Fujitaauthor=H.+Sawaiauthor=S.+Ikegawaauthor=N.+Tsumaki&title=Statin+treatment+rescues+FGFR3+skeletal+dysplasia+phenotypes&doi=10.1038%2Fnature13775"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1038%2Fnature13775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13775%26sid%3Dliteratum%253Aachs%26aulast%3DYamashita%26aufirst%3DA.%26aulast%3DMorioka%26aufirst%3DM.%26aulast%3DKishi%26aufirst%3DH.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DYahara%26aufirst%3DY.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DFujita%26aufirst%3DK.%26aulast%3DSawai%26aufirst%3DH.%26aulast%3DIkegawa%26aufirst%3DS.%26aulast%3DTsumaki%26aufirst%3DN.%26atitle%3DStatin%2520treatment%2520rescues%2520FGFR3%2520skeletal%2520dysplasia%2520phenotypes%26jtitle%3DNature%26date%3D2014%26volume%3D513%26spage%3D507%26epage%3D511%26doi%3D10.1038%2Fnature13775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Vajo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francomano, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkin, D. J.</span><span> </span><span class="NLM_article-title">The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1210/edrv.21.1.0387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1210%2Fedrv.21.1.0387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10696568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhs12hurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=23-39&author=Z.+Vajoauthor=C.+A.+Francomanoauthor=D.+J.+Wilkin&title=The+molecular+and+genetic+basis+of+fibroblast+growth+factor+receptor+3+disorders%3A+the+achondroplasia+family+of+skeletal+dysplasias%2C+Muenke+craniosynostosis%2C+and+Crouzon+syndrome+with+acanthosis+nigricans&doi=10.1210%2Fedrv.21.1.0387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans</span></div><div class="casAuthors">Vajo, Zoltan; Francomano, Clair A.; Wilkin, Douglas J.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-39</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review, with 149 refs.  Achondroplasia, the most common form of short-limbed dwarfism in humans, occurs between 1 in 15,000 and 40,000 live births.  More than 90% of cases are sporadic and there is, on av., an increased paternal age at the time of conception of affected individuals.  More then 97% of persons with achondroplasia have a Gly380Arg mutation in the transmembrane domain of the fibroblast growth factor receptor (FGFR) 3 gene.  Mutations in the FGFR3 gene also result in hypochondroplasia, the lethal thanatophoric dysplasias, the recently described SADDAN (severe achondroplasia with developmental delay and acanthosis nigricans) dysplasia, and two craniosynostosis disorders: Muenke coronal craniosynostosis and Crouzon syndrome with acanthosis nigricans.  Recent evidence suggests that the phenotypic differences may be due to specific alleles with varying degrees of ligand-independent activation, allowing the receptor to be constitutively active.  Since the Gly380Arg achondroplasia mutation was recognized, similar observations regarding the conserved nature of FGFR mutations and resulting phenotype have been made regarding other skeletal phenotypes, including hypochondroplasia, thanatophoric dysplasia, and Muenke coronal craniosynostosis.  These specific genotype-phenotype correlations in the FGFR disorders seem to be unprecedented in the study of human disease.  The explanation for this high degree of mutability at specific bases remains an intriguing question.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPf8IBwDCf07Vg90H21EOLACvtfcHk0lj2amwC3IQoYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhs12hurc%253D&md5=373fb19253c7f8c4a819f8917050250c</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1210%2Fedrv.21.1.0387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fedrv.21.1.0387%26sid%3Dliteratum%253Aachs%26aulast%3DVajo%26aufirst%3DZ.%26aulast%3DFrancomano%26aufirst%3DC.%2BA.%26aulast%3DWilkin%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520molecular%2520and%2520genetic%2520basis%2520of%2520fibroblast%2520growth%2520factor%2520receptor%25203%2520disorders%253A%2520the%2520achondroplasia%2520family%2520of%2520skeletal%2520dysplasias%252C%2520Muenke%2520craniosynostosis%252C%2520and%2520Crouzon%2520syndrome%2520with%2520acanthosis%2520nigricans%26jtitle%3DEndocr.%2520Rev.%26date%3D2000%26volume%3D21%26spage%3D23%26epage%3D39%26doi%3D10.1210%2Fedrv.21.1.0387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Bayart, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Haguenauer, O.</span><span> </span><span class="NLM_article-title">Technological overview of iPS induction from human adult somatic cells</span> <span class="citation_source-journal">Curr. Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span><span class="refDoi"> DOI: 10.2174/1566523211313020002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.2174%2F1566523211313020002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23320476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1ynsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=73-92&author=E.+Bayartauthor=O.+Cohen-Haguenauer&title=Technological+overview+of+iPS+induction+from+human+adult+somatic+cells&doi=10.2174%2F1566523211313020002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Technological overview of iPS induction from human adult somatic cells</span></div><div class="casAuthors">Bayart, Emilie; Cohen-Haguenauer, Odile</div><div class="citationInfo"><span class="NLM_cas:title">Current Gene Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">73-92</span>CODEN:
                <span class="NLM_cas:coden">CGTUAH</span>;
        ISSN:<span class="NLM_cas:issn">1566-5232</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The unlimited proliferation capacity of embryonic stem cells (ESCs) combined with their pluripotent differentiation potential in various lineages raised great interest in both the scientific community and the public at large with hope for future prospects of regenerative medicine.  However, since ESCs are derived from human embryos, their use is assocd. with significant ethical issues preventing broad studies and therapeutic applications.  To get around this bottleneck, Takahashi and Yamanaka have recently achieved the conversion of adult somatic cells into ES-like cells via the forced expression of 4 transcription factors: Oct3/4, Sox2, Klf4 and c-Myc.  This first demonstration attracted public attention and opened a new field of stem cells research with both cognitive - such as disease modeling - and therapeutic prospects.  This pioneer work just received the 2012 Nobel Prize in Physiol. or Medicine.  Many methods were reported since 2006, for the generation of induced pluripotent stem (iPS) cells.  Most strategies currently under use are based on gene delivery via gamma-retroviral or lentiviral vectors; some expts. were also successful using plasmids or transposons- based systems and few with adenovirus.  However, most expts. involve integration in the host cell genome with an identified risk for insertional mutagenesis and oncogenic transformation.  To circumvent such risks which are deemed incompatible with therapeutic prospects, significant progress was made with transgene-free reprogramming methods based on e.g.: sendai virus or direct mRNA or protein delivery to achieve conversion of adult cells into iPS.  In this review the authors aim to cover current knowledge relating to both delivery systems and combinations of inducing factors including chems. which are used to generate human iPS cells.  Finally, genetic instability resulting from the reprogramming process is also being considered as a safety bottleneck for future clin. translation and stem cell-therapy prospects based on iPS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnf8DhExBwCbVg90H21EOLACvtfcHk0lj2amwC3IQoYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1ynsbg%253D&md5=e4cea44c1d7126cdc66912becb38c12e</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.2174%2F1566523211313020002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1566523211313020002%26sid%3Dliteratum%253Aachs%26aulast%3DBayart%26aufirst%3DE.%26aulast%3DCohen-Haguenauer%26aufirst%3DO.%26atitle%3DTechnological%2520overview%2520of%2520iPS%2520induction%2520from%2520human%2520adult%2520somatic%2520cells%26jtitle%3DCurr.%2520Gene%2520Ther.%26date%3D2013%26volume%3D13%26spage%3D73%26epage%3D92%26doi%3D10.2174%2F1566523211313020002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Engle, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puppala, D.</span><span> </span><span class="NLM_article-title">Integrating human pluripotent stem cells into drug development</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span><span class="refDoi"> DOI: 10.1016/j.stem.2013.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.stem.2013.05.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=669-677&author=S.+J.+Engleauthor=D.+Puppala&title=Integrating+human+pluripotent+stem+cells+into+drug+development&doi=10.1016%2Fj.stem.2013.05.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2013.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2013.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DEngle%26aufirst%3DS.%2BJ.%26aulast%3DPuppala%26aufirst%3DD.%26atitle%3DIntegrating%2520human%2520pluripotent%2520stem%2520cells%2520into%2520drug%2520development%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2013%26volume%3D12%26spage%3D669%26epage%3D677%26doi%3D10.1016%2Fj.stem.2013.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pabon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murry, C. E.</span><span> </span><span class="NLM_article-title">Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span><span class="refDoi"> DOI: 10.1161/CIRCRESAHA.114.300558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1161%2FCIRCRESAHA.114.300558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24481842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=511-523&author=X.+Yangauthor=L.+Pabonauthor=C.+E.+Murry&title=Engineering+adolescence%3A+maturation+of+human+pluripotent+stem+cell-derived+cardiomyocytes&doi=10.1161%2FCIRCRESAHA.114.300558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Engineering Adolescence: Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes</span></div><div class="casAuthors">Yang, Xiulan; Pabon, Lil; Murry, Charles E.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">511-523</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  The discovery of human pluripotent stem cells (hPSCs), including both human embryonic stem cells and human-induced pluripotent stem cells, has opened up novel paths for a wide range of scientific studies.  The capability to direct the differentiation of hPSCs into functional cardiomyocytes has provided a platform for regenerative medicine, development, tissue engineering, disease modeling, and drug toxicity testing.  Despite exciting progress, achieving the optimal benefits has been hampered by the immature nature of these cardiomyocytes.  Cardiac maturation has long been studied in vivo using animal models; however, finding ways to mature hPSC cardiomyocytes is only in its initial stages.  In this review, we discuss progress in promoting the maturation of the hPSC cardiomyocytes, in the context of our current knowledge of developmental cardiac maturation and in relation to in vitro model systems such as rodent ventricular myocytes.  Promising approaches that have begun to be examd. in hPSC cardiomyocytes include long-term culturing, 3-dimensional tissue engineering, mech. loading, elec. stimulation, modulation of substrate stiffness, and treatment with neurohormonal factors.  Future studies will benefit from the combinatorial use of different approaches that more closely mimic nature's diverse cues, which may result in broader changes in structure, function, and therapeutic applicability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFZvY_Y_H1R7Vg90H21EOLACvtfcHk0lj2amwC3IQoYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yhsbs%253D&md5=14b79ca4775b01d25d516cd8f7453fed</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.114.300558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.114.300558%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DPabon%26aufirst%3DL.%26aulast%3DMurry%26aufirst%3DC.%2BE.%26atitle%3DEngineering%2520adolescence%253A%2520maturation%2520of%2520human%2520pluripotent%2520stem%2520cell-derived%2520cardiomyocytes%26jtitle%3DCirc.%2520Res.%26date%3D2014%26volume%3D114%26spage%3D511%26epage%3D523%26doi%3D10.1161%2FCIRCRESAHA.114.300558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Burridge, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churko, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diecke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordwinkin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plews, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abilez, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span> </span><span class="NLM_article-title">Chemically defined generation of human cardiomyocytes</span> <span class="citation_source-journal">Nat. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">860</span><span class="refDoi"> DOI: 10.1038/nmeth.2999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnmeth.2999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=24930130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslGis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=855-860&author=P.+W.+Burridgeauthor=E.+Matsaauthor=P.+Shuklaauthor=Z.+C.+Linauthor=J.+M.+Churkoauthor=A.+D.+Ebertauthor=F.+Lanauthor=S.+Dieckeauthor=B.+Huberauthor=N.+M.+Mordwinkinauthor=J.+R.+Plewsauthor=O.+J.+Abilezauthor=B.+Cuiauthor=J.+D.+Goldauthor=J.+C.+Wu&title=Chemically+defined+generation+of+human+cardiomyocytes&doi=10.1038%2Fnmeth.2999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Chemically defined generation of human cardiomyocytes</span></div><div class="casAuthors">Burridge, Paul W.; Matsa, Elena; Shukla, Praveen; Lin, Ziliang C.; Churko, Jared M.; Ebert, Antje D.; Lan, Feng; Diecke, Sebastian; Huber, Bruno; Mordwinkin, Nicholas M.; Plews, Jordan R.; Abilez, Oscar J.; Cui, Bianxiao; Gold, Joseph D.; Wu, Joseph C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">855-860</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Existing methods for human induced pluripotent stem cell (hiPSC) cardiac differentiation are efficient but require complex, undefined medium constituents that hinder further elucidation of the mol. mechanisms of cardiomyogenesis.  Using hiPSCs derived under chem. defined conditions on synthetic matrixes, we systematically developed an optimized cardiac differentiation strategy, using a chem. defined medium consisting of just three components: the basal medium RPMI 1640, L-ascorbic acid 2-phosphate and rice-derived recombinant human albumin.  Along with small mol.-based induction of differentiation, this protocol produced contractile sheets of up to 95% TNNT2+ cardiomyocytes at a yield of up to 100 cardiomyocytes for every input pluripotent cell and was effective in 11 hiPSC lines tested.  This chem. defined platform for cardiac specification of hiPSCs will allow the elucidation of cardiomyocyte macromol. and metabolic requirements and will provide a minimal system for the study of maturation and subtype specification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI4kKlfNA1fLVg90H21EOLACvtfcHk0lg36lHUtpp_-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslGis7c%253D&md5=153be90e038f00ce022ac16e9919cfcc</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.2999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.2999%26sid%3Dliteratum%253Aachs%26aulast%3DBurridge%26aufirst%3DP.%2BW.%26aulast%3DMatsa%26aufirst%3DE.%26aulast%3DShukla%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DZ.%2BC.%26aulast%3DChurko%26aufirst%3DJ.%2BM.%26aulast%3DEbert%26aufirst%3DA.%2BD.%26aulast%3DLan%26aufirst%3DF.%26aulast%3DDiecke%26aufirst%3DS.%26aulast%3DHuber%26aufirst%3DB.%26aulast%3DMordwinkin%26aufirst%3DN.%2BM.%26aulast%3DPlews%26aufirst%3DJ.%2BR.%26aulast%3DAbilez%26aufirst%3DO.%2BJ.%26aulast%3DCui%26aufirst%3DB.%26aulast%3DGold%26aufirst%3DJ.%2BD.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26atitle%3DChemically%2520defined%2520generation%2520of%2520human%2520cardiomyocytes%26jtitle%3DNat.%2520Methods%26date%3D2014%26volume%3D11%26spage%3D855%26epage%3D860%26doi%3D10.1038%2Fnmeth.2999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Musunuru, K.</span><span> </span><span class="NLM_article-title">Genome editing of human pluripotent stem cells to generate human cellular disease models</span> <span class="citation_source-journal">Dis. Models &amp; Mech.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">896</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span><span class="refDoi"> DOI: 10.1242/dmm.012054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1242%2Fdmm.012054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23751357" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=896-904&author=K.+Musunuru&title=Genome+editing+of+human+pluripotent+stem+cells+to+generate+human+cellular+disease+models&doi=10.1242%2Fdmm.012054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1242%2Fdmm.012054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdmm.012054%26sid%3Dliteratum%253Aachs%26aulast%3DMusunuru%26aufirst%3DK.%26atitle%3DGenome%2520editing%2520of%2520human%2520pluripotent%2520stem%2520cells%2520to%2520generate%2520human%2520cellular%2520disease%2520models%26jtitle%3DDis.%2520Models%2520%2526amp%253B%2520Mech.%26date%3D2013%26volume%3D6%26spage%3D896%26epage%3D904%26doi%3D10.1242%2Fdmm.012054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Vincent, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loria, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pregel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitching, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nocka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyonnas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steppan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peakman, M. C.</span><span> </span><span class="NLM_article-title">Developing predictive assays: The phenotypic screening "rule of 3"</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">293ps15</span><span class="refDoi"> DOI: 10.1126/scitranslmed.aab1201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1126%2Fscitranslmed.aab1201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=26109101" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=293ps15&author=F.+Vincentauthor=P.+Loriaauthor=M.+Pregelauthor=R.+Stantonauthor=L.+Kitchingauthor=K.+Nockaauthor=R.+Doyonnasauthor=C.+Steppanauthor=A.+Gilbertauthor=T.+Schroeterauthor=M.+C.+Peakman&title=Developing+predictive+assays%3A+The+phenotypic+screening+%22rule+of+3%22&doi=10.1126%2Fscitranslmed.aab1201"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aab1201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aab1201%26sid%3Dliteratum%253Aachs%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DLoria%26aufirst%3DP.%26aulast%3DPregel%26aufirst%3DM.%26aulast%3DStanton%26aufirst%3DR.%26aulast%3DKitching%26aufirst%3DL.%26aulast%3DNocka%26aufirst%3DK.%26aulast%3DDoyonnas%26aufirst%3DR.%26aulast%3DSteppan%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DA.%26aulast%3DSchroeter%26aufirst%3DT.%26aulast%3DPeakman%26aufirst%3DM.%2BC.%26atitle%3DDeveloping%2520predictive%2520assays%253A%2520The%2520phenotypic%2520screening%2520%2522rule%2520of%25203%2522%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D293ps15%26doi%3D10.1126%2Fscitranslmed.aab1201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Hynds, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giangreco, A.</span><span> </span><span class="NLM_article-title">Concise review: the relevance of human stem cell-derived organoid models for epithelial translational medicine</span> <span class="citation_source-journal">Stem Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span><span class="refDoi"> DOI: 10.1002/stem.1290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1002%2Fstem.1290" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=417-422&author=R.+E.+Hyndsauthor=A.+Giangreco&title=Concise+review%3A+the+relevance+of+human+stem+cell-derived+organoid+models+for+epithelial+translational+medicine&doi=10.1002%2Fstem.1290"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1002%2Fstem.1290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fstem.1290%26sid%3Dliteratum%253Aachs%26aulast%3DHynds%26aufirst%3DR.%2BE.%26aulast%3DGiangreco%26aufirst%3DA.%26atitle%3DConcise%2520review%253A%2520the%2520relevance%2520of%2520human%2520stem%2520cell-derived%2520organoid%2520models%2520for%2520epithelial%2520translational%2520medicine%26jtitle%3DStem%2520Cells%26date%3D2013%26volume%3D31%26spage%3D417%26epage%3D422%26doi%3D10.1002%2Fstem.1290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Mathur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loskill, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huebsch, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandegar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, K. E.</span><span> </span><span class="NLM_article-title">Human iPSC-based cardiac microphysiological system for drug screening applications</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">8883</span><span class="refDoi"> DOI: 10.1038/srep08883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fsrep08883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=25748532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKhur%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=8883&author=A.+Mathurauthor=P.+Loskillauthor=K.+Shaoauthor=N.+Huebschauthor=S.+Hongauthor=S.+G.+Marcusauthor=N.+Marksauthor=M.+Mandegarauthor=B.+R.+Conklinauthor=L.+P.+Leeauthor=K.+E.+Healy&title=Human+iPSC-based+cardiac+microphysiological+system+for+drug+screening+applications&doi=10.1038%2Fsrep08883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications</span></div><div class="casAuthors">Mathur, Anurag; Loskill, Peter; Shao, Kaifeng; Huebsch, Nathaniel; Hong, Soon Gweon; Marcus, Sivan G.; Marks, Natalie; Mandegar, Mohammad; Conklin, Bruce R.; Lee, Luke P.; Healy, Kevin E.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8883</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drug discovery and development are hampered by high failure rates attributed to the reliance on non-human animal models employed during safety and efficacy testing.  A fundamental problem in this inefficient process is that non-human animal models cannot adequately represent human biol.  Thus, there is an urgent need for high-content in vitro systems that can better predict drug-induced toxicity.  Systems that predict cardiotoxicity are of uppermost significance, as approx. one third of safety-based pharmaceutical withdrawals are due to cardiotoxicty.  Here, we present a cardiac microphysiol. system (MPS) with the attributes required for an ideal in vitro system to predict cardiotoxicity: i) cells with a human genetic background; ii) physiol. relevant tissue structure (e.g. aligned cells); iii) computationally predictable perfusion mimicking human vasculature; and, iv) multiple modes of anal. (e.g. biol., electrophysiol., and physiol.).  Our MPS is able to keep human induced pluripotent stem cell derived cardiac tissue viable and functional over multiple weeks.  Pharmacol. studies using the cardiac MPS show half maximal inhibitory/effective concn. values (IC50/EC50) that are more consistent with the data on tissue scale refs. compared to cellular scale studies.  We anticipate the widespread adoption of MPSs for drug screening and disease modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCeMW615OeRrVg90H21EOLACvtfcHk0lg36lHUtpp_-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKhur%252FE&md5=3ad2b2791b5f84e98a7eeba633376507</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1038%2Fsrep08883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep08883%26sid%3Dliteratum%253Aachs%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DLoskill%26aufirst%3DP.%26aulast%3DShao%26aufirst%3DK.%26aulast%3DHuebsch%26aufirst%3DN.%26aulast%3DHong%26aufirst%3DS.%26aulast%3DMarcus%26aufirst%3DS.%2BG.%26aulast%3DMarks%26aufirst%3DN.%26aulast%3DMandegar%26aufirst%3DM.%26aulast%3DConklin%26aufirst%3DB.%2BR.%26aulast%3DLee%26aufirst%3DL.%2BP.%26aulast%3DHealy%26aufirst%3DK.%2BE.%26atitle%3DHuman%2520iPSC-based%2520cardiac%2520microphysiological%2520system%2520for%2520drug%2520screening%2520applications%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D8883%26doi%3D10.1038%2Fsrep08883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Lancaster, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bicknell, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurles, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homfray, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penninger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoblich, J. A.</span><span> </span><span class="NLM_article-title">Cerebral organoids model human brain development and microcephaly</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">501</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span><span class="refDoi"> DOI: 10.1038/nature12517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature12517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=23995685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlCntb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=501&publication_year=2013&pages=373-379&author=M.+A.+Lancasterauthor=M.+Rennerauthor=C.+A.+Martinauthor=D.+Wenzelauthor=L.+S.+Bicknellauthor=M.+E.+Hurlesauthor=T.+Homfrayauthor=J.+M.+Penningerauthor=A.+P.+Jacksonauthor=J.+A.+Knoblich&title=Cerebral+organoids+model+human+brain+development+and+microcephaly&doi=10.1038%2Fnature12517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebral organoids model human brain development and microcephaly</span></div><div class="casAuthors">Lancaster, Madeline A.; Renner, Magdalena; Martin, Carol-Anne; Wenzel, Daniel; Bicknell, Louise S.; Hurles, Matthew E.; Homfray, Tessa; Penninger, Josef M.; Jackson, Andrew P.; Knoblich, Juergen A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">501</span>
        (<span class="NLM_cas:issue">7467</span>),
    <span class="NLM_cas:pages">373-379</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The complexity of the human brain has made it difficult to study many brain disorders in model organisms, highlighting the need for an in vitro model of human brain development.  Here we have developed a human pluripotent stem cell-derived three-dimensional organoid culture system, termed cerebral organoids, that develop various discrete, although interdependent, brain regions.  These include a cerebral cortex contg. progenitor populations that organize and produce mature cortical neuron subtypes.  Furthermore, cerebral organoids are shown to recapitulate features of human cortical development, namely characteristic progenitor zone organization with abundant outer radial glial stem cells.  Finally, we use RNA interference and patient-specific induced pluripotent stem cells to model microcephaly, a disorder that has been difficult to recapitulate in mice.  We demonstrate premature neuronal differentiation in patient organoids, a defect that could help to explain the disease phenotype.  Together, these data show that three-dimensional organoids can recapitulate development and disease even in this most complex human tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1ooY8YMg5k7Vg90H21EOLACvtfcHk0li0tIoq52gF7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlCntb3F&md5=96195248e51aa62a5a5d761aa56814a1</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1038%2Fnature12517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12517%26sid%3Dliteratum%253Aachs%26aulast%3DLancaster%26aufirst%3DM.%2BA.%26aulast%3DRenner%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DC.%2BA.%26aulast%3DWenzel%26aufirst%3DD.%26aulast%3DBicknell%26aufirst%3DL.%2BS.%26aulast%3DHurles%26aufirst%3DM.%2BE.%26aulast%3DHomfray%26aufirst%3DT.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26aulast%3DJackson%26aufirst%3DA.%2BP.%26aulast%3DKnoblich%26aufirst%3DJ.%2BA.%26atitle%3DCerebral%2520organoids%2520model%2520human%2520brain%2520development%2520and%2520microcephaly%26jtitle%3DNature%26date%3D2013%26volume%3D501%26spage%3D373%26epage%3D379%26doi%3D10.1038%2Fnature12517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Choi, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebisch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sliwinski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Avanzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asselin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muffat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klee, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainger, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovacs, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D. Y.</span><span> </span><span class="NLM_article-title">A three-dimensional human neural cell culture model of Alzheimer’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">515</span><span class="NLM_x">, </span> <span class="NLM_fpage">274</span><span class="NLM_x">–</span> <span class="NLM_lpage">278</span><span class="refDoi"> DOI: 10.1038/nature13800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnature13800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=25307057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVemtr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=515&publication_year=2014&pages=274-278&author=S.+H.+Choiauthor=Y.+H.+Kimauthor=M.+Hebischauthor=C.+Sliwinskiauthor=S.+Leeauthor=C.+D%E2%80%99Avanzoauthor=H.+Chenauthor=B.+Hooliauthor=C.+Asselinauthor=J.+Muffatauthor=J.+B.+Kleeauthor=C.+Zhangauthor=B.+J.+Waingerauthor=M.+Peitzauthor=D.+M.+Kovacsauthor=C.+J.+Woolfauthor=S.+L.+Wagnerauthor=R.+E.+Tanziauthor=D.+Y.+Kim&title=A+three-dimensional+human+neural+cell+culture+model+of+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnature13800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">A three-dimensional human neural cell culture model of Alzheimer's disease</span></div><div class="casAuthors">Choi, Se Hoon; Kim, Young Hye; Hebisch, Matthias; Sliwinski, Christopher; Lee, Seungkyu; D'Avanzo, Carla; Chen, Hechao; Hooli, Basavaraj; Asselin, Caroline; Muffat, Julien; Klee, Justin B.; Zhang, Can; Wainger, Brian J.; Peitz, Michael; Kovacs, Dora M.; Woolf, Clifford J.; Wagner, Steven L.; Tanzi, Rudolph E.; Kim, Doo Yeon</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">515</span>
        (<span class="NLM_cas:issue">7526</span>),
    <span class="NLM_cas:pages">274-278</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer's disease is the most common form of dementia, characterized by two pathol. hallmarks: amyloid-β plaques and neurofibrillary tangles.  The amyloid hypothesis of Alzheimer's disease posits that the excessive accumulation of amyloid-β peptide leads to neurofibrillary tangles composed of aggregated hyperphosphorylated tau.  However, to date, no single disease model has serially linked these two pathol. events using human neuronal cells.  Mouse models with familial Alzheimer's disease (FAD) mutations exhibit amyloid-β-induced synaptic and memory deficits but they do not fully recapitulate other key pathol. events of Alzheimer's disease, including distinct neurofibrillary tangle pathol.  Human neurons derived from Alzheimer's disease patients have shown elevated levels of toxic amyloid-β species and phosphorylated tau but did not demonstrate amyloid-β plaques or neurofibrillary tangles.  Here we report that FAD mutations in β-amyloid precursor protein and presenilin 1 are able to induce robust extracellular deposition of amyloid-β, including amyloid-β plaques, in a human neural stem-cell-derived three-dimensional (3D) culture system.  More importantly, the 3D-differentiated neuronal cells expressing FAD mutations exhibited high levels of detergent-resistant, silver-pos. aggregates of phosphorylated tau in the soma and neurites, as well as filamentous tau, as detected by immunoelectron microscopy.  Inhibition of amyloid-β generation with β- or γ-secretase inhibitors not only decreased amyloid-β pathol., but also attenuated tauopathy.  We also found that glycogen synthase kinase 3 (GSK3) regulated amyloid-β-mediated tau phosphorylation.  We have successfully recapitulated amyloid-β and tau pathol. in a single 3D human neural cell culture system.  Our unique strategy for recapitulating Alzheimer's disease pathol. in a 3D neural cell culture model should also serve to facilitate the development of more precise human neural cell models of other neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3vp1KMszwpLVg90H21EOLACvtfcHk0li0tIoq52gF7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVemtr3L&md5=491938dac75824c5d642891c660a8885</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1038%2Fnature13800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13800%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DHebisch%26aufirst%3DM.%26aulast%3DSliwinski%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DD%25E2%2580%2599Avanzo%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DHooli%26aufirst%3DB.%26aulast%3DAsselin%26aufirst%3DC.%26aulast%3DMuffat%26aufirst%3DJ.%26aulast%3DKlee%26aufirst%3DJ.%2BB.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWainger%26aufirst%3DB.%2BJ.%26aulast%3DPeitz%26aufirst%3DM.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26aulast%3DWagner%26aufirst%3DS.%2BL.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DKim%26aufirst%3DD.%2BY.%26atitle%3DA%2520three-dimensional%2520human%2520neural%2520cell%2520culture%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2014%26volume%3D515%26spage%3D274%26epage%3D278%26doi%3D10.1038%2Fnature13800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Matsusaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akashi, M.</span><span> </span><span class="NLM_article-title">Three-dimensional cell culture technique and pathophysiology</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span><span class="refDoi"> DOI: 10.1016/j.addr.2014.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1016%2Fj.addr.2014.01.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=95-103&author=M.+Matsusakiauthor=C.+P.+Caseauthor=M.+Akashi&title=Three-dimensional+cell+culture+technique+and+pathophysiology&doi=10.1016%2Fj.addr.2014.01.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2014.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2014.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DMatsusaki%26aufirst%3DM.%26aulast%3DCase%26aufirst%3DC.%2BP.%26aulast%3DAkashi%26aufirst%3DM.%26atitle%3DThree-dimensional%2520cell%2520culture%2520technique%2520and%2520pathophysiology%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2014%26volume%3D74%26spage%3D95%26epage%3D103%26doi%3D10.1016%2Fj.addr.2014.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Wagner, B. K.; Tolliday, N. J.; Clemons, P. A.</span>, Eds.  <span class="citation_source-book">Cell-Based Assays for High-Throughput Screening: Methods and Protocols</span>; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=B.+K.+Wagner&author=N.+J.+Tolliday&author=P.+A.+Clemons&title=Cell-Based+Assays+for+High-Throughput+Screening%3A+Methods+and+Protocols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DB.%2BK.%26btitle%3DCell-Based%2520Assays%2520for%2520High-Throughput%2520Screening%253A%2520Methods%2520and%2520Protocols%26pub%3DHumana%2520Press%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Harrison, C.</span><span> </span><span class="NLM_article-title">Phenotypic screening: A more rapid route to target deconvolution</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span><span class="refDoi"> DOI: 10.1038/nrd4243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;key=10.1038%2Fnrd4243" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=102-103&author=C.+Harrison&title=Phenotypic+screening%3A+A+more+rapid+route+to+target+deconvolution&doi=10.1038%2Fnrd4243"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1038%2Fnrd4243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4243%26sid%3Dliteratum%253Aachs%26aulast%3DHarrison%26aufirst%3DC.%26atitle%3DPhenotypic%2520screening%253A%2520A%2520more%2520rapid%2520route%2520to%2520target%2520deconvolution%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D102%26epage%3D103%26doi%3D10.1038%2Fnrd4243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00789&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-1%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00789%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00789" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                764KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679944c1a886238c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
